cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
LIHC	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.35	4.47	1.04E-5	Crohn's disease	
LIHC	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.56	7.93	3.08E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs10005733	chr4:292001	ZNF718	chr4:53272-156488:+	0.27	5.1	5.59E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs1001530	chr5:176985515	DOK3	chr5:176928915-176937427:-	0.21	3.84	0.000145	Alzheimer disease and age of onset	
LIHC	cis	1	rs10021364	chr4:310691	ZNF718	chr4:53272-156488:+	-0.34	-5.26	2.57E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs1002675	chr3:38445226	XYLB	chr3:38388251-38456467:+	0.27	5.25	2.71E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs1002676	chr3:38444932	XYLB	chr3:38388251-38456467:+	-0.26	-5.05	7.05E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs10027325	chr4:282608	ZNF718	chr4:53272-156488:+	0.29	5.22	3.09E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs10030019	chr4:106998448	TBCK	chr4:106967233-107237861:-	0.21	3.86	0.000136	Airflow obstruction	
LIHC	cis	1	rs10037055	chr5:176691279	PRELID1	chr5:176730835-176733949:+	-0.23	-5.08	6.11E-7	Migraine without aura	
LIHC	cis	1	rs10041072	chr5:150259642	LOC134466	chr5:150310000-150326146:-	0.34	4.49	9.72E-6	Crohn's disease	
LIHC	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.7	12.63	2.69E-30	Type 2 diabetes	
LIHC	cis	1	rs10051804	chr5:150226424	LOC134466	chr5:150310000-150326146:-	0.32	4.13	4.51E-5	Crohn's disease	
LIHC	cis	1	rs10051924	chr5:150226639	LOC134466	chr5:150310000-150326146:-	0.32	4.13	4.51E-5	Crohn's disease	
LIHC	cis	1	rs1005224	chr14:76173860	TTLL5	chr14:76127621-76421421:+	0.21	4.11	4.85E-5	Large artery stroke	
LIHC	cis	1	rs1005225	chr12:114545205	IQCD	chr12:113633248-113658880:-	0.31	3.83	0.000152	Visceral fat	
LIHC	cis	1	rs10052606	chr5:150272217	LOC134466	chr5:150310000-150326146:-	0.34	4.53	8.01E-6	Crohn's disease	
LIHC	cis	1	rs10053750	chr5:150270051	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs10057988	chr5:150272062	LOC134466	chr5:150310000-150326146:-	0.34	4.53	8.01E-6	Crohn's disease	
LIHC	cis	1	rs10058821	chr5:150226385	LOC134466	chr5:150310000-150326146:-	0.33	4.2	3.38E-5	Crohn's disease	
LIHC	cis	1	rs10058943	chr5:150226586	LOC134466	chr5:150310000-150326146:-	0.32	4.08	5.72E-5	Crohn's disease	
LIHC	cis	1	rs10061105	chr5:150255185	LOC134466	chr5:150310000-150326146:-	0.33	4.36	1.73E-5	Crohn's disease	
LIHC	cis	1	rs10065172	chr5:150227998	LOC134466	chr5:150310000-150326146:-	0.33	4.3	2.24E-5	Crohn's disease	
LIHC	cis	1	rs10078968	chr5:150244273	LOC134466	chr5:150310000-150326146:-	0.32	4.22	3.16E-5	Crohn's disease	
LIHC	cis	1	rs10082867	chr12:123796997	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.47E-5	HDL cholesterol	
LIHC	cis	1	rs1008435	chr10:89754445	FAM35A	chr10:88854953-88951220:+	-0.26	-3.96	9.16E-5	Type 2 diabetes	
LIHC	cis	1	rs10088139	chr8:27740661	PNOC	chr8:28174649-28200866:+	0.17	4.19	3.6E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
LIHC	cis	1	rs10088835	chr8:27740523	PNOC	chr8:28174649-28200866:+	0.17	4.19	3.6E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
LIHC	cis	1	rs10092003	chr8:96036422	C8orf38	chr8:95908040-96088396:+	-0.3	-4.1	5.12E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs10096455	chr8:96041250	C8orf38	chr8:95908040-96088396:+	-0.27	-3.87	0.000131	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs10098197	chr8:96042890	C8orf38	chr8:95908040-96088396:+	-0.27	-3.87	0.000131	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs10103507	chr8:27740693	PNOC	chr8:28174649-28200866:+	0.17	4.19	3.6E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
LIHC	cis	1	rs1010447	chr1:11269796	KIAA2013	chr1:11980124-11986480:-	0.22	3.85	0.000144	Body mass index	
LIHC	cis	1	rs10106491	chr8:96038959	C8orf38	chr8:95908040-96088396:+	-0.3	-4.22	3.08E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs10112230	chr8:96038072	C8orf38	chr8:95908040-96088396:+	-0.31	-4.37	1.63E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs10115492	chr9:99550737	FAM22G	chr9:99690592-99704572:+	0.66	8.68	1.67E-16	Height	
LIHC	cis	1	rs10116439	chr9:99552105	FAM22G	chr9:99690592-99704572:+	0.66	8.59	3.17E-16	Height	
LIHC	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.26	-3.95	9.63E-5	Rheumatoid arthritis	
LIHC	cis	1	rs10117162	chr9:99603996	FAM22G	chr9:99690592-99704572:+	0.7	9	1.53E-17	Height	
LIHC	cis	1	rs10117921	chr9:99550434	FAM22G	chr9:99690592-99704572:+	0.66	8.63	2.37E-16	Height	
LIHC	cis	1	rs10117923	chr9:99550447	FAM22G	chr9:99690592-99704572:+	0.66	8.68	1.67E-16	Height	
LIHC	cis	1	rs10118617	chr9:99550469	FAM22G	chr9:99690592-99704572:+	0.58	7.63	2.31E-13	Height	
LIHC	cis	1	rs10119556	chr9:99551986	FAM22G	chr9:99690592-99704572:+	0.67	8.84	4.88E-17	Height	
LIHC	cis	1	rs10120515	chr9:99547165	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs10122464	chr9:99552321	FAM22G	chr9:99690592-99704572:+	0.68	7.44	7.91E-13	Height	
LIHC	cis	1	rs10124033	chr9:99614104	FAM22G	chr9:99690592-99704572:+	-0.71	-9.34	1.21E-18	Height	
LIHC	cis	1	rs10124911	chr9:99567384	FAM22G	chr9:99690592-99704572:+	-0.61	-6.73	6.92E-11	Height	
LIHC	cis	1	rs10127888	chr1:120498250	NOTCH2	chr1:120454178-120612276:-	-0.33	-3.82	0.000157	Crohn's disease	
LIHC	cis	1	rs10128711	chr11:18632984	SPTY2D1	chr11:18627949-18656020:-	-0.27	-5.64	3.57E-8	Cholesterol, total	
LIHC	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.31	-5.34	1.73E-7	Homocysteine levels	
LIHC	cis	1	rs10162376	chr14:81030493	C14orf145	chr14:80943332-81425828:-	0.43	4.43	1.28E-5	Mild influenza (H1N1) infection	
LIHC	cis	1	rs10162376	chr14:81030493	SEL1L	chr14:81939240-82000205:-	0.5	4.66	4.49E-6	Mild influenza (H1N1) infection	
LIHC	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs1017302	chr12:9367402	LOC642846	chr12:9436253-9466684:+	0.28	3.95	9.44E-5	Non-alcoholic fatty liver disease histology (AST)	
LIHC	cis	1	rs10173181	chr2:17780733	GEN1	chr2:17935162-17966632:+	0.45	5.24	2.81E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.53	9.61	1.6E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs10186758	chr2:104030640	IL18RAP	chr2:103035254-103069022:+	-0.28	-4.17	3.8E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs10193218	chr2:104032471	IL18RAP	chr2:103035254-103069022:+	-0.3	-4.29	2.3E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs10210727	chr2:104030463	IL18RAP	chr2:103035254-103069022:+	-0.3	-4.29	2.3E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	0.57	7.83	6.25E-14	Diastolic blood pressure	
LIHC	cis	1	rs10218458	chr1:107571327	PRMT6	chr1:107599267-107601907:+	0.27	3.84	0.000148	AIDS	
LIHC	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.69	9.75	5.38E-20	Coronary heart disease	
LIHC	cis	1	rs10220332	chr14:24937479	SDR39U1	chr14:24908974-24912064:-	-0.5	-5.13	4.95E-7	Smooth-surface caries	
LIHC	cis	1	rs10229552	chr7:99234899	CYP3A5	chr7:99245818-99332821:-	0.98	16.54	1.24E-45	Blood metabolite levels	
LIHC	cis	1	rs10229552	chr7:99234899	ZKSCAN5	chr7:99102273-99131444:+	0.34	3.95	9.38E-5	Blood metabolite levels	
LIHC	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.4	5.87	1.01E-8	Paget's disease	
LIHC	cis	1	rs10234309	chr7:135311167	SLC13A4	chr7:135365993-135412933:-	-0.46	-7.1	7.26E-12	Paget's disease	
LIHC	cis	1	rs1023586	chr14:81462283	TSHR	chr14:81421869-81612646:+	-0.23	-4.14	4.41E-5	Graves' disease	
LIHC	cis	1	rs10242455	chr7:99240179	CYP3A5	chr7:99245818-99332821:-	-0.93	-16.22	2.4E-44	Blood metabolite levels	
LIHC	cis	1	rs10247526	chr7:65780696	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.19	3.62E-5	Diabetic kidney disease	
LIHC	cis	1	rs1025646	chr3:41754422	ULK4	chr3:41288091-42003660:-	0.6	7.98	2.13E-14	Diastolic blood pressure	
LIHC	cis	1	rs1028449	chr14:35512995	PPP2R3C	chr14:35554679-35591679:-	0.37	4.96	1.11E-6	Atopic dermatitis	
LIHC	cis	1	rs1030420	chr8:67360725	ADHFE1	chr8:67344718-67381042:+	-0.23	-3.82	0.000159	Blood metabolite levels	
LIHC	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.56	-8.29	2.56E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1033299	chr2:17774153	GEN1	chr2:17935162-17966632:+	0.41	5.06	6.9E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs1033301	chr2:17773998	GEN1	chr2:17935162-17966632:+	0.41	5.06	6.9E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs1033667	chr22:29130300	CHEK2	chr22:29083731-29137822:-	0.48	7.23	3.09E-12	Esophageal cancer and gastric cancer	
LIHC	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.56	-8.4	1.23E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1039664	chr7:65449716	CCT6P1	chr7:65216092-65228661:+	0.36	4.92	1.33E-6	Diabetic kidney disease	
LIHC	cis	1	rs10400248	chr11:247029	PSMD13	chr11:236808-252984:+	-0.23	-4.02	7.15E-5	Menarche (age at onset)	
LIHC	cis	1	rs10402468	chr19:17384003	ANKLE1	chr19:17392454-17398454:+	0.4	3.98	8.49E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs1040316	chr10:89757173	FAM35A	chr10:88854953-88951220:+	-0.27	-4.06	6.0E-5	Type 2 diabetes	
LIHC	cis	1	rs1040317	chr10:89762464	FAM35A	chr10:88854953-88951220:+	-0.28	-4.12	4.84E-5	Type 2 diabetes	
LIHC	cis	1	rs10404486	chr19:53284135	ZNF600	chr19:53268750-53290034:-	0.35	3.86	0.000134	Phospholipid levels (plasma)	
LIHC	cis	1	rs10413237	chr19:18548249	ISYNA1	chr19:18545625-18548943:-	0.18	3.87	0.000129	Breast cancer	
LIHC	cis	1	rs10415145	chr19:32841053	DPY19L3	chr19:32896677-32975236:+	-0.2	-4.03	6.74E-5	Bipolar disorder	
LIHC	cis	1	rs10416654	chr19:17385176	ANKLE1	chr19:17392454-17398454:+	0.39	3.94	9.85E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs10418154	chr19:17386006	ANKLE1	chr19:17392454-17398454:+	0.39	3.94	9.85E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs10418362	chr19:17386107	ANKLE1	chr19:17392454-17398454:+	0.39	3.94	9.95E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs10425939	chr19:17397244	ANKLE1	chr19:17392454-17398454:+	0.43	3.96	9.09E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.59	-11.5	3.9E-26	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs10427083	chr19:18550276	ISYNA1	chr19:18545625-18548943:-	0.17	3.83	0.000152	Breast cancer	
LIHC	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.4	6.28	1.04E-9	Multiple sclerosis	
LIHC	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.38	-6.57	1.82E-10	Multiple sclerosis	
LIHC	cis	1	rs10431505	chr12:58178589	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-4.71	3.57E-6	Multiple sclerosis	
LIHC	cis	1	rs10444439	chr12:123766437	ABCB9	chr12:123413540-123459752:-	0.36	4.69	3.86E-6	HDL cholesterol	
LIHC	cis	1	rs10445014	chr16:58160974	CX3CL1	chr16:57406414-57418954:+	-0.39	-4.12	4.75E-5	Telomere length	
LIHC	cis	1	rs1044595	chr1:180943529	STX6	chr1:180913175-180992046:-	-0.19	-4.42	1.35E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.3	-5.13	4.95E-7	Homocysteine levels	
LIHC	cis	1	rs10448080	chr8:28604791	C8orf80	chr8:27879483-27941388:-	0.19	4.13	4.62E-5	Height	
LIHC	cis	1	rs10448080	chr8:28604791	CCDC25	chr8:27590835-27630170:-	0.3	5.27	2.46E-7	Height	
LIHC	cis	1	rs10448080	chr8:28604791	ELP3	chr8:27947749-28048667:+	0.32	4.72	3.4E-6	Height	
LIHC	cis	1	rs10448080	chr8:28604791	ESCO2	chr8:27632058-27670141:+	0.21	5.24	2.83E-7	Height	
LIHC	cis	1	rs10448080	chr8:28604791	INTS9	chr8:28625180-28747698:-	0.31	5.17	3.93E-7	Height	
LIHC	cis	1	rs10448080	chr8:28604791	KIF13B	chr8:28924796-29120610:-	0.32	5.18	3.81E-7	Height	
LIHC	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.52	-9.14	5.46E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.59	-10.7	3.06E-23	Response to antipsychotic treatment	
LIHC	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.56	-9.93	1.32E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.52	-9.22	3.11E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs10456622	chr6:49396453	CENPQ	chr6:49431096-49460820:+	-0.2	-4.1	5.18E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.68	12.34	3.16E-29	Type 2 diabetes	
LIHC	cis	1	rs10463240	chr5:150256853	LOC134466	chr5:150310000-150326146:-	0.33	4.36	1.73E-5	Crohn's disease	
LIHC	cis	1	rs10463307	chr5:150254620	LOC134466	chr5:150310000-150326146:-	0.35	4.48	1.01E-5	Crohn's disease	
LIHC	cis	1	rs10463310	chr5:150260905	LOC134466	chr5:150310000-150326146:-	0.34	4.46	1.1E-5	Crohn's disease	
LIHC	cis	1	rs10467994	chr15:51008687	USP8	chr15:50716579-50793276:+	-0.21	-4.36	1.73E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.34	5.64	3.55E-8	Glycated hemoglobin levels	
LIHC	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.35	5.74	2.03E-8	Glycated hemoglobin levels	
LIHC	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.35	5.7	2.55E-8	Glycated hemoglobin levels	
LIHC	cis	1	rs10491438	chr5:109701604	MAN2A1	chr5:109025156-109203429:+	0.32	5.05	7.25E-7	Cardiac structure and function	
LIHC	cis	1	rs10491438	chr5:109701604	TMEM232	chr5:109624934-110062381:-	0.41	4.07	5.92E-5	Cardiac structure and function	
LIHC	cis	1	rs10496370	chr2:104017337	IL18RAP	chr2:103035254-103069022:+	-0.28	-4.25	2.81E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs10496372	chr2:104019740	IL18RAP	chr2:103035254-103069022:+	-0.29	-4.18	3.76E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.58	10.12	2.98E-21	Response to antipsychotic treatment	
LIHC	cis	1	rs10503998	chr8:36926949	ERLIN2	chr8:37594097-37615318:+	0.32	4.02	7.13E-5	Insulin resistance/response	
LIHC	cis	1	rs10503998	chr8:36926949	PROSC	chr8:37620101-37637285:+	0.37	4.51	9.1E-6	Insulin resistance/response	
LIHC	cis	1	rs10503998	chr8:36926949	RAB11FIP1	chr8:37716470-37757003:-	0.4	5.43	1.05E-7	Insulin resistance/response	
LIHC	cis	1	rs10503999	chr8:36958821	PROSC	chr8:37620101-37637285:+	0.32	3.93	0.000103	Insulin resistance/response	
LIHC	cis	1	rs10503999	chr8:36958821	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.9	1.47E-6	Insulin resistance/response	
LIHC	cis	1	rs10507233	chr12:109103684	SELPLG	chr12:109015682-109027670:-	0.1	3.84	0.000148	Low high density lipoprotein cholesterol levels	
LIHC	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.59	-8.02	1.72E-14	Diastolic blood pressure	
LIHC	cis	1	rs1056964	chr22:51017476	CPT1B	chr22:51007291-51017096:-	-0.31	-4.23	3.02E-5	Narcolepsy	
LIHC	cis	1	rs1072078	chr8:36963456	PROSC	chr8:37620101-37637285:+	0.32	3.91	0.000109	Insulin resistance/response	
LIHC	cis	1	rs1072078	chr8:36963456	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.86	1.82E-6	Insulin resistance/response	
LIHC	cis	1	rs10734765	chr12:9369385	LOC642846	chr12:9436253-9466684:+	0.28	3.95	9.44E-5	Non-alcoholic fatty liver disease histology (AST)	
LIHC	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.3	5.33	1.74E-7	Homocysteine levels	
LIHC	cis	1	rs1074263	chr5:42750751	CCDC152	chr5:42756920-42802539:+	0.19	4.07	5.87E-5	Height	
LIHC	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.39	5.96	6.41E-9	Multiple sclerosis	
LIHC	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.4	-6.78	5.29E-11	Multiple sclerosis	
LIHC	cis	1	rs10747783	chr12:58176614	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.87	1.73E-6	Multiple sclerosis	
LIHC	cis	1	rs10750173	chr11:120288368	TMEM136	chr11:120196016-120204388:+	0.25	4.45	1.17E-5	Intraocular pressure	
LIHC	cis	1	rs10750174	chr11:120292097	TMEM136	chr11:120196016-120204388:+	0.24	4.28	2.41E-5	Intraocular pressure	
LIHC	cis	1	rs10752615	chr1:156248609	BGLAP	chr1:156182784-156213112:+	0.21	4.24	2.91E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs10753232	chr1:180950126	STX6	chr1:180913175-180992046:-	0.19	4.36	1.76E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs10758161	chr9:32755028	APTX	chr9:32972609-33025110:-	-0.45	-5.27	2.39E-7	Immune response to anthrax vaccine	
LIHC	cis	1	rs10758161	chr9:32755028	NFX1	chr9:33290510-33371154:+	-0.43	-4.55	7.5E-6	Immune response to anthrax vaccine	
LIHC	cis	1	rs10758161	chr9:32755028	NOL6	chr9:33461352-33473941:-	-0.38	-3.99	8.1E-5	Immune response to anthrax vaccine	
LIHC	cis	1	rs10758161	chr9:32755028	SMU1	chr9:33041850-33076714:-	-0.46	-5.04	7.59E-7	Immune response to anthrax vaccine	
LIHC	cis	1	rs10759636	chr9:116018777	SLC31A1	chr9:115983808-116029215:+	0.18	4.02	7.07E-5	Hematology traits	
LIHC	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.25	-3.94	9.82E-5	Rheumatoid arthritis	
LIHC	cis	1	rs10760589	chr9:131906293	CRAT	chr9:131857075-131873070:-	0.23	4.18	3.74E-5	Blood metabolite ratios	
LIHC	cis	1	rs10761723	chr10:64955581	NRBF2	chr10:64893007-64914785:+	-0.25	-4.21	3.32E-5	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LIHC	cis	1	rs10761727	chr10:64995493	NRBF2	chr10:64893007-64914785:+	-0.25	-4.21	3.32E-5	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LIHC	cis	1	rs10771431	chr12:9380859	LOC642846	chr12:9436253-9466684:+	0.22	4.3	2.21E-5	Breast size	
LIHC	cis	1	rs10773003	chr12:123775127	ABCB9	chr12:123413540-123459752:-	-0.31	-3.99	8.07E-5	HDL cholesterol	
LIHC	cis	1	rs10773004	chr12:123788758	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.47E-5	HDL cholesterol	
LIHC	cis	1	rs10773005	chr12:123790007	ABCB9	chr12:123413540-123459752:-	0.31	3.97	8.6E-5	HDL cholesterol	
LIHC	cis	1	rs10773006	chr12:123790051	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.47E-5	HDL cholesterol	
LIHC	cis	1	rs10783445	chr12:51879826	KRT80	chr12:52562781-52585784:-	-0.39	-3.87	0.00013	White matter lesion progression;White matter lesion progression (adjusted for white matter lesion burden at baseline)	
LIHC	cis	1	rs10783594	chr12:54067135	ATP5G2	chr12:54058945-54070512:-	0.17	4.05	6.34E-5	Height	
LIHC	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.4	6.28	1.04E-9	Multiple sclerosis	
LIHC	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.38	-6.57	1.82E-10	Multiple sclerosis	
LIHC	cis	1	rs10783847	chr12:58196447	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-4.71	3.57E-6	Multiple sclerosis	
LIHC	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.4	6.28	1.04E-9	Multiple sclerosis	
LIHC	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.38	-6.57	1.82E-10	Multiple sclerosis	
LIHC	cis	1	rs10783848	chr12:58196528	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-4.71	3.57E-6	Multiple sclerosis	
LIHC	cis	1	rs10785814	chr1:107610540	PRMT6	chr1:107599267-107601907:+	0.29	3.94	0.0001	AIDS	
LIHC	cis	1	rs10788574	chr10:89768488	FAM35A	chr10:88854953-88951220:+	-0.26	-3.97	8.74E-5	Type 2 diabetes	
LIHC	cis	1	rs1078968	chr3:53123486	RFT1	chr3:53122503-53164470:-	-0.37	-6	5.12E-9	Height	
LIHC	cis	1	rs10789823	chr11:111172403	C11orf92	chr11:111164171-111175770:-	-0.32	-5.02	8.38E-7	Colorectal cancer	
LIHC	cis	1	rs10790380	chr11:120233158	TMEM136	chr11:120196016-120204388:+	0.25	4.47	1.05E-5	Intraocular pressure	
LIHC	cis	1	rs10790382	chr11:120288372	TMEM136	chr11:120196016-120204388:+	0.25	4.4	1.43E-5	Intraocular pressure	
LIHC	cis	1	rs10790383	chr11:120344526	TMEM136	chr11:120196016-120204388:+	0.23	4.14	4.38E-5	Intraocular pressure	
LIHC	cis	1	rs10794302	chr11:234102	PSMD13	chr11:236808-252984:+	-0.23	-4.12	4.84E-5	Menarche (age at onset)	
LIHC	cis	1	rs10798686	chr1:179470357	C1orf125	chr1:179335107-179523868:+	0.35	3.84	0.000147	Multiple sclerosis (age of onset)	
LIHC	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.62	8.85	4.8E-17	Height	
LIHC	cis	1	rs10806701	chr6:159385223	RSPH3	chr6:159398268-159421198:-	0.27	3.9	0.000115	Bladder cancer (smoking interaction)	
LIHC	cis	1	rs10807701	chr7:65724686	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.17	3.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs10807702	chr7:65767843	CCT6P1	chr7:65216092-65228661:+	0.28	3.83	0.000151	Diabetic kidney disease	
LIHC	cis	1	rs10816533	chr9:99539138	FAM22G	chr9:99690592-99704572:+	-0.66	-8.66	1.91E-16	Height	
LIHC	cis	1	rs10822145	chr10:64934548	NRBF2	chr10:64893007-64914785:+	-0.23	-3.93	0.000101	Triglycerides	
LIHC	cis	1	rs10822149	chr10:64987412	NRBF2	chr10:64893007-64914785:+	-0.25	-4.21	3.32E-5	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LIHC	cis	1	rs10824114	chr10:75970503	CHCHD1	chr10:75541808-75543405:+	0.23	3.85	0.00014	Soluble interleukin-2 receptor subunit alpha	
LIHC	cis	1	rs10832956	chr11:18645668	SPTY2D1	chr11:18627949-18656020:-	-0.22	-4.65	4.82E-6	Cholesterol, total	
LIHC	cis	1	rs10832962	chr11:18656271	SPTY2D1	chr11:18627949-18656020:-	-0.23	-4.73	3.29E-6	Cholesterol, total	
LIHC	cis	1	rs10837697	chr11:5281018	HBG2	chr11:5269502-5667011:-	0.32	4.57	6.79E-6	Hemoglobin levels	
LIHC	cis	1	rs10838738	chr11:47663049	C1QTNF4	chr11:47611216-47615961:-	-0.57	-9.03	1.24E-17	Subjective well-being	
LIHC	cis	1	rs10838747	chr11:47716324	C1QTNF4	chr11:47611216-47615961:-	-0.55	-8.7	1.43E-16	Subjective well-being	
LIHC	cis	1	rs10838748	chr11:47716381	C1QTNF4	chr11:47611216-47615961:-	-0.55	-8.61	2.67E-16	Subjective well-being	
LIHC	cis	1	rs10838757	chr11:47763016	C1QTNF4	chr11:47611216-47615961:-	-0.55	-8.64	2.18E-16	Subjective well-being	
LIHC	cis	1	rs10842708	chr12:26474867	SSPN	chr12:26348269-26405853:+	0.18	4.1	5.2E-5	Waist-hip ratio;Renal cell carcinoma	
LIHC	cis	1	rs10846506	chr12:123777815	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.59E-5	HDL cholesterol	
LIHC	cis	1	rs10853057	chr17:62998023	AMZ2P1	chr17:62962668-62971703:-	0.44	4.13	4.55E-5	White matter microstructure (global fractional anisotropy)	
LIHC	cis	1	rs10857712	chr10:135225666	LOC619207	chr10:135267432-135337062:+	-0.29	-4.44	1.2E-5	Systemic lupus erythematosus	
LIHC	cis	1	rs10857712	chr10:135225666	MTG1	chr10:135207621-135234173:+	0.24	4.54	7.84E-6	Systemic lupus erythematosus	
LIHC	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.58	-7.67	1.75E-13	Diastolic blood pressure	
LIHC	cis	1	rs10867161	chr9:91806749	S1PR3	chr9:91606362-91619924:+	0.36	4.43	1.27E-5	Pelvic organ prolapse (moderate/severe)	
LIHC	cis	1	rs10876176	chr12:51811832	KRT80	chr12:52562781-52585784:-	-0.39	-3.84	0.000147	White matter lesion progression;White matter lesion progression (adjusted for white matter lesion burden at baseline)	
LIHC	cis	1	rs10876480	chr12:54066271	ATP5G2	chr12:54058945-54070512:-	0.16	4.05	6.25E-5	Height	
LIHC	cis	1	rs10876481	chr12:54066743	ATP5G2	chr12:54058945-54070512:-	0.16	4.05	6.25E-5	Height	
LIHC	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.37	5.48	8.42E-8	Multiple sclerosis	
LIHC	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.41	-6.9	2.53E-11	Multiple sclerosis	
LIHC	cis	1	rs10877012	chr12:58162085	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-4.44	1.24E-5	Multiple sclerosis	
LIHC	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.35	5.32	1.92E-7	Multiple sclerosis	
LIHC	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.38	-6.41	4.91E-10	Multiple sclerosis	
LIHC	cis	1	rs10877013	chr12:58165085	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-4.6	6.02E-6	Multiple sclerosis	
LIHC	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.37	5.68	2.87E-8	Multiple sclerosis	
LIHC	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.39	-6.73	7.2E-11	Multiple sclerosis	
LIHC	cis	1	rs10877014	chr12:58167661	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-4.59	6.29E-6	Multiple sclerosis	
LIHC	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.37	5.5	7.56E-8	Multiple sclerosis	
LIHC	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.41	-6.93	2.04E-11	Multiple sclerosis	
LIHC	cis	1	rs10877015	chr12:58167788	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-4.51	9.03E-6	Multiple sclerosis	
LIHC	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.38	-5.67	3.07E-8	Multiple sclerosis	
LIHC	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.41	6.85	3.47E-11	Multiple sclerosis	
LIHC	cis	1	rs10877019	chr12:58172929	XRCC6BP1	chr12:58335445-58351051:+	0.27	4.78	2.57E-6	Multiple sclerosis	
LIHC	cis	1	rs10882643	chr10:97375171	ALDH18A1	chr10:97365687-97416567:-	0.28	4.1	5.08E-5	Blood metabolite levels	
LIHC	cis	1	rs10882643	chr10:97375171	ENTPD1	chr10:97471536-97637022:+	0.2	3.93	0.000103	Blood metabolite levels	
LIHC	cis	1	rs10882644	chr10:97388579	ALDH18A1	chr10:97365687-97416567:-	0.29	4.36	1.69E-5	Blood metabolite levels	
LIHC	cis	1	rs10882644	chr10:97388579	ENTPD1	chr10:97471536-97637022:+	0.2	3.99	8.08E-5	Blood metabolite levels	
LIHC	cis	1	rs10887765	chr10:89754941	FAM35A	chr10:88854953-88951220:+	-0.26	-4.06	6.03E-5	Type 2 diabetes	
LIHC	cis	1	rs10887766	chr10:89755075	FAM35A	chr10:88854953-88951220:+	0.27	4.23	2.98E-5	Type 2 diabetes	
LIHC	cis	1	rs10887767	chr10:89755089	FAM35A	chr10:88854953-88951220:+	-0.26	-3.96	9.19E-5	Type 2 diabetes	
LIHC	cis	1	rs10887770	chr10:89760474	FAM35A	chr10:88854953-88951220:+	-0.27	-4.05	6.25E-5	Type 2 diabetes	
LIHC	cis	1	rs10887771	chr10:89760477	FAM35A	chr10:88854953-88951220:+	-0.28	-4.12	4.84E-5	Type 2 diabetes	
LIHC	cis	1	rs10887772	chr10:89761243	FAM35A	chr10:88854953-88951220:+	-0.28	-4.12	4.84E-5	Type 2 diabetes	
LIHC	cis	1	rs10887773	chr10:89765945	FAM35A	chr10:88854953-88951220:+	-0.28	-4.13	4.55E-5	Type 2 diabetes	
LIHC	cis	1	rs10887775	chr10:89766368	FAM35A	chr10:88854953-88951220:+	-0.28	-4.17	3.83E-5	Type 2 diabetes	
LIHC	cis	1	rs1088984	chr11:2377581	C11orf21	chr11:2317507-2323143:-	-0.19	-3.94	9.93E-5	Bacteremia	
LIHC	cis	1	rs1088985	chr11:2377852	C11orf21	chr11:2317507-2323143:-	-0.18	-3.92	0.000109	Bacteremia	
LIHC	cis	1	rs1088986	chr11:2377862	C11orf21	chr11:2317507-2323143:-	-0.19	-4.05	6.36E-5	Bacteremia	
LIHC	cis	1	rs1088987	chr11:2379196	C11orf21	chr11:2317507-2323143:-	-0.19	-4.02	7.08E-5	Bacteremia	
LIHC	cis	1	rs1088988	chr11:2380470	C11orf21	chr11:2317507-2323143:-	-0.18	-3.87	0.000132	Bacteremia	
LIHC	cis	1	rs10892566	chr11:120241923	TMEM136	chr11:120196016-120204388:+	0.25	4.42	1.35E-5	Intraocular pressure	
LIHC	cis	1	rs10892567	chr11:120244192	TMEM136	chr11:120196016-120204388:+	0.26	4.51	8.82E-6	Intraocular pressure	
LIHC	cis	1	rs10892574	chr11:120288944	TMEM136	chr11:120196016-120204388:+	0.25	4.42	1.33E-5	Intraocular pressure	
LIHC	cis	1	rs10892576	chr11:120294423	TMEM136	chr11:120196016-120204388:+	0.24	4.2	3.45E-5	Intraocular pressure	
LIHC	cis	1	rs10892578	chr11:120308290	TMEM136	chr11:120196016-120204388:+	0.23	4.05	6.25E-5	Intraocular pressure	
LIHC	cis	1	rs10892582	chr11:120347715	TMEM136	chr11:120196016-120204388:+	0.25	4.4	1.47E-5	Intraocular pressure	
LIHC	cis	1	rs10893380	chr11:125311674	STT3A	chr11:125462739-125491280:+	0.3	4.35	1.81E-5	Schizophrenia	
LIHC	cis	1	rs10896043	chr11:65543827	CTSW	chr11:65647284-65651212:+	0.24	4.04	6.48E-5	Systemic lupus erythematosus	
LIHC	cis	1	rs10902110	chr11:237648	PSMD13	chr11:236808-252984:+	-0.24	-4.19	3.5E-5	Menarche (age at onset)	
LIHC	cis	1	rs10902112	chr11:244106	PSMD13	chr11:236808-252984:+	-0.23	-4.06	6.02E-5	Menarche (age at onset)	
LIHC	cis	1	rs10902113	chr11:245523	PSMD13	chr11:236808-252984:+	-0.23	-4.06	6.02E-5	Menarche (age at onset)	
LIHC	cis	1	rs10902114	chr11:246234	PSMD13	chr11:236808-252984:+	-0.23	-4.1	5.09E-5	Menarche (age at onset)	
LIHC	cis	1	rs10908494	chr1:156263097	BGLAP	chr1:156182784-156213112:+	0.2	3.93	0.000101	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs10908495	chr1:156263940	BGLAP	chr1:156182784-156213112:+	0.2	3.92	0.000109	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs10908496	chr1:156264000	BGLAP	chr1:156182784-156213112:+	0.2	3.92	0.000107	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs10908498	chr1:156278175	BGLAP	chr1:156182784-156213112:+	0.2	3.87	0.000128	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs10908499	chr1:156279176	BGLAP	chr1:156182784-156213112:+	0.2	3.87	0.000128	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs10913582	chr1:171715585	VAMP4	chr1:171669298-171711214:-	0.24	4.04	6.59E-5	Hippocampal atrophy	
LIHC	cis	1	rs10916814	chr1:20892931	FAM43B	chr1:20878932-20881512:+	-0.21	-4.58	6.51E-6	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs10929965	chr2:160906931	LY75	chr2:160625141-160761262:-	-0.25	-5.56	5.33E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs10929966	chr2:160908341	LY75	chr2:160625141-160761262:-	0.25	5.54	6.04E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs10933518	chr2:241838091	C2orf54	chr2:241825466-241835573:-	0.67	11.19	5.18E-25	Urinary metabolites	
LIHC	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.63	-9.18	4.21E-18	Height	
LIHC	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.54	-9.77	4.67E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.56	-9.9	1.7E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.53	-9.54	2.79E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.51	-9	1.55E-17	Response to antipsychotic treatment	
LIHC	cis	1	rs10945682	chr6:161069941	LPA	chr6:160952516-161087407:-	-0.22	-4.38	1.59E-5	Lipoprotein (a) levels	
LIHC	cis	1	rs10950032	chr7:65738591	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.17	3.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs10951192	chr7:28161033	JAZF1	chr7:27870196-28220437:-	0.35	4.64	4.88E-6	Rheumatoid arthritis	
LIHC	cis	1	rs10957375	chr8:67355484	ADHFE1	chr8:67344718-67381042:+	0.26	4.15	4.22E-5	Blood metabolite levels	
LIHC	cis	1	rs10978963	chr9:99546081	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs10978968	chr9:99546449	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs10978970	chr9:99546458	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs10978971	chr9:99546485	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs10978973	chr9:99546586	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs10979353	chr9:99625525	FAM22G	chr9:99690592-99704572:+	0.93	9.58	1.99E-19	Height	
LIHC	cis	1	rs10979353	chr9:99625525	HIATL2	chr9:99695549-99775862:-	0.42	3.9	0.000116	Height	
LIHC	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.2	4.41	1.41E-5	Blood metabolite levels	
LIHC	cis	1	rs10988125	chr9:131572903	PKN3	chr9:131464802-131483198:+	-0.33	-5.07	6.62E-7	Blood metabolite levels	
LIHC	cis	1	rs10988223	chr9:131903021	CRAT	chr9:131857075-131873070:-	0.22	3.99	8.16E-5	Blood metabolite ratios	
LIHC	cis	1	rs10988224	chr9:131903334	CRAT	chr9:131857075-131873070:-	0.23	4.1	5.14E-5	Blood metabolite ratios	
LIHC	cis	1	rs10988232	chr9:131915348	CRAT	chr9:131857075-131873070:-	0.23	4.12	4.83E-5	Blood metabolite ratios	
LIHC	cis	1	rs11000019	chr10:73591530	DNAJB12	chr10:74092588-74114907:-	0.31	3.87	0.000131	Asthma (childhood onset)	
LIHC	cis	1	rs11000924	chr10:75972311	CHCHD1	chr10:75541808-75543405:+	0.23	3.85	0.00014	Soluble interleukin-2 receptor subunit alpha	
LIHC	cis	1	rs11000925	chr10:75972601	CHCHD1	chr10:75541808-75543405:+	0.23	3.85	0.00014	Soluble interleukin-2 receptor subunit alpha	
LIHC	cis	1	rs11024739	chr11:18645843	SPTY2D1	chr11:18627949-18656020:-	0.23	4.78	2.6E-6	Cholesterol, total	
LIHC	cis	1	rs11036474	chr11:5275178	HBG2	chr11:5269502-5667011:-	0.31	4.4	1.44E-5	Hemoglobin levels	
LIHC	cis	1	rs11039255	chr11:47495746	C1QTNF4	chr11:47611216-47615961:-	-0.55	-8.63	2.3E-16	Subjective well-being	
LIHC	cis	1	rs11039390	chr11:47796295	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.89	3.63E-17	Subjective well-being	
LIHC	cis	1	rs11039412	chr11:47841581	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.83	5.46E-17	Subjective well-being	
LIHC	cis	1	rs11039426	chr11:47863119	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.8	6.55E-17	Subjective well-being	
LIHC	cis	1	rs11046430	chr12:22566429	KIAA0528	chr12:22601526-22697452:-	0.39	4.04	6.47E-5	Coronary artery calcification	
LIHC	cis	1	rs11057223	chr12:123755055	ABCB9	chr12:123413540-123459752:-	0.33	4.25	2.72E-5	HDL cholesterol	
LIHC	cis	1	rs11057224	chr12:123755179	ABCB9	chr12:123413540-123459752:-	0.34	4.36	1.7E-5	HDL cholesterol	
LIHC	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.5	6.89	2.72E-11	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs11066962	chr12:114588144	IQCD	chr12:113633248-113658880:-	0.31	3.86	0.000135	Visceral fat	
LIHC	cis	1	rs11070798	chr15:50883263	USP8	chr15:50716579-50793276:+	-0.23	-4.67	4.25E-6	QT interval	
LIHC	cis	1	rs11070800	chr15:50907347	USP8	chr15:50716579-50793276:+	-0.22	-4.51	9.06E-6	QT interval	
LIHC	cis	1	rs11070805	chr15:50964192	USP8	chr15:50716579-50793276:+	-0.22	-4.4	1.46E-5	QT interval	
LIHC	cis	1	rs11070807	chr15:50974505	USP8	chr15:50716579-50793276:+	-0.22	-4.38	1.55E-5	QT interval	
LIHC	cis	1	rs11073619	chr15:85188839	WDR73	chr15:85186012-85197524:-	0.45	3.82	0.000159	Positive affect	
LIHC	cis	1	rs11079034	chr17:40288890	HSPB9	chr17:40274756-40275371:+	0.28	4.26	2.69E-5	Fibrinogen levels	
LIHC	cis	1	rs11080471	chr18:10932326	CHMP1B	chr18:11851389-11854447:+	0.2	3.81	0.000163	Major depressive disorder	
LIHC	cis	1	rs1109560	chr12:123757905	ABCB9	chr12:123413540-123459752:-	0.32	4.18	3.64E-5	HDL cholesterol	
LIHC	cis	1	rs11097912	chr4:107000462	TBCK	chr4:106967233-107237861:-	0.22	3.92	0.000105	Airflow obstruction	
LIHC	cis	1	rs11098499	chr4:120187611	FABP2	chr4:120238406-120243316:-	-0.22	-3.82	0.00016	Corneal astigmatism	
LIHC	cis	1	rs11098500	chr4:120219239	FABP2	chr4:120238406-120243316:-	-0.22	-3.94	9.81E-5	Corneal astigmatism	
LIHC	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.48	6.67	1.03E-10	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs1111863	chr6:109611206	CD164	chr6:109687718-109703762:-	0.26	5.08	6.26E-7	Red blood cell traits	
LIHC	cis	1	rs1111864	chr6:109611138	CD164	chr6:109687718-109703762:-	-0.27	-5.22	3.05E-7	Red blood cell traits	
LIHC	cis	1	rs1111865	chr6:109610863	CD164	chr6:109687718-109703762:-	0.24	4.69	4.01E-6	Red blood cell traits	
LIHC	cis	1	rs1111866	chr6:109610846	CD164	chr6:109687718-109703762:-	0.25	4.82	2.14E-6	Red blood cell traits	
LIHC	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.68	-10.56	9.06E-23	Renal function-related traits (BUN)	
LIHC	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.41	-6.44	4.1E-10	Renal function-related traits (BUN)	
LIHC	cis	1	rs11130214	chr3:49735746	GPX1	chr3:49394611-49395791:-	-0.21	-3.89	0.000121	Resting heart rate	
LIHC	cis	1	rs11130338	chr3:53120924	RFT1	chr3:53122503-53164470:-	-0.38	-6.1	2.82E-9	Height	
LIHC	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.82	-7.57	3.37E-13	Triptolide cytotoxicity	
LIHC	cis	1	rs11134654	chr5:170240423	RANBP17	chr5:170289022-170727018:+	0.48	3.88	0.000123	Smooth-surface caries	
LIHC	cis	1	rs11137528	chr9:91790626	S1PR3	chr9:91606362-91619924:+	0.41	4.94	1.23E-6	Pelvic organ prolapse (moderate/severe)	
LIHC	cis	1	rs11148252	chr13:53009048	VPS36	chr13:52986739-53024763:-	0.26	5.46	9.28E-8	Lewy body disease	
LIHC	cis	1	rs11156875	chr14:35619816	PPP2R3C	chr14:35554679-35591679:-	0.36	4.87	1.69E-6	Atopic dermatitis	
LIHC	cis	1	rs111596617	chr6:26191678	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.47	1.05E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.37	4.6	5.92E-6	Crohn's disease	
LIHC	cis	1	rs11167518	chr5:150258920	LOC134466	chr5:150310000-150326146:-	0.34	4.44	1.19E-5	Crohn's disease	
LIHC	cis	1	rs11167519	chr5:150265407	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs11167520	chr5:150265639	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs11167521	chr5:150271785	LOC134466	chr5:150310000-150326146:-	0.34	4.53	8.01E-6	Crohn's disease	
LIHC	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.37	4.74	3.13E-6	Crohn's disease	
LIHC	cis	1	rs111704178	chr10:75957251	CHCHD1	chr10:75541808-75543405:+	0.24	3.99	7.94E-5	Soluble interleukin-2 receptor subunit alpha	
LIHC	cis	1	rs11172254	chr12:57968738	XRCC6BP1	chr12:58335445-58351051:+	0.22	4.03	6.73E-5	Rheumatoid arthritis	
LIHC	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.4	6.1	2.79E-9	Multiple sclerosis	
LIHC	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.41	-6.92	2.26E-11	Multiple sclerosis	
LIHC	cis	1	rs11172333	chr12:58170335	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.81	2.3E-6	Multiple sclerosis	
LIHC	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.4	6.11	2.63E-9	Multiple sclerosis	
LIHC	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.41	-6.86	3.18E-11	Multiple sclerosis	
LIHC	cis	1	rs11172335	chr12:58175201	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.68	4.19E-6	Multiple sclerosis	
LIHC	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.4	6.11	2.73E-9	Multiple sclerosis	
LIHC	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.41	-6.88	2.92E-11	Multiple sclerosis	
LIHC	cis	1	rs11172342	chr12:58187758	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.7	3.84E-6	Multiple sclerosis	
LIHC	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.4	6.11	2.73E-9	Multiple sclerosis	
LIHC	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.41	-6.88	2.92E-11	Multiple sclerosis	
LIHC	cis	1	rs11172343	chr12:58188157	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.7	3.84E-6	Multiple sclerosis	
LIHC	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.4	6.28	1.04E-9	Multiple sclerosis	
LIHC	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.38	-6.57	1.82E-10	Multiple sclerosis	
LIHC	cis	1	rs11172344	chr12:58193448	XRCC6BP1	chr12:58335445-58351051:+	-0.26	-4.71	3.57E-6	Multiple sclerosis	
LIHC	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.37	5.54	5.93E-8	Multiple sclerosis	
LIHC	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.4	-6.82	4.21E-11	Multiple sclerosis	
LIHC	cis	1	rs11172349	chr12:58212528	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-5.08	6.32E-7	Multiple sclerosis	
LIHC	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.37	5.56	5.45E-8	Multiple sclerosis	
LIHC	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.4	-6.81	4.39E-11	Multiple sclerosis	
LIHC	cis	1	rs11172351	chr12:58213485	XRCC6BP1	chr12:58335445-58351051:+	-0.29	-5.08	6.14E-7	Multiple sclerosis	
LIHC	cis	1	rs11185057	chr1:107596964	PRMT6	chr1:107599267-107601907:+	0.29	4.05	6.36E-5	AIDS	
LIHC	cis	1	rs11185058	chr1:107603269	PRMT6	chr1:107599267-107601907:+	0.28	4.07	5.85E-5	AIDS	
LIHC	cis	1	rs11185780	chr10:91363624	FLJ37201	chr10:91451057-91457685:-	0.27	3.81	0.000162	Metabolic traits	
LIHC	cis	1	rs11188394	chr10:97365458	ENTPD1	chr10:97471536-97637022:+	0.22	4.28	2.38E-5	Blood metabolite levels	
LIHC	cis	1	rs11188396	chr10:97367510	ALDH18A1	chr10:97365687-97416567:-	0.29	4.22	3.17E-5	Blood metabolite levels	
LIHC	cis	1	rs11188396	chr10:97367510	ENTPD1	chr10:97471536-97637022:+	0.23	4.47	1.05E-5	Blood metabolite levels	
LIHC	cis	1	rs11188398	chr10:97369093	ALDH18A1	chr10:97365687-97416567:-	0.29	4.36	1.72E-5	Blood metabolite levels	
LIHC	cis	1	rs11188398	chr10:97369093	ENTPD1	chr10:97471536-97637022:+	0.22	4.34	1.86E-5	Blood metabolite levels	
LIHC	cis	1	rs11188400	chr10:97371327	ALDH18A1	chr10:97365687-97416567:-	0.29	4.31	2.14E-5	Blood metabolite levels	
LIHC	cis	1	rs11188400	chr10:97371327	ENTPD1	chr10:97471536-97637022:+	0.22	4.44	1.22E-5	Blood metabolite levels	
LIHC	cis	1	rs11188406	chr10:97390195	ALDH18A1	chr10:97365687-97416567:-	0.3	4.46	1.14E-5	Blood metabolite levels	
LIHC	cis	1	rs11188406	chr10:97390195	ENTPD1	chr10:97471536-97637022:+	0.2	3.98	8.3E-5	Blood metabolite levels	
LIHC	cis	1	rs11188407	chr10:97390533	ALDH18A1	chr10:97365687-97416567:-	0.3	4.46	1.14E-5	Blood metabolite levels	
LIHC	cis	1	rs11188407	chr10:97390533	ENTPD1	chr10:97471536-97637022:+	0.2	3.98	8.3E-5	Blood metabolite levels	
LIHC	cis	1	rs11188411	chr10:97397344	ALDH18A1	chr10:97365687-97416567:-	0.32	4.69	3.99E-6	Blood metabolite levels	
LIHC	cis	1	rs11188411	chr10:97397344	ENTPD1	chr10:97471536-97637022:+	0.21	4.07	5.93E-5	Blood metabolite levels	
LIHC	cis	1	rs11188417	chr10:97411680	ALDH18A1	chr10:97365687-97416567:-	-0.29	-4.22	3.08E-5	Blood metabolite levels	
LIHC	cis	1	rs11188417	chr10:97411680	ENTPD1	chr10:97471536-97637022:+	-0.23	-4.54	7.94E-6	Blood metabolite levels	
LIHC	cis	1	rs111901203	chr11:58297542	CNTF	chr11:58390146-58393203:+	0.37	4.64	4.96E-6	Lymphoma	
LIHC	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.29	-4.1	5.2E-5	Chronic obstructive pulmonary disease-related biomarkers	
LIHC	cis	1	rs11202614	chr10:89755643	FAM35A	chr10:88854953-88951220:+	-0.27	-4.05	6.45E-5	Type 2 diabetes	
LIHC	cis	1	rs11202627	chr10:89769340	ATAD1	chr10:89512875-89577917:-	-0.28	-3.82	0.000159	Type 2 diabetes	
LIHC	cis	1	rs11202627	chr10:89769340	FAM35A	chr10:88854953-88951220:+	-0.32	-4.84	1.96E-6	Type 2 diabetes	
LIHC	cis	1	rs1121090	chr4:17676437	LDB2	chr4:16503167-16900424:-	0.14	3.95	9.43E-5	Parasitemia in Tripanosoma cruzi seropositivity	
LIHC	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.31	-5.34	1.73E-7	Homocysteine levels	
LIHC	cis	1	rs11217841	chr11:120238721	TMEM136	chr11:120196016-120204388:+	0.25	4.33	1.97E-5	Intraocular pressure	
LIHC	cis	1	rs11217852	chr11:120261187	TMEM136	chr11:120196016-120204388:+	0.25	4.37	1.68E-5	Intraocular pressure	
LIHC	cis	1	rs1122326	chr17:40274873	HSPB9	chr17:40274756-40275371:+	0.32	4.51	8.78E-6	Fibrinogen levels	
LIHC	cis	1	rs11227284	chr11:65503224	CTSW	chr11:65647284-65651212:+	-0.28	-4.58	6.38E-6	Systemic lupus erythematosus	
LIHC	cis	1	rs11227288	chr11:65516588	CTSW	chr11:65647284-65651212:+	-0.25	-4.1	5.15E-5	Systemic lupus erythematosus	
LIHC	cis	1	rs11229535	chr11:58348386	CNTF	chr11:58390146-58393203:+	0.37	4.63	5.21E-6	Lymphoma	
LIHC	cis	1	rs11231757	chr11:64106317	COX8A	chr11:63742079-63744014:+	0.19	4	7.85E-5	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
LIHC	cis	1	rs112410718	chr14:24942556	SDR39U1	chr14:24908974-24912064:-	-0.5	-5.13	4.95E-7	Smooth-surface caries	
LIHC	cis	1	rs11242	chr3:53125922	RFT1	chr3:53122503-53164470:-	0.33	5.35	1.57E-7	Height	
LIHC	cis	1	rs11248009	chr4:220149	ZNF718	chr4:53272-156488:+	0.36	5.39	1.32E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11248013	chr4:311425	ZNF718	chr4:53272-156488:+	0.35	5.27	2.42E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs1125203	chr3:41760895	ULK4	chr3:41288091-42003660:-	0.6	8.05	1.33E-14	Diastolic blood pressure	
LIHC	cis	1	rs112529587	chr8:96060035	C8orf38	chr8:95908040-96088396:+	-0.33	-4.57	6.9E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs11264464	chr1:156250887	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs11264468	chr1:156274585	BGLAP	chr1:156182784-156213112:+	0.2	3.87	0.000131	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs112751982	chr6:26191958	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.47	1.05E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs1128320	chr11:244167	PSMD13	chr11:236808-252984:+	-0.23	-4.06	6.02E-5	Menarche (age at onset)	
LIHC	cis	1	rs1128322	chr11:244197	PSMD13	chr11:236808-252984:+	0.21	3.87	0.000129	Menarche (age at onset)	
LIHC	cis	1	rs113227361	chr5:109731861	MAN2A1	chr5:109025156-109203429:+	0.25	3.84	0.000147	Cardiac structure and function	
LIHC	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.36	-4.86	1.79E-6	Esophageal cancer (squamous cell)	
LIHC	cis	1	rs113427979	chr19:32855408	DPY19L3	chr19:32896677-32975236:+	0.21	4	7.81E-5	Bipolar disorder	
LIHC	cis	1	rs113638727	chr15:40706101	C15orf23	chr15:40674922-40686488:+	0.57	5.94	6.84E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.67	9.55	2.49E-19	Height	
LIHC	cis	1	rs113995589	chr3:53132372	RFT1	chr3:53122503-53164470:-	0.49	4.62	5.55E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs114121665	chr10:96533587	CYP2C18	chr10:96443251-96495945:+	-0.35	-4	7.62E-5	Blood metabolite levels	
LIHC	cis	1	rs1141321	chr6:49412433	CENPQ	chr6:49431096-49460820:+	-0.21	-4.18	3.7E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs114244137	chr5:150264753	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs114931426	chr10:96552327	CYP2C18	chr10:96443251-96495945:+	-0.34	-3.85	0.00014	Blood metabolite levels	
LIHC	cis	1	rs11495981	chr7:28177301	JAZF1	chr7:27870196-28220437:-	0.34	4.54	7.63E-6	Rheumatoid arthritis	
LIHC	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.58	7.83	6.25E-14	Diastolic blood pressure	
LIHC	cis	1	rs11532322	chr12:123731423	ABCB9	chr12:123413540-123459752:-	-0.49	-7.37	1.31E-12	Schizophrenia	
LIHC	cis	1	rs11538349	chr7:65421871	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs11538349	chr7:65421871	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs11541642	chr15:40683702	C15orf23	chr15:40674922-40686488:+	0.59	5.35	1.57E-7	Heschl's gyrus morphology	
LIHC	cis	1	rs11556025	chr22:29168755	CHEK2	chr22:29083731-29137822:-	-0.27	-4.34	1.9E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	0.59	6.04	4.08E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs115582426	chr5:109757121	MAN2A1	chr5:109025156-109203429:+	0.29	4.5	9.49E-6	Cardiac structure and function	
LIHC	cis	1	rs115743514	chr22:51011933	CPT1B	chr22:51007291-51017096:-	-0.28	-3.84	0.000146	Narcolepsy	
LIHC	cis	1	rs1158282	chr14:76172916	TTLL5	chr14:76127621-76421421:+	0.21	4.01	7.49E-5	Large artery stroke	
LIHC	cis	1	rs115852057	chr6:55983101	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000164	Psychosis (atypical)	
LIHC	cis	1	rs11588062	chr1:46779764	C1orf190	chr1:46669006-46686927:+	0.47	7.51	5.18E-13	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs11592213	chr10:97396103	ALDH18A1	chr10:97365687-97416567:-	0.3	4.41	1.36E-5	Blood metabolite levels	
LIHC	cis	1	rs11592213	chr10:97396103	ENTPD1	chr10:97471536-97637022:+	0.21	4.23	3.06E-5	Blood metabolite levels	
LIHC	cis	1	rs11600703	chr11:120249287	TMEM136	chr11:120196016-120204388:+	0.25	4.37	1.63E-5	Intraocular pressure	
LIHC	cis	1	rs11601205	chr11:34768479	ABTB2	chr11:34172535-34378802:-	0.24	3.85	0.000139	Systemic lupus erythematosus and Systemic sclerosis	
LIHC	cis	1	rs11601535	chr11:120333801	TMEM136	chr11:120196016-120204388:+	0.24	4.31	2.14E-5	Intraocular pressure	
LIHC	cis	1	rs1160267	chr8:23529521	NKX3-1	chr8:23536207-23540450:-	0.35	5.68	2.93E-8	Prostate cancer (gene x gene interaction);Prostate cancer	
LIHC	cis	1	rs11605774	chr11:47832793	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.84	5.19E-17	Subjective well-being	
LIHC	cis	1	rs1160671	chr22:30550010	CABP7	chr22:30116344-30127818:+	0.5	4.1	5.21E-5	LDL cholesterol	
LIHC	cis	1	rs11611670	chr12:9385535	LOC642846	chr12:9436253-9466684:+	0.23	4.5	9.45E-6	Breast size	
LIHC	cis	1	rs116139393	chr7:6771660	PMS2CL	chr7:6749757-6793492:+	-0.27	-3.86	0.000135	Alzheimer's disease (APOE e4 interaction)	
LIHC	cis	1	rs11621007	chr14:90743967	C14orf102	chr14:90744398-90798279:-	0.29	3.89	0.000121	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs11626016	chr14:90747979	C14orf102	chr14:90744398-90798279:-	0.29	3.87	0.000132	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs11626933	chr14:90754311	C14orf102	chr14:90744398-90798279:-	0.3	4.04	6.7E-5	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs11632465	chr15:85282045	NMB	chr15:85198362-85201802:-	-0.4	-6.36	6.53E-10	Schizophrenia	
LIHC	cis	1	rs11634746	chr15:50941496	USP8	chr15:50716579-50793276:+	-0.23	-4.69	4.03E-6	QT interval	
LIHC	cis	1	rs11636964	chr15:50899616	USP8	chr15:50716579-50793276:+	-0.22	-4.51	8.98E-6	QT interval	
LIHC	cis	1	rs11637142	chr15:85295927	NMB	chr15:85198362-85201802:-	-0.38	-5.9	8.85E-9	Schizophrenia	
LIHC	cis	1	rs11637142	chr15:85295927	UBE2Q2P1	chr15:85070427-85114026:-	0.23	3.88	0.000124	Schizophrenia	
LIHC	cis	1	rs11637228	chr15:50899972	USP8	chr15:50716579-50793276:+	-0.22	-4.51	8.98E-6	QT interval	
LIHC	cis	1	rs11638290	chr15:85227636	NMB	chr15:85198362-85201802:-	-0.4	-6.2	1.66E-9	Schizophrenia	
LIHC	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.32	-4.72	3.47E-6	Schizophrenia	
LIHC	cis	1	rs11638297	chr15:84782417	NMB	chr15:85198362-85201802:-	-0.3	-4.2	3.38E-5	Schizophrenia	
LIHC	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.34	-4.93	1.26E-6	Schizophrenia	
LIHC	cis	1	rs11638394	chr15:84778928	NMB	chr15:85198362-85201802:-	-0.36	-4.95	1.17E-6	Schizophrenia	
LIHC	cis	1	rs11638815	chr15:83352282	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.23	4.27	2.56E-5	Lipoprotein-associated phospholipase A2 activity change in response to statin therapy	
LIHC	cis	1	rs11645002	chr16:20617841	ACSM1	chr16:20634559-20709066:-	0.32	4.03	6.93E-5	Urinary metabolites	
LIHC	cis	1	rs11650372	chr17:45721795	C17orf57	chr17:45401142-45518675:+	0.28	5.33	1.75E-7	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.49	-7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.49	7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs116616340	chr3:53132371	RFT1	chr3:53122503-53164470:-	0.49	4.62	5.55E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs1167613	chr7:65487439	CCT6P1	chr7:65216092-65228661:+	0.36	4.98	9.93E-7	Diabetic kidney disease	
LIHC	cis	1	rs1167613	chr7:65487439	INTS4L1	chr7:64601603-64694599:+	0.33	3.96	9.18E-5	Diabetic kidney disease	
LIHC	cis	1	rs11685222	chr2:120748571	TMEM177	chr2:120436743-120481191:+	-0.32	-4.01	7.56E-5	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	
LIHC	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.66	9.17	4.44E-18	Height	
LIHC	cis	1	rs11707575	chr3:53113762	RFT1	chr3:53122503-53164470:-	0.41	4.08	5.63E-5	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs11707780	chr3:53084326	RFT1	chr3:53122503-53164470:-	-0.39	-3.92	0.000109	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.66	9.51	3.47E-19	Height	
LIHC	cis	1	rs11710292	chr3:53117798	RFT1	chr3:53122503-53164470:-	0.56	4.94	1.25E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs11712653	chr3:53070875	RFT1	chr3:53122503-53164470:-	-0.41	-3.84	0.000147	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs11714876	chr3:53101640	RFT1	chr3:53122503-53164470:-	-0.49	-4.73	3.23E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs11718752	chr3:53130745	RFT1	chr3:53122503-53164470:-	0.5	4.73	3.22E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs11722197	chr4:281707	ZNF718	chr4:53272-156488:+	0.3	4.8	2.4E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11722521	chr4:276765	ZNF718	chr4:53272-156488:+	0.29	4.74	3.15E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11723261	chr4:282499	ZNF718	chr4:53272-156488:+	0.3	4.8	2.4E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11723615	chr4:276983	ZNF718	chr4:53272-156488:+	0.29	4.69	4.02E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11723803	chr4:292369	ZNF718	chr4:53272-156488:+	0.24	4.61	5.61E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11724176	chr4:224901	ZNF718	chr4:53272-156488:+	0.35	5.43	1.09E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11724417	chr4:223352	ZNF718	chr4:53272-156488:+	0.35	5.43	1.09E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11726829	chr4:224948	ZNF718	chr4:53272-156488:+	0.34	6.04	3.97E-9	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11729365	chr4:272524	ZNF718	chr4:53272-156488:+	0.29	4.74	3.15E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11729657	chr4:1737585	FAM53A	chr4:1641609-1685854:-	-0.39	-5.03	7.97E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs11730202	chr4:210096	ZNF718	chr4:53272-156488:+	0.27	4.11	4.87E-5	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs11732213	chr4:1704244	FAM53A	chr4:1641609-1685854:-	0.38	4.63	5.28E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs11733284	chr4:48028097	NIPAL1	chr4:48018791-48039078:+	0.15	4	7.64E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs11737268	chr4:224452	ZNF718	chr4:53272-156488:+	0.34	6.04	3.97E-9	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs117381226	chr10:96553520	CYP2C18	chr10:96443251-96495945:+	-0.34	-3.85	0.00014	Blood metabolite levels	
LIHC	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.7	12.81	5.5E-31	Type 2 diabetes	
LIHC	cis	1	rs117395468	chr10:96529544	CYP2C18	chr10:96443251-96495945:+	-0.35	-4.01	7.6E-5	Blood metabolite levels	
LIHC	cis	1	rs11739619	chr5:150264662	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.36	4.71	3.64E-6	Crohn's disease	
LIHC	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.36	4.71	3.59E-6	Crohn's disease	
LIHC	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.36	-4.61	5.67E-6	Crohn's disease	
LIHC	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.37	4.75	2.96E-6	Crohn's disease	
LIHC	cis	1	rs11746108	chr5:150264622	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.37	4.87	1.7E-6	Crohn's disease	
LIHC	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.36	4.71	3.59E-6	Crohn's disease	
LIHC	cis	1	rs11747270	chr5:150258867	LOC134466	chr5:150310000-150326146:-	-0.34	-4.44	1.19E-5	Crohn's disease	
LIHC	cis	1	rs11748151	chr5:150226292	LOC134466	chr5:150310000-150326146:-	0.33	4.2	3.38E-5	Crohn's disease	
LIHC	cis	1	rs11748158	chr5:150226345	LOC134466	chr5:150310000-150326146:-	0.33	4.2	3.38E-5	Crohn's disease	
LIHC	cis	1	rs11749391	chr5:150229066	LOC134466	chr5:150310000-150326146:-	0.33	4.33	1.98E-5	Crohn's disease	
LIHC	cis	1	rs11754744	chr6:26202605	HIST1H2AE	chr6:26217148-26217711:+	-0.36	-3.89	0.000121	Renal underexcretion gout;Gout	
LIHC	cis	1	rs11755210	chr6:26202768	HIST1H2AE	chr6:26217148-26217711:+	-0.36	-3.89	0.000121	Renal underexcretion gout;Gout	
LIHC	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.55	-9.91	1.58E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.57	-10.28	8.47E-22	Response to antipsychotic treatment	
LIHC	cis	1	rs11774576	chr8:27740417	PNOC	chr8:28174649-28200866:+	-0.17	-4.26	2.69E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
LIHC	cis	1	rs11776189	chr8:96036741	C8orf38	chr8:95908040-96088396:+	-0.3	-4.1	5.12E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs11779860	chr8:98850330	LAPTM4B	chr8:98787809-98864829:+	-0.24	-4.26	2.7E-5	QT interval	
LIHC	cis	1	rs11780931	chr8:96043829	C8orf38	chr8:95908040-96088396:+	-0.34	-4.85	1.88E-6	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs11781040	chr8:96041746	C8orf38	chr8:95908040-96088396:+	-0.27	-3.87	0.000131	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.63	-14.41	3.73E-37	Response to antipsychotic treatment	
LIHC	cis	1	rs11823543	chr11:116649135	APOA1	chr11:116706469-116708338:-	-0.33	-3.96	9.2E-5	Triglycerides;Lipid traits	
LIHC	cis	1	rs11855605	chr15:51019117	USP8	chr15:50716579-50793276:+	-0.21	-4.32	2.08E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.34	-5.15	4.43E-7	Tumor biomarkers	
LIHC	cis	1	rs11856184	chr15:43919162	CATSPER2	chr15:43922774-43959900:-	-0.35	-4.89	1.52E-6	Tumor biomarkers	
LIHC	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	0.58	5.97	6.02E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs11861657	chr16:67824395	DPEP2	chr16:68021295-68034489:-	0.42	4.08	5.57E-5	Crohn's disease	
LIHC	cis	1	rs11869069	chr17:40287101	HSPB9	chr17:40274756-40275371:+	0.28	4.17	3.84E-5	Fibrinogen levels	
LIHC	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.3	-5.66	3.26E-8	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.51	7.38	1.22E-12	Schizophrenia	
LIHC	cis	1	rs11893118	chr2:241828308	AGXT	chr2:241808162-241818535:+	-0.15	-4.08	5.57E-5	Urinary metabolites	
LIHC	cis	1	rs11893118	chr2:241828308	C2orf54	chr2:241825466-241835573:-	0.62	10.37	4.15E-22	Urinary metabolites	
LIHC	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.66	-6.84	3.58E-11	Plasma clusterin levels	
LIHC	cis	1	rs11898716	chr2:241828311	AGXT	chr2:241808162-241818535:+	-0.16	-3.93	0.000101	Urinary metabolites	
LIHC	cis	1	rs11898716	chr2:241828311	C2orf54	chr2:241825466-241835573:-	0.52	7.35	1.46E-12	Urinary metabolites	
LIHC	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs11920570	chr3:122090102	CCDC58	chr3:122078437-122102074:-	0.2	3.82	0.000157	Resting heart rate	
LIHC	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.58	7.84	5.72E-14	Diastolic blood pressure	
LIHC	cis	1	rs11942153	chr4:106960172	TBCK	chr4:106967233-107237861:-	0.27	4.86	1.75E-6	Airflow obstruction	
LIHC	cis	1	rs11950957	chr5:150253914	LOC134466	chr5:150310000-150326146:-	0.33	4.36	1.73E-5	Crohn's disease	
LIHC	cis	1	rs11951694	chr5:150254338	LOC134466	chr5:150310000-150326146:-	0.33	4.36	1.73E-5	Crohn's disease	
LIHC	cis	1	rs11955172	chr5:150254378	LOC134466	chr5:150310000-150326146:-	0.33	4.36	1.73E-5	Crohn's disease	
LIHC	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.35	-4.48	1.01E-5	Crohn's disease	
LIHC	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	0.78	12.42	1.64E-29	Educational attainment (years of education)	
LIHC	cis	1	rs1198433	chr1:23756695	ASAP3	chr1:23755056-23811057:-	0.24	4.09	5.45E-5	Cholesterol, total	
LIHC	cis	1	rs1198440	chr1:23780861	ASAP3	chr1:23755056-23811057:-	0.22	3.85	0.000142	Cholesterol, total	
LIHC	cis	1	rs12021578	chr1:107597501	PRMT6	chr1:107599267-107601907:+	0.28	3.9	0.000115	AIDS	
LIHC	cis	1	rs12022452	chr1:40953300	DEM1	chr1:40974433-40982212:+	0.29	4	7.74E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs12022784	chr1:179469016	C1orf125	chr1:179335107-179523868:+	0.39	4.04	6.54E-5	Multiple sclerosis (age of onset)	
LIHC	cis	1	rs12023357	chr1:179474732	C1orf125	chr1:179335107-179523868:+	0.39	4.04	6.67E-5	Multiple sclerosis (age of onset)	
LIHC	cis	1	rs12023438	chr1:156254358	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12027103	chr1:156244856	BGLAP	chr1:156182784-156213112:+	0.21	4.24	2.91E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12027741	chr1:156248148	BGLAP	chr1:156182784-156213112:+	0.21	4.24	2.91E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12029787	chr1:179473917	C1orf125	chr1:179335107-179523868:+	0.39	4.04	6.67E-5	Multiple sclerosis (age of onset)	
LIHC	cis	1	rs12030612	chr1:113215637	ST7L	chr1:113066142-113162405:-	0.41	5.52	6.6E-8	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs12030641	chr1:113215717	ST7L	chr1:113066142-113162405:-	0.41	5.52	6.6E-8	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs12031278	chr1:40976918	DEM1	chr1:40974433-40982212:+	0.29	4.1	5.1E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs12034162	chr1:40964605	DEM1	chr1:40974433-40982212:+	0.3	4.21	3.27E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs12038203	chr1:156248265	BGLAP	chr1:156182784-156213112:+	0.21	4.24	2.91E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12038217	chr1:156248297	BGLAP	chr1:156182784-156213112:+	0.21	4.24	2.91E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs1203875	chr20:22540321	C20orf56	chr20:22541194-22559280:-	-0.3	-4.33	1.97E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs1203876	chr20:22540915	C20orf56	chr20:22541194-22559280:-	-0.31	-4.36	1.69E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs1203877	chr20:22541476	C20orf56	chr20:22541194-22559280:-	-0.3	-4.33	1.97E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs1203879	chr20:22541816	C20orf56	chr20:22541194-22559280:-	-0.3	-4.33	1.97E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs1203880	chr20:22542023	C20orf56	chr20:22541194-22559280:-	-0.3	-4.33	1.97E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs1203881	chr20:22542521	C20orf56	chr20:22541194-22559280:-	-0.3	-4.33	1.97E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs1203883	chr20:22543646	C20orf56	chr20:22541194-22559280:-	-0.3	-4.33	1.97E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs1203884	chr20:22543700	C20orf56	chr20:22541194-22559280:-	-0.31	-4.36	1.69E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs1203886	chr20:22544515	C20orf56	chr20:22541194-22559280:-	-0.31	-4.36	1.69E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.42	5.63	3.75E-8	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs12041164	chr1:156279811	BGLAP	chr1:156182784-156213112:+	0.2	3.9	0.000115	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12048678	chr1:40947768	DEM1	chr1:40974433-40982212:+	0.29	3.97	8.65E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs12053254	chr2:190607153	ORMDL1	chr2:190634994-190649097:-	0.42	4.09	5.43E-5	Subcutaneous adipose tissue	
LIHC	cis	1	rs12054923	chr5:150249059	LOC134466	chr5:150310000-150326146:-	0.35	4.48	1.01E-5	Crohn's disease	
LIHC	cis	1	rs12061304	chr1:111237685	AHCYL1	chr1:110527308-110566363:+	0.25	3.97	8.72E-5	Panic disorder	
LIHC	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.57	-8.15	6.86E-15	Coronary heart disease	
LIHC	cis	1	rs12101255	chr14:81451052	TSHR	chr14:81421869-81612646:+	-0.21	-3.88	0.000125	Graves' disease	
LIHC	cis	1	rs12101261	chr14:81451229	TSHR	chr14:81421869-81612646:+	-0.22	-3.88	0.000123	Graves' disease	
LIHC	cis	1	rs12101597	chr15:65935195	DPP8	chr15:65737999-65810035:-	-0.15	-3.83	0.000151	Mean corpuscular hemoglobin	
LIHC	cis	1	rs12117947	chr1:156244058	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12120956	chr1:113202571	ST7L	chr1:113066142-113162405:-	0.42	5.63	3.78E-8	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs12121805	chr1:156257876	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12122180	chr1:156244559	BGLAP	chr1:156182784-156213112:+	0.21	4.24	2.91E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12126971	chr1:113231286	ST7L	chr1:113066142-113162405:-	0.42	5.61	4.19E-8	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.43	5.75	1.92E-8	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs12130361	chr1:156260301	BGLAP	chr1:156182784-156213112:+	0.21	4.24	2.91E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12132794	chr1:156281020	BGLAP	chr1:156182784-156213112:+	-0.2	-3.85	0.000141	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.5	6.89	2.65E-11	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs12145310	chr1:20901064	FAM43B	chr1:20878932-20881512:+	0.21	4.4	1.45E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs12145351	chr1:20901181	FAM43B	chr1:20878932-20881512:+	0.2	4.35	1.83E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.54	-9.77	4.67E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.54	7.69	1.55E-13	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.53	-9.24	2.58E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.53	-9.26	2.28E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs12190930	chr6:55977027	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000164	Psychosis (atypical)	
LIHC	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.58	-10.52	1.26E-22	Response to antipsychotic treatment	
LIHC	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.54	-9.44	5.75E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12196050	chr6:55985113	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000164	Psychosis (atypical)	
LIHC	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.55	-9.55	2.58E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12196937	chr6:49382808	CENPQ	chr6:49431096-49460820:+	-0.21	-4.23	3.06E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs12197114	chr6:109735498	MICAL1	chr6:109765268-109787171:-	-0.13	-4.24	2.9E-5	Height	
LIHC	cis	1	rs12198637	chr6:55981400	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000163	Psychosis (atypical)	
LIHC	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.53	-9.41	7.33E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.53	-9.5	3.75E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.57	-10.03	6.21E-21	Response to antipsychotic treatment	
LIHC	cis	1	rs12200525	chr6:55982301	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000164	Psychosis (atypical)	
LIHC	cis	1	rs12200667	chr6:55982461	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000164	Psychosis (atypical)	
LIHC	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.57	-10.28	8.47E-22	Response to antipsychotic treatment	
LIHC	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.53	-9.26	2.18E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.54	-9.47	4.65E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.54	-9.77	4.67E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs12202075	chr6:49427655	CENPQ	chr6:49431096-49460820:+	-0.21	-4.28	2.42E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs12203179	chr6:55994237	COL21A1	chr6:55921389-56258892:-	0.34	4.6	6.06E-6	Psychosis (atypical)	
LIHC	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.55	-9.58	1.98E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.55	-9.58	1.98E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.65	-14.97	2.31E-39	Response to antipsychotic treatment	
LIHC	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.5	-8.81	6.28E-17	Response to antipsychotic treatment	
LIHC	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.55	-9.87	2.17E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.54	-9.4	8.09E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.53	-9.5	3.75E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.51	-8.98	1.84E-17	Response to antipsychotic treatment	
LIHC	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.56	-9.99	8.35E-21	Response to antipsychotic treatment	
LIHC	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.55	-9.87	2.17E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs12212032	chr6:56005703	COL21A1	chr6:55921389-56258892:-	-0.32	-3.84	0.000149	Psychosis (atypical)	
LIHC	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.54	-9.65	1.21E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.56	-9.99	8.35E-21	Response to antipsychotic treatment	
LIHC	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.53	-9.31	1.6E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.55	-9.79	3.97E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.5	-8.88	3.81E-17	Response to antipsychotic treatment	
LIHC	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.54	-9.63	1.36E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.53	-9.32	1.46E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs12216994	chr1:179477137	C1orf125	chr1:179335107-179523868:+	0.39	3.99	8.14E-5	Multiple sclerosis (age of onset)	
LIHC	cis	1	rs12216996	chr1:179477591	C1orf125	chr1:179335107-179523868:+	-0.37	-3.85	0.000142	Multiple sclerosis (age of onset)	
LIHC	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-0.54	-7.64	2.14E-13	Chronic obstructive pulmonary disease-related biomarkers	
LIHC	cis	1	rs12236125	chr9:99583468	FAM22G	chr9:99690592-99704572:+	0.55	6.17	1.93E-9	Height	
LIHC	cis	1	rs12236179	chr9:99625730	FAM22G	chr9:99690592-99704572:+	0.68	8.98	1.83E-17	Height	
LIHC	cis	1	rs12237908	chr9:99583394	FAM22G	chr9:99690592-99704572:+	0.68	8.85	4.6E-17	Height	
LIHC	cis	1	rs12274192	chr11:116652351	APOA1	chr11:116706469-116708338:-	-0.33	-3.89	0.00012	Triglycerides;Lipid traits	
LIHC	cis	1	rs12285276	chr11:45813581	DKFZp779M0652	chr11:45792983-45793908:+	0.21	4.38	1.58E-5	Visceral fat	
LIHC	cis	1	rs12287832	chr11:65553492	CTSW	chr11:65647284-65651212:+	-0.3	-4.95	1.14E-6	Systemic lupus erythematosus	
LIHC	cis	1	rs12314948	chr12:114543717	IQCD	chr12:113633248-113658880:-	0.31	3.83	0.000152	Visceral fat	
LIHC	cis	1	rs12317103	chr12:123802814	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.47E-5	HDL cholesterol	
LIHC	cis	1	rs12317452	chr12:123788246	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.47E-5	HDL cholesterol	
LIHC	cis	1	rs12317634	chr12:114572588	IQCD	chr12:113633248-113658880:-	0.3	3.82	0.000161	Visceral fat	
LIHC	cis	1	rs12323581	chr14:24944564	SDR39U1	chr14:24908974-24912064:-	-0.49	-4.82	2.12E-6	Smooth-surface caries	
LIHC	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.47	7.27	2.38E-12	Blood trace element (Zn levels)	
LIHC	cis	1	rs12328085	chr2:86262009	LOC90784	chr2:86247339-86250991:-	-0.77	-5.75	2.02E-8	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs12328085	chr2:86262009	POLR1A	chr2:86253453-86333278:-	0.84	8.9	3.21E-17	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs12333080	chr6:118845410	C6orf204	chr6:118786239-119031238:-	-0.28	-4.17	3.81E-5	Renal cell carcinoma	
LIHC	cis	1	rs12339579	chr9:99594611	FAM22G	chr9:99690592-99704572:+	0.7	7.73	1.16E-13	Height	
LIHC	cis	1	rs12340602	chr9:99540709	FAM22G	chr9:99690592-99704572:+	0.67	7.53	4.5E-13	Height	
LIHC	cis	1	rs12359272	chr10:97365163	ALDH18A1	chr10:97365687-97416567:-	0.26	3.9	0.000117	Blood metabolite levels	
LIHC	cis	1	rs12359272	chr10:97365163	ENTPD1	chr10:97471536-97637022:+	0.21	4.13	4.6E-5	Blood metabolite levels	
LIHC	cis	1	rs12361031	chr11:47783076	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.89	3.63E-17	Subjective well-being	
LIHC	cis	1	rs12363232	chr11:47623890	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.89	3.47E-17	Subjective well-being	
LIHC	cis	1	rs12365551	chr11:58358368	CNTF	chr11:58390146-58393203:+	0.37	4.66	4.49E-6	Lymphoma	
LIHC	cis	1	rs12366872	chr12:123804721	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.47E-5	HDL cholesterol	
LIHC	cis	1	rs12417256	chr11:120337519	TMEM136	chr11:120196016-120204388:+	0.25	4.38	1.59E-5	Intraocular pressure	
LIHC	cis	1	rs12418852	chr11:47868853	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.8	6.55E-17	Subjective well-being	
LIHC	cis	1	rs12419692	chr11:47624714	C1QTNF4	chr11:47611216-47615961:-	0.57	9.09	7.77E-18	Subjective well-being	
LIHC	cis	1	rs12421210	chr11:47779586	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.89	3.63E-17	Subjective well-being	
LIHC	cis	1	rs12427083	chr12:109113241	SELPLG	chr12:109015682-109027670:-	0.1	3.81	0.000164	Low high density lipoprotein cholesterol levels	
LIHC	cis	1	rs12438305	chr15:50912454	USP8	chr15:50716579-50793276:+	-0.22	-4.41	1.41E-5	QT interval	
LIHC	cis	1	rs12438326	chr15:51037974	USP8	chr15:50716579-50793276:+	-0.2	-4.12	4.76E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs12439744	chr15:50899211	USP8	chr15:50716579-50793276:+	-0.22	-4.51	8.98E-6	QT interval	
LIHC	cis	1	rs12440841	chr15:51005821	USP8	chr15:50716579-50793276:+	-0.21	-4.37	1.65E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs12442787	chr15:50918107	USP8	chr15:50716579-50793276:+	-0.23	-4.58	6.46E-6	QT interval	
LIHC	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.35	-5.23	3.02E-7	Tumor biomarkers	
LIHC	cis	1	rs12443102	chr15:43932103	CATSPER2	chr15:43922774-43959900:-	-0.35	-4.92	1.32E-6	Tumor biomarkers	
LIHC	cis	1	rs12446319	chr16:81774798	SDR42E1	chr16:82031252-82045093:-	-0.25	-3.95	9.33E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	
LIHC	cis	1	rs12448617	chr16:11543836	RSL1D1	chr16:11928055-11945442:-	-0.21	-3.82	0.000161	Hepatitis	
LIHC	cis	1	rs12448617	chr16:11543836	SNX29	chr16:12146055-12668145:+	-0.24	-4.33	1.99E-5	Hepatitis	
LIHC	cis	1	rs12459965	chr19:18452195	GDF1	chr19:18979361-19006953:-	-0.21	-4.1	5.23E-5	Life satisfaction	
LIHC	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.56	-5.74	2.12E-8	Plasma clusterin levels	
LIHC	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.67	9.56	2.27E-19	Height	
LIHC	cis	1	rs12505835	chr4:297525	ZNF718	chr4:53272-156488:+	0.3	4.9	1.49E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs12509366	chr4:107003343	TBCK	chr4:106967233-107237861:-	0.22	3.97	8.87E-5	Airflow obstruction	
LIHC	cis	1	rs12510966	chr4:106983604	TBCK	chr4:106967233-107237861:-	0.25	4.52	8.53E-6	Airflow obstruction	
LIHC	cis	1	rs12512683	chr4:106999471	TBCK	chr4:106967233-107237861:-	0.22	3.94	9.76E-5	Airflow obstruction	
LIHC	cis	1	rs12513391	chr5:109774372	MAN2A1	chr5:109025156-109203429:+	0.26	4.25	2.75E-5	Cardiac structure and function	
LIHC	cis	1	rs12513391	chr5:109774372	TMEM232	chr5:109624934-110062381:-	0.39	4.04	6.58E-5	Cardiac structure and function	
LIHC	cis	1	rs12513985	chr5:109750483	MAN2A1	chr5:109025156-109203429:+	0.27	4.09	5.34E-5	Cardiac structure and function	
LIHC	cis	1	rs12517986	chr5:172995160	LOC100268168	chr5:172381788-172386371:-	0.34	3.98	8.52E-5	Height	
LIHC	cis	1	rs12519401	chr5:153609014	MFAP3	chr5:153418519-153437014:+	-0.19	-3.82	0.00016	Carotid artery intima media thickness (sex interaction)	
LIHC	cis	1	rs12520182	chr5:109769710	MAN2A1	chr5:109025156-109203429:+	-0.29	-4.51	8.92E-6	Cardiac structure and function	
LIHC	cis	1	rs12521554	chr5:153603003	MFAP3	chr5:153418519-153437014:+	-0.25	-4.91	1.38E-6	Carotid artery intima media thickness (sex interaction)	
LIHC	cis	1	rs12538804	chr7:7693919	ZNF12	chr7:6728064-6746566:-	-0.24	-3.9	0.000115	Urate levels in obese individuals	
LIHC	cis	1	rs12543128	chr8:144595042	ZC3H3	chr8:144519825-144623620:-	-0.28	-4.72	3.45E-6	Venous thromboembolism (SNP x SNP interaction)	
LIHC	cis	1	rs12543517	chr8:36919153	ERLIN2	chr8:37594097-37615318:+	0.31	3.92	0.000106	Insulin resistance/response	
LIHC	cis	1	rs12543517	chr8:36919153	PROSC	chr8:37620101-37637285:+	0.34	4.19	3.6E-5	Insulin resistance/response	
LIHC	cis	1	rs12543517	chr8:36919153	RAB11FIP1	chr8:37716470-37757003:-	0.38	5.29	2.22E-7	Insulin resistance/response	
LIHC	cis	1	rs12545911	chr8:36920743	ERLIN2	chr8:37594097-37615318:+	0.31	3.93	0.000104	Insulin resistance/response	
LIHC	cis	1	rs12545911	chr8:36920743	PROSC	chr8:37620101-37637285:+	0.36	4.33	1.99E-5	Insulin resistance/response	
LIHC	cis	1	rs12545911	chr8:36920743	RAB11FIP1	chr8:37716470-37757003:-	0.39	5.27	2.45E-7	Insulin resistance/response	
LIHC	cis	1	rs12547277	chr8:36926607	ERLIN2	chr8:37594097-37615318:+	0.32	3.97	8.88E-5	Insulin resistance/response	
LIHC	cis	1	rs12547277	chr8:36926607	PROSC	chr8:37620101-37637285:+	0.36	4.37	1.68E-5	Insulin resistance/response	
LIHC	cis	1	rs12547277	chr8:36926607	RAB11FIP1	chr8:37716470-37757003:-	0.39	5.32	1.86E-7	Insulin resistance/response	
LIHC	cis	1	rs12548289	chr8:36919332	RAB11FIP1	chr8:37716470-37757003:-	-0.33	-4.59	6.23E-6	Insulin resistance/response	
LIHC	cis	1	rs12549353	chr8:36929508	RAB11FIP1	chr8:37716470-37757003:-	-0.32	-4.6	6.01E-6	Insulin resistance/response	
LIHC	cis	1	rs12563631	chr1:156258953	BGLAP	chr1:156182784-156213112:+	0.21	4.18	3.64E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.85	1.15E-8	Forced vital capacity	
LIHC	cis	1	rs12581386	chr12:109082999	SELPLG	chr12:109015682-109027670:-	-0.1	-3.92	0.000107	Low high density lipoprotein cholesterol levels	
LIHC	cis	1	rs12590520	chr14:76715934	TTLL5	chr14:76127621-76421421:+	-0.21	-3.82	0.000158	Acute lymphoblastic leukemia (childhood)	
LIHC	cis	1	rs12591751	chr15:50972497	USP8	chr15:50716579-50793276:+	-0.21	-4.1	5.26E-5	QT interval	
LIHC	cis	1	rs12593469	chr15:51051044	USP8	chr15:50716579-50793276:+	-0.21	-4.16	4.06E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs12603327	chr17:40290552	HSPB9	chr17:40274756-40275371:+	0.28	4.28	2.43E-5	Fibrinogen levels	
LIHC	cis	1	rs12603330	chr17:40290589	HSPB9	chr17:40274756-40275371:+	0.28	4.27	2.54E-5	Fibrinogen levels	
LIHC	cis	1	rs12604278	chr18:10929314	CHMP1B	chr18:11851389-11854447:+	0.2	3.88	0.000124	Major depressive disorder	
LIHC	cis	1	rs12612513	chr2:86301225	POLR1A	chr2:86253453-86333278:-	-0.37	-4.89	1.58E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs12612513	chr2:86301225	REEP1	chr2:86441122-86564777:-	0.41	3.88	0.000126	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs12614260	chr2:86303079	POLR1A	chr2:86253453-86333278:-	-0.38	-4.99	9.83E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs12614260	chr2:86303079	REEP1	chr2:86441122-86564777:-	0.42	3.88	0.000127	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs12616040	chr2:104001263	IL18RAP	chr2:103035254-103069022:+	-0.27	-3.98	8.3E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs12621992	chr2:86345349	POLR1A	chr2:86253453-86333278:-	-0.37	-4.69	3.93E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs12624126	chr2:86342366	POLR1A	chr2:86253453-86333278:-	-0.37	-4.69	3.93E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.11E-14	Diastolic blood pressure	
LIHC	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.36	4.54	7.7E-6	Crohn's disease	
LIHC	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.38	4.69	3.9E-6	Crohn's disease	
LIHC	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.36	4.72	3.47E-6	Crohn's disease	
LIHC	cis	1	rs12659118	chr5:150324622	LOC134466	chr5:150310000-150326146:-	0.36	4.6	5.84E-6	Crohn's disease	
LIHC	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.55	-9.76	4.87E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.5	-8.81	6.28E-17	Response to antipsychotic treatment	
LIHC	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.53	9.53	2.84E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.53	9.75	5.4E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.55	-9.58	1.98E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs1267657	chr15:83215251	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.2	-4.01	7.43E-5	Schizophrenia	
LIHC	cis	1	rs1267817	chr7:66110040	CCT6P1	chr7:65216092-65228661:+	0.32	4.41	1.36E-5	Gout	
LIHC	cis	1	rs1267818	chr7:66107024	CCT6P1	chr7:65216092-65228661:+	0.32	4.36	1.72E-5	Gout	
LIHC	cis	1	rs1267820	chr7:66050295	CCT6P1	chr7:65216092-65228661:+	0.31	4.25	2.81E-5	Diabetic kidney disease	
LIHC	cis	1	rs12691307	chr16:29939877	TBX6	chr16:30097117-30103208:-	0.23	3.96	9.27E-5	Schizophrenia	
LIHC	cis	1	rs12698509	chr7:65418876	CCT6P1	chr7:65216092-65228661:+	0.32	4.43	1.28E-5	Diabetic kidney disease	
LIHC	cis	1	rs12740374	chr1:109817590	CELSR2	chr1:109792641-109818377:+	0.45	5.48	8.06E-8	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs12740374	chr1:109817590	MYBPHL	chr1:109834987-109849663:-	0.34	4.25	2.72E-5	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs12740374	chr1:109817590	PSRC1	chr1:109822179-109825808:-	0.58	9.68	9.66E-20	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs12740374	chr1:109817590	SORT1	chr1:109852192-109940563:-	0.67	7.83	6.11E-14	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs12744212	chr1:180952516	STX6	chr1:180913175-180992046:-	-0.19	-4.41	1.36E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs12754041	chr1:180957962	STX6	chr1:180913175-180992046:-	-0.18	-4.36	1.69E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs12769346	chr10:89764490	FAM35A	chr10:88854953-88951220:+	-0.28	-4.13	4.55E-5	Type 2 diabetes	
LIHC	cis	1	rs12787330	chr11:47812311	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.83	5.46E-17	Subjective well-being	
LIHC	cis	1	rs12787909	chr11:117546482	ATP5L	chr11:118272104-118280561:+	0.55	5.2	3.46E-7	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12787909	chr11:117546482	BACE1	chr11:117156417-117186972:-	0.52	3.85	0.000138	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12787909	chr11:117546482	BUD13	chr11:116618888-116643714:-	0.68	5.43	1.06E-7	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12787909	chr11:117546482	MLL	chr11:118307205-118397538:+	0.37	3.96	9.15E-5	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12787909	chr11:117546482	PCSK7	chr11:117075789-117102811:-	0.56	3.89	0.000121	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12787909	chr11:117546482	RNF214	chr11:117103404-117156402:+	0.73	5.75	1.93E-8	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12787909	chr11:117546482	SIDT2	chr11:117049939-117068161:+	0.55	4.19	3.48E-5	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12787909	chr11:117546482	SIK3	chr11:116714120-116968993:-	0.63	4.69	3.9E-6	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12787909	chr11:117546482	UBE4A	chr11:118230302-118269924:+	0.61	4.59	6.14E-6	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12787909	chr11:117546482	ZNF259	chr11:116649277-116658739:-	0.78	6.09	2.94E-9	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs12800378	chr11:87865942	RAB38	chr11:87846431-87908599:-	0.28	4.63	5.25E-6	Frontotemporal dementia	
LIHC	cis	1	rs12828421	chr12:7335217	PEX5	chr12:7341759-7371167:+	-0.24	-4.12	4.79E-5	IgG glycosylation	
LIHC	cis	1	rs12899981	chr15:85302373	NMB	chr15:85198362-85201802:-	-0.38	-5.9	8.58E-9	Schizophrenia	
LIHC	cis	1	rs12900658	chr15:51016364	USP8	chr15:50716579-50793276:+	0.21	4.26	2.67E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.34	-4.83	2.11E-6	Schizophrenia	
LIHC	cis	1	rs12902672	chr15:84716986	NMB	chr15:85198362-85201802:-	-0.35	-4.78	2.61E-6	Schizophrenia	
LIHC	cis	1	rs12903134	chr15:85337699	NMB	chr15:85198362-85201802:-	-0.38	-5.98	5.49E-9	Schizophrenia	
LIHC	cis	1	rs12903134	chr15:85337699	UBE2Q2P1	chr15:85070427-85114026:-	0.23	3.84	0.000146	Schizophrenia	
LIHC	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.34	-4.83	2.11E-6	Schizophrenia	
LIHC	cis	1	rs12903820	chr15:84723820	NMB	chr15:85198362-85201802:-	-0.35	-4.78	2.61E-6	Schizophrenia	
LIHC	cis	1	rs12903915	chr15:51028748	USP8	chr15:50716579-50793276:+	-0.21	-4.19	3.5E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs12905057	chr15:85210765	NMB	chr15:85198362-85201802:-	-0.4	-6.14	2.25E-9	Schizophrenia	
LIHC	cis	1	rs12908161	chr15:85207825	NMB	chr15:85198362-85201802:-	-0.41	-6.24	1.26E-9	Schizophrenia	
LIHC	cis	1	rs12908161	chr15:85207825	UBE2Q2P1	chr15:85070427-85114026:-	0.24	3.82	0.000158	Schizophrenia	
LIHC	cis	1	rs12908549	chr15:85322351	NMB	chr15:85198362-85201802:-	-0.38	-5.98	5.49E-9	Schizophrenia	
LIHC	cis	1	rs12908549	chr15:85322351	UBE2Q2P1	chr15:85070427-85114026:-	0.23	3.84	0.000146	Schizophrenia	
LIHC	cis	1	rs12910012	chr15:85298662	NMB	chr15:85198362-85201802:-	-0.38	-5.92	7.95E-9	Schizophrenia	
LIHC	cis	1	rs12910371	chr15:51017577	USP8	chr15:50716579-50793276:+	-0.21	-4.32	2.08E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs12911578	chr15:51026955	USP8	chr15:50716579-50793276:+	-0.19	-3.81	0.000164	Alzheimer's disease (late onset)	
LIHC	cis	1	rs12911736	chr15:85240008	NMB	chr15:85198362-85201802:-	-0.39	-6.15	2.21E-9	Schizophrenia	
LIHC	cis	1	rs12911736	chr15:85240008	UBE2Q2P1	chr15:85070427-85114026:-	0.23	3.86	0.000134	Schizophrenia	
LIHC	cis	1	rs12912388	chr15:85344550	NMB	chr15:85198362-85201802:-	-0.38	-5.98	5.49E-9	Schizophrenia	
LIHC	cis	1	rs12912388	chr15:85344550	UBE2Q2P1	chr15:85070427-85114026:-	0.23	3.84	0.000146	Schizophrenia	
LIHC	cis	1	rs12913259	chr15:51014716	USP8	chr15:50716579-50793276:+	-0.2	-3.89	0.00012	Fibrinogen levels	
LIHC	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.34	-4.83	2.11E-6	Schizophrenia	
LIHC	cis	1	rs12915234	chr15:84758301	NMB	chr15:85198362-85201802:-	-0.35	-4.78	2.61E-6	Schizophrenia	
LIHC	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.34	-4.93	1.3E-6	Schizophrenia	
LIHC	cis	1	rs12916348	chr15:84765527	NMB	chr15:85198362-85201802:-	-0.35	-4.82	2.12E-6	Schizophrenia	
LIHC	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.48	7.72	1.29E-13	Eye color traits	
LIHC	cis	1	rs12995491	chr2:88527414	THNSL2	chr2:88469835-88486145:+	-0.35	-5.91	8.24E-9	Response to metformin (IC50)	
LIHC	cis	1	rs13003040	chr2:66756270	MEIS1	chr2:66662532-66799890:+	0.28	3.96	8.96E-5	PR interval	
LIHC	cis	1	rs13006833	chr2:191205499	HIBCH	chr2:191069361-191184559:-	0.57	10.73	2.29E-23	Urinary metabolites	
LIHC	cis	1	rs13029602	chr2:29574875	SPDYA	chr2:29005383-29073473:+	-0.23	-3.94	9.94E-5	Adiponectin levels (BMI-adjusted)	
LIHC	cis	1	rs13053765	chr22:30485082	CABP7	chr22:30116344-30127818:+	0.51	4.24	2.93E-5	LDL cholesterol	
LIHC	cis	1	rs13054837	chr22:30575749	CABP7	chr22:30116344-30127818:+	0.52	4.28	2.44E-5	LDL cholesterol	
LIHC	cis	1	rs13056990	chr22:30534161	CABP7	chr22:30116344-30127818:+	0.48	3.82	0.000158	LDL cholesterol	
LIHC	cis	1	rs13058903	chr3:38513365	XYLB	chr3:38388251-38456467:+	-0.27	-5.27	2.45E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.3	1.62E-18	Height	
LIHC	cis	1	rs13072457	chr3:53102389	RFT1	chr3:53122503-53164470:-	0.53	4.74	3.19E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs13072809	chr3:38468171	XYLB	chr3:38388251-38456467:+	0.27	5.28	2.25E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs13072818	chr3:53074263	RFT1	chr3:53122503-53164470:-	0.49	4.47	1.07E-5	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs13074025	chr3:38455704	XYLB	chr3:38388251-38456467:+	0.27	5.16	4.11E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs13074160	chr3:38455650	XYLB	chr3:38388251-38456467:+	0.27	5.16	4.11E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs13078971	chr3:53103645	RFT1	chr3:53122503-53164470:-	0.52	4.73	3.3E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs13079757	chr3:38491444	XYLB	chr3:38388251-38456467:+	0.28	5.28	2.26E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.23	2.84E-18	Height	
LIHC	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs13085791	chr3:49721798	CYB561D2	chr3:50388289-50391494:+	0.3	4.06	6.12E-5	Crohn's disease;Ulcerative colitis	
LIHC	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-0.6	-8.2	4.94E-15	Diastolic blood pressure	
LIHC	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs13088281	chr3:53147576	RFT1	chr3:53122503-53164470:-	-0.48	-4.53	7.97E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs13089394	chr3:38446309	XYLB	chr3:38388251-38456467:+	0.28	5.29	2.19E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs13090388	chr3:49391082	SLC26A6	chr3:48663158-48672926:-	0.27	3.87	0.000132	Educational attainment (years of education)	
LIHC	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.3	1.62E-18	Height	
LIHC	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.59	-8.55	4.06E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs13120847	chr4:48030036	NIPAL1	chr4:48018791-48039078:+	0.15	4	7.64E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs13122400	chr4:39713743	RPL9	chr4:39455747-39460568:-	-0.43	-6.72	7.72E-11	Plasma amyloid beta peptide concentrations (ABx-40)	
LIHC	cis	1	rs13125949	chr4:48026560	NIPAL1	chr4:48018791-48039078:+	0.16	4.17	3.87E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.56	-8.49	6.46E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs13140968	chr4:48025095	NIPAL1	chr4:48018791-48039078:+	0.16	4.17	3.88E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs13142905	chr4:48025298	NIPAL1	chr4:48018791-48039078:+	0.16	4.15	4.28E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs1317149	chr11:47486885	C1QTNF4	chr11:47611216-47615961:-	-0.55	-8.64	2.08E-16	Subjective well-being	
LIHC	cis	1	rs13177431	chr5:153608112	MFAP3	chr5:153418519-153437014:+	-0.25	-4.91	1.39E-6	Carotid artery intima media thickness (sex interaction)	
LIHC	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.57	-10.17	2.03E-21	Response to antipsychotic treatment	
LIHC	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.58	-10.18	1.92E-21	Response to antipsychotic treatment	
LIHC	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.63	-13.94	2.52E-35	Response to antipsychotic treatment	
LIHC	cis	1	rs13201929	chr6:117605991	GOPC	chr6:117639351-117923681:-	0.23	3.81	0.000167	Myopia (pathological)	
LIHC	cis	1	rs13201929	chr6:117605991	NUS1	chr6:117996617-118031884:+	0.28	3.91	0.00011	Myopia (pathological)	
LIHC	cis	1	rs1320612	chr6:109611990	CD164	chr6:109687718-109703762:-	-0.26	-5.14	4.72E-7	Red blood cell traits	
LIHC	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.75	2.93E-6	Obesity-related traits	
LIHC	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.29	-4.45	1.17E-5	Obesity-related traits	
LIHC	cis	1	rs1320996	chr6:56100431	COL21A1	chr6:55921389-56258892:-	0.57	10.31	6.72E-22	Pulse pressure	
LIHC	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.52	-9	1.53E-17	Response to antipsychotic treatment	
LIHC	cis	1	rs13220979	chr7:65363204	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.75E-6	Diabetic kidney disease	
LIHC	cis	1	rs13220979	chr7:65363204	INTS4L1	chr7:64601603-64694599:+	0.33	3.82	0.000159	Diabetic kidney disease	
LIHC	cis	1	rs13235972	chr7:65883605	CCT6P1	chr7:65216092-65228661:+	0.3	4.14	4.33E-5	Diabetic kidney disease	
LIHC	cis	1	rs13237037	chr7:65997882	CCT6P1	chr7:65216092-65228661:+	0.31	4.25	2.81E-5	Diabetic kidney disease	
LIHC	cis	1	rs1323884	chr13:51401993	FAM124A	chr13:51796507-51855616:+	-0.2	-3.84	0.000148	Primary tooth development (number of teeth)	
LIHC	cis	1	rs13240464	chr7:110898915	IMMP2L	chr7:110303110-111202538:-	0.2	3.81	0.000164	Schizophrenia	
LIHC	cis	1	rs13247184	chr7:65358928	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.3E-6	Diabetic kidney disease	
LIHC	cis	1	rs13257518	chr8:32635574	C8orf41	chr8:33330904-33370703:-	0.49	5.17	4.0E-7	Refractive astigmatism	
LIHC	cis	1	rs13266699	chr8:8570313	CLDN23	chr8:8559666-8561616:+	-0.27	-4.16	3.97E-5	Obesity-related traits	
LIHC	cis	1	rs13267838	chr8:25196710	CDCA2	chr8:25316513-25365425:+	-0.34	-5.26	2.51E-7	Glucose homeostasis traits	
LIHC	cis	1	rs13267838	chr8:25196710	DOCK5	chr8:25042287-25270618:+	-0.33	-3.98	8.51E-5	Glucose homeostasis traits	
LIHC	cis	1	rs13267838	chr8:25196710	KCTD9	chr8:25285366-25315920:-	-0.45	-4.99	9.8E-7	Glucose homeostasis traits	
LIHC	cis	1	rs13267838	chr8:25196710	PPP2R2A	chr8:25230075-26228645:+	-0.54	-5.25	2.73E-7	Glucose homeostasis traits	
LIHC	cis	1	rs13310597	chr7:65598540	CCT6P1	chr7:65216092-65228661:+	0.29	3.99	8.07E-5	Diabetic kidney disease	
LIHC	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.64	8.97	1.91E-17	Height	
LIHC	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.55	7.15	5.39E-12	Diastolic blood pressure	
LIHC	cis	1	rs13332819	chr16:83142060	HSBP1	chr16:83841593-83846594:+	-0.25	-3.83	0.000153	Maximal oxygen uptake response	
LIHC	cis	1	rs13361189	chr5:150223387	LOC134466	chr5:150310000-150326146:-	0.33	4.19	3.54E-5	Crohn's disease	
LIHC	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.52	-9.14	5.46E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.55	-9.79	3.97E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.52	-7.72	1.26E-13	Prostate cancer	
LIHC	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.58	4.59	6.19E-6	Rheumatoid arthritis	
LIHC	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.47	-3.86	0.000137	Rheumatoid arthritis	
LIHC	cis	1	rs13409322	chr2:104034033	IL18RAP	chr2:103035254-103069022:+	-0.28	-4.17	3.8E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs1341759	chr6:26195502	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.42	1.3E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs1344513	chr12:109090581	SELPLG	chr12:109015682-109027670:-	0.1	3.84	0.000148	Low high density lipoprotein cholesterol levels	
LIHC	cis	1	rs1345824	chr5:42724062	CCDC152	chr5:42756920-42802539:+	0.19	4	7.8E-5	Height	
LIHC	cis	1	rs1346719	chr3:53077372	RFT1	chr3:53122503-53164470:-	0.39	3.91	0.000112	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.19	-4.14	4.46E-5	Cognitive function	
LIHC	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.18	-4	7.78E-5	Cognitive function	
LIHC	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.18	-3.95	9.47E-5	Cognitive function	
LIHC	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.2	-4.49	9.9E-6	Cognitive function	
LIHC	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.2	-4.63	5.12E-6	Cognitive function	
LIHC	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.65	9.35	1.16E-18	Height	
LIHC	cis	1	rs1360172	chr9:131907980	CRAT	chr9:131857075-131873070:-	0.23	4.02	7.14E-5	Blood metabolite ratios	
LIHC	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.67	-10.38	3.75E-22	Type 2 diabetes	
LIHC	cis	1	rs1373270	chr11:120324080	TMEM136	chr11:120196016-120204388:+	0.23	4.01	7.41E-5	Intraocular pressure	
LIHC	cis	1	rs1374469	chr4:1724799	FAM53A	chr4:1641609-1685854:-	-0.41	-5.18	3.76E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs138544659	chr15:78900701	CHRNA5	chr15:78857906-78886458:+	-0.26	-3.91	0.000111	Post bronchodilator FEV1;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
LIHC	cis	1	rs1391708	chr12:57305580	ATP5B	chr12:57031961-57039852:-	0.26	3.86	0.000138	Airway wall thickness	
LIHC	cis	1	rs1392104	chr7:65759107	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.17	3.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs1395297	chr15:50878509	USP8	chr15:50716579-50793276:+	0.21	4.29	2.37E-5	QT interval	
LIHC	cis	1	rs1401796	chr17:54839759	ANKFN1	chr17:54230836-54560007:+	-0.18	-3.96	9.05E-5	Height	
LIHC	cis	1	rs1404147	chr7:65264524	CCT6P1	chr7:65216092-65228661:+	0.35	5.02	8.48E-7	Diabetic kidney disease	
LIHC	cis	1	rs1404147	chr7:65264524	INTS4L1	chr7:64601603-64694599:+	0.35	4.28	2.42E-5	Diabetic kidney disease	
LIHC	cis	1	rs1411478	chr1:180962282	STX6	chr1:180913175-180992046:-	-0.17	-4.12	4.73E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs1412444	chr10:91002927	LIPA	chr10:90973328-91174382:-	0.26	4.76	2.84E-6	Fibrinogen levels	
LIHC	cis	1	rs1412445	chr10:91002804	LIPA	chr10:90973328-91174382:-	0.26	4.61	5.62E-6	Fibrinogen levels	
LIHC	cis	1	rs141518190	chr15:78900647	CHRNA5	chr15:78857906-78886458:+	-0.26	-3.91	0.000111	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
LIHC	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.55	-9.58	1.98E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs1422160	chr5:170243433	RANBP17	chr5:170289022-170727018:+	0.47	3.88	0.000126	Smooth-surface caries	
LIHC	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.65	11.71	6.9E-27	Type 2 diabetes	
LIHC	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.62	11.22	4.34E-25	Type 2 diabetes	
LIHC	cis	1	rs1423653	chr5:42751448	CCDC152	chr5:42756920-42802539:+	0.19	4.07	5.87E-5	Height	
LIHC	cis	1	rs1428551	chr5:150259832	LOC134466	chr5:150310000-150326146:-	0.35	4.61	5.68E-6	Crohn's disease	
LIHC	cis	1	rs1428552	chr5:150259831	LOC134466	chr5:150310000-150326146:-	0.35	4.58	6.45E-6	Crohn's disease	
LIHC	cis	1	rs1428554	chr5:150257616	LOC134466	chr5:150310000-150326146:-	0.34	4.4	1.42E-5	Crohn's disease	
LIHC	cis	1	rs1428555	chr5:150257391	LOC134466	chr5:150310000-150326146:-	-0.32	-4.22	3.08E-5	Crohn's disease	
LIHC	cis	1	rs1466389	chr17:2096384	SRR	chr17:2207248-2228553:+	-0.29	-4.14	4.42E-5	Esophageal cancer (squamous cell)	
LIHC	cis	1	rs1472750	chr10:115235114	DCLRE1A	chr10:115594484-115613859:-	-0.39	-4.15	4.24E-5	Migraine without aura	
LIHC	cis	1	rs1472750	chr10:115235114	HABP2	chr10:115312778-115349358:+	-0.42	-4.21	3.28E-5	Migraine without aura	
LIHC	cis	1	rs1472750	chr10:115235114	TCF7L2	chr10:114710009-114927434:+	-0.41	-3.84	0.000148	Migraine without aura	
LIHC	cis	1	rs1474698	chr6:56064197	COL21A1	chr6:55921389-56258892:-	-0.58	-10.47	1.84E-22	Pulse pressure	
LIHC	cis	1	rs147499554	chr15:78900650	CHRNA5	chr15:78857906-78886458:+	-0.26	-3.91	0.000111	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
LIHC	cis	1	rs148734725	chr3:49406708	SLC26A6	chr3:48663158-48672926:-	0.27	3.94	0.0001	Educational attainment (college completion)	
LIHC	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.63	9.06	1.02E-17	Height	
LIHC	cis	1	rs1499613	chr7:65730860	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.17	3.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs1499614	chr7:65730798	CCT6P1	chr7:65216092-65228661:+	0.31	4.3	2.27E-5	Diabetic kidney disease	
LIHC	cis	1	rs1511218	chr2:160906390	LY75	chr2:160625141-160761262:-	0.25	5.52	6.68E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs151222	chr16:20674492	ACSM5	chr16:20420856-20452278:+	0.2	4.07	5.91E-5	Schizophrenia	
LIHC	cis	1	rs1512268	chr8:23526463	NKX3-1	chr8:23536207-23540450:-	0.31	5.51	7.01E-8	Prostate cancer (gene x gene interaction);Prostate cancer	
LIHC	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.6	-11.58	2.02E-26	Ankylosing spondylitis	
LIHC	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.53	7.93	3.05E-14	Ankylosing spondylitis	
LIHC	cis	1	rs1521908	chr6:109613986	CD164	chr6:109687718-109703762:-	-0.26	-5.05	7.14E-7	Red blood cell traits	
LIHC	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.63	5.24E-6	Obesity-related traits	
LIHC	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs1533825	chr11:214163	PSMD13	chr11:236808-252984:+	0.24	4.36	1.72E-5	Menarche (age at onset)	
LIHC	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.3	1.69E-18	Height	
LIHC	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.65	9.44	6.03E-19	Height	
LIHC	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.36	-5.4	1.23E-7	Obesity-related traits	
LIHC	cis	1	rs1553174	chr7:65731194	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.17	3.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.65	11.74	5.43E-27	Type 2 diabetes	
LIHC	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.11E-14	Diastolic blood pressure	
LIHC	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.21	-4.72	3.46E-6	Blood metabolite levels	
LIHC	cis	1	rs15676	chr9:131572027	PKN3	chr9:131464802-131483198:+	0.29	4.52	8.7E-6	Blood metabolite levels	
LIHC	cis	1	rs1569933	chr6:161071212	LPA	chr6:160952516-161087407:-	-0.2	-4.15	4.25E-5	Lipoprotein (a) levels	
LIHC	cis	1	rs1571229	chr9:131913711	CRAT	chr9:131857075-131873070:-	0.23	4.13	4.62E-5	Blood metabolite ratios	
LIHC	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.56	-10.26	9.8E-22	Response to antipsychotic treatment	
LIHC	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.55	-9.58	1.98E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs1593071	chr5:42786309	CCDC152	chr5:42756920-42802539:+	0.19	3.97	8.84E-5	Height	
LIHC	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.4	6.11	2.73E-9	Multiple sclerosis	
LIHC	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.41	-6.88	2.92E-11	Multiple sclerosis	
LIHC	cis	1	rs1599932	chr12:58177943	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.7	3.84E-6	Multiple sclerosis	
LIHC	cis	1	rs160633	chr7:65528228	CCT6P1	chr7:65216092-65228661:+	0.31	4.33	1.99E-5	Diabetic kidney disease	
LIHC	cis	1	rs160633	chr7:65528228	INTS4L1	chr7:64601603-64694599:+	0.34	4.05	6.28E-5	Diabetic kidney disease	
LIHC	cis	1	rs160634	chr7:65528664	CCT6P1	chr7:65216092-65228661:+	-0.34	-4.95	1.17E-6	Diabetic kidney disease	
LIHC	cis	1	rs160634	chr7:65528664	INTS4L1	chr7:64601603-64694599:+	-0.33	-4.23	3.04E-5	Diabetic kidney disease	
LIHC	cis	1	rs160637	chr7:65584318	CCT6P1	chr7:65216092-65228661:+	0.29	4.12	4.7E-5	Diabetic kidney disease	
LIHC	cis	1	rs160639	chr7:65579987	CCT6P1	chr7:65216092-65228661:+	0.31	4.32	2.0E-5	Diabetic kidney disease	
LIHC	cis	1	rs160642	chr7:65558373	CCT6P1	chr7:65216092-65228661:+	0.31	4.32	2.05E-5	Diabetic kidney disease	
LIHC	cis	1	rs160643	chr7:65558222	CCT6P1	chr7:65216092-65228661:+	0.28	4.07	5.9E-5	Diabetic kidney disease	
LIHC	cis	1	rs160643	chr7:65558222	INTS4L1	chr7:64601603-64694599:+	0.32	4.07	5.73E-5	Diabetic kidney disease	
LIHC	cis	1	rs160644	chr7:65558186	CCT6P1	chr7:65216092-65228661:+	0.31	4.34	1.85E-5	Diabetic kidney disease	
LIHC	cis	1	rs160646	chr7:65556280	CCT6P1	chr7:65216092-65228661:+	0.3	4.22	3.1E-5	Diabetic kidney disease	
LIHC	cis	1	rs160648	chr7:65543384	CCT6P1	chr7:65216092-65228661:+	0.32	4.4	1.46E-5	Diabetic kidney disease	
LIHC	cis	1	rs160648	chr7:65543384	INTS4L1	chr7:64601603-64694599:+	0.32	3.83	0.000153	Diabetic kidney disease	
LIHC	cis	1	rs160652	chr7:65538431	CCT6P1	chr7:65216092-65228661:+	0.29	3.92	0.000108	Diabetic kidney disease	
LIHC	cis	1	rs160655	chr7:65533214	CCT6P1	chr7:65216092-65228661:+	0.32	4.41	1.38E-5	Diabetic kidney disease	
LIHC	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.58	-7.9	3.8E-14	Diastolic blood pressure	
LIHC	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.59	-8.13	8.06E-15	Diastolic blood pressure	
LIHC	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-0.6	-8.22	4.33E-15	Diastolic blood pressure	
LIHC	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.6	-8.1	9.8E-15	Diastolic blood pressure	
LIHC	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.28	4.89	1.57E-6	Rheumatoid arthritis	
LIHC	cis	1	rs1638731	chr7:66144679	CCT6P1	chr7:65216092-65228661:+	0.32	4.45	1.17E-5	Gout	
LIHC	cis	1	rs1638734	chr7:66097539	CCT6P1	chr7:65216092-65228661:+	0.29	3.96	8.95E-5	Diabetic kidney disease	
LIHC	cis	1	rs1659695	chr2:27406944	C2orf28	chr2:27434899-27440044:+	-0.25	-3.96	9.19E-5	Blood metabolite levels	
LIHC	cis	1	rs1665362	chr4:1726367	FAM53A	chr4:1641609-1685854:-	-0.39	-5.08	6.26E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs1665364	chr4:1727206	FAM53A	chr4:1641609-1685854:-	0.39	5.04	7.42E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs1665366	chr4:1728381	FAM53A	chr4:1641609-1685854:-	0.39	4.99	9.56E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.59	4.67	4.3E-6	Rheumatoid arthritis	
LIHC	cis	1	rs16844715	chr2:160915106	LY75	chr2:160625141-160761262:-	-0.25	-5.55	5.59E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs16863064	chr3:187887577	FLJ42393	chr3:187896331-187898596:+	0.34	5.6	4.38E-8	Schizophrenia	
LIHC	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.65	-14.97	2.31E-39	Response to antipsychotic treatment	
LIHC	cis	1	rs16885753	chr8:36883562	ERLIN2	chr8:37594097-37615318:+	0.32	3.97	8.65E-5	Insulin resistance/response	
LIHC	cis	1	rs16885753	chr8:36883562	PROSC	chr8:37620101-37637285:+	0.33	3.94	9.69E-5	Insulin resistance/response	
LIHC	cis	1	rs16885753	chr8:36883562	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.73	3.24E-6	Insulin resistance/response	
LIHC	cis	1	rs16885761	chr8:36894918	ERLIN2	chr8:37594097-37615318:+	0.32	4.12	4.66E-5	Insulin resistance/response	
LIHC	cis	1	rs16885761	chr8:36894918	PROSC	chr8:37620101-37637285:+	0.34	4.21	3.2E-5	Insulin resistance/response	
LIHC	cis	1	rs16885761	chr8:36894918	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.97	1.04E-6	Insulin resistance/response	
LIHC	cis	1	rs16885776	chr8:36899107	ERLIN2	chr8:37594097-37615318:+	0.33	4.19	3.5E-5	Insulin resistance/response	
LIHC	cis	1	rs16885776	chr8:36899107	PROSC	chr8:37620101-37637285:+	0.35	4.24	2.93E-5	Insulin resistance/response	
LIHC	cis	1	rs16885776	chr8:36899107	RAB11FIP1	chr8:37716470-37757003:-	0.38	5.19	3.52E-7	Insulin resistance/response	
LIHC	cis	1	rs16885813	chr8:36913144	ERLIN2	chr8:37594097-37615318:+	0.33	4.11	4.87E-5	Insulin resistance/response	
LIHC	cis	1	rs16885813	chr8:36913144	PROSC	chr8:37620101-37637285:+	0.37	4.49	9.82E-6	Insulin resistance/response	
LIHC	cis	1	rs16885813	chr8:36913144	RAB11FIP1	chr8:37716470-37757003:-	0.41	5.54	6.03E-8	Insulin resistance/response	
LIHC	cis	1	rs16885830	chr8:36924119	RAB11FIP1	chr8:37716470-37757003:-	-0.37	-5.05	7.07E-7	Insulin resistance/response	
LIHC	cis	1	rs16885838	chr8:36929372	ERLIN2	chr8:37594097-37615318:+	-0.34	-4.5	9.46E-6	Insulin resistance/response	
LIHC	cis	1	rs16885838	chr8:36929372	PROSC	chr8:37620101-37637285:+	-0.39	-5.12	5.02E-7	Insulin resistance/response	
LIHC	cis	1	rs16885838	chr8:36929372	RAB11FIP1	chr8:37716470-37757003:-	-0.39	-5.7	2.62E-8	Insulin resistance/response	
LIHC	cis	1	rs16885876	chr8:36939955	PROSC	chr8:37620101-37637285:+	0.33	4.1	5.08E-5	Insulin resistance/response	
LIHC	cis	1	rs16885876	chr8:36939955	RAB11FIP1	chr8:37716470-37757003:-	0.37	5.24	2.78E-7	Insulin resistance/response	
LIHC	cis	1	rs16885905	chr8:36960089	PROSC	chr8:37620101-37637285:+	0.32	3.93	0.000103	Insulin resistance/response	
LIHC	cis	1	rs16885905	chr8:36960089	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.9	1.47E-6	Insulin resistance/response	
LIHC	cis	1	rs16891378	chr6:26188864	HIST1H2AE	chr6:26217148-26217711:+	-0.36	-4.13	4.53E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs16891397	chr6:26200256	HIST1H2AE	chr6:26217148-26217711:+	-0.36	-3.95	9.47E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs16891401	chr6:26202337	HIST1H2AE	chr6:26217148-26217711:+	-0.36	-3.89	0.000121	Renal underexcretion gout;Gout	
LIHC	cis	1	rs16891405	chr6:26204506	HIST1H2AE	chr6:26217148-26217711:+	-0.37	-4.07	5.74E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs16928809	chr11:2936952	SLC22A18	chr11:2920951-2946475:+	-0.3	-4.09	5.47E-5	Bilirubin levels	
LIHC	cis	1	rs16943730	chr12:114576081	IQCD	chr12:113633248-113658880:-	0.31	3.83	0.000155	Visceral fat	
LIHC	cis	1	rs16943732	chr12:114577947	IQCD	chr12:113633248-113658880:-	0.31	3.83	0.000155	Visceral fat	
LIHC	cis	1	rs16945894	chr16:48180110	LONP2	chr16:48278211-48387407:+	-0.23	-3.94	9.79E-5	Amyotrophic lateral sclerosis (sporadic)	
LIHC	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.32	-4.69	3.88E-6	Esophageal cancer (squamous cell)	
LIHC	cis	1	rs16957590	chr16:67934725	DPEP2	chr16:68021295-68034489:-	-0.39	-3.91	0.00011	Crohn's disease	
LIHC	cis	1	rs16967057	chr19:32914078	DPY19L3	chr19:32896677-32975236:+	-0.19	-4	7.61E-5	Bipolar disorder	
LIHC	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.59	-8.62	2.42E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.6	-8.57	3.52E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.6	-8.57	3.52E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.56	-8.49	6.46E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.55	-8.12	8.49E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.55	-8.03	1.57E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1701750	chr7:65467145	CCT6P1	chr7:65216092-65228661:+	0.36	4.89	1.55E-6	Diabetic kidney disease	
LIHC	cis	1	rs1701758	chr7:65470201	CCT6P1	chr7:65216092-65228661:+	0.36	4.89	1.55E-6	Diabetic kidney disease	
LIHC	cis	1	rs17026854	chr2:86280496	POLR1A	chr2:86253453-86333278:-	-0.36	-4.96	1.13E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs17028778	chr2:104012172	IL18RAP	chr2:103035254-103069022:+	-0.27	-3.94	9.88E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs17028798	chr2:104016446	IL18RAP	chr2:103035254-103069022:+	0.27	4.2	3.4E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.43	5.71	2.43E-8	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs17030651	chr1:113239382	ST7L	chr1:113066142-113162405:-	0.44	5.9	8.84E-9	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs17036023	chr1:117129711	TTF2	chr1:117602949-117645489:+	0.28	4.12	4.7E-5	Asthma (childhood onset)	
LIHC	cis	1	rs17036023	chr1:117129711	VANGL1	chr1:116184574-116240845:+	0.38	4.31	2.16E-5	Asthma (childhood onset)	
LIHC	cis	1	rs17040870	chr12:109085410	SELPLG	chr12:109015682-109027670:-	0.1	3.86	0.000138	Low high density lipoprotein cholesterol levels	
LIHC	cis	1	rs17052727	chr3:53070914	RFT1	chr3:53122503-53164470:-	0.4	3.92	0.000108	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.0E-14	Diastolic blood pressure	
LIHC	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.53	7.23	3.13E-12	Diastolic blood pressure	
LIHC	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.11E-14	Diastolic blood pressure	
LIHC	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.11E-14	Diastolic blood pressure	
LIHC	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.11E-14	Diastolic blood pressure	
LIHC	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	0.59	7.89	3.96E-14	Diastolic blood pressure	
LIHC	cis	1	rs17080292	chr6:118850266	C6orf204	chr6:118786239-119031238:-	-0.28	-4.17	3.81E-5	Renal cell carcinoma	
LIHC	cis	1	rs17080302	chr6:118854037	C6orf204	chr6:118786239-119031238:-	-0.28	-4.17	3.81E-5	Renal cell carcinoma	
LIHC	cis	1	rs17104012	chr14:24930321	SDR39U1	chr14:24908974-24912064:-	0.52	4.87	1.73E-6	Smooth-surface caries	
LIHC	cis	1	rs17111346	chr14:81452172	TSHR	chr14:81421869-81612646:+	-0.21	-3.84	0.000149	Graves' disease	
LIHC	cis	1	rs17111376	chr5:150226899	LOC134466	chr5:150310000-150326146:-	0.32	4.13	4.51E-5	Crohn's disease	
LIHC	cis	1	rs17116334	chr11:113961762	REXO2	chr11:114310108-114320998:+	-0.32	-3.88	0.000124	Conduct disorder (interaction)	
LIHC	cis	1	rs17131992	chr5:109687439	MAN2A1	chr5:109025156-109203429:+	0.31	4.74	3.09E-6	Cardiac structure and function	
LIHC	cis	1	rs17131992	chr5:109687439	TMEM232	chr5:109624934-110062381:-	0.42	4.12	4.79E-5	Cardiac structure and function	
LIHC	cis	1	rs17132018	chr5:109696836	MAN2A1	chr5:109025156-109203429:+	0.29	4.48	9.99E-6	Cardiac structure and function	
LIHC	cis	1	rs17132018	chr5:109696836	TMEM232	chr5:109624934-110062381:-	0.41	4.03	6.85E-5	Cardiac structure and function	
LIHC	cis	1	rs17132029	chr5:109702488	MAN2A1	chr5:109025156-109203429:+	0.31	4.85	1.91E-6	Cardiac structure and function	
LIHC	cis	1	rs17132029	chr5:109702488	TMEM232	chr5:109624934-110062381:-	0.41	4.09	5.43E-5	Cardiac structure and function	
LIHC	cis	1	rs17132042	chr5:109711476	MAN2A1	chr5:109025156-109203429:+	0.29	4.64	4.9E-6	Cardiac structure and function	
LIHC	cis	1	rs17132042	chr5:109711476	TMEM232	chr5:109624934-110062381:-	0.4	4.03	6.89E-5	Cardiac structure and function	
LIHC	cis	1	rs17132261	chr5:110008214	TMEM232	chr5:109624934-110062381:-	-0.34	-3.82	0.000156	Cardiac structure and function	
LIHC	cis	1	rs1715235	chr7:65488394	CCT6P1	chr7:65216092-65228661:+	0.36	4.98	9.93E-7	Diabetic kidney disease	
LIHC	cis	1	rs1715235	chr7:65488394	INTS4L1	chr7:64601603-64694599:+	0.33	3.96	9.18E-5	Diabetic kidney disease	
LIHC	cis	1	rs17161692	chr7:98953863	CYP3A5	chr7:99245818-99332821:-	-0.66	-10.28	8.68E-22	Blood metabolite levels	
LIHC	cis	1	rs17164747	chr4:260587	ZNF718	chr4:53272-156488:+	0.3	4.85	1.84E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.47	4.73	3.24E-6	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.59	-8.13	8.06E-15	Diastolic blood pressure	
LIHC	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.58	-7.9	3.8E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.6	-8.2	4.71E-15	Diastolic blood pressure	
LIHC	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.58	-7.67	1.75E-13	Diastolic blood pressure	
LIHC	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-0.61	-8.18	5.64E-15	Diastolic blood pressure	
LIHC	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.58	-8.08	1.14E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.6	-8.15	6.72E-15	Diastolic blood pressure	
LIHC	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-0.58	-7.67	1.75E-13	Diastolic blood pressure	
LIHC	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.59	8.04	1.46E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.59	-8.02	1.72E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-0.58	-7.67	1.75E-13	Diastolic blood pressure	
LIHC	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-0.59	-8.06	1.3E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-0.59	-8.03	1.52E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-0.6	-8.18	5.46E-15	Diastolic blood pressure	
LIHC	cis	1	rs1716984	chr3:41965532	ULK4	chr3:41288091-42003660:-	-0.59	-8.19	5.22E-15	Diastolic blood pressure	
LIHC	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.58	-7.9	3.8E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.58	-7.92	3.26E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-0.59	-8.02	1.72E-14	Diastolic blood pressure	
LIHC	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-0.61	-8.18	5.64E-15	Diastolic blood pressure	
LIHC	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-0.61	-8.18	5.64E-15	Diastolic blood pressure	
LIHC	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.59	-8.1	9.41E-15	Diastolic blood pressure	
LIHC	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.6	8.15	6.72E-15	Diastolic blood pressure	
LIHC	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.6	-8.23	3.89E-15	Diastolic blood pressure	
LIHC	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.59	-8.13	8.06E-15	Diastolic blood pressure	
LIHC	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.58	7.67	1.75E-13	Diastolic blood pressure	
LIHC	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.58	7.67	1.75E-13	Diastolic blood pressure	
LIHC	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.58	8.08	1.14E-14	Diastolic blood pressure	
LIHC	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-0.59	-8.13	7.65E-15	Diastolic blood pressure	
LIHC	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-0.53	-7.37	1.29E-12	Diastolic blood pressure	
LIHC	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-0.58	-7.96	2.57E-14	Diastolic blood pressure	
LIHC	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.59	7.89	3.96E-14	Diastolic blood pressure	
LIHC	cis	1	rs17219063	chr6:56000228	COL21A1	chr6:55921389-56258892:-	-0.33	-4.01	7.58E-5	Psychosis (atypical)	
LIHC	cis	1	rs17219382	chr6:56009638	COL21A1	chr6:55921389-56258892:-	0.34	4.06	6.13E-5	Psychosis (atypical)	
LIHC	cis	1	rs1723267	chr7:65473314	CCT6P1	chr7:65216092-65228661:+	0.37	5.12	5.09E-7	Diabetic kidney disease	
LIHC	cis	1	rs1723267	chr7:65473314	INTS4L1	chr7:64601603-64694599:+	0.33	3.94	0.0001	Diabetic kidney disease	
LIHC	cis	1	rs1723269	chr7:65472786	CCT6P1	chr7:65216092-65228661:+	0.37	5.14	4.64E-7	Diabetic kidney disease	
LIHC	cis	1	rs1723269	chr7:65472786	INTS4L1	chr7:64601603-64694599:+	0.34	4.02	7.27E-5	Diabetic kidney disease	
LIHC	cis	1	rs1723270	chr7:65469830	CCT6P1	chr7:65216092-65228661:+	0.36	4.91	1.43E-6	Diabetic kidney disease	
LIHC	cis	1	rs17341301	chr2:160902420	LY75	chr2:160625141-160761262:-	0.23	4.95	1.17E-6	Idiopathic membranous nephropathy	
LIHC	cis	1	rs17412623	chr8:20221586	ATP6V1B2	chr8:20054704-20079205:+	0.35	4.45	1.17E-5	Preeclampsia	
LIHC	cis	1	rs17412978	chr8:20275296	ATP6V1B2	chr8:20054704-20079205:+	-0.34	-3.84	0.000146	Preeclampsia	
LIHC	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.78	15.94	3.09E-43	Carotid intima media thickness	
LIHC	cis	1	rs174551	chr11:61573684	FADS1	chr11:61567103-61584529:-	-0.51	-8.15	6.8E-15	LDL cholesterol	
LIHC	cis	1	rs174551	chr11:61573684	FADS2	chr11:61583728-61634825:+	-0.31	-4.71	3.55E-6	LDL cholesterol	
LIHC	cis	1	rs174551	chr11:61573684	FADS3	chr11:61640999-61659422:-	-0.29	-4.88	1.63E-6	LDL cholesterol	
LIHC	cis	1	rs17496332	chr1:107546375	PRMT6	chr1:107599267-107601907:+	0.64	12.34	3.26E-29	Sex hormone-binding globulin levels	
LIHC	cis	1	rs17511672	chr6:107776430	LACE1	chr6:108616098-108844249:+	0.49	3.83	0.000152	Airway responsiveness in chronic obstructive pulmonary disease	
LIHC	cis	1	rs17511672	chr6:107776430	OSTM1	chr6:108362615-108395941:-	0.42	4.54	7.79E-6	Airway responsiveness in chronic obstructive pulmonary disease	
LIHC	cis	1	rs17511672	chr6:107776430	SNX3	chr6:108532718-108582464:-	0.51	4.16	4.06E-5	Airway responsiveness in chronic obstructive pulmonary disease	
LIHC	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.52	-7.8	7.68E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.52	8.01	1.84E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.56	-8.49	6.46E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.56	-8.49	6.46E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.58	-8.6	2.94E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.56	-8.49	6.46E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.49	-6.26	1.11E-9	Forced vital capacity	
LIHC	cis	1	rs17598927	chr6:26184640	HIST1H2AE	chr6:26217148-26217711:+	0.43	4.62	5.44E-6	Renal underexcretion gout;Gout	
LIHC	cis	1	rs17600551	chr15:85319258	NMB	chr15:85198362-85201802:-	-0.38	-5.96	6.16E-9	Schizophrenia	
LIHC	cis	1	rs17600551	chr15:85319258	UBE2Q2P1	chr15:85070427-85114026:-	0.24	3.97	8.86E-5	Schizophrenia	
LIHC	cis	1	rs17601029	chr15:85347709	NMB	chr15:85198362-85201802:-	-0.38	-5.98	5.45E-9	Schizophrenia	
LIHC	cis	1	rs17601029	chr15:85347709	UBE2Q2P1	chr15:85070427-85114026:-	0.23	3.87	0.000132	Schizophrenia	
LIHC	cis	1	rs17601264	chr13:44636472	ENOX1	chr13:43787680-44361106:-	-0.29	-3.87	0.000131	Prostate cancer (gene x gene interaction)	
LIHC	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.4	-7.32	1.79E-12	Temperament	
LIHC	cis	1	rs17609940	chr6:35034800	TCP11	chr6:35085849-35109187:-	-0.42	-3.97	8.74E-5	Coronary heart disease	
LIHC	cis	1	rs17618001	chr2:86289303	POLR1A	chr2:86253453-86333278:-	-0.38	-5.13	4.97E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs17645523	chr15:50882645	USP8	chr15:50716579-50793276:+	-0.22	-4.5	9.31E-6	QT interval	
LIHC	cis	1	rs17645649	chr15:50900370	USP8	chr15:50716579-50793276:+	-0.24	-4.82	2.21E-6	QT interval	
LIHC	cis	1	rs17645826	chr15:50950141	USP8	chr15:50716579-50793276:+	-0.23	-4.6	5.82E-6	QT interval	
LIHC	cis	1	rs17671194	chr15:40667539	C15orf23	chr15:40674922-40686488:+	0.67	6.75	6.31E-11	Heschl's gyrus morphology	
LIHC	cis	1	rs17671250	chr15:40673124	C15orf23	chr15:40674922-40686488:+	-0.43	-4.99	9.75E-7	Heschl's gyrus morphology	
LIHC	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.66	9.52	3.27E-19	Height	
LIHC	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.38	4.69	3.94E-6	Crohn's disease	
LIHC	cis	1	rs17733640	chr3:38446742	XYLB	chr3:38388251-38456467:+	0.28	5.31	1.95E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs177377	chr14:73753519	ACOT1	chr14:74003928-74042357:+	-0.23	-4.18	3.67E-5	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs177377	chr14:73753519	ACOT2	chr14:74034324-74042357:+	-0.23	-4.2	3.41E-5	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs177377	chr14:73753519	HEATR4	chr14:73945193-74025651:-	-0.42	-6.83	3.88E-11	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs1775148	chr1:205757824	RAB7L1	chr1:205737115-205744610:-	0.22	3.81	0.000165	Prostate cancer	
LIHC	cis	1	rs1775151	chr1:205745684	RAB7L1	chr1:205737115-205744610:-	0.23	4.18	3.76E-5	Parkinson's disease	
LIHC	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.39	5.78	1.69E-8	Esophageal cancer (squamous cell)	
LIHC	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.38	4.94	1.23E-6	Crohn's disease	
LIHC	cis	1	rs17800987	chr5:150323428	LOC134466	chr5:150310000-150326146:-	0.34	4.46	1.12E-5	Crohn's disease	
LIHC	cis	1	rs17831161	chr2:160909360	LY75	chr2:160625141-160761262:-	0.25	5.54	6.04E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs17831191	chr2:160911332	LY75	chr2:160625141-160761262:-	0.25	5.54	6.04E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs17831251	chr2:160914156	LY75	chr2:160625141-160761262:-	0.24	5.22	3.08E-7	Idiopathic membranous nephropathy	
LIHC	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.36	-4.82	2.2E-6	Esophageal cancer (squamous cell)	
LIHC	cis	1	rs1783521	chr11:64106291	COX8A	chr11:63742079-63744014:+	0.2	4.22	3.13E-5	Crohn's disease;Alopecia areata;Psoriasis vulgaris	
LIHC	cis	1	rs17836662	chr22:50672154	SELO	chr22:50639408-50656044:+	-0.21	-4.45	1.15E-5	Obesity-related traits	
LIHC	cis	1	rs17848459	chr22:51012311	CPT1B	chr22:51007291-51017096:-	-0.28	-3.84	0.000146	Narcolepsy	
LIHC	cis	1	rs17884832	chr10:96534475	CYP2C18	chr10:96443251-96495945:+	-0.34	-3.85	0.00014	Blood metabolite levels	
LIHC	cis	1	rs1796220	chr7:66062100	CCT6P1	chr7:65216092-65228661:+	0.31	4.22	3.11E-5	Diabetic kidney disease	
LIHC	cis	1	rs1796228	chr7:66033084	CCT6P1	chr7:65216092-65228661:+	0.31	4.25	2.81E-5	Diabetic kidney disease	
LIHC	cis	1	rs1800615	chr1:15832281	CASP9	chr1:15817324-15851384:-	0.21	3.85	0.000139	Glomerular filtration rate (creatinine)	
LIHC	cis	1	rs1803037	chr4:99993151	RG9MTD2	chr4:100467874-100485189:-	-0.45	-4.09	5.34E-5	Smoking initiation	
LIHC	cis	1	rs1807609	chr22:29131129	CHEK2	chr22:29083731-29137822:-	-0.49	-7.55	3.82E-13	Esophageal cancer and gastric cancer	
LIHC	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.66	9.38	9.19E-19	Height	
LIHC	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.64	9.32	1.46E-18	Height	
LIHC	cis	1	rs1816256	chr5:150272853	LOC134466	chr5:150310000-150326146:-	0.34	4.56	7.11E-6	Crohn's disease	
LIHC	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.34	-4.87	1.67E-6	Schizophrenia	
LIHC	cis	1	rs1818950	chr15:84722521	NMB	chr15:85198362-85201802:-	-0.35	-4.75	2.99E-6	Schizophrenia	
LIHC	cis	1	rs1820682	chr5:150262142	LOC134466	chr5:150310000-150326146:-	0.34	4.46	1.1E-5	Crohn's disease	
LIHC	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.65	11.74	5.43E-27	Type 2 diabetes	
LIHC	cis	1	rs1841777	chr3:38484819	XYLB	chr3:38388251-38456467:+	0.28	5.28	2.26E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.34	-4.83	2.11E-6	Schizophrenia	
LIHC	cis	1	rs1848093	chr15:84755527	NMB	chr15:85198362-85201802:-	-0.35	-4.78	2.61E-6	Schizophrenia	
LIHC	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.58	-8.37	1.5E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.57	-10.28	8.47E-22	Response to antipsychotic treatment	
LIHC	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.54	-9.77	4.67E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs1859690	chr7:99227172	CYP3A5	chr7:99245818-99332821:-	0.94	15.73	2.11E-42	Blood metabolite levels	
LIHC	cis	1	rs1859690	chr7:99227172	ZKSCAN5	chr7:99102273-99131444:+	0.33	3.92	0.000106	Blood metabolite levels	
LIHC	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.65	11.74	5.43E-27	Type 2 diabetes	
LIHC	cis	1	rs1862630	chr5:42754243	CCDC152	chr5:42756920-42802539:+	0.19	4.11	5.01E-5	Height	
LIHC	cis	1	rs186378	chr7:65582058	CCT6P1	chr7:65216092-65228661:+	0.29	4.12	4.7E-5	Diabetic kidney disease	
LIHC	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.62	8.98	1.84E-17	Height	
LIHC	cis	1	rs1863998	chr5:150271753	LOC134466	chr5:150310000-150326146:-	0.33	4.39	1.48E-5	Crohn's disease	
LIHC	cis	1	rs1864367	chr3:53111704	RFT1	chr3:53122503-53164470:-	-0.37	-6.11	2.67E-9	Height	
LIHC	cis	1	rs1865144	chr2:104000985	IL18RAP	chr2:103035254-103069022:+	-0.27	-4	7.86E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs1869365	chr17:40293865	HSPB9	chr17:40274756-40275371:+	0.27	4.08	5.6E-5	Fibrinogen levels	
LIHC	cis	1	rs1873862	chr12:51914220	KRT80	chr12:52562781-52585784:-	0.39	3.81	0.000165	White matter lesion progression;White matter lesion progression (adjusted for white matter lesion burden at baseline)	
LIHC	cis	1	rs1874883	chr3:134205071	ANAPC13	chr3:134196547-134204865:-	0.66	9.43	6.06E-19	Height	
LIHC	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.4	6.11	2.73E-9	Multiple sclerosis	
LIHC	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.41	-6.88	2.92E-11	Multiple sclerosis	
LIHC	cis	1	rs1875124	chr12:58196802	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.7	3.84E-6	Multiple sclerosis	
LIHC	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs1882655	chr7:66147057	CCT6P1	chr7:65216092-65228661:+	-0.32	-4.45	1.17E-5	Gout	
LIHC	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.37	-5.06	6.98E-7	Esophageal cancer (squamous cell)	
LIHC	cis	1	rs1892894	chr11:120254684	TMEM136	chr11:120196016-120204388:+	0.26	4.5	9.4E-6	Intraocular pressure	
LIHC	cis	1	rs1895409	chr5:170241249	RANBP17	chr5:170289022-170727018:+	0.48	3.88	0.000123	Smooth-surface caries	
LIHC	cis	1	rs1895457	chr5:42765332	CCDC152	chr5:42756920-42802539:+	0.19	4.11	4.86E-5	Height	
LIHC	cis	1	rs1896707	chr5:150245129	LOC134466	chr5:150310000-150326146:-	0.32	4.22	3.16E-5	Crohn's disease	
LIHC	cis	1	rs1896708	chr5:150245076	LOC134466	chr5:150310000-150326146:-	0.35	4.48	1.01E-5	Crohn's disease	
LIHC	cis	1	rs1896709	chr5:150245032	LOC134466	chr5:150310000-150326146:-	0.32	4.22	3.16E-5	Crohn's disease	
LIHC	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.69	12.59	3.6E-30	Type 2 diabetes	
LIHC	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.34	-4.84	2.0E-6	Schizophrenia	
LIHC	cis	1	rs1911155	chr15:84787635	NMB	chr15:85198362-85201802:-	-0.36	-4.95	1.19E-6	Schizophrenia	
LIHC	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.63	-14	1.48E-35	Response to antipsychotic treatment	
LIHC	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.54	-9.77	4.67E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.64	-8.92	2.72E-17	Height	
LIHC	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.74	3.14E-6	Obesity-related traits	
LIHC	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.69	4.02E-6	Obesity-related traits	
LIHC	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.37	-5.71	2.46E-8	Obesity-related traits	
LIHC	cis	1	rs1920581	chr12:114587388	IQCD	chr12:113633248-113658880:-	0.31	3.98	8.5E-5	Visceral fat	
LIHC	cis	1	rs1920588	chr12:114566615	IQCD	chr12:113633248-113658880:-	0.31	3.95	9.54E-5	Visceral fat	
LIHC	cis	1	rs1925148	chr6:56095672	COL21A1	chr6:55921389-56258892:-	0.59	10.59	6.99E-23	Pulse pressure	
LIHC	cis	1	rs1925152	chr6:56102709	COL21A1	chr6:55921389-56258892:-	0.55	9.47	4.73E-19	Pulse pressure	
LIHC	cis	1	rs1930961	chr22:25875265	CRYBB2	chr22:25615612-25627836:+	0.84	9.11	6.74E-18	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs1933182	chr1:109999838	SYPL2	chr1:110009100-110024763:+	-0.65	-7.61	2.64E-13	Chronic kidney disease	
LIHC	cis	1	rs1935	chr10:64927823	NRBF2	chr10:64893007-64914785:+	-0.23	-3.94	9.91E-5	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LIHC	cis	1	rs1947861	chr6:49482687	CENPQ	chr6:49431096-49460820:+	-0.22	-4.66	4.49E-6	Brain structure	
LIHC	cis	1	rs1949510	chr2:17778129	GEN1	chr2:17935162-17966632:+	0.41	5.11	5.44E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs1951137	chr14:24950703	SDR39U1	chr14:24908974-24912064:-	-0.48	-4.63	5.11E-6	Smooth-surface caries	
LIHC	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.59	-11.13	8.59E-25	Response to antipsychotic treatment	
LIHC	cis	1	rs1964692	chr7:65454183	CCT6P1	chr7:65216092-65228661:+	0.36	4.89	1.55E-6	Diabetic kidney disease	
LIHC	cis	1	rs1971762	chr12:54058238	ATP5G2	chr12:54058945-54070512:-	0.17	4.18	3.65E-5	Height	
LIHC	cis	1	rs1979823	chr7:65704613	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.07	5.85E-5	Diabetic kidney disease	
LIHC	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.68	-7.59	3.08E-13	Schizophrenia	
LIHC	cis	1	rs1981898	chr14:76175565	TTLL5	chr14:76127621-76421421:+	0.21	3.89	0.000121	Large artery stroke	
LIHC	cis	1	rs1986074	chr15:50857452	USP8	chr15:50716579-50793276:+	-0.2	-3.96	9.04E-5	QT interval	
LIHC	cis	1	rs1986557	chr4:283118	ZNF718	chr4:53272-156488:+	0.29	5.22	3.09E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.58	7.47	6.47E-13	Diastolic blood pressure	
LIHC	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.54	-9.77	4.67E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.52	-9.38	9.07E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs2004711	chr5:150225068	LOC134466	chr5:150310000-150326146:-	0.33	4.26	2.67E-5	Crohn's disease	
LIHC	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.83	1.28E-8	Forced vital capacity	
LIHC	cis	1	rs2010648	chr14:35604892	PPP2R3C	chr14:35554679-35591679:-	0.36	4.86	1.83E-6	Atopic dermatitis	
LIHC	cis	1	rs2010916	chr22:30441219	CABP7	chr22:30116344-30127818:+	0.49	4.04	6.56E-5	LDL cholesterol	
LIHC	cis	1	rs2011064	chr15:50957625	USP8	chr15:50716579-50793276:+	-0.2	-4.06	6.14E-5	QT interval	
LIHC	cis	1	rs2012798	chr2:86182756	POLR1A	chr2:86253453-86333278:-	-0.38	-5.06	6.73E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs2014521	chr17:40283413	HSPB9	chr17:40274756-40275371:+	0.28	4.18	3.68E-5	Fibrinogen levels	
LIHC	cis	1	rs2015336	chr17:18073610	LOC220594	chr17:18414577-18445234:-	-0.42	-4.16	4.0E-5	Obesity-related traits	
LIHC	cis	1	rs2028062	chr11:61745953	DAK	chr11:61100654-61116230:+	0.22	3.82	0.000158	Phospholipid levels (plasma)	
LIHC	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.65	9.25	2.44E-18	Height	
LIHC	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.64	8.97	1.91E-17	Height	
LIHC	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.55	-7.28	2.28E-12	Subcutaneous adipose tissue	
LIHC	cis	1	rs2061973	chr6:49487125	CENPQ	chr6:49431096-49460820:+	0.22	4.72	3.47E-6	Brain structure	
LIHC	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.42	-6.05	3.88E-9	Multiple sclerosis	
LIHC	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.37	5.93	7.23E-9	Multiple sclerosis	
LIHC	cis	1	rs2069502	chr12:58144665	XRCC6BP1	chr12:58335445-58351051:+	0.26	4.41	1.38E-5	Multiple sclerosis	
LIHC	cis	1	rs2070488	chr3:38442490	XYLB	chr3:38388251-38456467:+	-0.26	-5.03	7.74E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.4	5.8	1.48E-8	Multiple sclerosis	
LIHC	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.37	-6.02	4.5E-9	Multiple sclerosis	
LIHC	cis	1	rs2072052	chr12:58146719	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-4.32	2.07E-5	Multiple sclerosis	
LIHC	cis	1	rs2072435	chr7:75959188	UPK3B	chr7:76139745-76157197:+	-0.26	-3.82	0.000157	Multiple sclerosis	
LIHC	cis	1	rs2074038	chr11:44087989	ACCS	chr11:44087475-44105569:+	0.73	10.83	1.03E-23	IgA nephropathy	
LIHC	cis	1	rs2075292	chr11:116732512	PCSK7	chr11:117075789-117102811:-	-0.34	-4.36	1.69E-5	Protein quantitative trait loci	
LIHC	cis	1	rs2076946	chr14:24951823	SDR39U1	chr14:24908974-24912064:-	-0.48	-4.77	2.7E-6	Smooth-surface caries	
LIHC	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.31	-5.34	1.73E-7	Homocysteine levels	
LIHC	cis	1	rs2081015	chr5:153606932	MFAP3	chr5:153418519-153437014:+	-0.24	-4.97	1.06E-6	Carotid artery intima media thickness (sex interaction)	
LIHC	cis	1	rs2081909	chr5:109724995	MAN2A1	chr5:109025156-109203429:+	0.29	4.43	1.28E-5	Cardiac structure and function	
LIHC	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.59	-8.5	5.8E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.43	6.7	8.67E-11	Blood trace element (Zn levels)	
LIHC	cis	1	rs2084220	chr11:18656932	SPTY2D1	chr11:18627949-18656020:-	-0.23	-4.73	3.28E-6	Cholesterol, total	
LIHC	cis	1	rs2106430	chr22:30597135	CABP7	chr22:30116344-30127818:+	0.52	3.81	0.000167	LDL cholesterol	
LIHC	cis	1	rs2106722	chr22:30543824	CABP7	chr22:30116344-30127818:+	0.52	4.28	2.44E-5	LDL cholesterol	
LIHC	cis	1	rs2111504	chr19:32917455	DPY19L3	chr19:32896677-32975236:+	0.2	4.07	5.9E-5	Bipolar disorder	
LIHC	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.65	12.01	5.48E-28	Type 2 diabetes	
LIHC	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.68	12.38	2.32E-29	Type 2 diabetes	
LIHC	cis	1	rs2115069	chr5:150252365	LOC134466	chr5:150310000-150326146:-	0.35	4.48	1.01E-5	Crohn's disease	
LIHC	cis	1	rs2115671	chr15:50956432	USP8	chr15:50716579-50793276:+	-0.2	-4.05	6.31E-5	QT interval	
LIHC	cis	1	rs2118521	chr2:86204379	POLR1A	chr2:86253453-86333278:-	-0.32	-4.49	9.83E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.58	7.75	1.08E-13	Diastolic blood pressure	
LIHC	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.59	7.94	2.96E-14	Diastolic blood pressure	
LIHC	cis	1	rs2141924	chr7:66186246	CCT6P1	chr7:65216092-65228661:+	0.33	4.52	8.55E-6	Gout	
LIHC	cis	1	rs2142136	chr10:89763070	FAM35A	chr10:88854953-88951220:+	-0.28	-4.12	4.84E-5	Type 2 diabetes	
LIHC	cis	1	rs2143346	chr6:26198449	HIST1H2AE	chr6:26217148-26217711:+	0.38	4.24	2.87E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs2143347	chr6:26198494	HIST1H2AE	chr6:26217148-26217711:+	-0.36	-4.07	5.91E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs2143950	chr14:35572357	PPP2R3C	chr14:35554679-35591679:-	0.38	5	9.03E-7	Atopic dermatitis	
LIHC	cis	1	rs2144726	chr6:161076247	LPA	chr6:160952516-161087407:-	0.19	3.92	0.000109	Lipoprotein (a) levels	
LIHC	cis	1	rs2152916	chr10:97392265	ALDH18A1	chr10:97365687-97416567:-	0.29	4.36	1.72E-5	Blood metabolite levels	
LIHC	cis	1	rs2152916	chr10:97392265	ENTPD1	chr10:97471536-97637022:+	0.22	4.29	2.29E-5	Blood metabolite levels	
LIHC	cis	1	rs2160215	chr14:81461472	TSHR	chr14:81421869-81612646:+	-0.23	-4.14	4.41E-5	Graves' disease	
LIHC	cis	1	rs2163167	chr3:53131772	RFT1	chr3:53122503-53164470:-	-0.36	-5.82	1.32E-8	Height	
LIHC	cis	1	rs2166580	chr4:1743169	FAM53A	chr4:1641609-1685854:-	-0.4	-5.18	3.88E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.63	-14.33	7.55E-37	Response to antipsychotic treatment	
LIHC	cis	1	rs2174608	chr15:50871993	USP8	chr15:50716579-50793276:+	-0.2	-4.07	5.9E-5	QT interval	
LIHC	cis	1	rs2175416	chr2:160904021	LY75	chr2:160625141-160761262:-	0.25	5.45	9.44E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs2177703	chr7:65391717	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs2177703	chr7:65391717	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs2184877	chr1:40996932	DEM1	chr1:40974433-40982212:+	0.29	4.14	4.38E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs2198042	chr4:129885499	C4orf33	chr4:130014829-130033842:+	0.52	7.41	9.67E-13	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs2210913	chr1:157668993	FCRL3	chr1:157646278-157670775:-	0.27	6.23	1.35E-9	Type 1 diabetes autoantibodies	
LIHC	cis	1	rs2217266	chr5:150272621	LOC134466	chr5:150310000-150326146:-	0.34	4.53	8.01E-6	Crohn's disease	
LIHC	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.59	-11.5	3.9E-26	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs2229238	chr1:154437896	TDRD10	chr1:154474695-154520622:+	0.27	3.92	0.000107	Coronary heart disease	
LIHC	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.4	9.12	6.38E-18	Homocysteine levels	
LIHC	cis	1	rs2236786	chr4:1719294	FAM53A	chr4:1641609-1685854:-	0.41	5.02	8.23E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs2239815	chr22:29192670	CHEK2	chr22:29083731-29137822:-	0.25	4.09	5.35E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs2240009	chr17:40283142	HSPB9	chr17:40274756-40275371:+	0.28	4.17	3.84E-5	Fibrinogen levels	
LIHC	cis	1	rs2240010	chr17:40278081	HSPB9	chr17:40274756-40275371:+	0.28	4.15	4.13E-5	Fibrinogen levels	
LIHC	cis	1	rs2241107	chr1:156182710	PMF1	chr1:156182784-156209831:+	0.19	3.81	0.000165	Testicular germ cell tumor	
LIHC	cis	1	rs2241437	chr2:86360573	POLR1A	chr2:86253453-86333278:-	-0.35	-4.81	2.23E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs2241437	chr2:86360573	REEP1	chr2:86441122-86564777:-	0.4	3.95	9.35E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs2243480	chr7:65599196	CCT6P1	chr7:65216092-65228661:+	0.28	3.83	0.000155	Diabetic kidney disease	
LIHC	cis	1	rs2245715	chr15:43818052	ADAL	chr15:43622872-43646094:+	-0.31	-5.07	6.67E-7	Tumor biomarkers	
LIHC	cis	1	rs2246833	chr10:91005854	LIPA	chr10:90973328-91174382:-	0.22	4.07	5.83E-5	Fibrinogen levels	
LIHC	cis	1	rs2246942	chr10:91004886	LIPA	chr10:90973328-91174382:-	0.25	4.38	1.54E-5	Fibrinogen levels	
LIHC	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.36	-8.03	1.61E-14	Homocysteine levels	
LIHC	cis	1	rs2251844	chr15:43836478	ADAL	chr15:43622872-43646094:+	-0.32	-5.18	3.86E-7	Tumor biomarkers	
LIHC	cis	1	rs2253209	chr3:53115160	RFT1	chr3:53122503-53164470:-	-0.36	-5.89	9.09E-9	Height	
LIHC	cis	1	rs2253656	chr3:53119099	RFT1	chr3:53122503-53164470:-	-0.37	-5.93	7.48E-9	Height	
LIHC	cis	1	rs2253685	chr3:53119703	RFT1	chr3:53122503-53164470:-	-0.38	-6.1	2.82E-9	Height	
LIHC	cis	1	rs2253796	chr3:53120098	RFT1	chr3:53122503-53164470:-	-0.38	-6.1	2.82E-9	Height	
LIHC	cis	1	rs2255042	chr15:43834318	ADAL	chr15:43622872-43646094:+	0.32	5.33	1.78E-7	Tumor biomarkers	
LIHC	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.32	-5.18	3.86E-7	Tumor biomarkers	
LIHC	cis	1	rs2255440	chr15:43830467	ADAL	chr15:43622872-43646094:+	-0.32	-5.18	3.79E-7	Tumor biomarkers	
LIHC	cis	1	rs2257790	chr7:65600450	CCT6P1	chr7:65216092-65228661:+	0.3	4.13	4.53E-5	Diabetic kidney disease	
LIHC	cis	1	rs2260160	chr15:43895643	ADAL	chr15:43622872-43646094:+	-0.33	-4.89	1.51E-6	Tumor biomarkers	
LIHC	cis	1	rs2268753	chr3:38500189	XYLB	chr3:38388251-38456467:+	0.27	5.27	2.36E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs2268757	chr3:38505853	XYLB	chr3:38388251-38456467:+	0.27	5.27	2.36E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs2268758	chr3:38514049	XYLB	chr3:38388251-38456467:+	0.27	5.27	2.36E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs2269381	chr22:51020069	NCAPH2	chr22:50946645-50961911:+	0.27	3.9	0.000118	Narcolepsy	
LIHC	cis	1	rs2269382	chr22:51018911	NCAPH2	chr22:50946645-50961911:+	0.27	3.95	9.5E-5	Narcolepsy	
LIHC	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.4	6.63	1.29E-10	Height	
LIHC	cis	1	rs2269577	chr22:29196757	CHEK2	chr22:29083731-29137822:-	-0.26	-4.3	2.24E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs2270291	chr1:156244992	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs2271976	chr12:123751726	ABCB9	chr12:123413540-123459752:-	0.34	4.36	1.7E-5	HDL cholesterol	
LIHC	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-0.59	-8.03	1.52E-14	Diastolic blood pressure	
LIHC	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.59	-8.05	1.33E-14	Diastolic blood pressure	
LIHC	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.7	-5.29	2.18E-7	Rheumatoid arthritis	
LIHC	cis	1	rs2272563	chr11:236871	PSMD13	chr11:236808-252984:+	-0.24	-4.19	3.5E-5	Menarche (age at onset)	
LIHC	cis	1	rs2272565	chr11:244414	PSMD13	chr11:236808-252984:+	-0.23	-4.06	6.02E-5	Menarche (age at onset)	
LIHC	cis	1	rs2276540	chr3:38512507	XYLB	chr3:38388251-38456467:+	0.27	5.27	2.36E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs2277762	chr20:22548283	C20orf56	chr20:22541194-22559280:-	-0.32	-4.08	5.49E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs2277763	chr20:22548294	C20orf56	chr20:22541194-22559280:-	-0.33	-4.3	2.22E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.5	-7.32	1.81E-12	Cholesterol, total	
LIHC	cis	1	rs2277870	chr1:156246792	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs2277871	chr1:156246742	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs2278087	chr2:86281946	POLR1A	chr2:86253453-86333278:-	-0.36	-4.95	1.16E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs2279588	chr5:1878021	MRPL36	chr5:1798500-1799956:-	0.21	3.89	0.000119	Cardiovascular disease risk factors	
LIHC	cis	1	rs2282679	chr4:72608383	GC	chr4:72607413-72669758:-	0.24	3.91	0.00011	Vitamin D levels;Vitamin D insufficiency	
LIHC	cis	1	rs2285657	chr17:40272594	HSPB9	chr17:40274756-40275371:+	0.31	4.52	8.34E-6	Fibrinogen levels	
LIHC	cis	1	rs2288073	chr2:24413298	C2orf84	chr2:24397531-24414566:+	-0.31	-4.19	3.51E-5	Venous thromboembolism (SNP x SNP interaction)	
LIHC	cis	1	rs2289237	chr2:86266274	POLR1A	chr2:86253453-86333278:-	0.37	5.05	7.36E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs2289681	chr17:42989088	CCDC103	chr17:42977154-42982758:+	0.32	4.11	4.92E-5	Cognitive function	
LIHC	cis	1	rs2290850	chr11:47807774	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.81	6.12E-17	Subjective well-being	
LIHC	cis	1	rs2292174	chr15:50924956	USP8	chr15:50716579-50793276:+	-0.24	-4.75	2.94E-6	QT interval	
LIHC	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.53	8.57	3.67E-16	Cognitive function	
LIHC	cis	1	rs2293167	chr11:211644	PSMD13	chr11:236808-252984:+	0.24	4.27	2.52E-5	Menarche (age at onset)	
LIHC	cis	1	rs2296691	chr10:97370989	ALDH18A1	chr10:97365687-97416567:-	0.29	4.31	2.14E-5	Blood metabolite levels	
LIHC	cis	1	rs2296691	chr10:97370989	ENTPD1	chr10:97471536-97637022:+	0.22	4.44	1.22E-5	Blood metabolite levels	
LIHC	cis	1	rs2297112	chr9:131900180	CRAT	chr9:131857075-131873070:-	0.23	4.05	6.34E-5	Blood metabolite ratios	
LIHC	cis	1	rs2298632	chr1:23710475	ZNF436	chr1:23685942-23696357:-	-0.2	-3.84	0.000144	QT interval	
LIHC	cis	1	rs2298755	chr4:100261038	ADH1C	chr4:100257651-100273917:-	0.26	3.99	8.06E-5	Oral cavity and pharyngeal cancer	
LIHC	cis	1	rs2300601	chr14:75639571	EIF2B2	chr14:75469612-75476292:+	0.25	3.82	0.000158	Height	
LIHC	cis	1	rs2300601	chr14:75639571	MLH3	chr14:75480467-75518235:-	0.27	4.17	3.93E-5	Height	
LIHC	cis	1	rs2301889	chr7:98931105	CYP3A5	chr7:99245818-99332821:-	0.66	9.9	1.73E-20	Blood metabolite levels	
LIHC	cis	1	rs2303759	chr19:49869051	CD37	chr19:49838428-49843859:+	-0.09	-4.19	3.61E-5	Multiple sclerosis	
LIHC	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.31	-5.07	6.53E-7	Multiple sclerosis	
LIHC	cis	1	rs2305008	chr11:120319064	TMEM136	chr11:120196016-120204388:+	0.26	4.53	8.27E-6	Intraocular pressure	
LIHC	cis	1	rs2305010	chr11:120330149	TMEM136	chr11:120196016-120204388:+	-0.24	-4.27	2.48E-5	Intraocular pressure	
LIHC	cis	1	rs2305188	chr4:1739592	FAM53A	chr4:1641609-1685854:-	-0.38	-4.97	1.08E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs2306937	chr1:113246506	ST7L	chr1:113066142-113162405:-	0.43	5.64	3.57E-8	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.5	6.84	3.57E-11	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs230812	chr5:42797761	CCDC152	chr5:42756920-42802539:+	-0.19	-3.98	8.43E-5	Height	
LIHC	cis	1	rs230813	chr5:42799033	CCDC152	chr5:42756920-42802539:+	-0.19	-3.98	8.43E-5	Height	
LIHC	cis	1	rs230814	chr5:42799271	CCDC152	chr5:42756920-42802539:+	-0.18	-3.96	9.1E-5	Height	
LIHC	cis	1	rs2315561	chr4:17679695	LDB2	chr4:16503167-16900424:-	0.13	3.81	0.000164	Parasitemia in Tripanosoma cruzi seropositivity	
LIHC	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.59	-10.54	1.08E-22	Response to antipsychotic treatment	
LIHC	cis	1	rs2331903	chr1:180950869	STX6	chr1:180913175-180992046:-	-0.19	-4.46	1.13E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs2332352	chr14:24953980	SDR39U1	chr14:24908974-24912064:-	0.45	4.5	9.29E-6	Smooth-surface caries	
LIHC	cis	1	rs2333194	chr14:73767214	ACOT1	chr14:74003928-74042357:+	-0.24	-4.42	1.32E-5	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs2333194	chr14:73767214	ACOT2	chr14:74034324-74042357:+	-0.23	-4.37	1.62E-5	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs2333194	chr14:73767214	HEATR4	chr14:73945193-74025651:-	-0.42	-6.87	3.02E-11	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs2336723	chr3:53106047	RFT1	chr3:53122503-53164470:-	-0.36	-5.89	9.06E-9	Height	
LIHC	cis	1	rs2344180	chr5:150267357	LOC134466	chr5:150310000-150326146:-	0.33	4.38	1.57E-5	Crohn's disease	
LIHC	cis	1	rs2344181	chr5:150262574	LOC134466	chr5:150310000-150326146:-	0.33	4.32	2.05E-5	Crohn's disease	
LIHC	cis	1	rs2345001	chr5:150266518	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs2347447	chr22:29179739	CHEK2	chr22:29083731-29137822:-	-0.26	-4.19	3.51E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs2349748	chr7:136130536	NUP205	chr7:135242662-135333489:+	-0.38	-4.42	1.33E-5	Late-onset Alzheimer's disease	
LIHC	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.65	-10.03	5.99E-21	Type 2 diabetes	
LIHC	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.65	-10.03	5.99E-21	Type 2 diabetes	
LIHC	cis	1	rs2353605	chr4:219538	ZNF718	chr4:53272-156488:+	0.35	5.91	8.32E-9	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.31	-5.42	1.11E-7	Homocysteine levels	
LIHC	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.29	-5.09	5.97E-7	Homocysteine levels	
LIHC	cis	1	rs2359155	chr19:21671869	ZNF493	chr19:21579921-21610294:+	-0.25	-3.93	0.000103	Pain	
LIHC	cis	1	rs2359155	chr19:21671869	ZNF708	chr19:21473963-21512212:-	-0.24	-4.78	2.58E-6	Pain	
LIHC	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.57	-5.85	1.17E-8	Plasma clusterin levels	
LIHC	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.65	9.12	6.49E-18	Height	
LIHC	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.66	9.51	3.47E-19	Height	
LIHC	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.67	9.56	2.27E-19	Height	
LIHC	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs2371623	chr3:41761083	ULK4	chr3:41288091-42003660:-	0.6	8.05	1.33E-14	Diastolic blood pressure	
LIHC	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	0.58	7.95	2.63E-14	Diastolic blood pressure	
LIHC	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.23	2.84E-18	Height	
LIHC	cis	1	rs2384207	chr12:113607502	C12orf52	chr12:113623555-113630119:+	-0.26	-4	7.77E-5	Response to fenofibrate (adiponectin levels)	
LIHC	cis	1	rs2412979	chr22:30580161	CABP7	chr22:30116344-30127818:+	0.5	4.32	2.06E-5	LDL cholesterol	
LIHC	cis	1	rs2414060	chr15:50873262	USP8	chr15:50716579-50793276:+	-0.2	-4.08	5.66E-5	QT interval	
LIHC	cis	1	rs2420170	chr7:65656053	CCT6P1	chr7:65216092-65228661:+	-0.28	-3.86	0.000135	Diabetic kidney disease	
LIHC	cis	1	rs2420171	chr7:65637760	CCT6P1	chr7:65216092-65228661:+	-0.29	-3.94	9.73E-5	Diabetic kidney disease	
LIHC	cis	1	rs2421332	chr2:61876965	C2orf74	chr2:61372243-61391964:+	-0.34	-4.04	6.67E-5	Homeostasis model assessment of beta-cell function (interaction)	
LIHC	cis	1	rs2421994	chr1:172279909	C1orf105	chr1:172389830-172437965:+	-0.26	-3.9	0.000115	Height	
LIHC	cis	1	rs2425031	chr20:33855284	MAP1LC3A	chr20:33134692-33148149:+	0.39	3.86	0.000133	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs2425032	chr20:33855454	MAP1LC3A	chr20:33134692-33148149:+	0.39	3.84	0.000148	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs2425034	chr20:33855814	MAP1LC3A	chr20:33134692-33148149:+	0.39	3.84	0.000148	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs2425036	chr20:33855981	MAP1LC3A	chr20:33134692-33148149:+	0.39	3.84	0.000148	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs2425040	chr20:33858878	MAP1LC3A	chr20:33134692-33148149:+	0.4	3.87	0.000132	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.69	12.52	7.0E-30	Type 2 diabetes	
LIHC	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.33	4.92	1.37E-6	Tumor biomarkers	
LIHC	cis	1	rs2447196	chr15:43893818	CATSPER2	chr15:43922774-43959900:-	0.34	4.78	2.59E-6	Tumor biomarkers	
LIHC	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.34	-5.15	4.41E-7	Tumor biomarkers	
LIHC	cis	1	rs2447208	chr15:43933895	CATSPER2	chr15:43922774-43959900:-	-0.38	-5.54	5.88E-8	Tumor biomarkers	
LIHC	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.34	-5.15	4.43E-7	Tumor biomarkers	
LIHC	cis	1	rs2447211	chr15:43936351	CATSPER2	chr15:43922774-43959900:-	-0.35	-4.89	1.52E-6	Tumor biomarkers	
LIHC	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.37	8.3	2.46E-15	Homocysteine levels	
LIHC	cis	1	rs2448707	chr6:49446951	CENPQ	chr6:49431096-49460820:+	0.2	3.97	8.65E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs244899	chr5:167911040	FBLL1	chr5:167956582-167957638:+	0.4	5.95	6.67E-9	Response to platinum-based chemotherapy (carboplatin)	
LIHC	cis	1	rs2457570	chr6:160829518	LPA	chr6:160952516-161087407:-	0.28	3.87	0.000129	Response to hepatitis C treatment	
LIHC	cis	1	rs2459629	chr5:42790874	CCDC152	chr5:42756920-42802539:+	-0.19	-3.97	8.87E-5	Height	
LIHC	cis	1	rs2460422	chr7:65601505	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs2462569	chr7:65474846	CCT6P1	chr7:65216092-65228661:+	-0.35	-4.9	1.5E-6	Diabetic kidney disease	
LIHC	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.6	-11.57	2.21E-26	Ankylosing spondylitis	
LIHC	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.53	7.95	2.75E-14	Ankylosing spondylitis	
LIHC	cis	1	rs2466096	chr8:32430732	NRG1	chr8:31497268-32622558:+	-0.28	-4.19	3.48E-5	Thyroid hormone levels	
LIHC	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.35	5.28	2.33E-7	Tumor biomarkers	
LIHC	cis	1	rs2470134	chr15:43849886	CATSPER2	chr15:43922774-43959900:-	0.35	4.85	1.87E-6	Tumor biomarkers	
LIHC	cis	1	rs2471	chr20:22544749	C20orf56	chr20:22541194-22559280:-	-0.31	-4.36	1.69E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs2498471	chr6:49484433	CENPQ	chr6:49431096-49460820:+	0.21	4.44	1.2E-5	Brain structure	
LIHC	cis	1	rs2501962	chr6:49453636	CENPQ	chr6:49431096-49460820:+	0.2	3.96	8.95E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs2501963	chr6:49454281	CENPQ	chr6:49431096-49460820:+	0.2	3.95	9.45E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs2524005	chr6:29899677	HLA-J	chr6:29973748-29977731:+	0.44	5.99	5.36E-9	Bipolar disorder and schizophrenia	
LIHC	cis	1	rs2524296	chr11:61601378	FADS1	chr11:61567103-61584529:-	-0.55	-7.08	8.21E-12	Gestational age at birth (child effect);Trans fatty acid levels	
LIHC	cis	1	rs2524296	chr11:61601378	FADS2	chr11:61583728-61634825:+	-0.41	-5.1	5.69E-7	Gestational age at birth (child effect);Trans fatty acid levels	
LIHC	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.68	12.35	3.08E-29	Type 2 diabetes	
LIHC	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.69	12.26	6.65E-29	Type 2 diabetes	
LIHC	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.68	12.38	2.21E-29	Type 2 diabetes	
LIHC	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.69	12.57	4.42E-30	Type 2 diabetes	
LIHC	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.69	12.46	1.15E-29	Type 2 diabetes	
LIHC	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	0.75	13.61	4.84E-34	Type 2 diabetes	
LIHC	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.67	-12.14	1.85E-28	Type 2 diabetes	
LIHC	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.69	12.42	1.57E-29	Type 2 diabetes	
LIHC	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.68	12.37	2.58E-29	Type 2 diabetes	
LIHC	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.69	12.55	5.44E-30	Type 2 diabetes	
LIHC	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.69	12.47	1.08E-29	Type 2 diabetes	
LIHC	cis	1	rs2533288	chr7:66056711	CCT6P1	chr7:65216092-65228661:+	0.31	4.22	3.11E-5	Diabetic kidney disease	
LIHC	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.68	12.35	2.94E-29	Type 2 diabetes	
LIHC	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.68	12.38	2.25E-29	Type 2 diabetes	
LIHC	cis	1	rs2562456	chr19:21666210	ZNF708	chr19:21473963-21512212:-	0.21	4.48	1.04E-5	Pain	
LIHC	cis	1	rs2564921	chr3:53125585	RFT1	chr3:53122503-53164470:-	0.36	5.92	7.99E-9	Height	
LIHC	cis	1	rs2564926	chr3:53094730	RFT1	chr3:53122503-53164470:-	-0.49	-4.74	3.19E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs2564940	chr3:53107569	RFT1	chr3:53122503-53164470:-	-0.37	-5.98	5.74E-9	Height	
LIHC	cis	1	rs2581782	chr3:53122257	RFT1	chr3:53122503-53164470:-	-0.37	-6	4.89E-9	Height	
LIHC	cis	1	rs2581783	chr3:53122258	RFT1	chr3:53122503-53164470:-	-0.37	-6	4.89E-9	Height	
LIHC	cis	1	rs2581786	chr3:53126143	RFT1	chr3:53122503-53164470:-	-0.36	-5.87	1.02E-8	Height	
LIHC	cis	1	rs2581787	chr3:53127677	RFT1	chr3:53122503-53164470:-	-0.38	-6.19	1.72E-9	Height	
LIHC	cis	1	rs2581794	chr3:53036206	RFT1	chr3:53122503-53164470:-	-0.25	-3.89	0.00012	Schizophrenia	
LIHC	cis	1	rs2581800	chr3:53109352	RFT1	chr3:53122503-53164470:-	-0.38	-6.1	2.78E-9	Height	
LIHC	cis	1	rs261431	chr13:21865738	MRP63	chr13:21750372-21753218:+	0.27	3.82	0.000161	White matter hyperintensity burden	
LIHC	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.36	-5.32	1.83E-7	Tumor biomarkers	
LIHC	cis	1	rs2614811	chr15:43913487	CATSPER2	chr15:43922774-43959900:-	-0.37	-5.11	5.32E-7	Tumor biomarkers	
LIHC	cis	1	rs2618516	chr11:14021639	SPON1	chr11:13983914-14289646:+	-0.26	-6.06	3.64E-9	Brain connectivity	
LIHC	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs2629540	chr10:126426148	METTL10	chr10:126447406-126480439:-	0.35	5.01	8.93E-7	Cocaine dependence	
LIHC	cis	1	rs2630	chr15:50849399	USP8	chr15:50716579-50793276:+	-0.21	-4.26	2.62E-5	QT interval	
LIHC	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.6	-11.63	1.36E-26	Ankylosing spondylitis	
LIHC	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.53	7.79	8.01E-14	Ankylosing spondylitis	
LIHC	cis	1	rs2651807	chr11:2378840	C11orf21	chr11:2317507-2323143:-	-0.19	-4.08	5.55E-5	Bacteremia	
LIHC	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.56	-8.37	1.42E-15	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs2659903	chr7:66180931	CCT6P1	chr7:65216092-65228661:+	0.33	4.52	8.55E-6	Gout	
LIHC	cis	1	rs2659911	chr7:66158420	CCT6P1	chr7:65216092-65228661:+	0.33	4.52	8.55E-6	Gout	
LIHC	cis	1	rs2659913	chr7:66157336	CCT6P1	chr7:65216092-65228661:+	0.33	4.52	8.55E-6	Gout	
LIHC	cis	1	rs267974	chr5:10723467	DAP	chr5:10679343-10761387:-	0.36	4.27	2.48E-5	Metabolite levels (Pyroglutamine)	
LIHC	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.59	7.89	3.96E-14	Diastolic blood pressure	
LIHC	cis	1	rs2683696	chr3:41914898	ULK4	chr3:41288091-42003660:-	0.59	7.88	4.47E-14	Diastolic blood pressure	
LIHC	cis	1	rs2707828	chr7:66171377	CCT6P1	chr7:65216092-65228661:+	0.33	4.52	8.55E-6	Gout	
LIHC	cis	1	rs2707830	chr7:66167645	CCT6P1	chr7:65216092-65228661:+	0.33	4.52	8.55E-6	Gout	
LIHC	cis	1	rs2707831	chr7:66062511	CCT6P1	chr7:65216092-65228661:+	0.31	4.22	3.11E-5	Diabetic kidney disease	
LIHC	cis	1	rs2707832	chr7:66136549	CCT6P1	chr7:65216092-65228661:+	0.31	4.51	8.87E-6	Gout	
LIHC	cis	1	rs2707838	chr7:66159201	CCT6P1	chr7:65216092-65228661:+	0.33	4.52	8.55E-6	Gout	
LIHC	cis	1	rs2707840	chr7:66158015	CCT6P1	chr7:65216092-65228661:+	0.33	4.52	8.55E-6	Gout	
LIHC	cis	1	rs2707844	chr7:66059509	CCT6P1	chr7:65216092-65228661:+	0.31	4.22	3.11E-5	Diabetic kidney disease	
LIHC	cis	1	rs271621	chr19:18631332	ISYNA1	chr19:18545625-18548943:-	0.2	4.53	8.09E-6	Breast cancer	
LIHC	cis	1	rs271623	chr19:18628947	ISYNA1	chr19:18545625-18548943:-	0.19	4.23	3.04E-5	Breast cancer	
LIHC	cis	1	rs271624	chr19:18627953	ISYNA1	chr19:18545625-18548943:-	0.18	4.16	3.98E-5	Breast cancer	
LIHC	cis	1	rs2717562	chr8:143776668	LYNX1	chr8:143845758-143859640:-	-0.23	-3.82	0.000161	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
LIHC	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.6	-11.68	9.23E-27	Ankylosing spondylitis	
LIHC	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.53	7.87	4.8E-14	Ankylosing spondylitis	
LIHC	cis	1	rs2762353	chr6:25794431	BTN2A2	chr6:26383354-26395098:+	-0.27	-4.71	3.67E-6	Blood metabolite levels	
LIHC	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.6	11.59	1.92E-26	Ankylosing spondylitis	
LIHC	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.52	-7.69	1.54E-13	Ankylosing spondylitis	
LIHC	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.55	-7.85	5.48E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.55	-7.93	3.18E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.62	-13.55	8.16E-34	Response to antipsychotic treatment	
LIHC	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.62	-13.66	3.08E-34	Response to antipsychotic treatment	
LIHC	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.63	-13.8	9.08E-35	Response to antipsychotic treatment	
LIHC	cis	1	rs2835872	chr21:39027272	PIGP	chr21:38437664-38445458:-	0.31	4.25	2.78E-5	Electroencephalographic traits in alcoholism	
LIHC	cis	1	rs28365850	chr14:35591316	PPP2R3C	chr14:35554679-35591679:-	0.38	4.98	1.02E-6	Atopic dermatitis	
LIHC	cis	1	rs28367503	chr16:67854534	DPEP2	chr16:68021295-68034489:-	0.42	4.08	5.57E-5	Crohn's disease	
LIHC	cis	1	rs2836974	chr21:40663181	HMGN1	chr21:40714247-40721270:-	0.28	4.09	5.29E-5	Cognitive function	
LIHC	cis	1	rs28372828	chr1:156253031	BGLAP	chr1:156182784-156213112:+	0.21	4.24	2.91E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.5	-9.36	1.06E-18	Testicular germ cell tumor	
LIHC	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.51	-9.54	2.69E-19	Testicular germ cell tumor	
LIHC	cis	1	rs2839337	chr21:47987167	C21orf57	chr21:47706267-47717664:+	0.23	3.96	9.05E-5	Lymphocyte counts	
LIHC	cis	1	rs2839434	chr21:43418905	C21orf121	chr21:43442113-43445060:+	0.3	3.91	0.00011	Hand grip strength	
LIHC	cis	1	rs2839466	chr21:43512324	NDUFV3	chr21:44313378-44329772:+	0.25	4.05	6.36E-5	IgG glycosylation	
LIHC	cis	1	rs28399702	chr14:35625217	PPP2R3C	chr14:35554679-35591679:-	0.36	4.84	1.93E-6	Atopic dermatitis	
LIHC	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs28410096	chr12:123880862	ABCB9	chr12:123413540-123459752:-	-0.36	-4.61	5.69E-6	HDL cholesterol	
LIHC	cis	1	rs2845573	chr11:61601908	FADS1	chr11:61567103-61584529:-	0.55	7.12	6.5E-12	Gestational age at birth (child effect);Trans fatty acid levels	
LIHC	cis	1	rs2845573	chr11:61601908	FADS2	chr11:61583728-61634825:+	0.41	5.09	5.89E-7	Gestational age at birth (child effect);Trans fatty acid levels	
LIHC	cis	1	rs2845573	chr11:61601908	FADS3	chr11:61640999-61659422:-	0.29	3.87	0.000132	Gestational age at birth (child effect);Trans fatty acid levels	
LIHC	cis	1	rs2845574	chr11:61601872	FADS1	chr11:61567103-61584529:-	-0.55	-7.1	7.04E-12	Gestational age at birth (child effect);Trans fatty acid levels	
LIHC	cis	1	rs2845574	chr11:61601872	FADS2	chr11:61583728-61634825:+	-0.41	-5.08	6.07E-7	Gestational age at birth (child effect);Trans fatty acid levels	
LIHC	cis	1	rs28468623	chr7:98922812	CYP3A5	chr7:99245818-99332821:-	0.67	9.67	1.03E-19	Blood metabolite levels	
LIHC	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.33	-5.38	1.39E-7	Glycated hemoglobin levels	
LIHC	cis	1	rs28489285	chr9:99543229	FAM22G	chr9:99690592-99704572:+	0.67	7.57	3.46E-13	Height	
LIHC	cis	1	rs28494067	chr15:50908272	USP8	chr15:50716579-50793276:+	-0.23	-4.53	8.01E-6	QT interval	
LIHC	cis	1	rs2851682	chr11:61616012	FADS1	chr11:61567103-61584529:-	-0.5	-6.22	1.42E-9	Gestational age at birth (child effect);Trans fatty acid levels	
LIHC	cis	1	rs2851682	chr11:61616012	FADS2	chr11:61583728-61634825:+	-0.37	-4.55	7.3E-6	Gestational age at birth (child effect);Trans fatty acid levels	
LIHC	cis	1	rs28532037	chr12:123883406	ABCB9	chr12:123413540-123459752:-	-0.35	-4.37	1.68E-5	HDL cholesterol	
LIHC	cis	1	rs2854218	chr17:61942940	TCAM1P	chr17:61934376-61941738:+	-0.3	-3.86	0.000136	Body mass index	
LIHC	cis	1	rs2855036	chr11:5272682	HBG2	chr11:5269502-5667011:-	0.31	4.44	1.22E-5	Hemoglobin levels	
LIHC	cis	1	rs2855039	chr11:5271671	HBG2	chr11:5269502-5667011:-	0.31	4.36	1.75E-5	Hemoglobin levels	
LIHC	cis	1	rs2855121	chr11:5277291	HBG2	chr11:5269502-5667011:-	0.31	4.45	1.18E-5	Hemoglobin levels	
LIHC	cis	1	rs28572537	chr19:18552208	ISYNA1	chr19:18545625-18548943:-	0.17	3.86	0.000136	Breast cancer	
LIHC	cis	1	rs28581850	chr12:123871717	ABCB9	chr12:123413540-123459752:-	-0.33	-4.25	2.81E-5	HDL cholesterol	
LIHC	cis	1	rs28592032	chr12:123879445	ABCB9	chr12:123413540-123459752:-	-0.33	-4.24	2.87E-5	HDL cholesterol	
LIHC	cis	1	rs2860305	chr8:36938201	RAB11FIP1	chr8:37716470-37757003:-	-0.28	-4.31	2.14E-5	Insulin resistance/response	
LIHC	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.46	5.94	7.15E-9	Forced vital capacity	
LIHC	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.46	5.94	7.15E-9	Forced vital capacity	
LIHC	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.94	7.15E-9	Forced vital capacity	
LIHC	cis	1	rs28660993	chr12:123875394	ABCB9	chr12:123413540-123459752:-	-0.33	-4.25	2.81E-5	HDL cholesterol	
LIHC	cis	1	rs28678226	chr9:99548146	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs28683528	chr12:123845351	ABCB9	chr12:123413540-123459752:-	0.46	4.82	2.17E-6	Educational attainment;Height;Head circumference (infant)	
LIHC	cis	1	rs28683528	chr12:123845351	CDK2AP1	chr12:123745542-123756687:-	-0.5	-5.89	8.98E-9	Educational attainment;Height;Head circumference (infant)	
LIHC	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.58	7.47	6.47E-13	Diastolic blood pressure	
LIHC	cis	1	rs28718130	chr15:50909489	USP8	chr15:50716579-50793276:+	-0.22	-4.51	9.06E-6	QT interval	
LIHC	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.11E-14	Diastolic blood pressure	
LIHC	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.59	7.6	2.85E-13	Diastolic blood pressure	
LIHC	cis	1	rs2876629	chr6:55981048	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000164	Psychosis (atypical)	
LIHC	cis	1	rs2877649	chr14:24954002	SDR39U1	chr14:24908974-24912064:-	0.45	4.5	9.29E-6	Smooth-surface caries	
LIHC	cis	1	rs28786462	chr9:99592991	FAM22G	chr9:99690592-99704572:+	0.7	7.73	1.16E-13	Height	
LIHC	cis	1	rs2880791	chr5:150267376	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs28817917	chr15:50965846	USP8	chr15:50716579-50793276:+	-0.21	-4.1	5.26E-5	QT interval	
LIHC	cis	1	rs28844439	chr9:99597385	FAM22G	chr9:99690592-99704572:+	0.7	7.73	1.16E-13	Height	
LIHC	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.66	9.38	8.99E-19	Height	
LIHC	cis	1	rs28897193	chr4:107005529	TBCK	chr4:106967233-107237861:-	0.21	3.9	0.000117	Airflow obstruction	
LIHC	cis	1	rs2899462	chr15:50939254	USP8	chr15:50716579-50793276:+	-0.23	-4.69	4.03E-6	QT interval	
LIHC	cis	1	rs2910851	chr5:42787232	CCDC152	chr5:42756920-42802539:+	0.19	3.97	8.87E-5	Height	
LIHC	cis	1	rs2910855	chr5:42782335	CCDC152	chr5:42756920-42802539:+	0.19	4.17	3.79E-5	Height	
LIHC	cis	1	rs2910856	chr5:42781376	CCDC152	chr5:42756920-42802539:+	0.19	4.03	6.85E-5	Height	
LIHC	cis	1	rs2910862	chr5:42766404	CCDC152	chr5:42756920-42802539:+	0.19	4.11	4.86E-5	Height	
LIHC	cis	1	rs2910864	chr5:42763707	CCDC152	chr5:42756920-42802539:+	0.19	4.11	4.86E-5	Height	
LIHC	cis	1	rs2910869	chr5:42741846	CCDC152	chr5:42756920-42802539:+	0.19	3.99	8.21E-5	Height	
LIHC	cis	1	rs2910875	chr5:42719826	CCDC152	chr5:42756920-42802539:+	0.18	3.85	0.000142	Height	
LIHC	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.34	-5.13	4.88E-7	Tumor biomarkers	
LIHC	cis	1	rs2920781	chr15:43924682	CATSPER2	chr15:43922774-43959900:-	-0.34	-4.79	2.49E-6	Tumor biomarkers	
LIHC	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.34	-5.13	4.88E-7	Tumor biomarkers	
LIHC	cis	1	rs2927072	chr15:43922398	CATSPER2	chr15:43922774-43959900:-	-0.34	-4.79	2.49E-6	Tumor biomarkers	
LIHC	cis	1	rs2932538	chr1:113216543	ST7L	chr1:113066142-113162405:-	-0.43	-5.25	2.68E-7	Systolic blood pressure;Hypertension;Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs2935183	chr17:45607572	C17orf57	chr17:45401142-45518675:+	-0.3	-5.63	3.66E-8	Multiple sclerosis or amyotrophic lateral sclerosis	
LIHC	cis	1	rs2935183	chr17:45607572	KPNB1	chr17:45727275-45761004:+	0.18	3.91	0.00011	Multiple sclerosis or amyotrophic lateral sclerosis	
LIHC	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.3	4.57	6.74E-6	Obesity-related traits	
LIHC	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.35	-5.23	3.02E-7	Obesity-related traits	
LIHC	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.3	-4.61	5.59E-6	Obesity-related traits	
LIHC	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.3	-4.61	5.59E-6	Obesity-related traits	
LIHC	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.29	-4.45	1.17E-5	Obesity-related traits	
LIHC	cis	1	rs2961102	chr7:65424658	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.31E-6	Diabetic kidney disease	
LIHC	cis	1	rs2961102	chr7:65424658	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000129	Diabetic kidney disease	
LIHC	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.35	-5.26	2.57E-7	Obesity-related traits	
LIHC	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.62	5.41E-6	Obesity-related traits	
LIHC	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.62	5.41E-6	Obesity-related traits	
LIHC	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.35	-5.23	3.02E-7	Obesity-related traits	
LIHC	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.3	-4.64	5.06E-6	Obesity-related traits	
LIHC	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.38	-5.77	1.81E-8	Obesity-related traits	
LIHC	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.29	4.49	9.88E-6	Obesity-related traits	
LIHC	cis	1	rs2970625	chr8:36942890	RAB11FIP1	chr8:37716470-37757003:-	-0.26	-4.05	6.29E-5	Insulin resistance/response	
LIHC	cis	1	rs2970691	chr8:36928675	RAB11FIP1	chr8:37716470-37757003:-	-0.31	-4.64	5.02E-6	Insulin resistance/response	
LIHC	cis	1	rs2970705	chr8:36936533	RAB11FIP1	chr8:37716470-37757003:-	-0.28	-4.31	2.14E-5	Insulin resistance/response	
LIHC	cis	1	rs2970708	chr8:36939390	RAB11FIP1	chr8:37716470-37757003:-	-0.27	-4.23	3.02E-5	Insulin resistance/response	
LIHC	cis	1	rs2972767	chr5:42749057	CCDC152	chr5:42756920-42802539:+	0.19	4.07	5.87E-5	Height	
LIHC	cis	1	rs2972770	chr5:42731772	CCDC152	chr5:42756920-42802539:+	0.19	4.02	7.29E-5	Height	
LIHC	cis	1	rs2972994	chr5:42756500	CCDC152	chr5:42756920-42802539:+	0.19	4.12	4.84E-5	Height	
LIHC	cis	1	rs2972998	chr5:42763512	CCDC152	chr5:42756920-42802539:+	0.19	4.11	4.86E-5	Height	
LIHC	cis	1	rs2972999	chr5:42763797	CCDC152	chr5:42756920-42802539:+	0.19	4.11	4.86E-5	Height	
LIHC	cis	1	rs2973006	chr5:42772154	CCDC152	chr5:42756920-42802539:+	0.19	4.11	4.86E-5	Height	
LIHC	cis	1	rs2973011	chr5:42782492	CCDC152	chr5:42756920-42802539:+	-0.2	-4.17	3.94E-5	Height	
LIHC	cis	1	rs2973015	chr5:42717992	CCDC152	chr5:42756920-42802539:+	0.19	3.96	9.02E-5	Height	
LIHC	cis	1	rs2973018	chr5:42723790	CCDC152	chr5:42756920-42802539:+	0.19	4	7.78E-5	Height	
LIHC	cis	1	rs2973023	chr5:42732883	CCDC152	chr5:42756920-42802539:+	0.19	4.02	7.29E-5	Height	
LIHC	cis	1	rs2973029	chr5:42746566	CCDC152	chr5:42756920-42802539:+	0.18	3.84	0.000147	Height	
LIHC	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.32	-5.62	3.96E-8	Homocysteine levels	
LIHC	cis	1	rs3015694	chr8:36944570	RAB11FIP1	chr8:37716470-37757003:-	-0.26	-4.11	4.99E-5	Insulin resistance/response	
LIHC	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.6	-11.55	2.59E-26	Ankylosing spondylitis	
LIHC	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.53	7.93	3.18E-14	Ankylosing spondylitis	
LIHC	cis	1	rs302660	chr11:87885448	RAB38	chr11:87846431-87908599:-	0.29	4.8	2.4E-6	Frontotemporal dementia	
LIHC	cis	1	rs302662	chr11:87881236	RAB38	chr11:87846431-87908599:-	0.29	4.72	3.5E-6	Frontotemporal dementia	
LIHC	cis	1	rs302663	chr11:87880759	RAB38	chr11:87846431-87908599:-	0.29	4.8	2.4E-6	Frontotemporal dementia	
LIHC	cis	1	rs302668	chr11:87876911	RAB38	chr11:87846431-87908599:-	0.29	4.75	2.95E-6	Frontotemporal dementia	
LIHC	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.6	-11.52	3.31E-26	Ankylosing spondylitis	
LIHC	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.54	8.06	1.3E-14	Ankylosing spondylitis	
LIHC	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.6	-11.54	2.83E-26	Ankylosing spondylitis	
LIHC	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.54	8.04	1.48E-14	Ankylosing spondylitis	
LIHC	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.6	-11.54	2.83E-26	Ankylosing spondylitis	
LIHC	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.54	8.04	1.48E-14	Ankylosing spondylitis	
LIHC	cis	1	rs3088303	chr12:123779489	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.59E-5	HDL cholesterol	
LIHC	cis	1	rs3091242	chr1:25674785	RHCE	chr1:25688741-25756683:-	0.39	6.92	2.18E-11	Erythrocyte sedimentation rate	
LIHC	cis	1	rs3097417	chr3:53088601	RFT1	chr3:53122503-53164470:-	-0.52	-4.83	2.03E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.68	12.41	1.78E-29	Type 2 diabetes	
LIHC	cis	1	rs3099555	chr4:1725651	FAM53A	chr4:1641609-1685854:-	-0.39	-5.09	6.03E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.55	-7.93	3.18E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.36	-5.33	1.74E-7	Tumor biomarkers	
LIHC	cis	1	rs3101443	chr15:43912372	CATSPER2	chr15:43922774-43959900:-	-0.37	-5.17	3.95E-7	Tumor biomarkers	
LIHC	cis	1	rs3101852	chr15:50848370	USP8	chr15:50716579-50793276:+	0.2	4.06	6.12E-5	QT interval	
LIHC	cis	1	rs3101853	chr15:50848382	USP8	chr15:50716579-50793276:+	0.2	4.06	6.08E-5	QT interval	
LIHC	cis	1	rs3101855	chr15:50859874	USP8	chr15:50716579-50793276:+	-0.2	-4	7.71E-5	QT interval	
LIHC	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.56	-8.49	6.46E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs3105590	chr15:50864145	USP8	chr15:50716579-50793276:+	-0.21	-4.24	2.84E-5	QT interval	
LIHC	cis	1	rs3105591	chr15:50869042	USP8	chr15:50716579-50793276:+	-0.2	-4.02	7.08E-5	QT interval	
LIHC	cis	1	rs3109879	chr15:50837618	USP8	chr15:50716579-50793276:+	-0.2	-4.01	7.5E-5	QT interval	
LIHC	cis	1	rs3109880	chr15:50837812	USP8	chr15:50716579-50793276:+	-0.2	-4.01	7.5E-5	QT interval	
LIHC	cis	1	rs3109881	chr15:50839272	USP8	chr15:50716579-50793276:+	-0.2	-3.99	7.98E-5	QT interval	
LIHC	cis	1	rs3109888	chr15:50860694	USP8	chr15:50716579-50793276:+	-0.2	-4	7.71E-5	QT interval	
LIHC	cis	1	rs3109892	chr15:50877011	USP8	chr15:50716579-50793276:+	-0.21	-4.28	2.41E-5	QT interval	
LIHC	cis	1	rs3109894	chr15:50878574	USP8	chr15:50716579-50793276:+	-0.26	-5.35	1.61E-7	QT interval	
LIHC	cis	1	rs3109895	chr15:50880560	USP8	chr15:50716579-50793276:+	-0.23	-4.67	4.25E-6	QT interval	
LIHC	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.55	-7.9	3.83E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs3118632	chr9:131901284	CRAT	chr9:131857075-131873070:-	-0.22	-3.96	9.15E-5	Blood metabolite ratios	
LIHC	cis	1	rs3124510	chr9:131899690	CRAT	chr9:131857075-131873070:-	-0.22	-3.98	8.46E-5	Blood metabolite ratios	
LIHC	cis	1	rs3124512	chr9:131903881	ASB6	chr9:132396883-132404444:-	-0.24	-4.03	6.75E-5	Blood metabolite ratios	
LIHC	cis	1	rs3124512	chr9:131903881	CRAT	chr9:131857075-131873070:-	-0.22	-3.93	0.000105	Blood metabolite ratios	
LIHC	cis	1	rs3124513	chr9:131904593	CRAT	chr9:131857075-131873070:-	-0.22	-4.01	7.58E-5	Blood metabolite ratios	
LIHC	cis	1	rs3124514	chr9:131904608	CRAT	chr9:131857075-131873070:-	-0.22	-4.01	7.58E-5	Blood metabolite ratios	
LIHC	cis	1	rs3125579	chr6:98908958	COQ3	chr6:99817349-99842082:-	0.44	4.76	2.91E-6	Brain imaging in schizophrenia (interaction)	
LIHC	cis	1	rs3125579	chr6:98908958	SFRS18	chr6:99846535-99873207:-	0.25	3.98	8.33E-5	Brain imaging in schizophrenia (interaction)	
LIHC	cis	1	rs3131573	chr15:50869601	USP8	chr15:50716579-50793276:+	-0.2	-4.07	5.92E-5	QT interval	
LIHC	cis	1	rs3131577	chr15:50863516	USP8	chr15:50716579-50793276:+	-0.2	-3.99	8.0E-5	QT interval	
LIHC	cis	1	rs3131578	chr15:50861470	USP8	chr15:50716579-50793276:+	0.21	4.24	2.82E-5	QT interval	
LIHC	cis	1	rs3131580	chr15:50854926	USP8	chr15:50716579-50793276:+	-0.2	-4	7.78E-5	QT interval	
LIHC	cis	1	rs3131582	chr15:50879670	USP8	chr15:50716579-50793276:+	-0.23	-4.59	6.17E-6	QT interval	
LIHC	cis	1	rs3131587	chr15:50845101	USP8	chr15:50716579-50793276:+	-0.21	-4.12	4.74E-5	QT interval	
LIHC	cis	1	rs3131589	chr15:50841053	USP8	chr15:50716579-50793276:+	-0.2	-3.96	9.23E-5	QT interval	
LIHC	cis	1	rs3131590	chr15:50840955	USP8	chr15:50716579-50793276:+	-0.21	-4.21	3.29E-5	QT interval	
LIHC	cis	1	rs3131596	chr15:50877575	USP8	chr15:50716579-50793276:+	-0.23	-4.57	6.93E-6	QT interval	
LIHC	cis	1	rs313798	chr7:65493031	CCT6P1	chr7:65216092-65228661:+	0.36	5	9.06E-7	Diabetic kidney disease	
LIHC	cis	1	rs313798	chr7:65493031	INTS4L1	chr7:64601603-64694599:+	0.34	4.04	6.6E-5	Diabetic kidney disease	
LIHC	cis	1	rs313799	chr7:65494330	CCT6P1	chr7:65216092-65228661:+	0.36	4.98	9.93E-7	Diabetic kidney disease	
LIHC	cis	1	rs313799	chr7:65494330	INTS4L1	chr7:64601603-64694599:+	0.33	3.96	9.18E-5	Diabetic kidney disease	
LIHC	cis	1	rs313802	chr7:65516373	CCT6P1	chr7:65216092-65228661:+	0.31	4.27	2.52E-5	Diabetic kidney disease	
LIHC	cis	1	rs313802	chr7:65516373	INTS4L1	chr7:64601603-64694599:+	0.32	3.88	0.000127	Diabetic kidney disease	
LIHC	cis	1	rs313803	chr7:65514731	CCT6P1	chr7:65216092-65228661:+	0.31	4.27	2.52E-5	Diabetic kidney disease	
LIHC	cis	1	rs313803	chr7:65514731	INTS4L1	chr7:64601603-64694599:+	0.32	3.88	0.000127	Diabetic kidney disease	
LIHC	cis	1	rs313807	chr7:65499481	CCT6P1	chr7:65216092-65228661:+	0.35	4.88	1.6E-6	Diabetic kidney disease	
LIHC	cis	1	rs313807	chr7:65499481	INTS4L1	chr7:64601603-64694599:+	0.33	3.94	9.99E-5	Diabetic kidney disease	
LIHC	cis	1	rs313809	chr7:65499983	CCT6P1	chr7:65216092-65228661:+	0.35	4.9	1.45E-6	Diabetic kidney disease	
LIHC	cis	1	rs313809	chr7:65499983	INTS4L1	chr7:64601603-64694599:+	0.34	4.02	7.18E-5	Diabetic kidney disease	
LIHC	cis	1	rs313813	chr7:65503500	CCT6P1	chr7:65216092-65228661:+	0.31	4.37	1.67E-5	Diabetic kidney disease	
LIHC	cis	1	rs313813	chr7:65503500	INTS4L1	chr7:64601603-64694599:+	0.32	3.83	0.000152	Diabetic kidney disease	
LIHC	cis	1	rs313814	chr7:65503293	CCT6P1	chr7:65216092-65228661:+	0.32	4.52	8.43E-6	Diabetic kidney disease	
LIHC	cis	1	rs313814	chr7:65503293	INTS4L1	chr7:64601603-64694599:+	0.34	4.07	5.73E-5	Diabetic kidney disease	
LIHC	cis	1	rs313820	chr7:65574466	CCT6P1	chr7:65216092-65228661:+	0.29	4.12	4.7E-5	Diabetic kidney disease	
LIHC	cis	1	rs313824	chr7:65581207	CCT6P1	chr7:65216092-65228661:+	0.29	4.12	4.7E-5	Diabetic kidney disease	
LIHC	cis	1	rs313831	chr7:65551226	CCT6P1	chr7:65216092-65228661:+	0.31	4.23	2.95E-5	Diabetic kidney disease	
LIHC	cis	1	rs313832	chr7:65550891	CCT6P1	chr7:65216092-65228661:+	0.31	4.2	3.44E-5	Diabetic kidney disease	
LIHC	cis	1	rs3138493	chr9:92219260	GADD45G	chr9:92219927-92221467:+	0.22	3.86	0.000136	Fibrinogen levels	
LIHC	cis	1	rs316307	chr7:65570171	CCT6P1	chr7:65216092-65228661:+	0.31	4.33	1.98E-5	Diabetic kidney disease	
LIHC	cis	1	rs316312	chr7:65596491	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs316313	chr7:65593548	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs316318	chr7:65612904	CCT6P1	chr7:65216092-65228661:+	0.28	3.85	0.00014	Diabetic kidney disease	
LIHC	cis	1	rs316321	chr7:65611613	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs316322	chr7:65611233	CCT6P1	chr7:65216092-65228661:+	0.29	3.89	0.000121	Diabetic kidney disease	
LIHC	cis	1	rs316325	chr7:65609518	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs316326	chr7:65609453	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs316329	chr7:65608416	CCT6P1	chr7:65216092-65228661:+	0.31	4.25	2.76E-5	Diabetic kidney disease	
LIHC	cis	1	rs316330	chr7:65605372	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs316331	chr7:65604622	CCT6P1	chr7:65216092-65228661:+	-0.29	-3.98	8.31E-5	Diabetic kidney disease	
LIHC	cis	1	rs316332	chr7:65604299	CCT6P1	chr7:65216092-65228661:+	0.3	4.13	4.53E-5	Diabetic kidney disease	
LIHC	cis	1	rs316334	chr7:65602126	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs3180872	chr22:51017394	CPT1B	chr22:51007291-51017096:-	-0.31	-4.2	3.39E-5	Narcolepsy	
LIHC	cis	1	rs3197999	chr3:49721532	CYB561D2	chr3:50388289-50391494:+	0.3	4.01	7.47E-5	Crohn's disease;Ulcerative colitis	
LIHC	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.71	-7.64	2.2E-13	Dental caries	
LIHC	cis	1	rs3213445	chr22:51015838	CPT1B	chr22:51007291-51017096:-	-0.29	-3.95	9.55E-5	Narcolepsy	
LIHC	cis	1	rs3213446	chr22:51015674	CHKB	chr22:51017378-51021428:-	0.31	3.81	0.000166	Narcolepsy	
LIHC	cis	1	rs3213446	chr22:51015674	NCAPH2	chr22:50946645-50961911:+	0.25	4.03	6.99E-5	Narcolepsy	
LIHC	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.58	-11.16	6.8E-25	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs321622	chr4:48024380	NIPAL1	chr4:48018791-48039078:+	0.16	4.15	4.16E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.68	12.24	7.67E-29	Type 2 diabetes	
LIHC	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.69	12.58	4.08E-30	Type 2 diabetes	
LIHC	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.69	12.52	6.77E-30	Type 2 diabetes	
LIHC	cis	1	rs335472	chr5:176984163	DOK3	chr5:176928915-176937427:-	-0.2	-3.99	8.16E-5	Alzheimer disease and age of onset	
LIHC	cis	1	rs34084277	chr19:17387176	ANKLE1	chr19:17392454-17398454:+	0.4	4.05	6.29E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs34088794	chr15:40665420	C15orf23	chr15:40674922-40686488:+	0.64	6.42	4.42E-10	Heschl's gyrus morphology	
LIHC	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.52	-9.14	5.46E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs34121720	chr3:53072167	RFT1	chr3:53122503-53164470:-	0.48	4.47	1.06E-5	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs34128973	chr11:47851376	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.76	8.86E-17	Subjective well-being	
LIHC	cis	1	rs34136756	chr7:65381256	CCT6P1	chr7:65216092-65228661:+	0.33	4.58	6.63E-6	Diabetic kidney disease	
LIHC	cis	1	rs34136756	chr7:65381256	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000128	Diabetic kidney disease	
LIHC	cis	1	rs34156253	chr5:150226230	LOC134466	chr5:150310000-150326146:-	0.35	4.5	9.17E-6	Crohn's disease	
LIHC	cis	1	rs34192067	chr7:65887657	CCT6P1	chr7:65216092-65228661:+	0.3	4.14	4.33E-5	Diabetic kidney disease	
LIHC	cis	1	rs34193460	chr7:65393110	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.31E-6	Diabetic kidney disease	
LIHC	cis	1	rs34193460	chr7:65393110	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000129	Diabetic kidney disease	
LIHC	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.47	7.27	2.38E-12	Blood trace element (Zn levels)	
LIHC	cis	1	rs34244302	chr3:53102236	RFT1	chr3:53122503-53164470:-	0.53	4.79	2.53E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs34258593	chr3:38464565	XYLB	chr3:38388251-38456467:+	0.27	5.19	3.67E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.52	-9.27	2.1E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs34340609	chr3:53077276	RFT1	chr3:53122503-53164470:-	0.41	4.2	3.36E-5	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs34474867	chr22:30563301	CABP7	chr22:30116344-30127818:+	0.48	3.82	0.000158	LDL cholesterol	
LIHC	cis	1	rs34522725	chr5:153606366	MFAP3	chr5:153418519-153437014:+	-0.25	-4.91	1.39E-6	Carotid artery intima media thickness (sex interaction)	
LIHC	cis	1	rs34529418	chr7:65403209	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs34529418	chr7:65403209	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs34545612	chr22:30566694	CABP7	chr22:30116344-30127818:+	0.5	4.1	5.21E-5	LDL cholesterol	
LIHC	cis	1	rs34560516	chr7:65404092	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.31E-6	Diabetic kidney disease	
LIHC	cis	1	rs34560516	chr7:65404092	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000129	Diabetic kidney disease	
LIHC	cis	1	rs34570071	chr15:85280212	NMB	chr15:85198362-85201802:-	-0.4	-6.37	5.99E-10	Schizophrenia	
LIHC	cis	1	rs34577383	chr7:65385726	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs34577383	chr7:65385726	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.53	-9.52	3.24E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.54	-9.77	4.67E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs34637256	chr7:65360131	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.75E-6	Diabetic kidney disease	
LIHC	cis	1	rs34637256	chr7:65360131	INTS4L1	chr7:64601603-64694599:+	0.33	3.82	0.000159	Diabetic kidney disease	
LIHC	cis	1	rs34655806	chr15:75362586	SCAMP5	chr15:75287901-75313836:+	0.42	6.37	6.11E-10	Blood trace element (Zn levels)	
LIHC	cis	1	rs34702770	chr7:65344823	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.75E-6	Diabetic kidney disease	
LIHC	cis	1	rs34702770	chr7:65344823	INTS4L1	chr7:64601603-64694599:+	0.33	3.82	0.000159	Diabetic kidney disease	
LIHC	cis	1	rs34703416	chr7:65300642	CCT6P1	chr7:65216092-65228661:+	0.31	4.29	2.28E-5	Diabetic kidney disease	
LIHC	cis	1	rs34703416	chr7:65300642	INTS4L1	chr7:64601603-64694599:+	0.33	3.86	0.000133	Diabetic kidney disease	
LIHC	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.34	-4.83	2.11E-6	Schizophrenia	
LIHC	cis	1	rs34751999	chr15:84758419	NMB	chr15:85198362-85201802:-	-0.35	-4.78	2.61E-6	Schizophrenia	
LIHC	cis	1	rs34815098	chr7:65292254	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.72E-6	Diabetic kidney disease	
LIHC	cis	1	rs34815098	chr7:65292254	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.5	6.91	2.29E-11	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.5	-8.81	6.28E-17	Response to antipsychotic treatment	
LIHC	cis	1	rs34900908	chr15:85257599	NMB	chr15:85198362-85201802:-	-0.4	-6.16	1.98E-9	Schizophrenia	
LIHC	cis	1	rs34910028	chr11:47758449	C1QTNF4	chr11:47611216-47615961:-	-0.55	-8.73	1.15E-16	Subjective well-being	
LIHC	cis	1	rs34933526	chr7:65383199	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs34933526	chr7:65383199	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs34970380	chr7:65431493	CCT6P1	chr7:65216092-65228661:+	0.35	4.8	2.39E-6	Diabetic kidney disease	
LIHC	cis	1	rs34970380	chr7:65431493	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000131	Diabetic kidney disease	
LIHC	cis	1	rs34974928	chr7:65364006	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.75E-6	Diabetic kidney disease	
LIHC	cis	1	rs34974928	chr7:65364006	INTS4L1	chr7:64601603-64694599:+	0.33	3.82	0.000159	Diabetic kidney disease	
LIHC	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.55	7.95	2.73E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs35046236	chr7:65408613	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs35046236	chr7:65408613	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs35058610	chr7:65390925	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs35058610	chr7:65390925	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.47	-6.11	2.67E-9	Forced vital capacity	
LIHC	cis	1	rs35067150	chr22:30537818	CABP7	chr22:30116344-30127818:+	0.46	3.84	0.000146	LDL cholesterol	
LIHC	cis	1	rs35160687	chr2:86472114	REEP1	chr2:86441122-86564777:-	0.36	5.54	5.87E-8	Night sleep phenotypes	
LIHC	cis	1	rs35163227	chr3:53127876	RFT1	chr3:53122503-53164470:-	0.56	4.94	1.25E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs35184688	chr17:40272406	HSPB9	chr17:40274756-40275371:+	0.3	4.51	9.06E-6	Fibrinogen levels	
LIHC	cis	1	rs35283677	chr7:65359233	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.3E-6	Diabetic kidney disease	
LIHC	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.34	-4.93	1.26E-6	Schizophrenia	
LIHC	cis	1	rs35297609	chr15:84772896	NMB	chr15:85198362-85201802:-	-0.36	-4.95	1.17E-6	Schizophrenia	
LIHC	cis	1	rs35316992	chr15:85248133	NMB	chr15:85198362-85201802:-	-0.4	-6.16	1.98E-9	Schizophrenia	
LIHC	cis	1	rs35334289	chr9:99540291	FAM22G	chr9:99690592-99704572:+	-0.68	-8.72	1.22E-16	Height	
LIHC	cis	1	rs35365094	chr11:34767790	ABTB2	chr11:34172535-34378802:-	0.24	3.92	0.000108	Systemic lupus erythematosus and Systemic sclerosis	
LIHC	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.63	-13.73	1.71E-34	Response to antipsychotic treatment	
LIHC	cis	1	rs35391607	chr7:65360829	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.75E-6	Diabetic kidney disease	
LIHC	cis	1	rs35391607	chr7:65360829	INTS4L1	chr7:64601603-64694599:+	0.33	3.82	0.000159	Diabetic kidney disease	
LIHC	cis	1	rs35396113	chr7:65495461	CCT6P1	chr7:65216092-65228661:+	0.36	5	9.06E-7	Diabetic kidney disease	
LIHC	cis	1	rs35396113	chr7:65495461	INTS4L1	chr7:64601603-64694599:+	0.34	4.04	6.6E-5	Diabetic kidney disease	
LIHC	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.52	-9.27	2.1E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs35421653	chr7:65363429	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.3E-6	Diabetic kidney disease	
LIHC	cis	1	rs35432774	chr7:65393019	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs35432774	chr7:65393019	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.49	7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs35524990	chr15:85258203	NMB	chr15:85198362-85201802:-	-0.4	-6.16	1.98E-9	Schizophrenia	
LIHC	cis	1	rs35542501	chr7:65431215	CCT6P1	chr7:65216092-65228661:+	0.34	4.64	4.87E-6	Diabetic kidney disease	
LIHC	cis	1	rs35542501	chr7:65431215	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs35576914	chr3:53092270	RFT1	chr3:53122503-53164470:-	0.52	4.73	3.3E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs35624992	chr11:47615798	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.91	3.13E-17	Subjective well-being	
LIHC	cis	1	rs35630683	chr15:85349231	NMB	chr15:85198362-85201802:-	-0.39	-6	4.99E-9	Schizophrenia	
LIHC	cis	1	rs35630683	chr15:85349231	UBE2Q2P1	chr15:85070427-85114026:-	0.25	4.02	7.16E-5	Schizophrenia	
LIHC	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.34	-4.83	2.11E-6	Schizophrenia	
LIHC	cis	1	rs35648189	chr15:84740748	NMB	chr15:85198362-85201802:-	-0.35	-4.78	2.61E-6	Schizophrenia	
LIHC	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.34	-4.93	1.26E-6	Schizophrenia	
LIHC	cis	1	rs35658069	chr15:84780146	NMB	chr15:85198362-85201802:-	-0.36	-4.95	1.17E-6	Schizophrenia	
LIHC	cis	1	rs35672725	chr8:89581838	MMP16	chr8:89049462-89339717:-	0.23	3.88	0.000123	Body mass index and cholesterol (psychopharmacological treatment)	
LIHC	cis	1	rs35715471	chr8:89582284	MMP16	chr8:89049462-89339717:-	0.22	3.81	0.000167	Body mass index and cholesterol (psychopharmacological treatment)	
LIHC	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs35726233	chr15:85337800	NMB	chr15:85198362-85201802:-	-0.38	-5.98	5.49E-9	Schizophrenia	
LIHC	cis	1	rs35726233	chr15:85337800	UBE2Q2P1	chr15:85070427-85114026:-	0.23	3.84	0.000146	Schizophrenia	
LIHC	cis	1	rs35735127	chr7:65300423	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.72E-6	Diabetic kidney disease	
LIHC	cis	1	rs35735127	chr7:65300423	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.63	-13.53	9.34E-34	Response to antipsychotic treatment	
LIHC	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.58	-10.43	2.65E-22	Response to antipsychotic treatment	
LIHC	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.52	-9.38	9.07E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs35808647	chr15:85377441	NMB	chr15:85198362-85201802:-	-0.38	-5.64	3.5E-8	Schizophrenia	
LIHC	cis	1	rs35808647	chr15:85377441	UBE2Q2P1	chr15:85070427-85114026:-	0.24	3.89	0.00012	Schizophrenia	
LIHC	cis	1	rs35820085	chr7:65442758	CCT6P1	chr7:65216092-65228661:+	0.34	4.67	4.39E-6	Diabetic kidney disease	
LIHC	cis	1	rs35820085	chr7:65442758	INTS4L1	chr7:64601603-64694599:+	0.33	3.88	0.000125	Diabetic kidney disease	
LIHC	cis	1	rs35825738	chr7:65318027	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.72E-6	Diabetic kidney disease	
LIHC	cis	1	rs35825738	chr7:65318027	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs35841610	chr5:109732832	MAN2A1	chr5:109025156-109203429:+	0.25	3.91	0.000112	Cardiac structure and function	
LIHC	cis	1	rs35902101	chr11:47795169	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.89	3.63E-17	Subjective well-being	
LIHC	cis	1	rs35960805	chr15:85343980	NMB	chr15:85198362-85201802:-	-0.38	-5.98	5.49E-9	Schizophrenia	
LIHC	cis	1	rs35960805	chr15:85343980	UBE2Q2P1	chr15:85070427-85114026:-	0.23	3.84	0.000146	Schizophrenia	
LIHC	cis	1	rs36006749	chr3:38443312	XYLB	chr3:38388251-38456467:+	0.27	5.22	3.04E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs36033484	chr7:65390558	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.31E-6	Diabetic kidney disease	
LIHC	cis	1	rs36033484	chr7:65390558	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000129	Diabetic kidney disease	
LIHC	cis	1	rs36033486	chr15:85319692	NMB	chr15:85198362-85201802:-	-0.38	-5.98	5.49E-9	Schizophrenia	
LIHC	cis	1	rs36033486	chr15:85319692	UBE2Q2P1	chr15:85070427-85114026:-	0.23	3.84	0.000146	Schizophrenia	
LIHC	cis	1	rs36035949	chr6:109736614	MICAL1	chr6:109765268-109787171:-	-0.13	-4.07	5.93E-5	Height	
LIHC	cis	1	rs36068983	chr7:65408991	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs36068983	chr7:65408991	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.5	-8.86	4.44E-17	Response to antipsychotic treatment	
LIHC	cis	1	rs3731819	chr2:86368641	POLR1A	chr2:86253453-86333278:-	-0.31	-4.28	2.42E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs3734530	chr6:26195408	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.42	1.3E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs3738471	chr1:41006545	DEM1	chr1:40974433-40982212:+	0.3	4.18	3.72E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs3739847	chr9:131911574	CRAT	chr9:131857075-131873070:-	-0.23	-4.05	6.37E-5	Blood metabolite ratios	
LIHC	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.47	-10.44	2.38E-22	IgG glycosylation	
LIHC	cis	1	rs3743161	chr15:85430838	UBE2Q2P1	chr15:85070427-85114026:-	0.24	3.91	0.000112	Alzheimer's disease (age of onset)	
LIHC	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.46	6.7	8.7E-11	Schizophrenia	
LIHC	cis	1	rs3746016	chr19:32877259	DPY19L3	chr19:32896677-32975236:+	0.2	3.84	0.000148	Bipolar disorder	
LIHC	cis	1	rs3747957	chr1:180953853	STX6	chr1:180913175-180992046:-	-0.18	-4.3	2.22E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.48	6.67	1.03E-10	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs3749591	chr4:120214030	FABP2	chr4:120238406-120243316:-	-0.23	-4.02	7.17E-5	Corneal astigmatism	
LIHC	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.28	4.19	3.5E-5	Fractional exhaled nitric oxide (childhood)	
LIHC	cis	1	rs3752749	chr4:1737262	FAM53A	chr4:1641609-1685854:-	-0.4	-5.15	4.47E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs3757135	chr6:26200707	HIST1H2AE	chr6:26217148-26217711:+	-0.36	-3.95	9.47E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs3760982	chr19:44286513	KCNN4	chr19:44270687-44285409:-	-0.14	-3.81	0.000167	Breast cancer	
LIHC	cis	1	rs3761959	chr1:157669278	FCRL3	chr1:157646278-157670775:-	0.29	6.71	7.99E-11	Type 1 diabetes autoantibodies	
LIHC	cis	1	rs3764796	chr8:17157677	PCM1	chr8:17780366-17887455:+	-0.4	-4.41	1.37E-5	Calcium levels	
LIHC	cis	1	rs3769825	chr2:202111380	CASP10	chr2:202047621-202094110:+	0.27	3.83	0.000153	Chronic lymphocytic leukemia	
LIHC	cis	1	rs3770066	chr2:86392350	POLR1A	chr2:86253453-86333278:-	-0.27	-3.87	0.000133	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs3770081	chr2:86280925	POLR1A	chr2:86253453-86333278:-	-0.36	-5.02	8.44E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs3770082	chr2:86280922	POLR1A	chr2:86253453-86333278:-	-0.36	-4.96	1.13E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs3770089	chr2:86263815	POLR1A	chr2:86253453-86333278:-	-0.38	-5.09	5.87E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.58	7.52	4.84E-13	Diastolic blood pressure	
LIHC	cis	1	rs3779195	chr7:97993362	BRI3	chr7:97910979-97922275:+	0.39	6.6	1.6E-10	Sex hormone-binding globulin levels	
LIHC	cis	1	rs3780551	chr9:99539739	FAM22G	chr9:99690592-99704572:+	0.67	8.74	1.01E-16	Height	
LIHC	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.37	5.48	8.42E-8	Multiple sclerosis	
LIHC	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.41	-6.9	2.53E-11	Multiple sclerosis	
LIHC	cis	1	rs3782130	chr12:58161898	XRCC6BP1	chr12:58335445-58351051:+	-0.25	-4.44	1.24E-5	Multiple sclerosis	
LIHC	cis	1	rs3788409	chr22:29198151	CHEK2	chr22:29083731-29137822:-	-0.26	-4.3	2.24E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs3789362	chr1:180951692	STX6	chr1:180913175-180992046:-	-0.17	-4.05	6.45E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs3789364	chr1:180951043	STX6	chr1:180913175-180992046:-	-0.19	-4.46	1.13E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs3792527	chr3:38493212	XYLB	chr3:38388251-38456467:+	0.28	5.28	2.26E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.47	-6.54	2.24E-10	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs3802840	chr11:111171646	C11orf92	chr11:111164171-111175770:-	0.32	5.22	3.12E-7	Colorectal cancer	
LIHC	cis	1	rs3802841	chr11:111171672	C11orf92	chr11:111164171-111175770:-	-0.32	-5.12	5.14E-7	Colorectal cancer	
LIHC	cis	1	rs3802842	chr11:111171709	C11orf92	chr11:111164171-111175770:-	-0.32	-5.12	5.14E-7	Colorectal cancer	
LIHC	cis	1	rs3803358	chr15:40662773	C15orf23	chr15:40674922-40686488:+	0.64	6.38	5.77E-10	Heschl's gyrus morphology	
LIHC	cis	1	rs3806407	chr1:156251742	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs3806408	chr1:156252137	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs3806409	chr1:156252291	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs3806692	chr3:53080987	RFT1	chr3:53122503-53164470:-	0.47	4.56	6.96E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs3806988	chr6:49431569	CENPQ	chr6:49431096-49460820:+	-0.19	-3.87	0.000128	Folate pathway vitamin levels	
LIHC	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.31	-5.8	1.54E-8	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs3809868	chr17:45750596	KPNB1	chr17:45727275-45761004:+	0.17	3.84	0.000148	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs3810827	chr2:86334386	POLR1A	chr2:86253453-86333278:-	-0.36	-4.88	1.61E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs3810827	chr2:86334386	REEP1	chr2:86441122-86564777:-	0.4	3.94	9.98E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs3813948	chr1:207269858	C4BPA	chr1:207277511-207318308:+	0.28	4.22	3.19E-5	C4b binding protein levels	
LIHC	cis	1	rs3814184	chr10:69966251	DNA2	chr10:70173822-70231879:-	-0.3	-5.01	8.58E-7	Optic nerve measurement (disc area)	
LIHC	cis	1	rs382031	chr5:10733749	DAP	chr5:10679343-10761387:-	0.38	4.44	1.19E-5	Metabolite levels (Pyroglutamine)	
LIHC	cis	1	rs3822651	chr5:109765661	MAN2A1	chr5:109025156-109203429:+	0.3	4.61	5.56E-6	Cardiac structure and function	
LIHC	cis	1	rs3822651	chr5:109765661	TMEM232	chr5:109624934-110062381:-	0.39	3.83	0.000153	Cardiac structure and function	
LIHC	cis	1	rs3823114	chr6:49431720	CENPQ	chr6:49431096-49460820:+	-0.2	-4.12	4.74E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs3824482	chr9:99539449	FAM22G	chr9:99690592-99704572:+	0.67	8.74	1.01E-16	Height	
LIHC	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.39	5.86	1.1E-8	Multiple sclerosis	
LIHC	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.41	-6.88	2.91E-11	Multiple sclerosis	
LIHC	cis	1	rs3825079	chr12:58203354	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.69	4.04E-6	Multiple sclerosis	
LIHC	cis	1	rs3825253	chr12:109109281	SELPLG	chr12:109015682-109027670:-	-0.1	-3.88	0.000127	Low high density lipoprotein cholesterol levels	
LIHC	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.59	11.66	1.1E-26	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs3829218	chr11:58331309	CNTF	chr11:58390146-58393203:+	0.38	4.72	3.45E-6	Lymphoma	
LIHC	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.66	9.42	6.98E-19	Height	
LIHC	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.66	9.51	3.47E-19	Height	
LIHC	cis	1	rs3846926	chr6:56092186	COL21A1	chr6:55921389-56258892:-	0.58	10.51	1.34E-22	Pulse pressure	
LIHC	cis	1	rs3848129	chr15:50892064	USP8	chr15:50716579-50793276:+	-0.23	-4.65	4.64E-6	QT interval	
LIHC	cis	1	rs3848130	chr15:50892111	USP8	chr15:50716579-50793276:+	-0.23	-4.66	4.45E-6	QT interval	
LIHC	cis	1	rs3850625	chr1:201016296	PHLDA3	chr1:201434623-201438299:-	0.41	4.15	4.13E-5	Glomerular filtration rate in non diabetics (creatinine)	
LIHC	cis	1	rs3857422	chr5:150268609	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs3860055	chr2:17775828	GEN1	chr2:17935162-17966632:+	0.41	5.11	5.25E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs3865391	chr18:34929280	KIAA1328	chr18:34409080-34809848:+	0.27	4.75	3.01E-6	Response to iloperidone treatment (QT prolongation)	
LIHC	cis	1	rs3865392	chr18:34929464	KIAA1328	chr18:34409080-34809848:+	0.27	4.83	2.06E-6	Response to iloperidone treatment (QT prolongation)	
LIHC	cis	1	rs387676	chr7:65598220	CCT6P1	chr7:65216092-65228661:+	0.29	3.9	0.000115	Diabetic kidney disease	
LIHC	cis	1	rs3885839	chr7:65290403	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.29E-6	Diabetic kidney disease	
LIHC	cis	1	rs3885839	chr7:65290403	INTS4L1	chr7:64601603-64694599:+	0.34	3.87	0.000132	Diabetic kidney disease	
LIHC	cis	1	rs3890604	chr3:41760625	ULK4	chr3:41288091-42003660:-	0.6	8.05	1.33E-14	Diastolic blood pressure	
LIHC	cis	1	rs3891585	chr2:66756976	MEIS1	chr2:66662532-66799890:+	-0.29	-4.09	5.45E-5	PR interval	
LIHC	cis	1	rs3892761	chr12:54070445	ATP5G2	chr12:54058945-54070512:-	0.16	4.05	6.25E-5	Height	
LIHC	cis	1	rs3900064	chr5:150264414	LOC134466	chr5:150310000-150326146:-	-0.33	-4.47	1.07E-5	Crohn's disease	
LIHC	cis	1	rs3906527	chr5:150266392	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs3906528	chr5:150266718	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.53	-7.74	1.11E-13	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.63	9.06	1.02E-17	Height	
LIHC	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.58	-7.9	3.8E-14	Diastolic blood pressure	
LIHC	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.49	7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs3936203	chr2:241834654	C2orf54	chr2:241825466-241835573:-	-0.53	-7.49	5.67E-13	Urinary metabolites	
LIHC	cis	1	rs394407	chr5:10734081	DAP	chr5:10679343-10761387:-	0.38	4.44	1.19E-5	Metabolite levels (Pyroglutamine)	
LIHC	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.66	-10.09	3.91E-21	Type 2 diabetes	
LIHC	cis	1	rs396508	chr16:20682354	ACSM1	chr16:20634559-20709066:-	-0.38	-6.88	2.76E-11	Schizophrenia	
LIHC	cis	1	rs3981351	chr10:115515120	CASP7	chr10:115438935-115490662:+	0.28	4.13	4.5E-5	Obesity-related traits	
LIHC	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.52	-9.41	7.21E-19	Inflammatory skin disease	
LIHC	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.53	7.72	1.27E-13	Inflammatory skin disease	
LIHC	cis	1	rs400736	chr1:8078309	UTS2	chr1:7903144-7973294:-	0.2	4.11	5.04E-5	Response to antidepressants and depression	
LIHC	cis	1	rs402418	chr7:65509469	CCT6P1	chr7:65216092-65228661:+	0.32	4.44	1.22E-5	Diabetic kidney disease	
LIHC	cis	1	rs402418	chr7:65509469	INTS4L1	chr7:64601603-64694599:+	0.34	4.05	6.27E-5	Diabetic kidney disease	
LIHC	cis	1	rs4037	chr10:97365820	ALDH18A1	chr10:97365687-97416567:-	0.28	4.14	4.31E-5	Blood metabolite levels	
LIHC	cis	1	rs4037	chr10:97365820	ENTPD1	chr10:97471536-97637022:+	0.22	4.31	2.1E-5	Blood metabolite levels	
LIHC	cis	1	rs4038129	chr2:17774746	GEN1	chr2:17935162-17966632:+	0.41	5.11	5.25E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs4038130	chr2:17774912	GEN1	chr2:17935162-17966632:+	-0.38	-4.62	5.43E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs4038131	chr2:17775032	GEN1	chr2:17935162-17966632:+	0.37	4.64	4.89E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.49	-7.9	3.71E-14	Eye color traits	
LIHC	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.49	-7.84	5.88E-14	Eye color traits	
LIHC	cis	1	rs4078160	chr10:52565940	ASAH2B	chr10:52499696-52514567:+	-0.46	-5.5	7.56E-8	Urate levels in lean individuals	
LIHC	cis	1	rs41266807	chr6:26199822	HIST1H2AE	chr6:26217148-26217711:+	-0.35	-3.85	0.000141	Renal underexcretion gout;Gout	
LIHC	cis	1	rs41271844	chr6:55988932	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000162	Psychosis (atypical)	
LIHC	cis	1	rs41280035	chr22:38054038	LGALS1	chr22:38071613-38075807:+	-0.21	-4.26	2.65E-5	Fat distribution (HIV)	
LIHC	cis	1	rs4129956	chr4:302008	ZNF718	chr4:53272-156488:+	0.36	5.4	1.23E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs4130590	chr9:130107964	ZNF79	chr9:130186653-130207650:+	0.29	4.37	1.63E-5	Bipolar disorder	
LIHC	cis	1	rs41343448	chr8:20271413	ATP6V1B2	chr8:20054704-20079205:+	0.36	4.83	2.1E-6	Preeclampsia	
LIHC	cis	1	rs41343448	chr8:20271413	INTS10	chr8:19674918-19709584:+	0.38	4.49	9.57E-6	Preeclampsia	
LIHC	cis	1	rs413846	chr5:10732289	DAP	chr5:10679343-10761387:-	0.34	3.89	0.000121	Metabolite levels (Pyroglutamine)	
LIHC	cis	1	rs4140574	chr6:56099424	COL21A1	chr6:55921389-56258892:-	0.56	9.97	1.01E-20	Pulse pressure	
LIHC	cis	1	rs4140575	chr6:56099222	COL21A1	chr6:55921389-56258892:-	0.58	10.39	3.55E-22	Pulse pressure	
LIHC	cis	1	rs4147024	chr3:38456664	XYLB	chr3:38388251-38456467:+	0.27	5.16	4.11E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs4147025	chr3:38456531	XYLB	chr3:38388251-38456467:+	0.28	5.3	2.11E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs4149468	chr7:65825690	CCT6P1	chr7:65216092-65228661:+	0.3	4.16	3.94E-5	Diabetic kidney disease	
LIHC	cis	1	rs4150550	chr11:18350898	LDHC	chr11:18433853-18472792:+	0.35	4.04	6.57E-5	Pancreatic cancer	
LIHC	cis	1	rs4150612	chr11:18364358	LDHC	chr11:18433853-18472792:+	0.33	3.92	0.000105	Pancreatic cancer	
LIHC	cis	1	rs4150661	chr11:18379629	LDHC	chr11:18433853-18472792:+	0.33	3.87	0.00013	Pancreatic cancer	
LIHC	cis	1	rs419603	chr7:65597341	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs420259	chr16:23634026	DCTN5	chr16:23652807-23681182:+	-0.32	-6.3	9.24E-10	Bipolar disorder	
LIHC	cis	1	rs422164	chr7:65586605	CCT6P1	chr7:65216092-65228661:+	0.29	3.94	9.68E-5	Diabetic kidney disease	
LIHC	cis	1	rs4233937	chr2:66752251	MEIS1	chr2:66662532-66799890:+	0.29	4.11	4.87E-5	PR interval	
LIHC	cis	1	rs4234797	chr4:7219907	SORCS2	chr4:7194374-7744563:+	-0.24	-4.03	6.84E-5	Insulin-like growth factors	
LIHC	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.45	5.81	1.4E-8	Forced vital capacity	
LIHC	cis	1	rs4246215	chr11:61564299	FADS1	chr11:61567103-61584529:-	-0.49	-7.99	2.1E-14	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
LIHC	cis	1	rs4246215	chr11:61564299	FADS2	chr11:61583728-61634825:+	-0.28	-4.34	1.85E-5	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
LIHC	cis	1	rs4246215	chr11:61564299	FADS3	chr11:61640999-61659422:-	-0.3	-5.05	7.05E-7	Phospholipid levels (plasma);Platelet count;Red blood cell fatty acid levels;Trans fatty acid levels;Inflammatory bowel disease	
LIHC	cis	1	rs4256922	chr10:52568616	ASAH2B	chr10:52499696-52514567:+	-0.47	-5.55	5.68E-8	Urate levels in lean individuals	
LIHC	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.47	-7.36	1.36E-12	Plasma amyloid beta peptide concentrations (ABx-40)	
LIHC	cis	1	rs4267943	chr6:49439805	CENPQ	chr6:49431096-49460820:+	0.25	4.84	1.95E-6	Folate pathway vitamin levels	
LIHC	cis	1	rs427044	chr7:65508545	CCT6P1	chr7:65216092-65228661:+	0.32	4.42	1.3E-5	Diabetic kidney disease	
LIHC	cis	1	rs427044	chr7:65508545	INTS4L1	chr7:64601603-64694599:+	0.33	3.97	8.73E-5	Diabetic kidney disease	
LIHC	cis	1	rs4272382	chr8:8433488	ERI1	chr8:8860314-8890849:+	-0.24	-3.85	0.000141	Response to cytidine analogues (gemcitabine)	
LIHC	cis	1	rs4272382	chr8:8433488	TNKS	chr8:9413445-9639855:+	-0.25	-3.81	0.000164	Response to cytidine analogues (gemcitabine)	
LIHC	cis	1	rs4293565	chr2:241834770	C2orf54	chr2:241825466-241835573:-	0.52	7.54	4.26E-13	Urinary metabolites	
LIHC	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.39	5.75	1.96E-8	Paget's disease	
LIHC	cis	1	rs4294134	chr7:135293128	SLC13A4	chr7:135365993-135412933:-	-0.45	-6.91	2.42E-11	Paget's disease	
LIHC	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs431076	chr7:65600320	CCT6P1	chr7:65216092-65228661:+	0.29	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs4311055	chr2:241821017	AGXT	chr2:241808162-241818535:+	-0.17	-4.23	2.95E-5	Urinary metabolites	
LIHC	cis	1	rs4311055	chr2:241821017	C2orf54	chr2:241825466-241835573:-	0.53	7.54	4.25E-13	Urinary metabolites	
LIHC	cis	1	rs431318	chr7:65511597	CCT6P1	chr7:65216092-65228661:+	0.32	4.44	1.22E-5	Diabetic kidney disease	
LIHC	cis	1	rs431318	chr7:65511597	INTS4L1	chr7:64601603-64694599:+	0.34	4.05	6.27E-5	Diabetic kidney disease	
LIHC	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.69	12.52	6.77E-30	Type 2 diabetes	
LIHC	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.25	-3.91	0.000111	Rheumatoid arthritis	
LIHC	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.64	8.97	1.91E-17	Height	
LIHC	cis	1	rs4344199	chr9:99549449	FAM22G	chr9:99690592-99704572:+	0.62	6.95	1.81E-11	Height	
LIHC	cis	1	rs4344931	chr2:241818527	AGXT	chr2:241808162-241818535:+	-0.17	-4.21	3.33E-5	Urinary metabolites	
LIHC	cis	1	rs4344931	chr2:241818527	C2orf54	chr2:241825466-241835573:-	0.53	7.62	2.48E-13	Urinary metabolites	
LIHC	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.65	9.44	6.03E-19	Height	
LIHC	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.25	2.5E-18	Height	
LIHC	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.28	5.43	1.05E-7	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs4375701	chr17:45712218	KPNB1	chr17:45727275-45761004:+	-0.17	-3.81	0.000163	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs437889	chr7:65509234	CCT6P1	chr7:65216092-65228661:+	0.32	4.44	1.22E-5	Diabetic kidney disease	
LIHC	cis	1	rs437889	chr7:65509234	INTS4L1	chr7:64601603-64694599:+	0.34	4.05	6.27E-5	Diabetic kidney disease	
LIHC	cis	1	rs4379723	chr10:64963449	NRBF2	chr10:64893007-64914785:+	-0.25	-4.21	3.32E-5	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LIHC	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.54	7.68	1.65E-13	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs4399232	chr10:64999490	NRBF2	chr10:64893007-64914785:+	-0.25	-4.21	3.32E-5	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LIHC	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.29	4.13	4.59E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
LIHC	cis	1	rs4408846	chr3:41753679	ULK4	chr3:41288091-42003660:-	0.6	7.95	2.66E-14	Diastolic blood pressure	
LIHC	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.67	9.49	4.05E-19	Height	
LIHC	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.63	-8.88	3.86E-17	Height	
LIHC	cis	1	rs4433986	chr2:66760311	MEIS1	chr2:66662532-66799890:+	0.29	4.08	5.7E-5	PR interval	
LIHC	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.56	-7.91	3.6E-14	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs4467099	chr16:11542894	SNX29	chr16:12146055-12668145:+	0.21	3.89	0.000119	Hepatitis	
LIHC	cis	1	rs4469291	chr6:49440614	CENPQ	chr6:49431096-49460820:+	-0.2	-4.03	6.8E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs4478072	chr3:53106125	RFT1	chr3:53122503-53164470:-	0.44	4.35	1.8E-5	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.65	9.12	6.49E-18	Height	
LIHC	cis	1	rs4509958	chr15:50894175	USP8	chr15:50716579-50793276:+	-0.23	-4.66	4.54E-6	QT interval	
LIHC	cis	1	rs4510228	chr2:17774685	GEN1	chr2:17935162-17966632:+	0.41	5.11	5.25E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs4510229	chr2:17774701	GEN1	chr2:17935162-17966632:+	0.41	5.11	5.25E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs451396	chr7:65484074	CCT6P1	chr7:65216092-65228661:+	0.36	4.98	9.93E-7	Diabetic kidney disease	
LIHC	cis	1	rs451396	chr7:65484074	INTS4L1	chr7:64601603-64694599:+	0.33	3.96	9.18E-5	Diabetic kidney disease	
LIHC	cis	1	rs4520624	chr11:111172210	C11orf92	chr11:111164171-111175770:-	-0.32	-5.13	4.89E-7	Colorectal cancer	
LIHC	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.28	2.0E-18	Height	
LIHC	cis	1	rs45463097	chr14:90744188	C14orf102	chr14:90744398-90798279:-	0.3	3.91	0.000109	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs4548056	chr7:65298873	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.72E-6	Diabetic kidney disease	
LIHC	cis	1	rs4548056	chr7:65298873	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs4549329	chr4:239785	ZNF718	chr4:53272-156488:+	0.33	5.57	5.11E-8	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs4559843	chr14:90747488	C14orf102	chr14:90744398-90798279:-	0.29	3.87	0.000132	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs4560537	chr5:150262586	LOC134466	chr5:150310000-150326146:-	0.34	4.46	1.1E-5	Crohn's disease	
LIHC	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.23	2.84E-18	Height	
LIHC	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.39	4.87	1.73E-6	Crohn's disease	
LIHC	cis	1	rs4582105	chr4:246342	ZNF718	chr4:53272-156488:+	0.33	5.16	4.15E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs458291	chr7:65520479	CCT6P1	chr7:65216092-65228661:+	0.31	4.27	2.52E-5	Diabetic kidney disease	
LIHC	cis	1	rs458291	chr7:65520479	INTS4L1	chr7:64601603-64694599:+	0.32	3.88	0.000127	Diabetic kidney disease	
LIHC	cis	1	rs4594164	chr14:35509571	PPP2R3C	chr14:35554679-35591679:-	0.37	5.01	8.67E-7	Atopic dermatitis	
LIHC	cis	1	rs4601178	chr6:109611246	CD164	chr6:109687718-109703762:-	-0.25	-4.76	2.91E-6	Red blood cell traits	
LIHC	cis	1	rs462853	chr7:65558167	CCT6P1	chr7:65216092-65228661:+	0.31	4.34	1.85E-5	Diabetic kidney disease	
LIHC	cis	1	rs4643294	chr15:85250253	NMB	chr15:85198362-85201802:-	-0.4	-6.16	1.98E-9	Schizophrenia	
LIHC	cis	1	rs4646457	chr7:99245080	CYP3A5	chr7:99245818-99332821:-	0.93	16.04	1.26E-43	Blood metabolite levels	
LIHC	cis	1	rs4646457	chr7:99245080	LRCH4	chr7:100171636-100183776:-	0.29	3.92	0.000107	Blood metabolite levels	
LIHC	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.35	5.4	1.26E-7	Multiple sclerosis	
LIHC	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.39	-6.7	8.67E-11	Multiple sclerosis	
LIHC	cis	1	rs4646536	chr12:58157988	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.81	2.28E-6	Multiple sclerosis	
LIHC	cis	1	rs464895	chr7:65527106	CCT6P1	chr7:65216092-65228661:+	0.29	4.05	6.46E-5	Diabetic kidney disease	
LIHC	cis	1	rs4652545	chr1:180947608	STX6	chr1:180913175-180992046:-	-0.19	-4.58	6.62E-6	Progressive supranuclear palsy	
LIHC	cis	1	rs4652547	chr1:180954089	STX6	chr1:180913175-180992046:-	-0.18	-4.3	2.22E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs4652548	chr1:180954130	STX6	chr1:180913175-180992046:-	-0.18	-4.3	2.22E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs465359	chr7:65558164	CCT6P1	chr7:65216092-65228661:+	0.31	4.34	1.85E-5	Diabetic kidney disease	
LIHC	cis	1	rs4654863	chr1:20902244	FAM43B	chr1:20878932-20881512:+	0.2	4.2	3.34E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs4657172	chr1:162179632	FCER1G	chr1:161185087-161189038:+	-0.24	-4.66	4.5E-6	QT interval	
LIHC	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.3	5.43	1.09E-7	Homocysteine levels	
LIHC	cis	1	rs4660456	chr1:41239511	LOC100130557	chr1:41154752-41157933:-	0.26	4.72	3.4E-6	Platelet count	
LIHC	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.3	-5.18	3.76E-7	Homocysteine levels	
LIHC	cis	1	rs4664308	chr2:160917497	LY75	chr2:160625141-160761262:-	0.25	5.37	1.45E-7	Idiopathic membranous nephropathy	
LIHC	cis	1	rs4665147	chr2:160917062	LY75	chr2:160625141-160761262:-	0.25	5.37	1.45E-7	Idiopathic membranous nephropathy	
LIHC	cis	1	rs4667304	chr2:190587103	ORMDL1	chr2:190634994-190649097:-	0.42	3.89	0.000122	Subcutaneous adipose tissue	
LIHC	cis	1	rs466983	chr7:65520496	CCT6P1	chr7:65216092-65228661:+	0.3	4.21	3.32E-5	Diabetic kidney disease	
LIHC	cis	1	rs4675863	chr2:241830763	AGXT	chr2:241808162-241818535:+	-0.16	-3.87	0.000131	Urinary metabolites	
LIHC	cis	1	rs4675863	chr2:241830763	C2orf54	chr2:241825466-241835573:-	0.52	7.49	5.83E-13	Urinary metabolites	
LIHC	cis	1	rs4675868	chr2:241828542	AGXT	chr2:241808162-241818535:+	-0.16	-3.87	0.000131	Urinary metabolites	
LIHC	cis	1	rs4675868	chr2:241828542	C2orf54	chr2:241825466-241835573:-	0.52	7.49	5.83E-13	Urinary metabolites	
LIHC	cis	1	rs4675874	chr2:241819796	AGXT	chr2:241808162-241818535:+	0.16	3.85	0.000138	Urinary metabolites	
LIHC	cis	1	rs4675874	chr2:241819796	C2orf54	chr2:241825466-241835573:-	-0.52	-7.4	1.05E-12	Urinary metabolites	
LIHC	cis	1	rs4687701	chr3:53121276	RFT1	chr3:53122503-53164470:-	0.37	6.13	2.47E-9	Height	
LIHC	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.6	-11.54	2.83E-26	Ankylosing spondylitis	
LIHC	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.54	8.04	1.48E-14	Ankylosing spondylitis	
LIHC	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.63	-13.75	1.4E-34	Response to antipsychotic treatment	
LIHC	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.63	-13.94	2.52E-35	Response to antipsychotic treatment	
LIHC	cis	1	rs4712120	chr6:56092916	COL21A1	chr6:55921389-56258892:-	0.56	9.69	8.6E-20	Pulse pressure	
LIHC	cis	1	rs4713	chr9:131910805	CRAT	chr9:131857075-131873070:-	-0.22	-4.05	6.27E-5	Blood metabolite ratios	
LIHC	cis	1	rs4715129	chr6:49415043	CENPQ	chr6:49431096-49460820:+	-0.21	-4.26	2.65E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs4715130	chr6:49416825	CENPQ	chr6:49431096-49460820:+	-0.21	-4.12	4.72E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs4715134	chr6:49488287	CENPQ	chr6:49431096-49460820:+	0.21	4.42	1.35E-5	Brain structure	
LIHC	cis	1	rs4715438	chr6:53901329	C6orf142	chr6:53883714-54131074:+	-0.24	-3.97	8.69E-5	Liver enzyme levels (gamma-glutamyl transferase)	
LIHC	cis	1	rs4715590	chr6:56060017	COL21A1	chr6:55921389-56258892:-	0.57	10.38	3.77E-22	Pulse pressure	
LIHC	cis	1	rs4718269	chr7:65200778	CCT6P1	chr7:65216092-65228661:+	-0.33	-4.58	6.37E-6	Diabetic kidney disease	
LIHC	cis	1	rs4718269	chr7:65200778	INTS4L1	chr7:64601603-64694599:+	-0.33	-3.86	0.000134	Diabetic kidney disease	
LIHC	cis	1	rs4718270	chr7:65202407	CCT6P1	chr7:65216092-65228661:+	0.36	4.92	1.36E-6	Diabetic kidney disease	
LIHC	cis	1	rs4718270	chr7:65202407	INTS4L1	chr7:64601603-64694599:+	0.35	4.11	4.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs4718317	chr7:65648901	CCT6P1	chr7:65216092-65228661:+	-0.27	-3.84	0.000148	Diabetic kidney disease	
LIHC	cis	1	rs4718333	chr7:65772758	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.19	3.62E-5	Diabetic kidney disease	
LIHC	cis	1	rs4718334	chr7:65789454	CCT6P1	chr7:65216092-65228661:+	-0.29	-4.1	5.26E-5	Diabetic kidney disease	
LIHC	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.31	-4.68	4.15E-6	Obesity-related traits	
LIHC	cis	1	rs4727443	chr7:99593346	TRIM4	chr7:99488037-99517154:-	-0.24	-4.72	3.41E-6	Interstitial lung disease	
LIHC	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.43	6.24	1.25E-9	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
LIHC	cis	1	rs4734494	chr8:101917721	RNF19A	chr8:101269288-101322327:-	-0.23	-4.07	5.95E-5	Attention deficit hyperactivity disorder and conduct disorder	
LIHC	cis	1	rs4734495	chr8:101917817	RNF19A	chr8:101269288-101322327:-	-0.25	-4.42	1.34E-5	Attention deficit hyperactivity disorder and conduct disorder	
LIHC	cis	1	rs4739332	chr8:36943115	PROSC	chr8:37620101-37637285:+	0.36	4.55	7.4E-6	Insulin resistance/response	
LIHC	cis	1	rs4739332	chr8:36943115	RAB11FIP1	chr8:37716470-37757003:-	0.38	5.3	2.1E-7	Insulin resistance/response	
LIHC	cis	1	rs4739334	chr8:36966807	PROSC	chr8:37620101-37637285:+	0.32	3.91	0.000109	Insulin resistance/response	
LIHC	cis	1	rs4739334	chr8:36966807	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.86	1.82E-6	Insulin resistance/response	
LIHC	cis	1	rs4739335	chr8:36966972	PROSC	chr8:37620101-37637285:+	0.33	4.01	7.37E-5	Insulin resistance/response	
LIHC	cis	1	rs4739335	chr8:36966972	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.95	1.17E-6	Insulin resistance/response	
LIHC	cis	1	rs4739466	chr8:36941542	RAB11FIP1	chr8:37716470-37757003:-	0.3	4.29	2.32E-5	Bipolar disorder	
LIHC	cis	1	rs4739467	chr8:36941900	ERLIN2	chr8:37594097-37615318:+	0.34	4.2	3.44E-5	Insulin resistance/response	
LIHC	cis	1	rs4739467	chr8:36941900	PROSC	chr8:37620101-37637285:+	0.38	4.66	4.49E-6	Insulin resistance/response	
LIHC	cis	1	rs4739467	chr8:36941900	RAB11FIP1	chr8:37716470-37757003:-	0.38	5.19	3.65E-7	Insulin resistance/response	
LIHC	cis	1	rs4739469	chr8:36960896	PROSC	chr8:37620101-37637285:+	0.32	3.93	0.000103	Insulin resistance/response	
LIHC	cis	1	rs4739469	chr8:36960896	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.9	1.47E-6	Insulin resistance/response	
LIHC	cis	1	rs4742711	chr9:100780790	C9orf156	chr9:100666772-100684852:-	0.32	3.84	0.000146	Coronary heart disease	
LIHC	cis	1	rs4743150	chr9:100740124	C9orf156	chr9:100666772-100684852:-	0.32	3.92	0.000107	Coronary heart disease	
LIHC	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.15	-3.88	0.000125	Response to temozolomide	
LIHC	cis	1	rs4752797	chr11:47874364	C1QTNF4	chr11:47611216-47615961:-	-0.57	-9.05	1.09E-17	Subjective well-being	
LIHC	cis	1	rs4752856	chr11:47648042	C1QTNF4	chr11:47611216-47615961:-	-0.57	-9.04	1.2E-17	Subjective well-being	
LIHC	cis	1	rs4752857	chr11:47655752	C1QTNF4	chr11:47611216-47615961:-	-0.57	-9.05	1.04E-17	Subjective well-being	
LIHC	cis	1	rs4752873	chr11:47857520	C1QTNF4	chr11:47611216-47615961:-	-0.57	-8.95	2.18E-17	Subjective well-being	
LIHC	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.93	7.52E-9	Forced vital capacity	
LIHC	cis	1	rs4757676	chr11:18640477	SPTY2D1	chr11:18627949-18656020:-	-0.25	-5.19	3.67E-7	Cholesterol, total	
LIHC	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.52	-7.81	7.11E-14	Cognitive function	
LIHC	cis	1	rs4759375	chr12:123796238	ABCB9	chr12:123413540-123459752:-	0.31	3.87	0.000132	HDL cholesterol	
LIHC	cis	1	rs4759377	chr12:123796849	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.47E-5	HDL cholesterol	
LIHC	cis	1	rs4761817	chr12:51846918	KRT80	chr12:52562781-52585784:-	0.4	4.01	7.44E-5	White matter lesion progression;White matter lesion progression (adjusted for white matter lesion burden at baseline)	
LIHC	cis	1	rs4761974	chr12:51880445	KRT80	chr12:52562781-52585784:-	0.4	3.93	0.000101	White matter lesion progression;White matter lesion progression (adjusted for white matter lesion burden at baseline)	
LIHC	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.22	-5.55	5.59E-8	Type 1 diabetes	
LIHC	cis	1	rs4775893	chr15:50898695	USP8	chr15:50716579-50793276:+	-0.22	-4.56	7.28E-6	QT interval	
LIHC	cis	1	rs4775897	chr15:50944066	USP8	chr15:50716579-50793276:+	-0.22	-4.39	1.5E-5	QT interval	
LIHC	cis	1	rs4784054	chr16:58776314	GOT2	chr16:58741035-58768246:-	-0.21	-3.93	0.000103	Blood metabolite levels	
LIHC	cis	1	rs4787491	chr16:30015337	TBX6	chr16:30097117-30103208:-	0.27	4.9	1.49E-6	Body mass index	
LIHC	cis	1	rs4788196	chr16:29967434	TBX6	chr16:30097117-30103208:-	0.25	4.23	2.95E-5	Pubertal anthropometrics	
LIHC	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.3	-5.64	3.48E-8	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.29	5.48	8.07E-8	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.38	-5	8.98E-7	Alzheimer's disease (cognitive decline)	
LIHC	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.61	-12.03	4.62E-28	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.59	-11.59	1.93E-26	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.62	-12.33	3.68E-29	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.61	-12.05	3.99E-28	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.61	-11.96	8.13E-28	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.61	-12.03	4.62E-28	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs4797492	chr18:10923570	CHMP1B	chr18:11851389-11854447:+	0.21	4	7.63E-5	Major depressive disorder	
LIHC	cis	1	rs4799915	chr18:34928639	KIAA1328	chr18:34409080-34809848:+	-0.26	-4.61	5.56E-6	Response to iloperidone treatment (QT prolongation)	
LIHC	cis	1	rs4802307	chr19:46849806	PPP1R13L	chr19:45882893-45909607:-	-0.28	-3.91	0.00011	Crohn's disease;Inflammatory bowel disease	
LIHC	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.43	6.46	3.61E-10	Schizophrenia	
LIHC	cis	1	rs4805754	chr19:32837166	DPY19L3	chr19:32896677-32975236:+	0.2	3.88	0.000126	Bipolar disorder	
LIHC	cis	1	rs4808801	chr19:18571141	ISYNA1	chr19:18545625-18548943:-	0.17	3.84	0.000147	Breast cancer	
LIHC	cis	1	rs4815127	chr20:22543034	C20orf56	chr20:22541194-22559280:-	-0.32	-4.09	5.36E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs4820294	chr22:38071043	LGALS1	chr22:38071613-38075807:+	-0.21	-4.08	5.68E-5	Fat distribution (HIV)	
LIHC	cis	1	rs4820829	chr22:30524248	CABP7	chr22:30116344-30127818:+	0.52	4.28	2.44E-5	LDL cholesterol	
LIHC	cis	1	rs4823071	chr22:30492300	CABP7	chr22:30116344-30127818:+	0.47	3.87	0.000132	LDL cholesterol	
LIHC	cis	1	rs4823082	chr22:30600105	CABP7	chr22:30116344-30127818:+	0.51	3.87	0.000129	LDL cholesterol	
LIHC	cis	1	rs486301	chr15:43836949	ADAL	chr15:43622872-43646094:+	-0.32	-5.18	3.86E-7	Tumor biomarkers	
LIHC	cis	1	rs4865463	chr4:1742400	FAM53A	chr4:1641609-1685854:-	-0.39	-5.06	6.79E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs4865467	chr4:1745500	FAM53A	chr4:1641609-1685854:-	0.38	4.8	2.36E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs4869313	chr5:96223880	ERAP1	chr5:96096515-96149837:-	0.28	4.77	2.7E-6	Pediatric autoimmune diseases	
LIHC	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1.05	-23.54	1.13E-73	Pediatric autoimmune diseases	
LIHC	cis	1	rs4886018	chr13:52990717	VPS36	chr13:52986739-53024763:-	0.25	5.36	1.54E-7	Lewy body disease	
LIHC	cis	1	rs4903961	chr14:81462649	TSHR	chr14:81421869-81612646:+	-0.23	-4.14	4.41E-5	Graves' disease	
LIHC	cis	1	rs4925166	chr17:18210810	SHMT1	chr17:18231195-18266856:-	0.29	6.31	8.5E-10	Multiple sclerosis	
LIHC	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.68	-10.59	7.22E-23	Type 2 diabetes	
LIHC	cis	1	rs4938804	chr11:120273865	TMEM136	chr11:120196016-120204388:+	0.25	4.49	9.57E-6	Intraocular pressure	
LIHC	cis	1	rs4938805	chr11:120274211	TMEM136	chr11:120196016-120204388:+	-0.23	-4.17	3.9E-5	Intraocular pressure	
LIHC	cis	1	rs4938808	chr11:120336902	TMEM136	chr11:120196016-120204388:+	0.24	4.19	3.59E-5	Intraocular pressure	
LIHC	cis	1	rs494003	chr11:65542298	CTSW	chr11:65647284-65651212:+	-0.24	-4.06	6.05E-5	Systemic lupus erythematosus	
LIHC	cis	1	rs4942487	chr13:46709389	CPB2	chr13:46627323-46679211:-	-0.28	-4.69	3.89E-6	Non-alcoholic fatty liver disease histology (other)	
LIHC	cis	1	rs4942487	chr13:46709389	ESD	chr13:47345392-47371367:-	-0.35	-4.21	3.3E-5	Non-alcoholic fatty liver disease histology (other)	
LIHC	cis	1	rs4951261	chr1:205717823	RAB7L1	chr1:205737115-205744610:-	-0.23	-3.93	0.000103	Menarche (age at onset)	
LIHC	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.63	8.95	2.29E-17	Height	
LIHC	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.65	9.44	6.03E-19	Height	
LIHC	cis	1	rs4957901	chr5:109707457	MAN2A1	chr5:109025156-109203429:+	0.31	5.01	8.75E-7	Cardiac structure and function	
LIHC	cis	1	rs4957901	chr5:109707457	TMEM232	chr5:109624934-110062381:-	0.38	3.93	0.000104	Cardiac structure and function	
LIHC	cis	1	rs4957902	chr5:109743657	MAN2A1	chr5:109025156-109203429:+	0.26	4.18	3.69E-5	Cardiac structure and function	
LIHC	cis	1	rs4958424	chr5:150225036	LOC134466	chr5:150310000-150326146:-	0.33	4.2	3.38E-5	Crohn's disease	
LIHC	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.38	4.84	1.96E-6	Crohn's disease	
LIHC	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.36	4.41	1.39E-5	Crohn's disease	
LIHC	cis	1	rs4958843	chr5:150224924	LOC134466	chr5:150310000-150326146:-	0.33	4.2	3.38E-5	Crohn's disease	
LIHC	cis	1	rs4958848	chr5:150271122	LOC134466	chr5:150310000-150326146:-	0.34	4.53	8.01E-6	Crohn's disease	
LIHC	cis	1	rs4958852	chr5:150330631	LOC134466	chr5:150310000-150326146:-	0.36	4.54	7.85E-6	Crohn's disease	
LIHC	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.29	-4.6	5.82E-6	Tumor biomarkers	
LIHC	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.6	-8.1	9.8E-15	Diastolic blood pressure	
LIHC	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.63	9.17	4.45E-18	Height	
LIHC	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.66	9.3	1.64E-18	Height	
LIHC	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.67	9.56	2.27E-19	Height	
LIHC	cis	1	rs4974559	chr4:1380848	KIAA1530	chr4:1341104-1381836:+	0.33	5.66	3.13E-8	Systolic blood pressure	
LIHC	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.59	-8.62	2.42E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.59	-8.62	2.42E-16	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs4975709	chr5:1877280	MRPL36	chr5:1798500-1799956:-	0.24	4.6	5.82E-6	Cardiovascular disease risk factors	
LIHC	cis	1	rs5003261	chr4:207023	ZNF718	chr4:53272-156488:+	0.26	3.83	0.000151	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs5022760	chr15:51020852	USP8	chr15:50716579-50793276:+	-0.21	-4.28	2.46E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs514591	chr1:196640320	CFHR4	chr1:196857212-196887762:+	-0.24	-5.19	3.64E-7	Circulating myeloperoxidase levels (serum)	
LIHC	cis	1	rs531676	chr10:99637578	CRTAC1	chr10:99624758-99790585:-	0.28	6.21	1.49E-9	Metabolic syndrome	
LIHC	cis	1	rs534417	chr1:23784965	ASAP3	chr1:23755056-23811057:-	0.25	4.24	2.86E-5	Cholesterol, total	
LIHC	cis	1	rs548181	chr11:125461709	DDX25	chr11:125774272-125793003:+	-0.45	-4.8	2.38E-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);Schizophrenia	
LIHC	cis	1	rs551397	chr1:196642072	CFHR4	chr1:196857212-196887762:+	-0.24	-5.18	3.76E-7	Circulating myeloperoxidase levels (serum)	
LIHC	cis	1	rs55756843	chr12:109092796	SELPLG	chr12:109015682-109027670:-	0.1	3.84	0.000148	Low high density lipoprotein cholesterol levels	
LIHC	cis	1	rs55788133	chr15:40664239	C15orf23	chr15:40674922-40686488:+	0.64	6.42	4.42E-10	Heschl's gyrus morphology	
LIHC	cis	1	rs55805503	chr10:96534043	CYP2C18	chr10:96443251-96495945:+	-0.34	-3.85	0.00014	Blood metabolite levels	
LIHC	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.28	-4.82	2.12E-6	Inflammatory skin disease	
LIHC	cis	1	rs55895244	chr7:65387678	CCT6P1	chr7:65216092-65228661:+	0.32	4.46	1.09E-5	Diabetic kidney disease	
LIHC	cis	1	rs55895244	chr7:65387678	INTS4L1	chr7:64601603-64694599:+	0.33	3.89	0.000122	Diabetic kidney disease	
LIHC	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.65	9.44	6.03E-19	Height	
LIHC	cis	1	rs56015123	chr15:50977228	USP8	chr15:50716579-50793276:+	-0.21	-4.1	5.26E-5	QT interval	
LIHC	cis	1	rs56016656	chr7:65383481	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.31E-6	Diabetic kidney disease	
LIHC	cis	1	rs56016656	chr7:65383481	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000129	Diabetic kidney disease	
LIHC	cis	1	rs56028644	chr19:17388790	ANKLE1	chr19:17392454-17398454:+	0.39	3.94	9.85E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.31	5.14	4.51E-7	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
LIHC	cis	1	rs56069965	chr15:50966973	USP8	chr15:50716579-50793276:+	-0.21	-4.1	5.26E-5	QT interval	
LIHC	cis	1	rs56077333	chr15:78899003	CHRNA5	chr15:78857906-78886458:+	-0.26	-3.95	9.32E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
LIHC	cis	1	rs56080544	chr15:50950970	USP8	chr15:50716579-50793276:+	-0.22	-4.3	2.25E-5	QT interval	
LIHC	cis	1	rs56105592	chr2:17779641	GEN1	chr2:17935162-17966632:+	0.41	5.15	4.4E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs56118429	chr15:50923849	USP8	chr15:50716579-50793276:+	-0.22	-4.46	1.12E-5	QT interval	
LIHC	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.57	7.5	5.57E-13	Diastolic blood pressure	
LIHC	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.57	7.5	5.57E-13	Diastolic blood pressure	
LIHC	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.62	5.66	3.28E-8	Diastolic blood pressure	
LIHC	cis	1	rs56291018	chr7:65390339	CCT6P1	chr7:65216092-65228661:+	0.35	4.78	2.56E-6	Diabetic kidney disease	
LIHC	cis	1	rs56291018	chr7:65390339	INTS4L1	chr7:64601603-64694599:+	0.33	3.84	0.000144	Diabetic kidney disease	
LIHC	cis	1	rs56297666	chr2:160902023	LY75	chr2:160625141-160761262:-	0.24	5.09	5.83E-7	Idiopathic membranous nephropathy	
LIHC	cis	1	rs56322409	chr10:97395962	ALDH18A1	chr10:97365687-97416567:-	0.3	4.41	1.36E-5	Blood metabolite levels	
LIHC	cis	1	rs56322409	chr10:97395962	ENTPD1	chr10:97471536-97637022:+	0.21	4.23	3.06E-5	Blood metabolite levels	
LIHC	cis	1	rs56326127	chr2:86212201	POLR1A	chr2:86253453-86333278:-	-0.37	-5.05	7.28E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs563538	chr13:37433721	FAM48A	chr13:37583453-37633850:-	0.32	4.61	5.74E-6	Spontaneous preterm birth (preterm birth)	
LIHC	cis	1	rs56761259	chr8:36891705	ERLIN2	chr8:37594097-37615318:+	0.32	4.12	4.66E-5	Insulin resistance/response	
LIHC	cis	1	rs56761259	chr8:36891705	PROSC	chr8:37620101-37637285:+	0.34	4.21	3.2E-5	Insulin resistance/response	
LIHC	cis	1	rs56761259	chr8:36891705	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.97	1.04E-6	Insulin resistance/response	
LIHC	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.57	7.59	3.02E-13	Diastolic blood pressure	
LIHC	cis	1	rs56818101	chr2:17776053	GEN1	chr2:17935162-17966632:+	0.41	5.1	5.68E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.59	-16.4	4.58E-45	Crohn's disease	
LIHC	cis	1	rs56864281	chr15:85357649	NMB	chr15:85198362-85201802:-	-0.37	-5.63	3.8E-8	Schizophrenia	
LIHC	cis	1	rs56864281	chr15:85357649	UBE2Q2P1	chr15:85070427-85114026:-	0.27	4.38	1.55E-5	Schizophrenia	
LIHC	cis	1	rs56901035	chr8:96043188	C8orf38	chr8:95908040-96088396:+	-0.27	-3.87	0.000131	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.61	-12.05	3.99E-28	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs56977454	chr2:86204014	POLR1A	chr2:86253453-86333278:-	-0.36	-4.98	9.89E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs569856	chr10:105942304	C10orf79	chr10:105889647-105992120:-	-0.25	-3.85	0.000141	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs56985706	chr7:65394562	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs56985706	chr7:65394562	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs569967	chr10:105942337	C10orf79	chr10:105889647-105992120:-	-0.25	-3.85	0.000141	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs57001853	chr5:150272452	LOC134466	chr5:150310000-150326146:-	0.34	4.56	7.11E-6	Crohn's disease	
LIHC	cis	1	rs57002197	chr15:50873760	USP8	chr15:50716579-50793276:+	-0.2	-4.07	5.92E-5	QT interval	
LIHC	cis	1	rs57057549	chr7:65405738	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.31E-6	Diabetic kidney disease	
LIHC	cis	1	rs57057549	chr7:65405738	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000129	Diabetic kidney disease	
LIHC	cis	1	rs57075379	chr14:35577801	PPP2R3C	chr14:35554679-35591679:-	0.38	5.01	8.65E-7	Atopic dermatitis	
LIHC	cis	1	rs57083584	chr2:86283648	POLR1A	chr2:86253453-86333278:-	-0.36	-4.74	3.1E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs57083584	chr2:86283648	REEP1	chr2:86441122-86564777:-	0.44	4.13	4.63E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs57120899	chr14:24936258	SDR39U1	chr14:24908974-24912064:-	-0.5	-5.13	4.95E-7	Smooth-surface caries	
LIHC	cis	1	rs57181681	chr8:36888805	ERLIN2	chr8:37594097-37615318:+	0.36	4.42	1.32E-5	Insulin resistance/response	
LIHC	cis	1	rs57181681	chr8:36888805	PROSC	chr8:37620101-37637285:+	0.39	4.6	5.89E-6	Insulin resistance/response	
LIHC	cis	1	rs57181681	chr8:36888805	RAB11FIP1	chr8:37716470-37757003:-	0.37	4.98	1.01E-6	Insulin resistance/response	
LIHC	cis	1	rs57259303	chr14:24928534	GMPR2	chr14:24701648-24708445:+	-0.45	-4.37	1.63E-5	Smooth-surface caries	
LIHC	cis	1	rs57259303	chr14:24928534	SDR39U1	chr14:24908974-24912064:-	-0.53	-5.14	4.55E-7	Smooth-surface caries	
LIHC	cis	1	rs57398459	chr2:86291326	POLR1A	chr2:86253453-86333278:-	-0.37	-5.03	8.01E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs5743044	chr2:190683265	ORMDL1	chr2:190634994-190649097:-	0.39	3.81	0.000165	Subcutaneous adipose tissue	
LIHC	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	0.6	8.06	1.26E-14	Diastolic blood pressure	
LIHC	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.19	-4.31	2.11E-5	Cognitive function	
LIHC	cis	1	rs57512806	chr2:17776078	GEN1	chr2:17935162-17966632:+	0.41	5.11	5.25E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs5752798	chr22:29181868	CHEK2	chr22:29083731-29137822:-	-0.26	-4.19	3.51E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs5753002	chr22:30435402	CABP7	chr22:30116344-30127818:+	0.48	3.92	0.000106	LDL cholesterol	
LIHC	cis	1	rs5753014	chr22:30515049	CABP7	chr22:30116344-30127818:+	0.5	4.1	5.21E-5	LDL cholesterol	
LIHC	cis	1	rs5753020	chr22:30524868	CABP7	chr22:30116344-30127818:+	0.48	3.82	0.000158	LDL cholesterol	
LIHC	cis	1	rs5753027	chr22:30554204	CABP7	chr22:30116344-30127818:+	0.5	4.1	5.21E-5	LDL cholesterol	
LIHC	cis	1	rs5753028	chr22:30556845	CABP7	chr22:30116344-30127818:+	0.49	3.92	0.000109	LDL cholesterol	
LIHC	cis	1	rs5753029	chr22:30557939	CABP7	chr22:30116344-30127818:+	0.48	3.82	0.000158	LDL cholesterol	
LIHC	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.19	-4.2	3.47E-5	Cognitive function	
LIHC	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.19	-4.1	5.19E-5	Cognitive function	
LIHC	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.19	-4.15	4.25E-5	Cognitive function	
LIHC	cis	1	rs5762784	chr22:29171298	CHEK2	chr22:29083731-29137822:-	-0.26	-4.15	4.17E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs5762788	chr22:29174770	CHEK2	chr22:29083731-29137822:-	-0.25	-4	7.78E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs5762815	chr22:29205076	CHEK2	chr22:29083731-29137822:-	-0.26	-4.15	4.15E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs5763763	chr22:30488627	CABP7	chr22:30116344-30127818:+	0.51	4.21	3.3E-5	LDL cholesterol	
LIHC	cis	1	rs5763766	chr22:30491512	CABP7	chr22:30116344-30127818:+	-0.46	-3.86	0.000133	LDL cholesterol	
LIHC	cis	1	rs5763769	chr22:30495745	CABP7	chr22:30116344-30127818:+	0.5	4.12	4.73E-5	LDL cholesterol	
LIHC	cis	1	rs5763774	chr22:30498550	CABP7	chr22:30116344-30127818:+	0.52	4.29	2.35E-5	LDL cholesterol	
LIHC	cis	1	rs5763794	chr22:30529960	CABP7	chr22:30116344-30127818:+	0.5	4.13	4.54E-5	LDL cholesterol	
LIHC	cis	1	rs5763805	chr22:30538398	CABP7	chr22:30116344-30127818:+	0.5	4.01	7.43E-5	LDL cholesterol	
LIHC	cis	1	rs5763810	chr22:30541670	CABP7	chr22:30116344-30127818:+	0.48	3.82	0.000158	LDL cholesterol	
LIHC	cis	1	rs5763852	chr22:30576125	CABP7	chr22:30116344-30127818:+	0.5	4.1	5.21E-5	LDL cholesterol	
LIHC	cis	1	rs5763854	chr22:30577589	CABP7	chr22:30116344-30127818:+	0.47	3.81	0.000165	LDL cholesterol	
LIHC	cis	1	rs5770911	chr22:51011241	NCAPH2	chr22:50946645-50961911:+	0.26	3.89	0.00012	Narcolepsy	
LIHC	cis	1	rs5771109	chr22:50678571	SELO	chr22:50639408-50656044:+	0.22	4.84	1.92E-6	Obesity-related traits	
LIHC	cis	1	rs578056	chr11:65514874	CTSW	chr11:65647284-65651212:+	-0.24	-4.06	6.04E-5	Systemic lupus erythematosus	
LIHC	cis	1	rs58062456	chr7:65394852	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs58062456	chr7:65394852	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs58349349	chr10:96553499	CYP2C18	chr10:96443251-96495945:+	-0.35	-4	7.62E-5	Blood metabolite levels	
LIHC	cis	1	rs583583	chr1:147083114	ACP6	chr1:147119168-147142634:-	0.4	7.1	7.15E-12	Schizophrenia (negative symptoms)	
LIHC	cis	1	rs58365138	chr2:86213105	POLR1A	chr2:86253453-86333278:-	-0.38	-5.21	3.33E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs58416181	chr15:85264461	NMB	chr15:85198362-85201802:-	-0.41	-6.29	9.44E-10	Schizophrenia	
LIHC	cis	1	rs58453750	chr2:17778329	GEN1	chr2:17935162-17966632:+	0.41	5.15	4.4E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs58554240	chr2:104002138	IL18RAP	chr2:103035254-103069022:+	-0.27	-4	7.86E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs58591218	chr19:32890782	DPY19L3	chr19:32896677-32975236:+	0.2	3.84	0.000145	Bipolar disorder	
LIHC	cis	1	rs58660500	chr3:53086573	RFT1	chr3:53122503-53164470:-	0.52	4.73	3.3E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs58669269	chr7:65951953	CCT6P1	chr7:65216092-65228661:+	0.32	4.27	2.51E-5	Diabetic kidney disease	
LIHC	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.36	4.6	5.84E-6	Crohn's disease	
LIHC	cis	1	rs58898686	chr2:86216909	POLR1A	chr2:86253453-86333278:-	-0.37	-5.08	6.18E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs59043558	chr5:150334662	LOC134466	chr5:150310000-150326146:-	0.34	4.44	1.2E-5	Crohn's disease	
LIHC	cis	1	rs59104589	chr2:242237902	ANO7	chr2:242127924-242164791:+	0.33	5.75	1.98E-8	Fibrinogen levels	
LIHC	cis	1	rs591058	chr11:102711338	MMP1	chr11:102660641-102668966:-	0.31	5.1	5.67E-7	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
LIHC	cis	1	rs59150578	chr11:18340862	LDHC	chr11:18433853-18472792:+	0.34	3.94	0.0001	Pancreatic cancer	
LIHC	cis	1	rs591784	chr10:105936290	C10orf79	chr10:105889647-105992120:-	-0.25	-3.87	0.000131	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs593151	chr10:105935979	C10orf79	chr10:105889647-105992120:-	-0.25	-3.87	0.000131	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs59321715	chr5:150313480	LOC134466	chr5:150310000-150326146:-	0.36	4.4	1.45E-5	Crohn's disease	
LIHC	cis	1	rs59343240	chr16:67850529	DPEP2	chr16:68021295-68034489:-	0.41	3.99	8.07E-5	Crohn's disease	
LIHC	cis	1	rs59448251	chr14:24928452	GMPR2	chr14:24701648-24708445:+	-0.45	-4.37	1.63E-5	Smooth-surface caries	
LIHC	cis	1	rs59448251	chr14:24928452	SDR39U1	chr14:24908974-24912064:-	-0.53	-5.14	4.55E-7	Smooth-surface caries	
LIHC	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.38	4.69	3.9E-6	Crohn's disease	
LIHC	cis	1	rs59583591	chr3:53119581	RFT1	chr3:53122503-53164470:-	0.46	4.52	8.6E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs59616627	chr2:88697600	EIF2AK3	chr2:88856261-88926994:-	0.35	3.82	0.000156	Visceral fat	
LIHC	cis	1	rs59794892	chr7:65415873	CCT6P1	chr7:65216092-65228661:+	0.33	4.53	8.29E-6	Diabetic kidney disease	
LIHC	cis	1	rs59794892	chr7:65415873	INTS4L1	chr7:64601603-64694599:+	0.33	3.95	9.35E-5	Diabetic kidney disease	
LIHC	cis	1	rs59905513	chr14:90749638	C14orf102	chr14:90744398-90798279:-	0.29	3.87	0.000132	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.59	-11.5	3.9E-26	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs5996946	chr22:25875988	CRYBB2	chr22:25615612-25627836:+	0.87	9.32	1.42E-18	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs5997408	chr22:29207915	CHEK2	chr22:29083731-29137822:-	-0.26	-4.15	4.15E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs59980321	chr5:150241813	LOC134466	chr5:150310000-150326146:-	0.35	4.53	8.25E-6	Crohn's disease	
LIHC	cis	1	rs60043652	chr2:17778944	GEN1	chr2:17935162-17966632:+	0.41	5.11	5.44E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs6004654	chr22:25855204	CRYBB2	chr22:25615612-25627836:+	0.84	9.19	3.74E-18	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004655	chr22:25855629	CRYBB2	chr22:25615612-25627836:+	0.88	9.59	1.87E-19	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004657	chr22:25855714	CRYBB2	chr22:25615612-25627836:+	0.82	9.02	1.3E-17	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004658	chr22:25856231	CRYBB2	chr22:25615612-25627836:+	0.84	9.2	3.47E-18	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004659	chr22:25856411	CRYBB2	chr22:25615612-25627836:+	0.84	9.2	3.47E-18	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004662	chr22:25862124	CRYBB2	chr22:25615612-25627836:+	0.86	9.41	7.56E-19	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004667	chr22:25874464	CRYBB2	chr22:25615612-25627836:+	-0.89	-9.9	1.66E-20	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004668	chr22:25874502	CRYBB2	chr22:25615612-25627836:+	-0.85	-9.33	1.36E-18	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004669	chr22:25875803	CRYBB2	chr22:25615612-25627836:+	0.88	9.41	7.35E-19	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004671	chr22:25879474	CRYBB2	chr22:25615612-25627836:+	0.86	9.69	8.61E-20	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004672	chr22:25881013	CRYBB2	chr22:25615612-25627836:+	0.86	9.62	1.52E-19	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004673	chr22:25885353	CRYBB2	chr22:25615612-25627836:+	0.82	9.55	2.58E-19	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6004675	chr22:25889385	CRYBB2	chr22:25615612-25627836:+	0.85	9.61	1.64E-19	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6005872	chr22:29172898	CHEK2	chr22:29083731-29137822:-	-0.26	-4.19	3.51E-5	Esophageal squamous cell carcinoma;Esophageal cancer (squamous cell)	
LIHC	cis	1	rs60072763	chr9:99547980	FAM22G	chr9:99690592-99704572:+	0.67	7.51	5.31E-13	Height	
LIHC	cis	1	rs60134818	chr5:150261043	LOC134466	chr5:150310000-150326146:-	0.34	4.44	1.24E-5	Crohn's disease	
LIHC	cis	1	rs602128	chr11:102713465	MMP1	chr11:102660641-102668966:-	0.32	5.29	2.17E-7	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
LIHC	cis	1	rs60326618	chr7:66166358	CCT6P1	chr7:65216092-65228661:+	0.33	4.52	8.55E-6	Gout	
LIHC	cis	1	rs6048196	chr20:22546186	C20orf56	chr20:22541194-22559280:-	-0.33	-4.35	1.81E-5	Fasting glucose-related traits (interaction with BMI)	
LIHC	cis	1	rs6051080	chr20:25975674	FAM182B	chr20:25744102-25848786:-	0.41	6.27	1.06E-9	Colorectal or endometrial cancer	
LIHC	cis	1	rs6058219	chr20:33859244	MAP1LC3A	chr20:33134692-33148149:+	0.4	3.84	0.000149	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs60649958	chr2:86283000	POLR1A	chr2:86253453-86333278:-	-0.36	-4.95	1.16E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs60683927	chr7:65394768	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs60683927	chr7:65394768	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs60693825	chr14:35514456	PPP2R3C	chr14:35554679-35591679:-	0.37	4.96	1.11E-6	Atopic dermatitis	
LIHC	cis	1	rs60777821	chr14:24936313	SDR39U1	chr14:24908974-24912064:-	-0.5	-5.13	4.95E-7	Smooth-surface caries	
LIHC	cis	1	rs6092354	chr20:55294474	PCK1	chr20:56136137-56141507:+	-0.31	-3.84	0.000148	Cognitive decline rate in late mild cognitive impairment	
LIHC	cis	1	rs60957376	chr15:85280792	NMB	chr15:85198362-85201802:-	-0.4	-6.36	6.53E-10	Schizophrenia	
LIHC	cis	1	rs60982898	chr6:49385806	CENPQ	chr6:49431096-49460820:+	-0.21	-4.19	3.57E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.77	1.73E-8	Forced vital capacity	
LIHC	cis	1	rs61153799	chr10:96547356	CYP2C18	chr10:96443251-96495945:+	-0.34	-3.85	0.00014	Blood metabolite levels	
LIHC	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.47	-6.86	3.27E-11	Triglycerides	
LIHC	cis	1	rs61270113	chr5:150226263	LOC134466	chr5:150310000-150326146:-	0.35	4.46	1.12E-5	Crohn's disease	
LIHC	cis	1	rs61316646	chr18:44610670	HDHD2	chr18:44633782-44676871:-	0.41	3.83	0.000152	Sitting height ratio	
LIHC	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.36	4.56	7.25E-6	Crohn's disease	
LIHC	cis	1	rs61634114	chr19:17387254	ANKLE1	chr19:17392454-17398454:+	0.4	3.98	8.49E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs61744385	chr3:41756986	ULK4	chr3:41288091-42003660:-	0.61	8.01	1.81E-14	Diastolic blood pressure	
LIHC	cis	1	rs61744388	chr3:41756965	ULK4	chr3:41288091-42003660:-	0.61	8.01	1.81E-14	Diastolic blood pressure	
LIHC	cis	1	rs617819	chr11:102714716	MMP1	chr11:102660641-102668966:-	0.33	5.31	1.96E-7	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
LIHC	cis	1	rs61792114	chr4:289139	ZNF718	chr4:53272-156488:+	0.28	4.93	1.26E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs61792116	chr4:301077	ZNF718	chr4:53272-156488:+	0.35	5.36	1.49E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs61794996	chr4:209328	ZNF718	chr4:53272-156488:+	0.34	5.1	5.57E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs61794997	chr4:222103	ZNF718	chr4:53272-156488:+	0.35	5.4	1.25E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs61795001	chr4:242057	ZNF718	chr4:53272-156488:+	0.33	5.08	6.12E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs61795002	chr4:242797	ZNF718	chr4:53272-156488:+	0.34	5.21	3.27E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs61795006	chr4:253601	ZNF718	chr4:53272-156488:+	0.33	5.54	5.95E-8	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs61795007	chr4:255264	ZNF718	chr4:53272-156488:+	0.33	5.54	5.95E-8	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs6180	chr5:42719239	CCDC152	chr5:42756920-42802539:+	0.19	4.08	5.59E-5	Height	
LIHC	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.42	5.63	3.75E-8	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs61854764	chr10:69965475	DNA2	chr10:70173822-70231879:-	-0.31	-5.25	2.62E-7	Optic nerve measurement (disc area)	
LIHC	cis	1	rs61871790	chr10:97391223	ALDH18A1	chr10:97365687-97416567:-	0.29	4.26	2.6E-5	Blood metabolite levels	
LIHC	cis	1	rs61871790	chr10:97391223	ENTPD1	chr10:97471536-97637022:+	0.21	4.11	4.99E-5	Blood metabolite levels	
LIHC	cis	1	rs61871792	chr10:97397586	ALDH18A1	chr10:97365687-97416567:-	0.3	4.41	1.36E-5	Blood metabolite levels	
LIHC	cis	1	rs61871792	chr10:97397586	ENTPD1	chr10:97471536-97637022:+	0.21	4.23	3.06E-5	Blood metabolite levels	
LIHC	cis	1	rs61871793	chr10:97407738	ALDH18A1	chr10:97365687-97416567:-	0.27	3.94	9.95E-5	Blood metabolite levels	
LIHC	cis	1	rs61871793	chr10:97407738	ENTPD1	chr10:97471536-97637022:+	0.21	4.14	4.45E-5	Blood metabolite levels	
LIHC	cis	1	rs61953394	chr12:123753372	ABCB9	chr12:123413540-123459752:-	0.34	4.36	1.7E-5	HDL cholesterol	
LIHC	cis	1	rs61986782	chr14:90751344	C14orf102	chr14:90744398-90798279:-	0.29	3.87	0.000132	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs61989986	chr14:90739180	C14orf102	chr14:90744398-90798279:-	0.28	3.82	0.000157	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs62017189	chr15:50922032	USP8	chr15:50716579-50793276:+	-0.22	-4.5	9.48E-6	QT interval	
LIHC	cis	1	rs62017206	chr15:50955626	USP8	chr15:50716579-50793276:+	-0.22	-4.42	1.31E-5	QT interval	
LIHC	cis	1	rs62017210	chr15:50960620	USP8	chr15:50716579-50793276:+	-0.22	-4.4	1.46E-5	QT interval	
LIHC	cis	1	rs62019464	chr15:85294469	NMB	chr15:85198362-85201802:-	-0.38	-5.92	7.95E-9	Schizophrenia	
LIHC	cis	1	rs62019469	chr15:85321220	NMB	chr15:85198362-85201802:-	-0.38	-5.96	6.16E-9	Schizophrenia	
LIHC	cis	1	rs62019469	chr15:85321220	UBE2Q2P1	chr15:85070427-85114026:-	0.24	3.97	8.86E-5	Schizophrenia	
LIHC	cis	1	rs62021219	chr15:85256159	NMB	chr15:85198362-85201802:-	-0.4	-6.16	1.98E-9	Schizophrenia	
LIHC	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.34	-4.93	1.26E-6	Schizophrenia	
LIHC	cis	1	rs62026530	chr15:84775840	NMB	chr15:85198362-85201802:-	-0.36	-4.95	1.17E-6	Schizophrenia	
LIHC	cis	1	rs62132091	chr2:17770276	GEN1	chr2:17935162-17966632:+	0.41	5.08	6.09E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132092	chr2:17770893	GEN1	chr2:17935162-17966632:+	0.46	4.93	1.28E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132093	chr2:17771207	GEN1	chr2:17935162-17966632:+	0.46	4.93	1.28E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132125	chr2:17776997	GEN1	chr2:17935162-17966632:+	0.41	5.11	5.44E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132127	chr2:17778708	GEN1	chr2:17935162-17966632:+	0.41	5.15	4.4E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132129	chr2:17778782	GEN1	chr2:17935162-17966632:+	0.43	4.77	2.72E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132133	chr2:17780483	GEN1	chr2:17935162-17966632:+	0.47	5.01	8.59E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132135	chr2:17783190	GEN1	chr2:17935162-17966632:+	0.45	4.99	9.54E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132137	chr2:17784194	GEN1	chr2:17935162-17966632:+	0.45	4.99	9.54E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132138	chr2:17784781	GEN1	chr2:17935162-17966632:+	0.45	4.99	9.54E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132139	chr2:17785987	GEN1	chr2:17935162-17966632:+	0.45	5.01	8.91E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132140	chr2:17786559	GEN1	chr2:17935162-17966632:+	0.46	5.02	8.11E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132141	chr2:17786758	GEN1	chr2:17935162-17966632:+	0.45	5.01	8.91E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132142	chr2:17788469	GEN1	chr2:17935162-17966632:+	0.45	5.01	8.91E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132143	chr2:17788743	GEN1	chr2:17935162-17966632:+	0.45	5.01	8.91E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132144	chr2:17788790	GEN1	chr2:17935162-17966632:+	0.45	5.01	8.91E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132145	chr2:17789253	GEN1	chr2:17935162-17966632:+	0.45	5.01	8.91E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132146	chr2:17790133	GEN1	chr2:17935162-17966632:+	0.45	5.01	8.91E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132147	chr2:17790876	GEN1	chr2:17935162-17966632:+	0.45	4.97	1.07E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132148	chr2:17791048	GEN1	chr2:17935162-17966632:+	0.45	4.97	1.07E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132150	chr2:17792359	GEN1	chr2:17935162-17966632:+	0.42	4.68	4.1E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132151	chr2:17792698	GEN1	chr2:17935162-17966632:+	0.42	4.68	4.1E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62132152	chr2:17794404	GEN1	chr2:17935162-17966632:+	0.42	4.68	4.1E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133576	chr2:17795297	GEN1	chr2:17935162-17966632:+	0.42	4.68	4.1E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133577	chr2:17798777	GEN1	chr2:17935162-17966632:+	0.44	4.75	2.97E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133578	chr2:17799575	GEN1	chr2:17935162-17966632:+	0.43	4.69	3.91E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133579	chr2:17800196	GEN1	chr2:17935162-17966632:+	0.43	4.69	3.91E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133583	chr2:17805779	GEN1	chr2:17935162-17966632:+	0.43	4.69	3.91E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133584	chr2:17805944	GEN1	chr2:17935162-17966632:+	0.43	4.69	3.91E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133586	chr2:17806579	GEN1	chr2:17935162-17966632:+	0.43	4.69	3.91E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133587	chr2:17806654	GEN1	chr2:17935162-17966632:+	0.43	4.69	3.91E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133588	chr2:17807469	GEN1	chr2:17935162-17966632:+	0.41	4.42	1.32E-5	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133589	chr2:17807626	GEN1	chr2:17935162-17966632:+	0.41	4.42	1.32E-5	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62133590	chr2:17811126	GEN1	chr2:17935162-17966632:+	0.4	4.19	3.56E-5	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs62136864	chr2:46829124	CRIPT	chr2:46844325-46852880:+	0.25	3.94	0.0001	Height	
LIHC	cis	1	rs62175515	chr2:160909524	LY75	chr2:160625141-160761262:-	0.25	5.54	6.04E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs62175517	chr2:160911575	LY75	chr2:160625141-160761262:-	0.25	5.54	6.04E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs62179067	chr2:180135183	CCDC141	chr2:179697347-179914786:-	0.61	4.56	6.98E-6	Late-onset Alzheimer's disease	
LIHC	cis	1	rs62229266	chr21:37460271	SETD4	chr21:37406840-37451687:-	-0.26	-4.62	5.38E-6	Mitral valve prolapse	
LIHC	cis	1	rs62236665	chr22:38059847	LGALS1	chr22:38071613-38075807:+	-0.2	-3.89	0.00012	Fat distribution (HIV)	
LIHC	cis	1	rs62236667	chr22:38061520	LGALS1	chr22:38071613-38075807:+	-0.2	-3.98	8.33E-5	Fat distribution (HIV)	
LIHC	cis	1	rs62236668	chr22:38063870	LGALS1	chr22:38071613-38075807:+	-0.19	-3.85	0.00014	Fat distribution (HIV)	
LIHC	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.66	9.52	3.27E-19	Height	
LIHC	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.63	-8.88	3.86E-17	Height	
LIHC	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.63	-8.88	3.86E-17	Height	
LIHC	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.63	8.92	2.79E-17	Height	
LIHC	cis	1	rs62402013	chr6:26915000	LOC100270746	chr6:26987146-26988085:-	-0.32	-5.24	2.79E-7	Schizophrenia	
LIHC	cis	1	rs62406152	chr6:55932036	COL21A1	chr6:55921389-56258892:-	-0.32	-3.82	0.000155	Psychosis (atypical)	
LIHC	cis	1	rs62412799	chr6:55977839	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000164	Psychosis (atypical)	
LIHC	cis	1	rs62412803	chr6:55986547	COL21A1	chr6:55921389-56258892:-	-0.33	-3.89	0.000118	Psychosis (atypical)	
LIHC	cis	1	rs62412806	chr6:55987105	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000162	Psychosis (atypical)	
LIHC	cis	1	rs62412807	chr6:55987693	COL21A1	chr6:55921389-56258892:-	-0.32	-3.83	0.000153	Psychosis (atypical)	
LIHC	cis	1	rs62412808	chr6:55987806	COL21A1	chr6:55921389-56258892:-	-0.32	-3.83	0.000153	Psychosis (atypical)	
LIHC	cis	1	rs62412809	chr6:55987863	COL21A1	chr6:55921389-56258892:-	-0.32	-3.83	0.000153	Psychosis (atypical)	
LIHC	cis	1	rs62412810	chr6:55988047	COL21A1	chr6:55921389-56258892:-	-0.32	-3.83	0.000153	Psychosis (atypical)	
LIHC	cis	1	rs62412811	chr6:55988062	COL21A1	chr6:55921389-56258892:-	-0.32	-3.83	0.000153	Psychosis (atypical)	
LIHC	cis	1	rs62412813	chr6:55988257	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000162	Psychosis (atypical)	
LIHC	cis	1	rs62412814	chr6:55988296	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000162	Psychosis (atypical)	
LIHC	cis	1	rs62412818	chr6:55989784	COL21A1	chr6:55921389-56258892:-	-0.32	-3.81	0.000162	Psychosis (atypical)	
LIHC	cis	1	rs62413479	chr6:56004203	COL21A1	chr6:55921389-56258892:-	-0.32	-3.84	0.000149	Psychosis (atypical)	
LIHC	cis	1	rs624159	chr10:105939451	C10orf79	chr10:105889647-105992120:-	-0.25	-3.87	0.000131	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs62424198	chr6:118827247	C6orf204	chr6:118786239-119031238:-	-0.28	-4.17	3.81E-5	Renal cell carcinoma	
LIHC	cis	1	rs629301	chr1:109818306	CELSR2	chr1:109792641-109818377:+	-0.42	-5.28	2.26E-7	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs629301	chr1:109818306	MYBPHL	chr1:109834987-109849663:-	-0.38	-5.09	5.86E-7	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs629301	chr1:109818306	PSRC1	chr1:109822179-109825808:-	-0.57	-9.92	1.43E-20	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs629301	chr1:109818306	SORT1	chr1:109852192-109940563:-	-0.67	-8.22	4.32E-15	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs632478	chr11:102715681	MMP1	chr11:102660641-102668966:-	0.32	5.24	2.74E-7	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
LIHC	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.59	-16.4	4.58E-45	Crohn's disease	
LIHC	cis	1	rs641862	chr13:110790232	ANKRD10	chr13:111530888-111567416:-	0.6	5.29	2.2E-7	Obesity-related traits	
LIHC	cis	1	rs641862	chr13:110790232	ARHGEF7	chr13:111767624-111958080:+	0.59	4.86	1.79E-6	Obesity-related traits	
LIHC	cis	1	rs641862	chr13:110790232	CARKD	chr13:111267881-111292340:+	0.71	6.42	4.5E-10	Obesity-related traits	
LIHC	cis	1	rs641862	chr13:110790232	CARS2	chr13:111293757-111365950:-	0.76	5.79	1.62E-8	Obesity-related traits	
LIHC	cis	1	rs641862	chr13:110790232	ING1	chr13:111365083-111373420:+	0.6	5	9.14E-7	Obesity-related traits	
LIHC	cis	1	rs6425657	chr1:180956905	STX6	chr1:180913175-180992046:-	-0.18	-4.24	2.83E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs6425658	chr1:180956985	STX6	chr1:180913175-180992046:-	-0.17	-4.2	3.46E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.29	-4.88	1.6E-6	Homocysteine levels	
LIHC	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.3	-5.53	6.45E-8	Homocysteine levels	
LIHC	cis	1	rs6429582	chr1:46321843	GPBP1L1	chr1:46092978-46152302:-	-0.21	-3.97	8.91E-5	Body mass index	
LIHC	cis	1	rs6430585	chr2:136506927	DARS	chr2:136664254-136743222:-	-0.28	-4.56	7.26E-6	Corneal structure	
LIHC	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs6445557	chr3:53083969	RFT1	chr3:53122503-53164470:-	-0.43	-4.4	1.48E-5	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.68	12.29	5.11E-29	Type 2 diabetes	
LIHC	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.65	11.8	3.35E-27	Type 2 diabetes	
LIHC	cis	1	rs645419	chr11:102716321	MMP1	chr11:102660641-102668966:-	0.32	5.24	2.74E-7	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
LIHC	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.62	13.5	1.24E-33	Response to antipsychotic treatment	
LIHC	cis	1	rs6455693	chr6:161026455	LPA	chr6:160952516-161087407:-	-0.18	-3.83	0.000154	Lipoprotein (a) levels	
LIHC	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.33	-7.17	4.74E-12	Homocysteine levels	
LIHC	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.34	-7.31	1.88E-12	Homocysteine levels	
LIHC	cis	1	rs6458690	chr6:49411619	CENPQ	chr6:49431096-49460820:+	-0.21	-4.26	2.67E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs6458694	chr6:49445306	CENPQ	chr6:49431096-49460820:+	-0.2	-4.03	6.8E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs6460260	chr7:65215455	CCT6P1	chr7:65216092-65228661:+	-0.36	-4.92	1.36E-6	Diabetic kidney disease	
LIHC	cis	1	rs6460260	chr7:65215455	INTS4L1	chr7:64601603-64694599:+	-0.35	-4.11	4.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs6460261	chr7:65215580	CCT6P1	chr7:65216092-65228661:+	-0.36	-4.92	1.36E-6	Diabetic kidney disease	
LIHC	cis	1	rs6460261	chr7:65215580	INTS4L1	chr7:64601603-64694599:+	-0.35	-4.11	4.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.28	4.25	2.79E-5	Obesity-related traits	
LIHC	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.34	-4.97	1.05E-6	Obesity-related traits	
LIHC	cis	1	rs6465750	chr7:99235522	CYP3A5	chr7:99245818-99332821:-	1.01	17.99	1.77E-51	Blood metabolite levels	
LIHC	cis	1	rs6465750	chr7:99235522	ZKSCAN5	chr7:99102273-99131444:+	0.33	3.86	0.000134	Blood metabolite levels	
LIHC	cis	1	rs646776	chr1:109818530	CELSR2	chr1:109792641-109818377:+	-0.45	-5.44	1.0E-7	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs646776	chr1:109818530	MYBPHL	chr1:109834987-109849663:-	-0.37	-4.68	4.07E-6	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs646776	chr1:109818530	PSRC1	chr1:109822179-109825808:-	-0.59	-9.8	3.63E-20	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs646776	chr1:109818530	SORT1	chr1:109852192-109940563:-	-0.7	-8.26	3.28E-15	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs6474359	chr8:41549194	AGPAT6	chr8:41435707-41482520:+	-0.48	-4.71	3.64E-6	Glycated hemoglobin levels	
LIHC	cis	1	rs6474359	chr8:41549194	AP3M2	chr8:42010464-42028702:+	-0.37	-4.45	1.16E-5	Glycated hemoglobin levels	
LIHC	cis	1	rs6474359	chr8:41549194	C8orf40	chr8:42396298-42408139:+	-0.43	-4.84	2.01E-6	Glycated hemoglobin levels	
LIHC	cis	1	rs6474359	chr8:41549194	GINS4	chr8:41386725-41402563:+	-0.28	-4.3	2.25E-5	Glycated hemoglobin levels	
LIHC	cis	1	rs6474359	chr8:41549194	GOLGA7	chr8:41348081-41368497:+	-0.53	-5.32	1.9E-7	Glycated hemoglobin levels	
LIHC	cis	1	rs6474359	chr8:41549194	IKBKB	chr8:42128829-42189965:+	-0.54	-5.35	1.64E-7	Glycated hemoglobin levels	
LIHC	cis	1	rs6474359	chr8:41549194	MYST3	chr8:41786998-41909505:-	-0.44	-5.61	4.18E-8	Glycated hemoglobin levels	
LIHC	cis	1	rs6474359	chr8:41549194	POLB	chr8:42196030-42229313:+	-0.49	-4.93	1.29E-6	Glycated hemoglobin levels	
LIHC	cis	1	rs6474359	chr8:41549194	VDAC3	chr8:42249346-42263413:+	-0.61	-5.82	1.37E-8	Glycated hemoglobin levels	
LIHC	cis	1	rs6477733	chr9:99625063	FAM22G	chr9:99690592-99704572:+	0.6	7.98	2.13E-14	Height	
LIHC	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.26	-3.98	8.43E-5	Rheumatoid arthritis	
LIHC	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.26	-3.97	8.91E-5	Rheumatoid arthritis	
LIHC	cis	1	rs6480314	chr10:69967447	DNA2	chr10:70173822-70231879:-	0.26	4.69	3.91E-6	Optic nerve measurement (disc area)	
LIHC	cis	1	rs6480723	chr10:75966366	CHCHD1	chr10:75541808-75543405:+	0.23	3.8	0.000168	Soluble interleukin-2 receptor subunit alpha	
LIHC	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.45	-5.9	8.53E-9	Forced vital capacity	
LIHC	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.47	6.13	2.44E-9	Forced vital capacity	
LIHC	cis	1	rs6487679	chr12:9371332	LOC642846	chr12:9436253-9466684:+	0.29	4.26	2.66E-5	Non-alcoholic fatty liver disease histology (AST)	
LIHC	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.67	-10.08	4.06E-21	Type 2 diabetes	
LIHC	cis	1	rs6503319	chr17:10574159	TMEM220	chr17:10616640-10633646:-	-0.2	-3.94	0.000101	Malaria	
LIHC	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.61	-12.03	4.62E-28	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs6519611	chr22:25845855	CRYBB2	chr22:25615612-25627836:+	0.84	9.2	3.47E-18	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.22	-4.32	2.03E-5	Tuberculosis	
LIHC	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.59	9.45	5.26E-19	Tuberculosis	
LIHC	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.59	-16.4	4.58E-45	Crohn's disease	
LIHC	cis	1	rs6575122	chr14:90753556	C14orf102	chr14:90744398-90798279:-	0.3	3.98	8.41E-5	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.48	-6.93	2.02E-11	Cholesterol, total	
LIHC	cis	1	rs6579803	chr5:150255559	LOC134466	chr5:150310000-150326146:-	0.33	4.36	1.73E-5	Crohn's disease	
LIHC	cis	1	rs6579804	chr5:150255931	LOC134466	chr5:150310000-150326146:-	0.33	4.36	1.73E-5	Crohn's disease	
LIHC	cis	1	rs6579806	chr5:150271084	LOC134466	chr5:150310000-150326146:-	0.34	4.56	7.11E-6	Crohn's disease	
LIHC	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.39	6.14	2.29E-9	Multiple sclerosis	
LIHC	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.38	-6.65	1.18E-10	Multiple sclerosis	
LIHC	cis	1	rs6581155	chr12:58178162	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.89	1.54E-6	Multiple sclerosis	
LIHC	cis	1	rs6589575	chr11:116733310	PCSK7	chr11:117075789-117102811:-	-0.34	-4.4	1.42E-5	Protein quantitative trait loci	
LIHC	cis	1	rs6589576	chr11:116735788	PCSK7	chr11:117075789-117102811:-	0.34	4.38	1.58E-5	Protein quantitative trait loci	
LIHC	cis	1	rs6589811	chr11:120235703	TMEM136	chr11:120196016-120204388:+	0.24	4.28	2.44E-5	Intraocular pressure	
LIHC	cis	1	rs6589812	chr11:120278359	TMEM136	chr11:120196016-120204388:+	0.25	4.48	1.0E-5	Intraocular pressure	
LIHC	cis	1	rs6589813	chr11:120293490	TMEM136	chr11:120196016-120204388:+	0.24	4.06	6.19E-5	Intraocular pressure	
LIHC	cis	1	rs6598061	chr11:243853	PSMD13	chr11:236808-252984:+	-0.23	-4.06	6.02E-5	Menarche (age at onset)	
LIHC	cis	1	rs6598062	chr11:243712	PSMD13	chr11:236808-252984:+	-0.23	-4.09	5.28E-5	Menarche (age at onset)	
LIHC	cis	1	rs6598063	chr11:243672	PSMD13	chr11:236808-252984:+	-0.23	-4.09	5.28E-5	Menarche (age at onset)	
LIHC	cis	1	rs6598065	chr11:243211	PSMD13	chr11:236808-252984:+	-0.23	-4.09	5.28E-5	Menarche (age at onset)	
LIHC	cis	1	rs6598066	chr11:243185	PSMD13	chr11:236808-252984:+	-0.23	-4.08	5.7E-5	Menarche (age at onset)	
LIHC	cis	1	rs6598069	chr11:240664	PSMD13	chr11:236808-252984:+	-0.24	-4.19	3.5E-5	Menarche (age at onset)	
LIHC	cis	1	rs6598074	chr11:219398	PSMD13	chr11:236808-252984:+	-0.24	-4.15	4.28E-5	Menarche (age at onset)	
LIHC	cis	1	rs6598289	chr15:100587324	ADAMTS17	chr15:100511643-100882183:-	-0.22	-3.82	0.000158	Gastroesophageal reflux disease	
LIHC	cis	1	rs6599170	chr3:41772718	ULK4	chr3:41288091-42003660:-	0.59	7.97	2.3E-14	Diastolic blood pressure	
LIHC	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.56	-7.69	1.54E-13	Diastolic blood pressure	
LIHC	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.59	-8	1.99E-14	Diastolic blood pressure	
LIHC	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	0.59	8.13	7.81E-15	Diastolic blood pressure	
LIHC	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	0.61	8.24	3.64E-15	Diastolic blood pressure	
LIHC	cis	1	rs6599318	chr4:243968	ZNF718	chr4:53272-156488:+	0.34	5.2	3.36E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs6601327	chr8:9395532	CLDN23	chr8:8559666-8561616:+	-0.24	-3.88	0.000124	Multiple myeloma (hyperdiploidy)	
LIHC	cis	1	rs6651271	chr8:96047621	C8orf38	chr8:95908040-96088396:+	-0.28	-3.88	0.000123	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs6663552	chr1:230358067	C1orf96	chr1:229456753-229478688:-	-0.22	-3.92	0.000108	Hematology traits	
LIHC	cis	1	rs6665134	chr1:180949628	MR1	chr1:181003139-181024633:+	-0.22	-3.87	0.000132	Progressive supranuclear palsy	
LIHC	cis	1	rs6665134	chr1:180949628	STX6	chr1:180913175-180992046:-	-0.2	-4.98	1.0E-6	Progressive supranuclear palsy	
LIHC	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.3	-4.95	1.16E-6	Homocysteine levels	
LIHC	cis	1	rs66753001	chr19:17394839	ANKLE1	chr19:17392454-17398454:+	0.42	4.01	7.33E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs6679145	chr1:156256000	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.49	6.74	6.74E-11	Diastolic blood pressure;Blood pressure	
LIHC	cis	1	rs6684514	chr1:156255456	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs6684571	chr1:107623224	PRMT6	chr1:107599267-107601907:+	0.28	3.93	0.000103	AIDS	
LIHC	cis	1	rs669260	chr9:32503440	ACO1	chr9:32384601-32450830:+	-0.3	-4.06	6.01E-5	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs669260	chr9:32503440	NDUFB6	chr9:32553523-32573182:-	-0.32	-4.21	3.23E-5	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs669260	chr9:32503440	NOL6	chr9:33461352-33473941:-	-0.52	-4.97	1.05E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs67034206	chr1:156270260	BGLAP	chr1:156182784-156213112:+	0.2	3.92	0.000107	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs67053500	chr2:103997940	IL18RAP	chr2:103035254-103069022:+	-0.27	-4	7.86E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs67055500	chr2:103996523	IL18RAP	chr2:103035254-103069022:+	-0.27	-4	7.86E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs6707103	chr2:103994511	IL18RAP	chr2:103035254-103069022:+	-0.26	-3.94	9.69E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.29	4.13	4.59E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
LIHC	cis	1	rs6707458	chr2:160914540	LY75	chr2:160625141-160761262:-	0.25	5.49	7.65E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs6708328	chr2:24412413	C2orf84	chr2:24397531-24414566:+	0.31	4.19	3.48E-5	Venous thromboembolism (SNP x SNP interaction)	
LIHC	cis	1	rs6710847	chr2:104007579	IL18RAP	chr2:103035254-103069022:+	-0.26	-3.84	0.000146	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.62	-4.72	3.39E-6	Rheumatoid arthritis	
LIHC	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.58	-4.53	8.27E-6	Rheumatoid arthritis	
LIHC	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.51	-4.17	3.88E-5	Rheumatoid arthritis	
LIHC	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.56	-4.55	7.31E-6	Rheumatoid arthritis	
LIHC	cis	1	rs6719686	chr2:160908292	LY75	chr2:160625141-160761262:-	0.25	5.42	1.15E-7	Idiopathic membranous nephropathy	
LIHC	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.57	-5.84	1.23E-8	Plasma clusterin levels	
LIHC	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.57	-5.84	1.23E-8	Plasma clusterin levels	
LIHC	cis	1	rs6724662	chr2:241831560	C2orf54	chr2:241825466-241835573:-	0.52	7.33	1.64E-12	Urinary metabolites	
LIHC	cis	1	rs67260601	chr2:103997539	IL18RAP	chr2:103035254-103069022:+	-0.27	-4	7.86E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs6732236	chr2:136501509	DARS	chr2:136664254-136743222:-	0.28	4.37	1.64E-5	Corneal structure	
LIHC	cis	1	rs67385638	chr11:5290370	HBG2	chr11:5269502-5667011:-	0.3	4.29	2.35E-5	Hemoglobin levels	
LIHC	cis	1	rs67412075	chr19:17385502	ANKLE1	chr19:17392454-17398454:+	0.39	3.94	9.85E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.27	-5.38	1.35E-7	Tuberculosis	
LIHC	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.58	9.36	1.1E-18	Tuberculosis	
LIHC	cis	1	rs67455729	chr2:104020201	IL18RAP	chr2:103035254-103069022:+	-0.26	-3.83	0.000154	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs6748734	chr2:241837452	C2orf54	chr2:241825466-241835573:-	0.54	7.57	3.54E-13	Urinary metabolites	
LIHC	cis	1	rs6750765	chr2:86300308	POLR1A	chr2:86253453-86333278:-	-0.35	-4.59	6.28E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs6751693	chr2:241837332	C2orf54	chr2:241825466-241835573:-	0.54	7.61	2.73E-13	Urinary metabolites	
LIHC	cis	1	rs67536397	chr7:65947917	CCT6P1	chr7:65216092-65228661:+	0.32	4.27	2.51E-5	Diabetic kidney disease	
LIHC	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.47	7.26	2.68E-12	Blood trace element (Zn levels)	
LIHC	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.38	-4.22	3.16E-5	Triptolide cytotoxicity	
LIHC	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.69	-6.8	4.61E-11	Triptolide cytotoxicity	
LIHC	cis	1	rs6759836	chr2:160912802	LY75	chr2:160625141-160761262:-	0.25	5.52	6.86E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs6759924	chr2:160912747	LY75	chr2:160625141-160761262:-	0.26	5.56	5.29E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs6761276	chr2:113832312	RABL2A	chr2:114384817-114400974:+	-0.23	-4.1	5.17E-5	Protein quantitative trait loci	
LIHC	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	0.59	7.89	3.96E-14	Diastolic blood pressure	
LIHC	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.65	9.43	6.34E-19	Height	
LIHC	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.67	9.56	2.27E-19	Height	
LIHC	cis	1	rs6766897	chr3:134191303	ANAPC13	chr3:134196547-134204865:-	0.53	7.76	9.46E-14	Height	
LIHC	cis	1	rs6766897	chr3:134191303	CEP63	chr3:134204575-134293852:+	0.26	3.92	0.000108	Height	
LIHC	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.57	7.58	3.17E-13	Diastolic blood pressure	
LIHC	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.57	7.55	3.87E-13	Diastolic blood pressure	
LIHC	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.57	7.55	3.87E-13	Diastolic blood pressure	
LIHC	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.65	9.44	6.03E-19	Height	
LIHC	cis	1	rs6772046	chr3:38479660	XYLB	chr3:38388251-38456467:+	0.27	5.23	2.96E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs67728539	chr7:65378124	CCT6P1	chr7:65216092-65228661:+	0.33	4.56	7.05E-6	Diabetic kidney disease	
LIHC	cis	1	rs67728539	chr7:65378124	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000128	Diabetic kidney disease	
LIHC	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.65	9.15	4.96E-18	Height	
LIHC	cis	1	rs677977	chr1:147083744	ACP6	chr1:147119168-147142634:-	-0.39	-6.8	4.62E-11	Schizophrenia (negative symptoms)	
LIHC	cis	1	rs6781326	chr3:41777028	ULK4	chr3:41288091-42003660:-	0.58	7.95	2.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.63	-8.95	2.29E-17	Height	
LIHC	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.6	8.15	6.72E-15	Diastolic blood pressure	
LIHC	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.64	-9.4	7.65E-19	Height	
LIHC	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs678815	chr11:102713777	MMP1	chr11:102660641-102668966:-	0.31	5.08	6.15E-7	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
LIHC	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.58	7.53	4.48E-13	Diastolic blood pressure	
LIHC	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.65	9.12	6.49E-18	Height	
LIHC	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.58	7.76	9.56E-14	Diastolic blood pressure	
LIHC	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.63	-8.95	2.29E-17	Height	
LIHC	cis	1	rs679620	chr11:102713620	MMP1	chr11:102660641-102668966:-	0.32	5.3	2.12E-7	Cerebrospinal fluid levels of Alzheimer's disease-related proteins	
LIHC	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	0.61	8.24	3.64E-15	Diastolic blood pressure	
LIHC	cis	1	rs6797165	chr3:41887777	ULK4	chr3:41288091-42003660:-	0.58	7.89	4.12E-14	Diastolic blood pressure	
LIHC	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.63	9.17	4.45E-18	Height	
LIHC	cis	1	rs6800	chr1:156262653	BGLAP	chr1:156182784-156213112:+	0.21	4.23	2.99E-5	Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels	
LIHC	cis	1	rs6801343	chr3:41767234	ULK4	chr3:41288091-42003660:-	0.59	7.89	4.0E-14	Diastolic blood pressure	
LIHC	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.63	9.17	4.45E-18	Height	
LIHC	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.66	9.52	3.27E-19	Height	
LIHC	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.58	7.92	3.37E-14	Diastolic blood pressure	
LIHC	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.58	7.92	3.37E-14	Diastolic blood pressure	
LIHC	cis	1	rs680379	chr20:12969400	SPTLC3	chr20:12989627-13147411:+	-0.38	-6.1	2.82E-9	Very long-chain saturated fatty acid levels (fatty acid 20:0);Sphingolipid levels;Glycerophospholipid levels	
LIHC	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.66	9.51	3.47E-19	Height	
LIHC	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.57	7.55	3.87E-13	Diastolic blood pressure	
LIHC	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.63	-9.37	9.85E-19	Height	
LIHC	cis	1	rs6807015	chr3:41754514	ULK4	chr3:41288091-42003660:-	0.6	7.91	3.5E-14	Diastolic blood pressure	
LIHC	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.54	-9.73	6.15E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs68189316	chr7:65409169	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs68189316	chr7:65409169	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs6823347	chr4:106962725	TBCK	chr4:106967233-107237861:-	0.28	4.92	1.33E-6	Airflow obstruction	
LIHC	cis	1	rs6862814	chr5:150245259	LOC134466	chr5:150310000-150326146:-	0.32	4.22	3.16E-5	Crohn's disease	
LIHC	cis	1	rs6867526	chr5:109662299	MAN2A1	chr5:109025156-109203429:+	0.3	4.93	1.27E-6	Cardiac structure and function	
LIHC	cis	1	rs6871931	chr5:170255591	RANBP17	chr5:170289022-170727018:+	0.52	4.48	1.04E-5	Smooth-surface caries	
LIHC	cis	1	rs6875011	chr5:150182710	LOC134466	chr5:150310000-150326146:-	0.32	3.93	0.000102	Crohn's disease	
LIHC	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.59	15.88	5.55E-43	Crohn's disease	
LIHC	cis	1	rs687672	chr11:65649984	OVOL1	chr11:65554529-65564683:+	-0.24	-4.06	6.09E-5	Crohn's disease	
LIHC	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.7	12.81	5.5E-31	Type 2 diabetes	
LIHC	cis	1	rs6886255	chr5:176718361	PRELID1	chr5:176730835-176733949:+	0.23	5.39	1.29E-7	Migraine without aura	
LIHC	cis	1	rs6902102	chr6:161025288	LPA	chr6:160952516-161087407:-	-0.18	-3.83	0.000154	Lipoprotein (a) levels	
LIHC	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.34	-7.32	1.74E-12	Homocysteine levels	
LIHC	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.63	-13.8	9.08E-35	Response to antipsychotic treatment	
LIHC	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.38	-8.64	2.13E-16	Homocysteine levels	
LIHC	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.33	-7.16	4.87E-12	Homocysteine levels	
LIHC	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.34	-7.4	1.08E-12	Homocysteine levels	
LIHC	cis	1	rs6923124	chr6:49419864	CENPQ	chr6:49431096-49460820:+	-0.2	-4.02	7.3E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.63	13.48	1.58E-33	Response to antipsychotic treatment	
LIHC	cis	1	rs6924776	chr6:109612276	CD164	chr6:109687718-109703762:-	-0.27	-5.19	3.58E-7	Red blood cell traits	
LIHC	cis	1	rs6924815	chr6:109612344	CD164	chr6:109687718-109703762:-	-0.26	-5.1	5.6E-7	Red blood cell traits	
LIHC	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.34	-3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs6929299	chr6:161032089	LPA	chr6:160952516-161087407:-	-0.24	-4.97	1.08E-6	Lipoprotein (a) levels	
LIHC	cis	1	rs6930342	chr6:161025442	LPA	chr6:160952516-161087407:-	-0.18	-3.81	0.000166	Lipoprotein (a) levels	
LIHC	cis	1	rs6932014	chr6:161026515	LPA	chr6:160952516-161087407:-	-0.18	-3.83	0.000155	Lipoprotein (a) levels	
LIHC	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.5	-8.81	6.28E-17	Response to antipsychotic treatment	
LIHC	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.59	-16.4	4.58E-45	Crohn's disease	
LIHC	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.55	-9.72	7.05E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs6948775	chr7:98945480	CYP3A5	chr7:99245818-99332821:-	0.68	10.31	6.82E-22	Blood metabolite levels	
LIHC	cis	1	rs6949812	chr7:65387101	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs6949812	chr7:65387101	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.59	-16.41	4.03E-45	Crohn's disease	
LIHC	cis	1	rs6958420	chr7:65751171	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.13	4.53E-5	Diabetic kidney disease	
LIHC	cis	1	rs6959670	chr7:110909169	IMMP2L	chr7:110303110-111202538:-	0.22	4.02	7.22E-5	Schizophrenia	
LIHC	cis	1	rs6964245	chr7:65718717	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.17	3.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs6964530	chr7:65718851	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.17	3.93E-5	Diabetic kidney disease	
LIHC	cis	1	rs6970243	chr7:65388490	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs6970243	chr7:65388490	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs6974373	chr7:99590893	TRIM4	chr7:99488037-99517154:-	-0.24	-4.57	6.86E-6	Interstitial lung disease	
LIHC	cis	1	rs6974723	chr7:65637939	CCT6P1	chr7:65216092-65228661:+	-0.29	-3.92	0.000106	Diabetic kidney disease	
LIHC	cis	1	rs6977955	chr7:28156887	JAZF1	chr7:27870196-28220437:-	0.36	4.83	2.02E-6	Rheumatoid arthritis	
LIHC	cis	1	rs6983473	chr8:27905888	ELP3	chr8:27947749-28048667:+	0.34	4.79	2.5E-6	Cardiac Troponin-T levels	
LIHC	cis	1	rs6989010	chr8:12772755	DLC1	chr8:12940872-13372429:-	-0.37	-4.39	1.51E-5	Colorectal cancer (diet interaction)	
LIHC	cis	1	rs6993656	chr8:36888460	ERLIN2	chr8:37594097-37615318:+	0.34	4.25	2.73E-5	Insulin resistance/response	
LIHC	cis	1	rs6993656	chr8:36888460	PROSC	chr8:37620101-37637285:+	0.36	4.33	1.94E-5	Insulin resistance/response	
LIHC	cis	1	rs6993656	chr8:36888460	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.9	1.5E-6	Insulin resistance/response	
LIHC	cis	1	rs7005702	chr8:36900887	ERLIN2	chr8:37594097-37615318:+	0.33	4.23	3.03E-5	Insulin resistance/response	
LIHC	cis	1	rs7005702	chr8:36900887	PROSC	chr8:37620101-37637285:+	0.36	4.4	1.45E-5	Insulin resistance/response	
LIHC	cis	1	rs7005702	chr8:36900887	RAB11FIP1	chr8:37716470-37757003:-	0.39	5.39	1.34E-7	Insulin resistance/response	
LIHC	cis	1	rs7014273	chr8:67358694	ADHFE1	chr8:67344718-67381042:+	0.25	4.05	6.22E-5	Blood metabolite levels	
LIHC	cis	1	rs7022397	chr9:116007677	SLC31A1	chr9:115983808-116029215:+	0.17	3.86	0.000138	Hematology traits	
LIHC	cis	1	rs7036236	chr9:131899299	CRAT	chr9:131857075-131873070:-	0.22	3.97	8.92E-5	Blood metabolite ratios	
LIHC	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.26	-3.92	0.000106	Rheumatoid arthritis	
LIHC	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.36	-5.66	3.22E-8	Multiple sclerosis	
LIHC	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.38	6.58	1.8E-10	Multiple sclerosis	
LIHC	cis	1	rs703842	chr12:58162739	XRCC6BP1	chr12:58335445-58351051:+	0.25	4.52	8.59E-6	Multiple sclerosis	
LIHC	cis	1	rs7038769	chr9:116007583	SLC31A1	chr9:115983808-116029215:+	0.17	3.86	0.000138	Hematology traits	
LIHC	cis	1	rs7046217	chr9:91780877	S1PR3	chr9:91606362-91619924:+	0.41	4.94	1.21E-6	Pelvic organ prolapse (moderate/severe)	
LIHC	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.49	7.25	2.74E-12	Cognitive function	
LIHC	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.43	6.84	3.66E-11	Metabolite levels	
LIHC	cis	1	rs7073497	chr10:100153688	C10orf62	chr10:99349484-99350690:+	0.41	3.82	0.000161	Aspartate aminotransferase	
LIHC	cis	1	rs7073746	chr10:64904071	NRBF2	chr10:64893007-64914785:+	-0.24	-3.92	0.000107	Educational attainment;Liver enzyme levels (alkaline phosphatase)	
LIHC	cis	1	rs7083534	chr10:75955672	CHCHD1	chr10:75541808-75543405:+	0.23	3.81	0.000162	Soluble interleukin-2 receptor subunit alpha	
LIHC	cis	1	rs7085387	chr10:60204602	TFAM	chr10:60145176-60155896:+	-0.21	-3.85	0.000142	Migraine without aura	
LIHC	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.59	-11.5	3.9E-26	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs709607	chr7:65449541	CCT6P1	chr7:65216092-65228661:+	-0.31	-4.11	4.87E-5	Diabetic kidney disease	
LIHC	cis	1	rs7101415	chr11:120239088	TMEM136	chr11:120196016-120204388:+	0.24	3.94	9.93E-5	Intraocular pressure	
LIHC	cis	1	rs7104639	chr11:120239456	TMEM136	chr11:120196016-120204388:+	0.25	4.45	1.18E-5	Intraocular pressure	
LIHC	cis	1	rs7104764	chr11:229977	PSMD13	chr11:236808-252984:+	-0.23	-4.16	3.95E-5	Menarche (age at onset)	
LIHC	cis	1	rs7105282	chr11:47805614	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.78	7.82E-17	Subjective well-being	
LIHC	cis	1	rs7107356	chr11:47676170	C1QTNF4	chr11:47611216-47615961:-	0.36	5.47	8.86E-8	Neuroticism	
LIHC	cis	1	rs7107356	chr11:47676170	SLC39A13	chr11:47377001-47438046:+	0.22	3.83	0.000155	Neuroticism	
LIHC	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.77	1.73E-8	Forced vital capacity	
LIHC	cis	1	rs7117063	chr11:120238824	TMEM136	chr11:120196016-120204388:+	0.25	4.33	1.97E-5	Intraocular pressure	
LIHC	cis	1	rs7117321	chr11:120239051	TMEM136	chr11:120196016-120204388:+	0.25	4.33	1.97E-5	Intraocular pressure	
LIHC	cis	1	rs7120333	chr11:47817441	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.83	5.46E-17	Subjective well-being	
LIHC	cis	1	rs7122375	chr11:111171071	C11orf92	chr11:111164171-111175770:-	-0.32	-5.15	4.36E-7	Colorectal cancer	
LIHC	cis	1	rs7126328	chr11:120244577	TMEM136	chr11:120196016-120204388:+	0.26	4.51	8.82E-6	Intraocular pressure	
LIHC	cis	1	rs7128029	chr11:244141	PSMD13	chr11:236808-252984:+	-0.23	-4.06	6.02E-5	Menarche (age at onset)	
LIHC	cis	1	rs7128044	chr11:244115	PSMD13	chr11:236808-252984:+	-0.23	-4.06	6.02E-5	Menarche (age at onset)	
LIHC	cis	1	rs71301804	chr3:53073314	RFT1	chr3:53122503-53164470:-	0.49	4.47	1.07E-5	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs71301808	chr3:53085577	RFT1	chr3:53122503-53164470:-	0.52	4.72	3.52E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs71301809	chr3:53090312	RFT1	chr3:53122503-53164470:-	0.52	4.73	3.3E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs71301814	chr3:53117663	RFT1	chr3:53122503-53164470:-	0.56	4.94	1.25E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs7131597	chr11:120303939	TMEM136	chr11:120196016-120204388:+	0.23	4.08	5.5E-5	Intraocular pressure	
LIHC	cis	1	rs713219	chr9:131900920	CRAT	chr9:131857075-131873070:-	0.21	3.86	0.000134	Blood metabolite ratios	
LIHC	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.61	5.71	2.41E-8	Metabolite levels (HVA/5-HIAA ratio)	
LIHC	cis	1	rs7134718	chr12:22568271	KIAA0528	chr12:22601526-22697452:-	0.4	4.05	6.26E-5	Coronary artery calcification	
LIHC	cis	1	rs713835	chr22:38064650	LGALS1	chr22:38071613-38075807:+	-0.2	-3.98	8.33E-5	Fat distribution (HIV)	
LIHC	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.37	4.93	1.29E-6	Atopic dermatitis	
LIHC	cis	1	rs7146724	chr14:90766092	C14orf102	chr14:90744398-90798279:-	0.3	4.09	5.29E-5	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs7149083	chr14:90754006	C14orf102	chr14:90744398-90798279:-	0.3	4.14	4.44E-5	Gut microbiota (bacterial taxa)	
LIHC	cis	1	rs7154306	chr14:35540499	PPP2R3C	chr14:35554679-35591679:-	0.38	5.03	7.99E-7	Atopic dermatitis	
LIHC	cis	1	rs7156322	chr14:35544330	PPP2R3C	chr14:35554679-35591679:-	0.38	5.03	8.09E-7	Atopic dermatitis	
LIHC	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.44	6.89	2.73E-11	Blood trace element (Zn levels)	
LIHC	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	0.58	6.15	2.09E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	0.59	6.19	1.75E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs7167138	chr15:50958998	USP8	chr15:50716579-50793276:+	-0.21	-4.1	5.26E-5	QT interval	
LIHC	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	0.58	6.15	2.09E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs7170303	chr15:51013786	USP8	chr15:50716579-50793276:+	-0.21	-4.24	2.89E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.4	6.44	4.13E-10	Blood trace element (Zn levels)	
LIHC	cis	1	rs7175720	chr15:75348962	SCAMP5	chr15:75287901-75313836:+	-0.48	-7.52	4.83E-13	Blood trace element (Zn levels)	
LIHC	cis	1	rs718847	chr11:116734146	PCSK7	chr11:117075789-117102811:-	-0.34	-4.4	1.42E-5	Protein quantitative trait loci	
LIHC	cis	1	rs7191888	chr16:73581058	ZFHX3	chr16:72816788-73093237:-	-0.26	-3.96	9.14E-5	Multiple sclerosis (severity)	
LIHC	cis	1	rs719756	chr5:42725629	CCDC152	chr5:42756920-42802539:+	0.19	4.02	7.29E-5	Height	
LIHC	cis	1	rs7205409	chr16:642610	WFIKKN1	chr16:679239-684116:+	0.26	4.15	4.21E-5	Height	
LIHC	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.49	7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.31	-5.8	1.54E-8	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs7210738	chr17:45757598	KPNB1	chr17:45727275-45761004:+	0.17	3.84	0.000148	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.49	7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.59	-11.5	3.9E-26	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs7214921	chr17:40294025	HSPB9	chr17:40274756-40275371:+	0.28	4.28	2.43E-5	Fibrinogen levels	
LIHC	cis	1	rs721869	chr5:153608050	MFAP3	chr5:153418519-153437014:+	-0.25	-4.91	1.39E-6	Carotid artery intima media thickness (sex interaction)	
LIHC	cis	1	rs7219220	chr17:40294280	HSPB9	chr17:40274756-40275371:+	0.28	4.28	2.43E-5	Fibrinogen levels	
LIHC	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.47	7.57	3.44E-13	Eye color traits	
LIHC	cis	1	rs7223231	chr17:18811846	FAM18B	chr17:18684582-18710026:+	-0.23	-4.12	4.75E-5	Educational attainment (years of education)	
LIHC	cis	1	rs7223257	chr17:61787684	TCAM1P	chr17:61934376-61941738:+	-0.31	-4.87	1.69E-6	Height	
LIHC	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.49	-7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs7224737	chr17:40289364	HSPB9	chr17:40274756-40275371:+	-0.27	-4.17	3.88E-5	Fibrinogen levels	
LIHC	cis	1	rs7225608	chr17:40298326	HSPB9	chr17:40274756-40275371:+	0.27	4.19	3.5E-5	Fibrinogen levels	
LIHC	cis	1	rs7238616	chr18:10927426	CHMP1B	chr18:11851389-11854447:+	0.21	4.17	3.93E-5	Major depressive disorder	
LIHC	cis	1	rs723937	chr11:120312746	TMEM136	chr11:120196016-120204388:+	0.23	4.04	6.48E-5	Intraocular pressure	
LIHC	cis	1	rs7252707	chr19:18612257	ISYNA1	chr19:18545625-18548943:-	0.17	3.89	0.000122	Breast cancer	
LIHC	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.41	6.01	4.71E-9	Schizophrenia	
LIHC	cis	1	rs7258465	chr19:18533642	ISYNA1	chr19:18545625-18548943:-	0.18	4.1	5.14E-5	Breast cancer	
LIHC	cis	1	rs72649163	chr1:20900592	FAM43B	chr1:20878932-20881512:+	0.2	4.35	1.81E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs72677306	chr4:106997678	TBCK	chr4:106967233-107237861:-	0.21	3.88	0.000127	Airflow obstruction	
LIHC	cis	1	rs727563	chr22:41867377	CYP2D6	chr22:42522502-42526883:-	-0.24	-4.88	1.6E-6	Crohn's disease;Inflammatory bowel disease	
LIHC	cis	1	rs72818709	chr10:91371446	FLJ37201	chr10:91451057-91457685:-	-0.29	-3.92	0.000105	Metabolic traits	
LIHC	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.36	-4.82	2.2E-6	Esophageal cancer (squamous cell)	
LIHC	cis	1	rs72833503	chr2:103996576	IL18RAP	chr2:103035254-103069022:+	-0.27	-4	7.86E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs72833528	chr2:104028153	IL18RAP	chr2:103035254-103069022:+	-0.28	-4.17	3.8E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs7285549	chr22:25874580	CRYBB2	chr22:25615612-25627836:+	0.86	9.32	1.42E-18	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs7286304	chr22:30473999	CABP7	chr22:30116344-30127818:+	0.49	4.05	6.37E-5	LDL cholesterol	
LIHC	cis	1	rs72872548	chr11:5289139	HBG2	chr11:5269502-5667011:-	0.32	4.42	1.31E-5	Hemoglobin levels	
LIHC	cis	1	rs7290710	chr22:50677454	SELO	chr22:50639408-50656044:+	0.22	4.59	6.15E-6	Obesity-related traits	
LIHC	cis	1	rs72922733	chr11:65520746	CTSW	chr11:65647284-65651212:+	-0.28	-4.58	6.38E-6	Systemic lupus erythematosus	
LIHC	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.58	-4.46	1.09E-5	Rheumatoid arthritis	
LIHC	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.64	-4.81	2.31E-6	Rheumatoid arthritis	
LIHC	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.62	-4.72	3.39E-6	Rheumatoid arthritis	
LIHC	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.57	-4.54	7.69E-6	Rheumatoid arthritis	
LIHC	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.57	-4.54	7.69E-6	Rheumatoid arthritis	
LIHC	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.57	-4.54	7.69E-6	Rheumatoid arthritis	
LIHC	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.62	-4.74	3.12E-6	Rheumatoid arthritis	
LIHC	cis	1	rs72952761	chr6:118866758	C6orf204	chr6:118786239-119031238:-	-0.28	-4.36	1.69E-5	Renal cell carcinoma	
LIHC	cis	1	rs7298108	chr12:9376168	LOC642846	chr12:9436253-9466684:+	-0.31	-4.72	3.51E-6	Non-alcoholic fatty liver disease histology (AST)	
LIHC	cis	1	rs7302923	chr12:51916586	KRT80	chr12:52562781-52585784:-	0.39	3.81	0.000163	White matter lesion progression;White matter lesion progression (adjusted for white matter lesion burden at baseline)	
LIHC	cis	1	rs73034207	chr19:32875769	DPY19L3	chr19:32896677-32975236:+	0.21	3.87	0.00013	Bipolar disorder	
LIHC	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.59	7.7	1.42E-13	Diastolic blood pressure	
LIHC	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.59	8.03	1.55E-14	Diastolic blood pressure	
LIHC	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.59	8.03	1.55E-14	Diastolic blood pressure	
LIHC	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.57	7.83	6.25E-14	Diastolic blood pressure	
LIHC	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.6	8.16	6.47E-15	Diastolic blood pressure	
LIHC	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.57	7.43	8.95E-13	Diastolic blood pressure	
LIHC	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.57	7.59	3.02E-13	Diastolic blood pressure	
LIHC	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.58	7.47	6.47E-13	Diastolic blood pressure	
LIHC	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.58	7.49	6.04E-13	Diastolic blood pressure	
LIHC	cis	1	rs731152	chr17:40279680	HSPB9	chr17:40274756-40275371:+	0.28	4.17	3.84E-5	Fibrinogen levels	
LIHC	cis	1	rs7312145	chr12:123825339	ABCB9	chr12:123413540-123459752:-	-0.32	-4.12	4.84E-5	HDL cholesterol	
LIHC	cis	1	rs73142121	chr7:65311206	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.72E-6	Diabetic kidney disease	
LIHC	cis	1	rs73142121	chr7:65311206	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs73142122	chr7:65311298	CCT6P1	chr7:65216092-65228661:+	0.35	4.73	3.29E-6	Diabetic kidney disease	
LIHC	cis	1	rs73142122	chr7:65311298	INTS4L1	chr7:64601603-64694599:+	0.34	3.87	0.000132	Diabetic kidney disease	
LIHC	cis	1	rs73142162	chr7:65374296	CCT6P1	chr7:65216092-65228661:+	0.35	4.68	4.05E-6	Diabetic kidney disease	
LIHC	cis	1	rs73142166	chr7:65375832	CCT6P1	chr7:65216092-65228661:+	0.34	4.67	4.29E-6	Diabetic kidney disease	
LIHC	cis	1	rs73150014	chr7:65450919	CCT6P1	chr7:65216092-65228661:+	0.36	4.94	1.22E-6	Diabetic kidney disease	
LIHC	cis	1	rs73150014	chr7:65450919	INTS4L1	chr7:64601603-64694599:+	0.33	3.85	0.000143	Diabetic kidney disease	
LIHC	cis	1	rs7315453	chr12:123825389	ABCB9	chr12:123413540-123459752:-	-0.32	-4.12	4.84E-5	HDL cholesterol	
LIHC	cis	1	rs731945	chr19:18567039	KIAA0892	chr19:19431630-19469562:+	0.18	4.41	1.38E-5	Self-reported allergy	
LIHC	cis	1	rs73220724	chr5:109776875	MAN2A1	chr5:109025156-109203429:+	0.27	4.15	4.26E-5	Cardiac structure and function	
LIHC	cis	1	rs73220724	chr5:109776875	TMEM232	chr5:109624934-110062381:-	0.38	3.81	0.000165	Cardiac structure and function	
LIHC	cis	1	rs73231952	chr12:123785538	ABCB9	chr12:123413540-123459752:-	0.32	4.13	4.59E-5	HDL cholesterol	
LIHC	cis	1	rs7323755	chr13:45900267	KIAA1704	chr13:45563687-45607742:+	0.41	4.15	4.14E-5	Myopia (pathological)	
LIHC	cis	1	rs73276437	chr8:96035511	C8orf38	chr8:95908040-96088396:+	-0.29	-4.07	5.78E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs73276444	chr8:96039247	C8orf38	chr8:95908040-96088396:+	-0.3	-4.22	3.08E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs73282234	chr5:150195924	LOC134466	chr5:150310000-150326146:-	0.33	4.02	7.03E-5	Crohn's disease	
LIHC	cis	1	rs73282255	chr5:150223647	LOC134466	chr5:150310000-150326146:-	0.32	4.11	4.94E-5	Crohn's disease	
LIHC	cis	1	rs73284126	chr5:150261307	LOC134466	chr5:150310000-150326146:-	0.34	4.46	1.1E-5	Crohn's disease	
LIHC	cis	1	rs73284141	chr5:150266086	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs73395547	chr7:98922746	CYP3A5	chr7:99245818-99332821:-	0.67	9.64	1.29E-19	Blood metabolite levels	
LIHC	cis	1	rs73395557	chr7:98934424	CYP3A5	chr7:99245818-99332821:-	0.67	9.99	8.44E-21	Blood metabolite levels	
LIHC	cis	1	rs73509996	chr19:17393449	ANKLE1	chr19:17392454-17398454:+	0.43	4.03	6.8E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
LIHC	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.67	9.55	2.49E-19	Height	
LIHC	cis	1	rs73590751	chr8:36897152	PROSC	chr8:37620101-37637285:+	0.31	3.87	0.000129	Insulin resistance/response	
LIHC	cis	1	rs73590751	chr8:36897152	RAB11FIP1	chr8:37716470-37757003:-	0.36	5	9.21E-7	Insulin resistance/response	
LIHC	cis	1	rs73590793	chr8:36921941	RAB11FIP1	chr8:37716470-37757003:-	0.36	5.07	6.41E-7	Insulin resistance/response	
LIHC	cis	1	rs73590799	chr8:36922500	PROSC	chr8:37620101-37637285:+	0.31	3.84	0.000147	Insulin resistance/response	
LIHC	cis	1	rs73590799	chr8:36922500	RAB11FIP1	chr8:37716470-37757003:-	0.37	5.13	4.83E-7	Insulin resistance/response	
LIHC	cis	1	rs7364173	chr22:50681029	SELO	chr22:50639408-50656044:+	-0.23	-5.09	6.0E-7	Obesity-related traits	
LIHC	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-0.59	-8.03	1.52E-14	Diastolic blood pressure	
LIHC	cis	1	rs737245	chr14:24927382	GMPR2	chr14:24701648-24708445:+	-0.45	-4.37	1.63E-5	Smooth-surface caries	
LIHC	cis	1	rs737245	chr14:24927382	SDR39U1	chr14:24908974-24912064:-	-0.53	-5.14	4.55E-7	Smooth-surface caries	
LIHC	cis	1	rs737246	chr14:24927313	GMPR2	chr14:24701648-24708445:+	-0.44	-4.3	2.21E-5	Smooth-surface caries	
LIHC	cis	1	rs737246	chr14:24927313	SDR39U1	chr14:24908974-24912064:-	-0.55	-5.46	9.26E-8	Smooth-surface caries	
LIHC	cis	1	rs737247	chr14:24927197	GMPR2	chr14:24701648-24708445:+	-0.45	-4.37	1.63E-5	Smooth-surface caries	
LIHC	cis	1	rs737247	chr14:24927197	SDR39U1	chr14:24908974-24912064:-	-0.53	-5.14	4.55E-7	Smooth-surface caries	
LIHC	cis	1	rs7373805	chr3:38455439	XYLB	chr3:38388251-38456467:+	0.27	5.16	4.11E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs7373816	chr3:38490443	XYLB	chr3:38388251-38456467:+	0.28	5.28	2.26E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.67	9.55	2.49E-19	Height	
LIHC	cis	1	rs738722	chr22:29130012	CHEK2	chr22:29083731-29137822:-	0.53	8.06	1.24E-14	Esophageal cancer and gastric cancer	
LIHC	cis	1	rs7388210	chr8:36902570	ERLIN2	chr8:37594097-37615318:+	0.33	4.17	3.89E-5	Insulin resistance/response	
LIHC	cis	1	rs7388210	chr8:36902570	PROSC	chr8:37620101-37637285:+	0.36	4.39	1.53E-5	Insulin resistance/response	
LIHC	cis	1	rs7388210	chr8:36902570	RAB11FIP1	chr8:37716470-37757003:-	0.38	5.35	1.61E-7	Insulin resistance/response	
LIHC	cis	1	rs739139	chr22:38067011	LGALS1	chr22:38071613-38075807:+	-0.2	-4.04	6.7E-5	Fat distribution (HIV)	
LIHC	cis	1	rs73921003	chr2:17775205	GEN1	chr2:17935162-17966632:+	0.41	5.11	5.25E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs73943920	chr2:86186195	POLR1A	chr2:86253453-86333278:-	-0.36	-4.98	1.01E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs73947314	chr2:86273116	POLR1A	chr2:86253453-86333278:-	-0.36	-4.95	1.19E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs7395213	chr11:87869579	RAB38	chr11:87846431-87908599:-	-0.27	-4.44	1.2E-5	Frontotemporal dementia	
LIHC	cis	1	rs7395328	chr11:242624	PSMD13	chr11:236808-252984:+	-0.23	-4.1	5.21E-5	Menarche (age at onset)	
LIHC	cis	1	rs73958618	chr2:136500475	DARS	chr2:136664254-136743222:-	0.26	4.02	7.03E-5	Corneal structure	
LIHC	cis	1	rs739616	chr22:30470925	CABP7	chr22:30116344-30127818:+	0.5	4.05	6.31E-5	LDL cholesterol	
LIHC	cis	1	rs739637	chr17:40280944	HSPB9	chr17:40274756-40275371:+	0.28	4.17	3.84E-5	Fibrinogen levels	
LIHC	cis	1	rs740122	chr7:28166442	JAZF1	chr7:27870196-28220437:-	-0.34	-4.44	1.22E-5	Rheumatoid arthritis	
LIHC	cis	1	rs74019802	chr16:58162210	CX3CL1	chr16:57406414-57418954:+	0.41	4.17	3.91E-5	Telomere length	
LIHC	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.49	7.86	4.99E-14	Eye color traits	
LIHC	cis	1	rs74152357	chr10:96508039	CYP2C18	chr10:96443251-96495945:+	-0.36	-4.15	4.23E-5	Blood metabolite levels	
LIHC	cis	1	rs74152360	chr10:96512547	CYP2C18	chr10:96443251-96495945:+	-0.36	-4.15	4.23E-5	Blood metabolite levels	
LIHC	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.59	-6.06	3.53E-9	Plasma clusterin levels	
LIHC	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.67	9.55	2.49E-19	Height	
LIHC	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.29	1.76E-18	Height	
LIHC	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.67	9.55	2.49E-19	Height	
LIHC	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs7433707	chr3:38443180	XYLB	chr3:38388251-38456467:+	0.28	5.3	2.1E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.64	8.97	1.91E-17	Height	
LIHC	cis	1	rs74363821	chr6:26189524	HIST1H2AE	chr6:26217148-26217711:+	-0.4	-4.38	1.59E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs7444	chr22:21976934	CCDC116	chr22:21987086-21991615:+	-0.33	-4.69	3.87E-6	Systemic lupus erythematosus	
LIHC	cis	1	rs7450517	chr6:53902843	C6orf142	chr6:53883714-54131074:+	0.25	4.16	3.98E-5	Liver enzyme levels (gamma-glutamyl transferase)	
LIHC	cis	1	rs74559059	chr8:36957106	PROSC	chr8:37620101-37637285:+	0.32	3.93	0.000103	Insulin resistance/response	
LIHC	cis	1	rs74559059	chr8:36957106	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.9	1.47E-6	Insulin resistance/response	
LIHC	cis	1	rs7456042	chr7:65299778	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.72E-6	Diabetic kidney disease	
LIHC	cis	1	rs7456042	chr7:65299778	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs74579195	chr8:36924529	ERLIN2	chr8:37594097-37615318:+	0.32	3.97	8.88E-5	Insulin resistance/response	
LIHC	cis	1	rs74579195	chr8:36924529	PROSC	chr8:37620101-37637285:+	0.36	4.37	1.68E-5	Insulin resistance/response	
LIHC	cis	1	rs74579195	chr8:36924529	RAB11FIP1	chr8:37716470-37757003:-	0.39	5.32	1.86E-7	Insulin resistance/response	
LIHC	cis	1	rs746489	chr9:131910093	CRAT	chr9:131857075-131873070:-	0.23	4.2	3.4E-5	Blood metabolite ratios	
LIHC	cis	1	rs74733602	chr2:86303442	POLR1A	chr2:86253453-86333278:-	-0.38	-4.99	9.83E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs74733602	chr2:86303442	REEP1	chr2:86441122-86564777:-	0.42	3.88	0.000127	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs74745713	chr5:109658789	MAN2A1	chr5:109025156-109203429:+	0.35	5.71	2.46E-8	Cardiac structure and function	
LIHC	cis	1	rs747782	chr11:47940925	C1QTNF4	chr11:47611216-47615961:-	0.29	3.83	0.000151	Intraocular pressure	
LIHC	cis	1	rs7478880	chr11:120261791	TMEM136	chr11:120196016-120204388:+	0.24	4.33	1.99E-5	Intraocular pressure	
LIHC	cis	1	rs7481993	chr11:237875	PSMD13	chr11:236808-252984:+	-0.24	-4.19	3.5E-5	Menarche (age at onset)	
LIHC	cis	1	rs7482591	chr11:245861	PSMD13	chr11:236808-252984:+	-0.23	-4.06	6.02E-5	Menarche (age at onset)	
LIHC	cis	1	rs7483951	chr11:231758	PSMD13	chr11:236808-252984:+	-0.23	-4.1	5.06E-5	Menarche (age at onset)	
LIHC	cis	1	rs749050	chr10:97376115	ALDH18A1	chr10:97365687-97416567:-	0.29	4.35	1.78E-5	Blood metabolite levels	
LIHC	cis	1	rs749050	chr10:97376115	ENTPD1	chr10:97471536-97637022:+	0.2	3.95	9.43E-5	Blood metabolite levels	
LIHC	cis	1	rs74928544	chr8:36897236	PROSC	chr8:37620101-37637285:+	0.31	3.87	0.000129	Insulin resistance/response	
LIHC	cis	1	rs74928544	chr8:36897236	RAB11FIP1	chr8:37716470-37757003:-	0.36	5	9.21E-7	Insulin resistance/response	
LIHC	cis	1	rs74984113	chr4:250522	ZNF718	chr4:53272-156488:+	0.33	5.16	4.15E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs74984740	chr2:17796007	GEN1	chr2:17935162-17966632:+	0.42	4.68	4.1E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs7499306	chr16:20555474	ACSM2B	chr16:20548084-20587695:-	-0.29	-4.24	2.88E-5	Serum metabolite levels	
LIHC	cis	1	rs74998394	chr5:109778413	MAN2A1	chr5:109025156-109203429:+	0.28	4.31	2.16E-5	Cardiac structure and function	
LIHC	cis	1	rs750176	chr13:51384053	FAM124A	chr13:51796507-51855616:+	-0.21	-3.84	0.000145	Primary tooth development (number of teeth)	
LIHC	cis	1	rs75026527	chr8:36963878	PROSC	chr8:37620101-37637285:+	0.32	3.91	0.000109	Insulin resistance/response	
LIHC	cis	1	rs75026527	chr8:36963878	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.86	1.82E-6	Insulin resistance/response	
LIHC	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.49	7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs75038217	chr2:86348025	POLR1A	chr2:86253453-86333278:-	-0.37	-4.7	3.78E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs750474	chr3:53085280	RFT1	chr3:53122503-53164470:-	0.48	4.88	1.63E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs7506045	chr18:11987272	TUBB6	chr18:12308240-12329822:+	0.21	4.21	3.2E-5	Stroke	
LIHC	cis	1	rs75071288	chr5:150224379	LOC134466	chr5:150310000-150326146:-	0.33	4.2	3.38E-5	Crohn's disease	
LIHC	cis	1	rs75085043	chr5:109729109	MAN2A1	chr5:109025156-109203429:+	0.26	4.11	5.01E-5	Cardiac structure and function	
LIHC	cis	1	rs75109362	chr2:86289889	POLR1A	chr2:86253453-86333278:-	-0.38	-5.13	4.97E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs7511006	chr22:50676259	SELO	chr22:50639408-50656044:+	0.22	4.6	5.96E-6	Obesity-related traits	
LIHC	cis	1	rs75128809	chr21:43418210	C21orf121	chr21:43442113-43445060:+	0.3	3.89	0.000121	Hand grip strength	
LIHC	cis	1	rs75159543	chr15:40665228	C15orf23	chr15:40674922-40686488:+	0.64	6.42	4.42E-10	Heschl's gyrus morphology	
LIHC	cis	1	rs7516739	chr1:180948506	STX6	chr1:180913175-180992046:-	-0.19	-4.56	7.11E-6	Progressive supranuclear palsy	
LIHC	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.58	-5.98	5.53E-9	Plasma clusterin levels	
LIHC	cis	1	rs75217232	chr3:53132373	RFT1	chr3:53122503-53164470:-	0.49	4.62	5.55E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.3	5.44	1.03E-7	Homocysteine levels	
LIHC	cis	1	rs752590	chr2:113972945	LOC654433	chr2:113993107-114024579:+	-0.33	-4	7.89E-5	Mucinous ovarian carcinoma	
LIHC	cis	1	rs75269301	chr22:30591798	CABP7	chr22:30116344-30127818:+	0.52	4	7.82E-5	LDL cholesterol	
LIHC	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	0.58	6.15	2.09E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs7528419	chr1:109817192	CELSR2	chr1:109792641-109818377:+	0.44	5.23	3.01E-7	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs7528419	chr1:109817192	MYBPHL	chr1:109834987-109849663:-	0.34	4.14	4.37E-5	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs7528419	chr1:109817192	PSRC1	chr1:109822179-109825808:-	0.56	9.02	1.38E-17	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs7528419	chr1:109817192	SORT1	chr1:109852192-109940563:-	0.66	7.43	8.8E-13	Cholesterol, total;Myocardial infarction;Coronary artery disease;Lipoprotein-associated phospholipase A2 activity and mass	
LIHC	cis	1	rs7528526	chr1:180948574	STX6	chr1:180913175-180992046:-	-0.19	-4.56	7.11E-6	Progressive supranuclear palsy	
LIHC	cis	1	rs7528684	chr1:157670816	FCRL3	chr1:157646278-157670775:-	0.23	5.45	9.55E-8	Type 1 diabetes autoantibodies	
LIHC	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.56	-5.77	1.76E-8	Plasma clusterin levels	
LIHC	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.31	-5.34	1.73E-7	Homocysteine levels	
LIHC	cis	1	rs75358288	chr6:55987364	COL21A1	chr6:55921389-56258892:-	-0.32	-3.83	0.000153	Psychosis (atypical)	
LIHC	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.29	-5.04	7.37E-7	Homocysteine levels	
LIHC	cis	1	rs7551124	chr1:23785760	ASAP3	chr1:23755056-23811057:-	0.25	4.14	4.29E-5	Cholesterol, total	
LIHC	cis	1	rs7551732	chr1:89139041	CCBL2	chr1:89401456-89458643:-	0.26	3.83	0.000152	Height	
LIHC	cis	1	rs7553330	chr1:180956015	STX6	chr1:180913175-180992046:-	-0.18	-4.24	2.87E-5	Progressive supranuclear palsy	
LIHC	cis	1	rs75552762	chr5:109715236	MAN2A1	chr5:109025156-109203429:+	0.31	4.77	2.71E-6	Cardiac structure and function	
LIHC	cis	1	rs75552762	chr5:109715236	TMEM232	chr5:109624934-110062381:-	0.42	4.18	3.66E-5	Cardiac structure and function	
LIHC	cis	1	rs75586243	chr8:36910312	ERLIN2	chr8:37594097-37615318:+	0.31	3.93	0.000104	Insulin resistance/response	
LIHC	cis	1	rs75586243	chr8:36910312	PROSC	chr8:37620101-37637285:+	0.34	4.16	3.98E-5	Insulin resistance/response	
LIHC	cis	1	rs75586243	chr8:36910312	RAB11FIP1	chr8:37716470-37757003:-	0.37	5.21	3.21E-7	Insulin resistance/response	
LIHC	cis	1	rs7564824	chr2:103998644	IL18RAP	chr2:103035254-103069022:+	-0.27	-4	7.86E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs75683693	chr14:24929640	GMPR2	chr14:24701648-24708445:+	-0.44	-4.24	2.84E-5	Smooth-surface caries	
LIHC	cis	1	rs75683693	chr14:24929640	SDR39U1	chr14:24908974-24912064:-	-0.54	-5.22	3.09E-7	Smooth-surface caries	
LIHC	cis	1	rs75713195	chr2:86290659	POLR1A	chr2:86253453-86333278:-	-0.37	-5.03	8.01E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs75774363	chr5:150223722	LOC134466	chr5:150310000-150326146:-	0.34	4.35	1.8E-5	Crohn's disease	
LIHC	cis	1	rs7578199	chr2:242192848	DTYMK	chr2:242615157-242626227:-	0.21	3.93	0.000105	Chronic lymphocytic leukemia	
LIHC	cis	1	rs7578199	chr2:242192848	PPP1R7	chr2:242089024-242122439:+	0.29	4.21	3.26E-5	Chronic lymphocytic leukemia	
LIHC	cis	1	rs7578199	chr2:242192848	SEPT2	chr2:242254723-242293439:+	0.26	4.09	5.37E-5	Chronic lymphocytic leukemia	
LIHC	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.28	4.03	6.9E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
LIHC	cis	1	rs7582966	chr2:104018063	IL18RAP	chr2:103035254-103069022:+	-0.27	-4.1	5.2E-5	Blood pressure (anthropometric measures interaction)	
LIHC	cis	1	rs75889859	chr14:35539054	PPP2R3C	chr14:35554679-35591679:-	0.39	5.23	2.98E-7	Atopic dermatitis	
LIHC	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.56	-5.67	3.01E-8	Plasma clusterin levels	
LIHC	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.74	-7.53	4.44E-13	Triptolide cytotoxicity	
LIHC	cis	1	rs75921373	chr6:26191843	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.47	1.05E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs75936657	chr1:41001689	DEM1	chr1:40974433-40982212:+	0.3	4.15	4.25E-5	Age-related hearing impairment (interaction)	
LIHC	cis	1	rs76021615	chr5:109824891	TMEM232	chr5:109624934-110062381:-	0.35	3.87	0.000128	Cardiac structure and function	
LIHC	cis	1	rs7604393	chr2:241825034	C2orf54	chr2:241825466-241835573:-	0.51	7.25	2.77E-12	Urinary metabolites	
LIHC	cis	1	rs76052260	chr2:86328727	POLR1A	chr2:86253453-86333278:-	-0.36	-4.88	1.61E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs76052260	chr2:86328727	REEP1	chr2:86441122-86564777:-	0.4	3.94	9.98E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs760554	chr22:25872592	CRYBB2	chr22:25615612-25627836:+	0.9	9.78	4.41E-20	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs760555	chr22:25872837	CRYBB2	chr22:25615612-25627836:+	0.89	9.63	1.38E-19	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs7608910	chr2:61204856	C2orf74	chr2:61372243-61391964:+	-0.42	-5.47	8.85E-8	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
LIHC	cis	1	rs76106381	chr5:109702528	MAN2A1	chr5:109025156-109203429:+	0.31	4.85	1.91E-6	Cardiac structure and function	
LIHC	cis	1	rs76106381	chr5:109702528	TMEM232	chr5:109624934-110062381:-	0.41	4.09	5.43E-5	Cardiac structure and function	
LIHC	cis	1	rs76112431	chr6:55988182	COL21A1	chr6:55921389-56258892:-	-0.32	-3.83	0.000153	Psychosis (atypical)	
LIHC	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.64	8.97	1.91E-17	Height	
LIHC	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs7613875	chr3:49971514	RBM6	chr3:49977592-50137484:+	-0.32	-6.05	3.75E-9	Body mass index	
LIHC	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.56	-6.34	7.24E-10	Blood pressure (smoking interaction)	
LIHC	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.61	6.75	6.36E-11	Blood pressure (smoking interaction)	
LIHC	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.59	7.9	3.71E-14	Diastolic blood pressure	
LIHC	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.6	-8.2	4.71E-15	Diastolic blood pressure	
LIHC	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.62	8.09	1.05E-14	Height	
LIHC	cis	1	rs76194	chr19:18630580	ISYNA1	chr19:18545625-18548943:-	0.19	4.47	1.07E-5	Breast cancer	
LIHC	cis	1	rs76198862	chr6:55988150	COL21A1	chr6:55921389-56258892:-	-0.32	-3.83	0.000153	Psychosis (atypical)	
LIHC	cis	1	rs76202526	chr8:36914435	ERLIN2	chr8:37594097-37615318:+	0.32	4.07	5.82E-5	Insulin resistance/response	
LIHC	cis	1	rs76202526	chr8:36914435	PROSC	chr8:37620101-37637285:+	0.36	4.35	1.8E-5	Insulin resistance/response	
LIHC	cis	1	rs76202526	chr8:36914435	RAB11FIP1	chr8:37716470-37757003:-	0.39	5.4	1.26E-7	Insulin resistance/response	
LIHC	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.58	7.83	6.25E-14	Diastolic blood pressure	
LIHC	cis	1	rs7622420	chr3:53111069	RFT1	chr3:53122503-53164470:-	0.45	4.52	8.47E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs762317	chr3:38497659	XYLB	chr3:38388251-38456467:+	0.28	5.28	2.26E-7	Electrocardiographic conduction measures	
LIHC	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.58	7.83	6.25E-14	Diastolic blood pressure	
LIHC	cis	1	rs7625448	chr3:53120766	RFT1	chr3:53122503-53164470:-	0.5	4.75	2.99E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs762676	chr22:51017794	CPT1B	chr22:51007291-51017096:-	-0.31	-4.18	3.76E-5	Narcolepsy	
LIHC	cis	1	rs762677	chr22:51017713	CPT1B	chr22:51007291-51017096:-	-0.3	-4.05	6.29E-5	Narcolepsy	
LIHC	cis	1	rs76277863	chr15:40649863	C15orf23	chr15:40674922-40686488:+	0.61	6.07	3.43E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs76297018	chr2:86227007	POLR1A	chr2:86253453-86333278:-	-0.37	-5.08	6.18E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.39	6.28	1.03E-9	Height	
LIHC	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.23	2.84E-18	Height	
LIHC	cis	1	rs7631057	chr3:41817951	ULK4	chr3:41288091-42003660:-	0.57	7.82	6.59E-14	Diastolic blood pressure	
LIHC	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.61	8.1	9.69E-15	Diastolic blood pressure	
LIHC	cis	1	rs76329209	chr6:26196430	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.42	1.3E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.66	9.44	5.88E-19	Height	
LIHC	cis	1	rs76403925	chr14:24930513	GMPR2	chr14:24701648-24708445:+	-0.43	-4	7.81E-5	Smooth-surface caries	
LIHC	cis	1	rs76403925	chr14:24930513	SDR39U1	chr14:24908974-24912064:-	-0.54	-5.15	4.45E-7	Smooth-surface caries	
LIHC	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.37	4.73	3.23E-6	Crohn's disease	
LIHC	cis	1	rs76435840	chr11:58285981	CNTF	chr11:58390146-58393203:+	0.36	4.55	7.55E-6	Lymphoma	
LIHC	cis	1	rs76449411	chr2:17799354	GEN1	chr2:17935162-17966632:+	0.43	4.69	3.91E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs7645295	chr3:134307734	ANAPC13	chr3:134196547-134204865:-	0.64	8.99	1.7E-17	Height	
LIHC	cis	1	rs7645611	chr3:53125297	RFT1	chr3:53122503-53164470:-	0.52	4.96	1.13E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.61	8.1	9.69E-15	Diastolic blood pressure	
LIHC	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	0.6	8.06	1.26E-14	Diastolic blood pressure	
LIHC	cis	1	rs76482184	chr12:109084848	SELPLG	chr12:109015682-109027670:-	0.1	3.86	0.000138	Low high density lipoprotein cholesterol levels	
LIHC	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	0.6	8.21	4.42E-15	Diastolic blood pressure	
LIHC	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.6	8.23	3.89E-15	Diastolic blood pressure	
LIHC	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.58	7.94	2.85E-14	Diastolic blood pressure	
LIHC	cis	1	rs76534589	chr14:24928909	GMPR2	chr14:24701648-24708445:+	-0.43	-3.98	8.55E-5	Smooth-surface caries	
LIHC	cis	1	rs76534589	chr14:24928909	SDR39U1	chr14:24908974-24912064:-	-0.52	-4.9	1.47E-6	Smooth-surface caries	
LIHC	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.36	-5.39	1.32E-7	Tumor biomarkers	
LIHC	cis	1	rs76542740	chr15:43891512	CATSPER2	chr15:43922774-43959900:-	-0.34	-4.8	2.33E-6	Tumor biomarkers	
LIHC	cis	1	rs76548544	chr5:150223515	LOC134466	chr5:150310000-150326146:-	0.32	4.11	4.94E-5	Crohn's disease	
LIHC	cis	1	rs76552490	chr11:212015	PSMD13	chr11:236808-252984:+	0.24	4.36	1.72E-5	Menarche (age at onset)	
LIHC	cis	1	rs7655841	chr4:129890790	C4orf33	chr4:130014829-130033842:+	0.54	7.6	2.91E-13	Chronic obstructive pulmonary disease (moderate to severe)	
LIHC	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.44	-7.02	1.16E-11	Plasma amyloid beta peptide concentrations (ABx-40)	
LIHC	cis	1	rs7657962	chr4:106966715	TBCK	chr4:106967233-107237861:-	0.25	4.53	8.14E-6	Airflow obstruction	
LIHC	cis	1	rs766011	chr22:30516927	CABP7	chr22:30116344-30127818:+	0.5	4.1	5.21E-5	LDL cholesterol	
LIHC	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.43	-6.65	1.17E-10	Plasma amyloid beta peptide concentrations (ABx-40)	
LIHC	cis	1	rs7665727	chr4:277057	ZNF718	chr4:53272-156488:+	0.29	4.74	3.15E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs76674971	chr8:36904372	ERLIN2	chr8:37594097-37615318:+	0.31	3.97	8.75E-5	Insulin resistance/response	
LIHC	cis	1	rs76674971	chr8:36904372	PROSC	chr8:37620101-37637285:+	0.34	4.22	3.11E-5	Insulin resistance/response	
LIHC	cis	1	rs76674971	chr8:36904372	RAB11FIP1	chr8:37716470-37757003:-	0.37	5.2	3.36E-7	Insulin resistance/response	
LIHC	cis	1	rs7669892	chr4:309253	ZNF718	chr4:53272-156488:+	-0.23	-4.76	2.81E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs76722536	chr6:26192946	HIST1H2AE	chr6:26217148-26217711:+	-0.42	-4.54	7.68E-6	Renal underexcretion gout;Gout	
LIHC	cis	1	rs7674560	chr4:263319	ZNF718	chr4:53272-156488:+	0.3	5.29	2.22E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs7677248	chr4:106960497	TBCK	chr4:106967233-107237861:-	-0.24	-4.32	2.05E-5	Airflow obstruction	
LIHC	cis	1	rs7678847	chr4:106987426	TBCK	chr4:106967233-107237861:-	0.23	4.11	4.96E-5	Airflow obstruction	
LIHC	cis	1	rs7682402	chr4:1743343	FAM53A	chr4:1641609-1685854:-	-0.4	-5.18	3.88E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs7686546	chr4:240614	ZNF718	chr4:53272-156488:+	0.35	5.37	1.42E-7	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.44	-6.91	2.34E-11	Plasma amyloid beta peptide concentrations (ABx-40)	
LIHC	cis	1	rs769044	chr14:90671138	C14orf102	chr14:90744398-90798279:-	0.24	3.9	0.000115	Mortality in heart failure	
LIHC	cis	1	rs76917914	chr9:100771440	C9orf156	chr9:100666772-100684852:-	0.32	3.86	0.000134	Coronary heart disease	
LIHC	cis	1	rs7692069	chr4:106959289	TBCK	chr4:106967233-107237861:-	0.27	4.86	1.75E-6	Airflow obstruction	
LIHC	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	0.57	5.94	6.97E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs7705093	chr5:96290647	ERAP1	chr5:96096515-96149837:-	-0.25	-4.31	2.13E-5	Birdshot chorioretinopathy	
LIHC	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	0.98	20.57	7.34E-62	Birdshot chorioretinopathy	
LIHC	cis	1	rs7705542	chr5:150228318	LOC134466	chr5:150310000-150326146:-	0.33	4.33	1.98E-5	Crohn's disease	
LIHC	cis	1	rs77057890	chr8:36943293	PROSC	chr8:37620101-37637285:+	0.36	4.55	7.4E-6	Insulin resistance/response	
LIHC	cis	1	rs77057890	chr8:36943293	RAB11FIP1	chr8:37716470-37757003:-	0.38	5.3	2.1E-7	Insulin resistance/response	
LIHC	cis	1	rs77078697	chr4:252048	ZNF718	chr4:53272-156488:+	0.33	5.54	5.95E-8	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs7709388	chr5:150246539	LOC134466	chr5:150310000-150326146:-	0.32	4.22	3.16E-5	Crohn's disease	
LIHC	cis	1	rs7709464	chr5:150269441	LOC134466	chr5:150310000-150326146:-	0.34	4.52	8.49E-6	Crohn's disease	
LIHC	cis	1	rs7709650	chr5:150246685	LOC134466	chr5:150310000-150326146:-	0.35	4.48	1.01E-5	Crohn's disease	
LIHC	cis	1	rs7714415	chr5:150270292	LOC134466	chr5:150310000-150326146:-	0.34	4.5	9.5E-6	Crohn's disease	
LIHC	cis	1	rs7714584	chr5:150270420	LOC134466	chr5:150310000-150326146:-	0.34	4.45	1.18E-5	Crohn's disease	
LIHC	cis	1	rs7715981	chr5:150258107	LOC134466	chr5:150310000-150326146:-	0.34	4.4	1.42E-5	Crohn's disease	
LIHC	cis	1	rs7716903	chr5:150258574	LOC134466	chr5:150310000-150326146:-	0.34	4.44	1.19E-5	Crohn's disease	
LIHC	cis	1	rs77187354	chr6:169983808	WDR27	chr6:169857307-170102159:-	-0.42	-3.97	8.83E-5	Response to anti-TNF therapy in rheumatoid arthritis	
LIHC	cis	1	rs7719149	chr5:109761489	MAN2A1	chr5:109025156-109203429:+	0.29	4.43	1.28E-5	Cardiac structure and function	
LIHC	cis	1	rs77234191	chr4:258294	ZNF718	chr4:53272-156488:+	0.32	4.88	1.61E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs7724036	chr5:150284808	LOC134466	chr5:150310000-150326146:-	-0.32	-4.39	1.49E-5	Crohn's disease	
LIHC	cis	1	rs77242938	chr8:36949527	PROSC	chr8:37620101-37637285:+	0.33	3.99	8.02E-5	Insulin resistance/response	
LIHC	cis	1	rs77242938	chr8:36949527	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.85	1.89E-6	Insulin resistance/response	
LIHC	cis	1	rs77245075	chr2:17810302	GEN1	chr2:17935162-17966632:+	0.41	4.41	1.41E-5	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs7724558	chr5:150328866	LOC134466	chr5:150310000-150326146:-	0.37	4.62	5.37E-6	Crohn's disease	
LIHC	cis	1	rs77257477	chr8:96045399	C8orf38	chr8:95908040-96088396:+	-0.28	-3.88	0.000123	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs77309268	chr2:86293294	POLR1A	chr2:86253453-86333278:-	-0.37	-5.03	8.01E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs7732643	chr5:150261436	LOC134466	chr5:150310000-150326146:-	0.33	4.32	2.05E-5	Crohn's disease	
LIHC	cis	1	rs7732945	chr5:150261601	LOC134466	chr5:150310000-150326146:-	0.34	4.46	1.1E-5	Crohn's disease	
LIHC	cis	1	rs7733195	chr5:172994624	LOC100268168	chr5:172381788-172386371:-	-0.33	-3.91	0.000112	Height	
LIHC	cis	1	rs7734778	chr5:150256556	LOC134466	chr5:150310000-150326146:-	0.31	4.1	5.27E-5	Crohn's disease	
LIHC	cis	1	rs7734928	chr5:150256613	LOC134466	chr5:150310000-150326146:-	0.33	4.36	1.73E-5	Crohn's disease	
LIHC	cis	1	rs7735640	chr5:109697113	MAN2A1	chr5:109025156-109203429:+	0.28	4.3	2.24E-5	Cardiac structure and function	
LIHC	cis	1	rs7735640	chr5:109697113	TMEM232	chr5:109624934-110062381:-	0.41	4	7.65E-5	Cardiac structure and function	
LIHC	cis	1	rs7736554	chr5:150258308	LOC134466	chr5:150310000-150326146:-	0.34	4.44	1.19E-5	Crohn's disease	
LIHC	cis	1	rs7736873	chr5:150258482	LOC134466	chr5:150310000-150326146:-	0.34	4.44	1.19E-5	Crohn's disease	
LIHC	cis	1	rs7740682	chr6:49488745	CENPQ	chr6:49431096-49460820:+	0.22	4.66	4.47E-6	Brain structure	
LIHC	cis	1	rs7741183	chr6:152641656	MTRF1L	chr6:153308401-153323925:-	-0.39	-3.82	0.000158	Post bronchodilator FEV1	
LIHC	cis	1	rs77477310	chr14:35615793	PPP2R3C	chr14:35554679-35591679:-	0.36	4.93	1.26E-6	Atopic dermatitis	
LIHC	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.63	-13.94	2.52E-35	Response to antipsychotic treatment	
LIHC	cis	1	rs7750918	chr6:49430082	CENPQ	chr6:49431096-49460820:+	-0.21	-4.14	4.42E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	0.55	5.85	1.12E-8	Heschl's gyrus morphology	
LIHC	cis	1	rs77543683	chr5:109953122	TMEM232	chr5:109624934-110062381:-	0.35	3.83	0.000155	Cardiac structure and function	
LIHC	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.54	-9.77	4.67E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs7757014	chr6:49491690	CENPQ	chr6:49431096-49460820:+	-0.23	-4.75	2.99E-6	Brain structure	
LIHC	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.37	-8.18	5.65E-15	Homocysteine levels	
LIHC	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.53	-9.41	7.05E-19	Response to antipsychotic treatment	
LIHC	cis	1	rs77621359	chr2:86330353	POLR1A	chr2:86253453-86333278:-	-0.36	-4.88	1.61E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs77621359	chr2:86330353	REEP1	chr2:86441122-86564777:-	0.4	3.94	9.98E-5	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.63	-14	1.48E-35	Response to antipsychotic treatment	
LIHC	cis	1	rs776746	chr7:99270539	CYP3A5	chr7:99245818-99332821:-	-0.97	-16.96	2.61E-47	Blood metabolite levels	
LIHC	cis	1	rs7769720	chr6:161023620	LPA	chr6:160952516-161087407:-	-0.18	-3.83	0.000154	Lipoprotein (a) levels	
LIHC	cis	1	rs77698001	chr5:150250367	LOC134466	chr5:150310000-150326146:-	0.35	4.48	1.01E-5	Crohn's disease	
LIHC	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.54	-9.77	4.67E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs7772602	chr6:109608661	CD164	chr6:109687718-109703762:-	0.24	4.78	2.56E-6	Red blood cell traits	
LIHC	cis	1	rs7773331	chr6:109609208	CD164	chr6:109687718-109703762:-	-0.26	-5.01	8.79E-7	Red blood cell traits	
LIHC	cis	1	rs77734751	chr5:109731517	MAN2A1	chr5:109025156-109203429:+	0.25	3.94	0.0001	Cardiac structure and function	
LIHC	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.34	-7.32	1.74E-12	Homocysteine levels	
LIHC	cis	1	rs7778911	chr7:65694506	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.07	5.85E-5	Diabetic kidney disease	
LIHC	cis	1	rs77790737	chr8:96037156	C8orf38	chr8:95908040-96088396:+	-0.31	-4.37	1.63E-5	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs77794066	chr5:109708872	MAN2A1	chr5:109025156-109203429:+	0.29	4.73	3.24E-6	Cardiac structure and function	
LIHC	cis	1	rs77819408	chr10:96552188	CYP2C18	chr10:96443251-96495945:+	-0.35	-4	7.62E-5	Blood metabolite levels	
LIHC	cis	1	rs77830639	chr5:109778777	MAN2A1	chr5:109025156-109203429:+	0.27	4.1	5.13E-5	Cardiac structure and function	
LIHC	cis	1	rs778679	chr7:65840911	CCT6P1	chr7:65216092-65228661:+	0.3	4.14	4.33E-5	Diabetic kidney disease	
LIHC	cis	1	rs778691	chr7:65873092	CCT6P1	chr7:65216092-65228661:+	0.3	4.14	4.33E-5	Diabetic kidney disease	
LIHC	cis	1	rs778704	chr7:65863467	CCT6P1	chr7:65216092-65228661:+	0.3	4.14	4.33E-5	Diabetic kidney disease	
LIHC	cis	1	rs778729	chr7:65824419	CCT6P1	chr7:65216092-65228661:+	0.3	4.14	4.33E-5	Diabetic kidney disease	
LIHC	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.27	-5.31	1.96E-7	Tuberculosis	
LIHC	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.58	9.06	9.68E-18	Tuberculosis	
LIHC	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.27	-5.22	3.12E-7	Tuberculosis	
LIHC	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.61	9.53	2.98E-19	Tuberculosis	
LIHC	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.28	-5.59	4.59E-8	Tuberculosis	
LIHC	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.58	9.17	4.33E-18	Tuberculosis	
LIHC	cis	1	rs7792391	chr7:65773429	CCT6P1	chr7:65216092-65228661:+	-0.3	-4.19	3.62E-5	Diabetic kidney disease	
LIHC	cis	1	rs77934570	chr5:109717789	MAN2A1	chr5:109025156-109203429:+	0.27	4.17	3.94E-5	Cardiac structure and function	
LIHC	cis	1	rs77934570	chr5:109717789	TMEM232	chr5:109624934-110062381:-	0.41	3.99	7.93E-5	Cardiac structure and function	
LIHC	cis	1	rs7794661	chr7:65389730	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs7794661	chr7:65389730	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs7795242	chr7:65390094	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs7795242	chr7:65390094	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs77957229	chr6:26185226	HIST1H2AE	chr6:26217148-26217711:+	-0.43	-4.63	5.09E-6	Renal underexcretion gout;Gout	
LIHC	cis	1	rs77961951	chr6:26186075	HIST1H2AE	chr6:26217148-26217711:+	-0.42	-4.51	8.85E-6	Renal underexcretion gout;Gout	
LIHC	cis	1	rs77977471	chr5:109696930	MAN2A1	chr5:109025156-109203429:+	0.29	4.48	9.99E-6	Cardiac structure and function	
LIHC	cis	1	rs77977471	chr5:109696930	TMEM232	chr5:109624934-110062381:-	0.41	4.03	6.85E-5	Cardiac structure and function	
LIHC	cis	1	rs78012445	chr6:26195080	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.42	1.3E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs7802797	chr7:110911133	IMMP2L	chr7:110303110-111202538:-	0.22	4.02	7.22E-5	Schizophrenia	
LIHC	cis	1	rs78032828	chr2:86309032	REEP1	chr2:86441122-86564777:-	0.38	3.84	0.000147	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs7804223	chr7:65664559	CCT6P1	chr7:65216092-65228661:+	-0.28	-3.83	0.000152	Diabetic kidney disease	
LIHC	cis	1	rs78075030	chr6:55987294	COL21A1	chr6:55921389-56258892:-	-0.32	-3.83	0.000153	Psychosis (atypical)	
LIHC	cis	1	rs7808022	chr7:99220083	CYP3A5	chr7:99245818-99332821:-	0.94	15.49	1.93E-41	Blood metabolite levels	
LIHC	cis	1	rs7808022	chr7:99220083	ZKSCAN5	chr7:99102273-99131444:+	0.33	3.93	0.000102	Blood metabolite levels	
LIHC	cis	1	rs781142	chr7:65438778	CCT6P1	chr7:65216092-65228661:+	0.34	4.64	4.87E-6	Diabetic kidney disease	
LIHC	cis	1	rs781142	chr7:65438778	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs781149	chr7:65481284	CCT6P1	chr7:65216092-65228661:+	0.36	4.98	9.93E-7	Diabetic kidney disease	
LIHC	cis	1	rs781149	chr7:65481284	INTS4L1	chr7:64601603-64694599:+	0.33	3.96	9.18E-5	Diabetic kidney disease	
LIHC	cis	1	rs781150	chr7:65480973	CCT6P1	chr7:65216092-65228661:+	0.36	5	9.06E-7	Diabetic kidney disease	
LIHC	cis	1	rs781150	chr7:65480973	INTS4L1	chr7:64601603-64694599:+	0.34	4.04	6.6E-5	Diabetic kidney disease	
LIHC	cis	1	rs781156	chr7:65479141	CCT6P1	chr7:65216092-65228661:+	0.36	4.98	9.93E-7	Diabetic kidney disease	
LIHC	cis	1	rs781156	chr7:65479141	INTS4L1	chr7:64601603-64694599:+	0.33	3.96	9.18E-5	Diabetic kidney disease	
LIHC	cis	1	rs781157	chr7:65478311	CCT6P1	chr7:65216092-65228661:+	0.36	4.98	9.93E-7	Diabetic kidney disease	
LIHC	cis	1	rs781157	chr7:65478311	INTS4L1	chr7:64601603-64694599:+	0.33	3.96	9.18E-5	Diabetic kidney disease	
LIHC	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	0.57	6.12	2.51E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs7816345	chr8:36846109	PROSC	chr8:37620101-37637285:+	0.27	3.86	0.000137	Breast size;Percent mammographic density;Mammographic density (non-dense area)	
LIHC	cis	1	rs7818942	chr8:36907645	ERLIN2	chr8:37594097-37615318:+	0.31	3.93	0.000104	Insulin resistance/response	
LIHC	cis	1	rs7818942	chr8:36907645	PROSC	chr8:37620101-37637285:+	0.34	4.16	3.98E-5	Insulin resistance/response	
LIHC	cis	1	rs7818942	chr8:36907645	RAB11FIP1	chr8:37716470-37757003:-	0.37	5.21	3.21E-7	Insulin resistance/response	
LIHC	cis	1	rs78207779	chr14:35506387	PPP2R3C	chr14:35554679-35591679:-	0.37	5.03	8.0E-7	Atopic dermatitis	
LIHC	cis	1	rs78224343	chr8:36897235	PROSC	chr8:37620101-37637285:+	0.31	3.87	0.000129	Insulin resistance/response	
LIHC	cis	1	rs78224343	chr8:36897235	RAB11FIP1	chr8:37716470-37757003:-	0.36	5	9.21E-7	Insulin resistance/response	
LIHC	cis	1	rs7825175	chr8:32416274	NRG1	chr8:31497268-32622558:+	0.26	3.84	0.000146	Thyroid hormone levels	
LIHC	cis	1	rs78261518	chr5:109838380	MAN2A1	chr5:109025156-109203429:+	0.25	4.07	5.95E-5	Cardiac structure and function	
LIHC	cis	1	rs78261518	chr5:109838380	TMEM232	chr5:109624934-110062381:-	0.39	4.08	5.6E-5	Cardiac structure and function	
LIHC	cis	1	rs7826393	chr8:36920041	ERLIN2	chr8:37594097-37615318:+	0.31	3.91	0.00011	Insulin resistance/response	
LIHC	cis	1	rs7826393	chr8:36920041	PROSC	chr8:37620101-37637285:+	0.36	4.32	2.05E-5	Insulin resistance/response	
LIHC	cis	1	rs7826393	chr8:36920041	RAB11FIP1	chr8:37716470-37757003:-	0.38	5.24	2.85E-7	Insulin resistance/response	
LIHC	cis	1	rs78267272	chr2:17790782	GEN1	chr2:17935162-17966632:+	0.45	4.97	1.07E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs7830925	chr8:36907468	RAB11FIP1	chr8:37716470-37757003:-	-0.27	-3.9	0.000115	Insulin resistance/response	
LIHC	cis	1	rs78343340	chr4:267437	ZNF718	chr4:53272-156488:+	0.3	4.87	1.69E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs783540	chr15:83254708	GOLGA6L9	chr15:82711895-82731584:+;chr15	0.21	4.18	3.75E-5	Schizophrenia	
LIHC	cis	1	rs78360366	chr5:109769080	MAN2A1	chr5:109025156-109203429:+	0.31	4.85	1.9E-6	Cardiac structure and function	
LIHC	cis	1	rs78397134	chr10:96549486	CYP2C18	chr10:96443251-96495945:+	-0.34	-3.85	0.00014	Blood metabolite levels	
LIHC	cis	1	rs78457084	chr12:109106800	SELPLG	chr12:109015682-109027670:-	0.1	3.84	0.000148	Low high density lipoprotein cholesterol levels	
LIHC	cis	1	rs7847117	chr9:99544187	FAM22G	chr9:99690592-99704572:+	0.67	7.57	3.46E-13	Height	
LIHC	cis	1	rs7847673	chr9:99544821	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs7848081	chr9:99545120	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs7850707	chr9:99544745	FAM22G	chr9:99690592-99704572:+	0.67	8.73	1.09E-16	Height	
LIHC	cis	1	rs7855278	chr9:131921365	CRAT	chr9:131857075-131873070:-	-0.24	-4.48	1.01E-5	Blood metabolite ratios	
LIHC	cis	1	rs7856667	chr9:99605179	FAM22G	chr9:99690592-99704572:+	0.7	7.73	1.16E-13	Height	
LIHC	cis	1	rs7859307	chr9:99604771	FAM22G	chr9:99690592-99704572:+	0.69	9.14	5.66E-18	Height	
LIHC	cis	1	rs78604110	chr15:40681854	C15orf23	chr15:40674922-40686488:+	0.58	6.16	2.03E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs786425	chr12:124085502	DDX55	chr12:124086672-124105483:+	0.26	4.07	5.8E-5	Pubertal anthropometrics	
LIHC	cis	1	rs78650586	chr2:86190783	POLR1A	chr2:86253453-86333278:-	-0.36	-4.95	1.15E-6	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs7869804	chr9:131913144	CRAT	chr9:131857075-131873070:-	0.24	4.22	3.11E-5	Blood metabolite ratios	
LIHC	cis	1	rs7874781	chr9:99573065	FAM22G	chr9:99690592-99704572:+	0.68	7.45	7.51E-13	Height	
LIHC	cis	1	rs78803505	chr7:65382572	CCT6P1	chr7:65216092-65228661:+	0.33	4.57	6.74E-6	Diabetic kidney disease	
LIHC	cis	1	rs78803505	chr7:65382572	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000102	Diabetic kidney disease	
LIHC	cis	1	rs78804957	chr14:24949205	SDR39U1	chr14:24908974-24912064:-	-0.48	-4.63	5.11E-6	Smooth-surface caries	
LIHC	cis	1	rs78886939	chr8:36928927	ERLIN2	chr8:37594097-37615318:+	0.32	4.02	7.13E-5	Insulin resistance/response	
LIHC	cis	1	rs78886939	chr8:36928927	PROSC	chr8:37620101-37637285:+	0.37	4.51	9.1E-6	Insulin resistance/response	
LIHC	cis	1	rs78886939	chr8:36928927	RAB11FIP1	chr8:37716470-37757003:-	0.4	5.43	1.05E-7	Insulin resistance/response	
LIHC	cis	1	rs78904161	chr8:36952153	PROSC	chr8:37620101-37637285:+	0.33	3.97	8.69E-5	Insulin resistance/response	
LIHC	cis	1	rs78904161	chr8:36952153	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.85	1.92E-6	Insulin resistance/response	
LIHC	cis	1	rs78953577	chr8:32429839	NRG1	chr8:31497268-32622558:+	0.29	4.12	4.81E-5	Thyroid hormone levels	
LIHC	cis	1	rs78962877	chr5:109663441	MAN2A1	chr5:109025156-109203429:+	0.31	5.16	4.21E-7	Cardiac structure and function	
LIHC	cis	1	rs78973981	chr5:109702558	MAN2A1	chr5:109025156-109203429:+	0.31	4.85	1.91E-6	Cardiac structure and function	
LIHC	cis	1	rs78973981	chr5:109702558	TMEM232	chr5:109624934-110062381:-	0.41	4.09	5.43E-5	Cardiac structure and function	
LIHC	cis	1	rs78974622	chr22:38059925	LGALS1	chr22:38071613-38075807:+	-0.2	-3.89	0.00012	Fat distribution (HIV)	
LIHC	cis	1	rs789970	chr10:105977721	C10orf79	chr10:105889647-105992120:-	-0.25	-3.82	0.000156	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	0.58	6.15	2.09E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs79152960	chr2:86290661	POLR1A	chr2:86253453-86333278:-	-0.37	-5.03	8.01E-7	Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)	
LIHC	cis	1	rs7916697	chr10:69991853	ATOH7	chr10:69990386-69991855:-	0.26	3.9	0.000116	Optic disc area	
LIHC	cis	1	rs7917792	chr10:97365627	ALDH18A1	chr10:97365687-97416567:-	0.28	4.13	4.61E-5	Blood metabolite levels	
LIHC	cis	1	rs7917792	chr10:97365627	ENTPD1	chr10:97471536-97637022:+	0.22	4.32	2.03E-5	Blood metabolite levels	
LIHC	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.63	14.13	4.48E-36	Response to antipsychotic treatment	
LIHC	cis	1	rs79187906	chr10:96560695	CYP2C18	chr10:96443251-96495945:+	-0.34	-3.85	0.00014	Blood metabolite levels	
LIHC	cis	1	rs79199019	chr14:35581125	PPP2R3C	chr14:35554679-35591679:-	0.38	5.01	8.65E-7	Atopic dermatitis	
LIHC	cis	1	rs79211555	chr17:77305203	CBX4	chr17:77806956-77813213:-	0.59	3.99	8.13E-5	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;3-hydroxypropylmercapturic acid levels in smokers	
LIHC	cis	1	rs79214560	chr5:109710289	MAN2A1	chr5:109025156-109203429:+	0.28	4.57	6.86E-6	Cardiac structure and function	
LIHC	cis	1	rs79214560	chr5:109710289	TMEM232	chr5:109624934-110062381:-	0.37	3.81	0.000166	Cardiac structure and function	
LIHC	cis	1	rs7924963	chr11:120233536	TMEM136	chr11:120196016-120204388:+	0.25	4.47	1.05E-5	Intraocular pressure	
LIHC	cis	1	rs79264785	chr6:26194121	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.47	1.05E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs7927771	chr11:47781306	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.89	3.63E-17	Subjective well-being	
LIHC	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.34	-4.84	2.0E-6	Schizophrenia	
LIHC	cis	1	rs79318564	chr15:84786150	NMB	chr15:85198362-85201802:-	-0.36	-4.95	1.19E-6	Schizophrenia	
LIHC	cis	1	rs79322080	chr8:36906379	ERLIN2	chr8:37594097-37615318:+	0.32	4.07	5.77E-5	Insulin resistance/response	
LIHC	cis	1	rs79322080	chr8:36906379	PROSC	chr8:37620101-37637285:+	0.35	4.35	1.81E-5	Insulin resistance/response	
LIHC	cis	1	rs79322080	chr8:36906379	RAB11FIP1	chr8:37716470-37757003:-	0.38	5.32	1.92E-7	Insulin resistance/response	
LIHC	cis	1	rs7933086	chr11:120269308	TMEM136	chr11:120196016-120204388:+	-0.23	-4.16	4.06E-5	Intraocular pressure	
LIHC	cis	1	rs79366248	chr4:266659	ZNF718	chr4:53272-156488:+	0.3	4.85	1.84E-6	Immune response to smallpox vaccine (IL-6)	
LIHC	cis	1	rs7937612	chr11:120278688	TMEM136	chr11:120196016-120204388:+	0.25	4.48	1.0E-5	Intraocular pressure	
LIHC	cis	1	rs7939137	chr11:120343271	TMEM136	chr11:120196016-120204388:+	0.23	4.17	3.88E-5	Intraocular pressure	
LIHC	cis	1	rs79419293	chr2:190625076	ORMDL1	chr2:190634994-190649097:-	0.43	4.04	6.54E-5	Subcutaneous adipose tissue	
LIHC	cis	1	rs7943121	chr11:18656062	SPTY2D1	chr11:18627949-18656020:-	-0.23	-4.73	3.29E-6	Cholesterol, total	
LIHC	cis	1	rs79436302	chr14:35578797	PPP2R3C	chr14:35554679-35591679:-	0.38	5	9.16E-7	Atopic dermatitis	
LIHC	cis	1	rs79475579	chr11:58295900	CNTF	chr11:58390146-58393203:+	0.37	4.64	4.96E-6	Lymphoma	
LIHC	cis	1	rs7947730	chr11:47786184	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.89	3.63E-17	Subjective well-being	
LIHC	cis	1	rs7948928	chr11:120273224	TMEM136	chr11:120196016-120204388:+	-0.25	-4.43	1.24E-5	Intraocular pressure	
LIHC	cis	1	rs7951250	chr11:120309036	TMEM136	chr11:120196016-120204388:+	0.23	4.05	6.25E-5	Intraocular pressure	
LIHC	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	0.6	7.97	2.38E-14	Diastolic blood pressure	
LIHC	cis	1	rs79573650	chr5:109732668	MAN2A1	chr5:109025156-109203429:+	0.25	3.91	0.000112	Cardiac structure and function	
LIHC	cis	1	rs7957635	chr12:1985156	DCP1B	chr12:2050757-2113677:-	0.37	3.84	0.000146	QRS duration in Tripanosoma cruzi seropositivity	
LIHC	cis	1	rs7957635	chr12:1985156	ERC1	chr12:1100404-1605099:+	0.3	4.32	2.04E-5	QRS duration in Tripanosoma cruzi seropositivity	
LIHC	cis	1	rs79702597	chr14:35558856	PPP2R3C	chr14:35554679-35591679:-	0.38	5.1	5.51E-7	Atopic dermatitis	
LIHC	cis	1	rs79738251	chr2:17786558	GEN1	chr2:17935162-17966632:+	0.45	5.01	8.91E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs79770253	chr2:17784158	GEN1	chr2:17935162-17966632:+	0.47	5.01	8.71E-7	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs7980687	chr12:123822711	ABCB9	chr12:123413540-123459752:-	0.48	4.93	1.26E-6	Educational attainment;Height;Head circumference (infant)	
LIHC	cis	1	rs7980687	chr12:123822711	CDK2AP1	chr12:123745542-123756687:-	-0.49	-5.65	3.39E-8	Educational attainment;Height;Head circumference (infant)	
LIHC	cis	1	rs7980828	chr12:114578279	IQCD	chr12:113633248-113658880:-	0.31	3.88	0.000126	Visceral fat	
LIHC	cis	1	rs79868973	chr6:26189312	HIST1H2AE	chr6:26217148-26217711:+	-0.4	-4.3	2.23E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs798719	chr4:1698183	FAM53A	chr4:1641609-1685854:-	-0.38	-4.9	1.49E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs798724	chr4:1704643	FAM53A	chr4:1641609-1685854:-	-0.36	-4.71	3.65E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs798741	chr4:1712413	FAM53A	chr4:1641609-1685854:-	-0.35	-4.57	6.75E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs798744	chr4:1714684	FAM53A	chr4:1641609-1685854:-	-0.38	-4.81	2.31E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs798754	chr4:1720757	FAM53A	chr4:1641609-1685854:-	-0.37	-4.9	1.5E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs798755	chr4:1720824	FAM53A	chr4:1641609-1685854:-	-0.37	-4.83	2.07E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs798756	chr4:1707447	FAM53A	chr4:1641609-1685854:-	-0.38	-4.9	1.47E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs798762	chr4:1731150	FAM53A	chr4:1641609-1685854:-	-0.38	-5	9.36E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs798766	chr4:1734239	FAM53A	chr4:1641609-1685854:-	0.37	4.85	1.87E-6	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs798767	chr4:1734281	FAM53A	chr4:1641609-1685854:-	-0.4	-5.15	4.47E-7	Urinary bladder cancer;Bladder cancer	
LIHC	cis	1	rs7988805	chr13:51404900	FAM124A	chr13:51796507-51855616:+	-0.2	-3.82	0.000159	Primary tooth development (number of teeth)	
LIHC	cis	1	rs79888893	chr14:35510676	PPP2R3C	chr14:35554679-35591679:-	0.37	4.96	1.11E-6	Atopic dermatitis	
LIHC	cis	1	rs79914759	chr8:36954559	PROSC	chr8:37620101-37637285:+	0.32	3.93	0.000103	Insulin resistance/response	
LIHC	cis	1	rs79914759	chr8:36954559	RAB11FIP1	chr8:37716470-37757003:-	0.36	4.9	1.47E-6	Insulin resistance/response	
LIHC	cis	1	rs800153	chr11:2373515	C11orf21	chr11:2317507-2323143:-	-0.19	-3.91	0.000112	Bacteremia	
LIHC	cis	1	rs800156	chr11:2376436	C11orf21	chr11:2317507-2323143:-	-0.18	-3.86	0.000137	Bacteremia	
LIHC	cis	1	rs800157	chr11:2376602	C11orf21	chr11:2317507-2323143:-	-0.18	-3.89	0.000122	Bacteremia	
LIHC	cis	1	rs800158	chr11:2378447	C11orf21	chr11:2317507-2323143:-	0.19	4.12	4.76E-5	Bacteremia	
LIHC	cis	1	rs800160	chr11:2380134	C11orf21	chr11:2317507-2323143:-	0.2	4.19	3.56E-5	Bacteremia	
LIHC	cis	1	rs800292	chr1:196642233	CFHR4	chr1:196857212-196887762:+	-0.23	-5.22	3.05E-7	Circulating myeloperoxidase levels (serum)	
LIHC	cis	1	rs8003061	chr14:81451956	TSHR	chr14:81421869-81612646:+	-0.21	-3.83	0.00015	Graves' disease	
LIHC	cis	1	rs80075680	chr5:150223737	LOC134466	chr5:150310000-150326146:-	0.32	4.15	4.11E-5	Crohn's disease	
LIHC	cis	1	rs80076579	chr4:106991115	TBCK	chr4:106967233-107237861:-	0.23	4.11	4.96E-5	Airflow obstruction	
LIHC	cis	1	rs80079664	chr8:36922351	ERLIN2	chr8:37594097-37615318:+	0.32	3.97	8.88E-5	Insulin resistance/response	
LIHC	cis	1	rs80079664	chr8:36922351	PROSC	chr8:37620101-37637285:+	0.36	4.37	1.68E-5	Insulin resistance/response	
LIHC	cis	1	rs80079664	chr8:36922351	RAB11FIP1	chr8:37716470-37757003:-	0.39	5.32	1.86E-7	Insulin resistance/response	
LIHC	cis	1	rs80095925	chr6:26184942	HIST1H2AE	chr6:26217148-26217711:+	-0.42	-4.51	8.85E-6	Renal underexcretion gout;Gout	
LIHC	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.5	-10.79	1.37E-23	IgG glycosylation	
LIHC	cis	1	rs8013540	chr14:35513760	PPP2R3C	chr14:35554679-35591679:-	0.37	4.96	1.11E-6	Atopic dermatitis	
LIHC	cis	1	rs80161161	chr2:17812016	GEN1	chr2:17935162-17966632:+	0.4	4.19	3.56E-5	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs8018967	chr14:73976934	ACOT1	chr14:74003928-74042357:+	-0.24	-4.54	7.92E-6	Blood metabolite ratios	
LIHC	cis	1	rs8018967	chr14:73976934	HEATR4	chr14:73945193-74025651:-	-0.4	-6.74	6.72E-11	Blood metabolite ratios	
LIHC	cis	1	rs8020496	chr14:24953750	SDR39U1	chr14:24908974-24912064:-	0.46	4.73	3.24E-6	Smooth-surface caries	
LIHC	cis	1	rs8023644	chr15:50937123	USP8	chr15:50716579-50793276:+	-0.22	-4.36	1.71E-5	QT interval	
LIHC	cis	1	rs80259160	chr6:26190199	HIST1H2AE	chr6:26217148-26217711:+	-0.41	-4.47	1.05E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs80260495	chr2:17803101	GEN1	chr2:17935162-17966632:+	0.41	4.44	1.23E-5	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs8028182	chr15:75718669	SNUPN	chr15:75890426-75918719:-	0.4	5.39	1.32E-7	Sudden cardiac arrest	
LIHC	cis	1	rs80313145	chr6:26194965	HIST1H2AE	chr6:26217148-26217711:+	-0.38	-4.07	5.89E-5	Renal underexcretion gout;Gout	
LIHC	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.63	-9.65	1.18E-19	Type 2 diabetes	
LIHC	cis	1	rs80317109	chr5:109891669	TMEM232	chr5:109624934-110062381:-	0.35	3.83	0.000154	Cardiac structure and function	
LIHC	cis	1	rs8033938	chr15:40703114	C15orf23	chr15:40674922-40686488:+	0.58	6.15	2.09E-9	Heschl's gyrus morphology	
LIHC	cis	1	rs8035452	chr15:51040798	USP8	chr15:50716579-50793276:+	-0.21	-4.13	4.55E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs8035635	chr15:51010829	USP8	chr15:50716579-50793276:+	0.2	4.05	6.37E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs8036588	chr15:50956834	USP8	chr15:50716579-50793276:+	-0.22	-4.33	1.94E-5	QT interval	
LIHC	cis	1	rs803688	chr15:83216793	GOLGA6L9	chr15:82711895-82731584:+;chr15	-0.2	-4.01	7.43E-5	Schizophrenia	
LIHC	cis	1	rs8047014	chr16:69135049	TMED6	chr16:69377160-69385689:-	-0.27	-4.16	3.98E-5	Attention deficit hyperactivity disorder	
LIHC	cis	1	rs8051653	chr16:67848515	DPEP2	chr16:68021295-68034489:-	0.41	3.99	8.07E-5	Crohn's disease	
LIHC	cis	1	rs8058835	chr16:67814865	DPEP2	chr16:68021295-68034489:-	0.42	4.08	5.57E-5	Crohn's disease	
LIHC	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.28	5.43	1.05E-7	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs8065437	chr17:45721653	KPNB1	chr17:45727275-45761004:+	-0.17	-3.81	0.000163	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs8065669	chr17:45724996	C17orf57	chr17:45401142-45518675:+	0.28	5.33	1.75E-7	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs8070446	chr17:40285879	HSPB9	chr17:40274756-40275371:+	0.28	4.17	3.84E-5	Fibrinogen levels	
LIHC	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.61	-12.05	3.99E-28	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs8071789	chr17:38006333	GSDMA	chr17:38119226-38134019:+	0.24	4.28	2.46E-5	Selective IgA deficiency	
LIHC	cis	1	rs8072100	chr17:45674687	C17orf57	chr17:45401142-45518675:+	-0.3	-5.81	1.43E-8	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
LIHC	cis	1	rs8074708	chr17:40286354	HSPB9	chr17:40274756-40275371:+	-0.27	-4.16	4.06E-5	Fibrinogen levels	
LIHC	cis	1	rs8076336	chr17:18212614	SHMT1	chr17:18231195-18266856:-	-0.26	-5.23	2.91E-7	Parental longevity (combined parental age at death)	
LIHC	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.26	-3.96	9.11E-5	Metabolite levels	
LIHC	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.6	-11.83	2.52E-27	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
LIHC	cis	1	rs8081537	chr17:77708264	ENPP7	chr17:77704882-77716020:+	0.25	3.93	0.000102	Diastolic blood pressure response to hydrochlorothiazide in hypertension	
LIHC	cis	1	rs8105994	chr19:18593553	ISYNA1	chr19:18545625-18548943:-	0.18	4.33	1.96E-5	Breast cancer	
LIHC	cis	1	rs8109573	chr19:18617151	ISYNA1	chr19:18545625-18548943:-	0.18	4.07	5.73E-5	Breast cancer	
LIHC	cis	1	rs8133949	chr21:43421114	C21orf121	chr21:43442113-43445060:+	0.31	3.95	9.4E-5	Hand grip strength	
LIHC	cis	1	rs8137478	chr22:51017296	CPT1B	chr22:51007291-51017096:-	-0.31	-4.18	3.76E-5	Narcolepsy	
LIHC	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.39	5.96	6.18E-9	Multiple sclerosis	
LIHC	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.4	-6.77	5.73E-11	Multiple sclerosis	
LIHC	cis	1	rs8181644	chr12:58173466	XRCC6BP1	chr12:58335445-58351051:+	-0.27	-4.85	1.89E-6	Multiple sclerosis	
LIHC	cis	1	rs823144	chr1:205744546	RAB7L1	chr1:205737115-205744610:-	0.26	4.37	1.64E-5	Parkinson's disease	
LIHC	cis	1	rs830407	chr9:33217266	APTX	chr9:32972609-33025110:-	0.31	3.86	0.000134	Bipolar disorder and schizophrenia	
LIHC	cis	1	rs830407	chr9:33217266	NOL6	chr9:33461352-33473941:-	0.4	4.54	7.62E-6	Bipolar disorder and schizophrenia	
LIHC	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.67	11.92	1.2E-27	Type 2 diabetes	
LIHC	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.7	12.83	4.74E-31	Type 2 diabetes	
LIHC	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.68	12.49	9.02E-30	Type 2 diabetes	
LIHC	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.69	12.52	6.77E-30	Type 2 diabetes	
LIHC	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.69	12.51	7.43E-30	Type 2 diabetes	
LIHC	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.69	12.51	7.43E-30	Type 2 diabetes	
LIHC	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.69	12.42	1.68E-29	Type 2 diabetes	
LIHC	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.67	12.1	2.6E-28	Type 2 diabetes	
LIHC	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.67	12.1	2.6E-28	Type 2 diabetes	
LIHC	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.66	-12.08	3.11E-28	Type 2 diabetes	
LIHC	cis	1	rs854572	chr7:94954696	PON1	chr7:94927671-95025687:-	0.3	6.55	2.09E-10	Paraoxonase activity	
LIHC	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.34	-7.24	2.92E-12	Homocysteine levels	
LIHC	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.69	-12.72	1.2E-30	Type 2 diabetes	
LIHC	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.67	12.1	2.6E-28	Type 2 diabetes	
LIHC	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.68	12.31	4.36E-29	Type 2 diabetes	
LIHC	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.67	12.1	2.6E-28	Type 2 diabetes	
LIHC	cis	1	rs871546	chr21:43413553	C21orf121	chr21:43442113-43445060:+	0.3	4.05	6.26E-5	Hand grip strength	
LIHC	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.36	8.84	5.18E-17	Kawasaki disease	
LIHC	cis	1	rs874610	chr9:100782695	C9orf156	chr9:100666772-100684852:-	0.31	3.83	0.00015	Coronary heart disease	
LIHC	cis	1	rs8758	chr10:97366107	ALDH18A1	chr10:97365687-97416567:-	0.28	4.16	4.05E-5	Blood metabolite levels	
LIHC	cis	1	rs8758	chr10:97366107	ENTPD1	chr10:97471536-97637022:+	0.22	4.43	1.26E-5	Blood metabolite levels	
LIHC	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.5	-7.8	7.43E-14	Cognitive function	
LIHC	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.26	-4	7.65E-5	Rheumatoid arthritis	
LIHC	cis	1	rs881827	chr21:48019868	C21orf57	chr21:47706267-47717664:+	-0.29	-4.94	1.21E-6	Lymphocyte counts	
LIHC	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.3	-5.35	1.58E-7	Homocysteine levels	
LIHC	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.51	-9.07	9.58E-18	Response to antipsychotic treatment	
LIHC	cis	1	rs889312	chr5:56031884	C5orf35	chr5:56205103-56213010:+	0.25	4.1	5.2E-5	Breast cancer (early onset);Breast cancer	
LIHC	cis	1	rs891368	chr3:53123273	RFT1	chr3:53122503-53164470:-	-0.37	-6	5.12E-9	Height	
LIHC	cis	1	rs892864	chr5:127835859	FBN2	chr5:127593602-127873916:-	0.77	6.5	2.91E-10	Multiple system atrophy	
LIHC	cis	1	rs894839	chr11:120337705	TMEM136	chr11:120196016-120204388:+	0.24	4.33	1.96E-5	Intraocular pressure	
LIHC	cis	1	rs906134	chr7:65444288	CCT6P1	chr7:65216092-65228661:+	0.35	4.8	2.39E-6	Diabetic kidney disease	
LIHC	cis	1	rs906134	chr7:65444288	INTS4L1	chr7:64601603-64694599:+	0.33	3.87	0.000131	Diabetic kidney disease	
LIHC	cis	1	rs913246	chr13:40948151	COG6	chr13:40229764-40365802:+	0.31	4.66	4.57E-6	Bipolar disorder and schizophrenia	
LIHC	cis	1	rs913246	chr13:40948151	ELF1	chr13:41506056-41593508:-	0.22	4.33	1.92E-5	Bipolar disorder and schizophrenia	
LIHC	cis	1	rs913246	chr13:40948151	FOXO1	chr13:41048131-41240734:-	0.28	4.13	4.52E-5	Bipolar disorder and schizophrenia	
LIHC	cis	1	rs913246	chr13:40948151	MRPS31	chr13:41303433-41345347:-	0.32	4.54	7.84E-6	Bipolar disorder and schizophrenia	
LIHC	cis	1	rs913246	chr13:40948151	NAA16	chr13:41885341-41951166:+	0.28	4.22	3.07E-5	Bipolar disorder and schizophrenia	
LIHC	cis	1	rs913246	chr13:40948151	WBP4	chr13:41635697-41658137:+	0.38	4.58	6.45E-6	Bipolar disorder and schizophrenia	
LIHC	cis	1	rs914187	chr21:42619749	BACE2	chr21:42539728-42648523:+	-0.29	-5.96	6.22E-9	Body mass index	
LIHC	cis	1	rs916134	chr12:54069803	ATP5G2	chr12:54058945-54070512:-	0.18	4.51	8.81E-6	Height	
LIHC	cis	1	rs917117	chr7:28176305	JAZF1	chr7:27870196-28220437:-	-0.36	-4.71	3.6E-6	Rheumatoid arthritis	
LIHC	cis	1	rs919586	chr8:13174671	DLC1	chr8:12940872-13372429:-	0.28	4.07	5.79E-5	Obesity-related traits	
LIHC	cis	1	rs919586	chr8:13174671	LONRF1	chr8:12579406-12612992:-	0.35	4.39	1.53E-5	Obesity-related traits	
LIHC	cis	1	rs925410	chr2:160912652	LY75	chr2:160625141-160761262:-	-0.25	-5.44	9.96E-8	Idiopathic membranous nephropathy	
LIHC	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.69	12.53	6.2E-30	Type 2 diabetes	
LIHC	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.62	6.71	7.82E-11	Blood pressure (smoking interaction)	
LIHC	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.63	9.22	3.03E-18	Height	
LIHC	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.63	9.17	4.45E-18	Height	
LIHC	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.63	9.17	4.45E-18	Height	
LIHC	cis	1	rs929039	chr22:38071511	LGALS1	chr22:38071613-38075807:+	-0.2	-3.91	0.00011	Fat distribution (HIV)	
LIHC	cis	1	rs929596	chr2:234674476	UGT1A1	chr2:234668919-234681945:+	-0.27	-5.12	5.07E-7	Total bilirubin levels in HIV-1 infection	
LIHC	cis	1	rs9296404	chr6:42925803	CRIP3	chr6:43273211-43276530:-	0.31	4.54	7.75E-6	Plasma homocysteine levels (post-methionine load test)	
LIHC	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.6	10.7	2.87E-23	Plasma homocysteine levels (post-methionine load test)	
LIHC	cis	1	rs9296616	chr6:49414235	CENPQ	chr6:49431096-49460820:+	-0.21	-4.12	4.72E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9296617	chr6:49428360	CENPQ	chr6:49431096-49460820:+	-0.21	-4.29	2.34E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9296736	chr6:53924697	C6orf142	chr6:53883714-54131074:+	0.28	4.58	6.6E-6	Liver enzyme levels (gamma-glutamyl transferase)	
LIHC	cis	1	rs9296832	chr6:56100909	COL21A1	chr6:55921389-56258892:-	0.57	10.05	5.27E-21	Pulse pressure	
LIHC	cis	1	rs9297951	chr8:96041437	C8orf38	chr8:95908040-96088396:+	-0.27	-3.87	0.000131	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	
LIHC	cis	1	rs929843	chr16:70045748	CLEC18A	chr16:69984626-69997887:+	-0.55	-5.42	1.12E-7	Menarche (age at onset)	
LIHC	cis	1	rs9303280	chr17:38074031	GSDMA	chr17:38119226-38134019:+	-0.25	-4.34	1.86E-5	Self-reported allergy	
LIHC	cis	1	rs9303280	chr17:38074031	PGAP3	chr17:37827376-37844310:-	0.22	3.93	0.000105	Self-reported allergy	
LIHC	cis	1	rs9304742	chr19:53451291	ZNF321	chr19:53430388-53466114:-	0.25	4.8	2.41E-6	Psoriasis	
LIHC	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.36	4.74	3.18E-6	Crohn's disease	
LIHC	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	0.59	7.94	2.89E-14	Diastolic blood pressure	
LIHC	cis	1	rs9316278	chr13:47841469	ESD	chr13:47345392-47371367:-	0.41	4.22	3.09E-5	Cannabis use (initiation)	
LIHC	cis	1	rs9316278	chr13:47841469	SUCLA2	chr13:48516792-48612125:-	0.39	4.63	5.29E-6	Cannabis use (initiation)	
LIHC	cis	1	rs931794	chr15:78826180	CHRNA5	chr15:78857906-78886458:+	0.27	4.18	3.67E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
LIHC	cis	1	rs931812	chr8:101919321	RNF19A	chr8:101269288-101322327:-	0.22	3.93	0.000104	Attention deficit hyperactivity disorder and conduct disorder	
LIHC	cis	1	rs9323503	chr14:24935595	SDR39U1	chr14:24908974-24912064:-	-0.5	-5.13	4.95E-7	Smooth-surface caries	
LIHC	cis	1	rs9324660	chr5:150257054	LOC134466	chr5:150310000-150326146:-	0.32	4.22	3.16E-5	Crohn's disease	
LIHC	cis	1	rs9333029	chr1:47396162	CYP4A22	chr1:47603107-47614526:+	0.21	3.81	0.000163	Blood metabolite levels	
LIHC	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.65	9.26	2.32E-18	Height	
LIHC	cis	1	rs934624	chr15:50968906	USP8	chr15:50716579-50793276:+	-0.21	-4.16	4.05E-5	QT interval	
LIHC	cis	1	rs934625	chr15:50968756	USP8	chr15:50716579-50793276:+	-0.22	-4.4	1.46E-5	QT interval	
LIHC	cis	1	rs9349804	chr6:56098876	COL21A1	chr6:55921389-56258892:-	0.58	10.5	1.42E-22	Pulse pressure	
LIHC	cis	1	rs9356009	chr6:158219013	SNX9	chr6:158244294-158366109:+	-0.38	-3.97	8.73E-5	Lipoprotein (a) - cholesterol levels	
LIHC	cis	1	rs9357619	chr6:49490094	CENPQ	chr6:49431096-49460820:+	0.22	4.73	3.32E-6	Brain structure	
LIHC	cis	1	rs9365179	chr6:161024848	LPA	chr6:160952516-161087407:-	-0.18	-3.83	0.000154	Lipoprotein (a) levels	
LIHC	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.33	-7.16	4.87E-12	Homocysteine levels	
LIHC	cis	1	rs937108	chr7:65428452	CCT6P1	chr7:65216092-65228661:+	0.34	4.64	4.87E-6	Diabetic kidney disease	
LIHC	cis	1	rs937108	chr7:65428452	INTS4L1	chr7:64601603-64694599:+	0.33	3.93	0.000104	Diabetic kidney disease	
LIHC	cis	1	rs9372211	chr6:109609648	CD164	chr6:109687718-109703762:-	-0.25	-4.91	1.38E-6	Red blood cell traits	
LIHC	cis	1	rs9374079	chr6:109609619	CD164	chr6:109687718-109703762:-	-0.26	-5.01	8.79E-7	Red blood cell traits	
LIHC	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.31	6.48	3.1E-10	Homocysteine levels	
LIHC	cis	1	rs9386789	chr6:109603218	CD164	chr6:109687718-109703762:-	-0.23	-4.51	8.94E-6	Red blood cell traits	
LIHC	cis	1	rs9386790	chr6:109608460	CD164	chr6:109687718-109703762:-	0.27	5.28	2.25E-7	Red blood cell traits	
LIHC	cis	1	rs9386791	chr6:109608497	CD164	chr6:109687718-109703762:-	-0.26	-5.05	7.2E-7	Red blood cell traits	
LIHC	cis	1	rs9386793	chr6:109610002	CD164	chr6:109687718-109703762:-	-0.25	-4.9	1.49E-6	Red blood cell traits	
LIHC	cis	1	rs9386794	chr6:109611521	CD164	chr6:109687718-109703762:-	-0.27	-5.28	2.33E-7	Red blood cell traits	
LIHC	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.32	-5.4	1.22E-7	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
LIHC	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.38	-8.6	2.92E-16	Homocysteine levels	
LIHC	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.6	-8.2	4.71E-15	Diastolic blood pressure	
LIHC	cis	1	rs9398197	chr6:109609988	CD164	chr6:109687718-109703762:-	-0.26	-5.05	7.05E-7	Red blood cell traits	
LIHC	cis	1	rs9400269	chr6:109606065	CD164	chr6:109687718-109703762:-	-0.23	-4.5	9.27E-6	Red blood cell traits	
LIHC	cis	1	rs9400271	chr6:109607556	CD164	chr6:109687718-109703762:-	-0.26	-5.05	7.2E-7	Red blood cell traits	
LIHC	cis	1	rs9403521	chr6:143994199	PEX3	chr6:143771918-143811749:+	0.24	4.1	5.1E-5	Obesity-related traits	
LIHC	cis	1	rs942812	chr10:100153664	C10orf62	chr10:99349484-99350690:+	0.41	3.82	0.000161	Aspartate aminotransferase	
LIHC	cis	1	rs945635	chr1:157670290	FCRL3	chr1:157646278-157670775:-	0.26	6.03	4.21E-9	Type 1 diabetes autoantibodies	
LIHC	cis	1	rs9463473	chr6:49380121	CENPQ	chr6:49431096-49460820:+	-0.21	-4.23	3.06E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9463474	chr6:49380199	CENPQ	chr6:49431096-49460820:+	-0.21	-4.23	3.06E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9463475	chr6:49380899	CENPQ	chr6:49431096-49460820:+	0.21	4.14	4.45E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9463477	chr6:49386446	CENPQ	chr6:49431096-49460820:+	-0.21	-4.19	3.57E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.33	-7.15	5.36E-12	Homocysteine levels	
LIHC	cis	1	rs9463479	chr6:49393275	CENPQ	chr6:49431096-49460820:+	-0.22	-4.3	2.26E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9463480	chr6:49400795	CENPQ	chr6:49431096-49460820:+	-0.22	-4.37	1.61E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs947211	chr1:205752665	RAB7L1	chr1:205737115-205744610:-	0.27	4.51	8.88E-6	Parkinson's disease	
LIHC	cis	1	rs9473549	chr6:49380020	CENPQ	chr6:49431096-49460820:+	-0.21	-4.09	5.32E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.32	-6.95	1.89E-11	Homocysteine levels	
LIHC	cis	1	rs9473552	chr6:49387154	CENPQ	chr6:49431096-49460820:+	-0.22	-4.3	2.26E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9473553	chr6:49395977	CENPQ	chr6:49431096-49460820:+	-0.22	-4.3	2.26E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9473555	chr6:49409487	CENPQ	chr6:49431096-49460820:+	-0.21	-4.26	2.67E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9473560	chr6:49427918	CENPQ	chr6:49431096-49460820:+	-0.21	-4.29	2.34E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9473561	chr6:49428755	CENPQ	chr6:49431096-49460820:+	-0.21	-4.28	2.42E-5	Folate pathway vitamin levels	
LIHC	cis	1	rs9473563	chr6:49453651	CENPQ	chr6:49431096-49460820:+	-0.19	-3.83	0.00015	Folate pathway vitamin levels	
LIHC	cis	1	rs9473582	chr6:49488908	CENPQ	chr6:49431096-49460820:+	0.22	4.66	4.47E-6	Brain structure	
LIHC	cis	1	rs9480922	chr6:109607211	CD164	chr6:109687718-109703762:-	-0.26	-5.12	5.2E-7	Red blood cell traits	
LIHC	cis	1	rs9480923	chr6:109607369	CD164	chr6:109687718-109703762:-	-0.26	-5.14	4.52E-7	Red blood cell traits	
LIHC	cis	1	rs9481821	chr6:118846022	C6orf204	chr6:118786239-119031238:-	-0.28	-4.18	3.69E-5	Renal cell carcinoma	
LIHC	cis	1	rs948562	chr11:58347765	CNTF	chr11:58390146-58393203:+	0.34	4.35	1.8E-5	Lymphoma	
LIHC	cis	1	rs9487032	chr6:109605323	CD164	chr6:109687718-109703762:-	-0.25	-4.96	1.11E-6	Red blood cell traits	
LIHC	cis	1	rs9487033	chr6:109605388	CD164	chr6:109687718-109703762:-	0.24	4.83	2.05E-6	Red blood cell traits	
LIHC	cis	1	rs9487034	chr6:109605899	CD164	chr6:109687718-109703762:-	-0.23	-4.68	4.18E-6	Red blood cell traits	
LIHC	cis	1	rs9487038	chr6:109610152	CD164	chr6:109687718-109703762:-	-0.25	-4.91	1.38E-6	Red blood cell traits	
LIHC	cis	1	rs9487042	chr6:109610443	CD164	chr6:109687718-109703762:-	-0.26	-5.06	6.72E-7	Red blood cell traits	
LIHC	cis	1	rs9487043	chr6:109610474	CD164	chr6:109687718-109703762:-	-0.25	-4.93	1.28E-6	Red blood cell traits	
LIHC	cis	1	rs9487605	chr6:111582885	KIAA1919	chr6:111580482-111590259:+	-0.32	-5.39	1.34E-7	Inflammatory skin disease	
LIHC	cis	1	rs9489407	chr6:118792337	C6orf204	chr6:118786239-119031238:-	0.31	5.21	3.31E-7	Renal cell carcinoma	
LIHC	cis	1	rs9489409	chr6:118802721	C6orf204	chr6:118786239-119031238:-	-0.3	-4.4	1.44E-5	Renal cell carcinoma	
LIHC	cis	1	rs9489428	chr6:118852935	C6orf204	chr6:118786239-119031238:-	-0.28	-4.17	3.81E-5	Renal cell carcinoma	
LIHC	cis	1	rs9489433	chr6:118867006	C6orf204	chr6:118786239-119031238:-	-0.28	-4.36	1.69E-5	Renal cell carcinoma	
LIHC	cis	1	rs9489436	chr6:118873817	C6orf204	chr6:118786239-119031238:-	-0.28	-4.36	1.69E-5	Renal cell carcinoma	
LIHC	cis	1	rs9500256	chr6:58308955	GUSBL2	chr6:58246159-58287724:-	-0.23	-3.83	0.000154	Eosinophilic esophagitis (pediatric)	
LIHC	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.34	-4.77	2.68E-6	Schizophrenia	
LIHC	cis	1	rs950169	chr15:84706461	NMB	chr15:85198362-85201802:-	-0.36	-4.95	1.19E-6	Schizophrenia	
LIHC	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.57	10.49	1.61E-22	Response to antipsychotic treatment	
LIHC	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.56	-9.9	1.66E-20	Response to antipsychotic treatment	
LIHC	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.58	-10.09	3.94E-21	Response to antipsychotic treatment	
LIHC	cis	1	rs9624834	chr22:25846015	CRYBB2	chr22:25615612-25627836:+	0.82	8.98	1.86E-17	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs9624835	chr22:25846021	CRYBB2	chr22:25615612-25627836:+	0.82	8.98	1.86E-17	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs9624836	chr22:25846087	CRYBB2	chr22:25615612-25627836:+	0.82	8.98	1.86E-17	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs9633950	chr11:120248249	TMEM136	chr11:120196016-120204388:+	0.25	4.27	2.56E-5	Intraocular pressure	
LIHC	cis	1	rs9642699	chr8:32414614	NRG1	chr8:31497268-32622558:+	0.29	3.95	9.64E-5	Thyroid hormone levels	
LIHC	cis	1	rs9642728	chr8:32430690	NRG1	chr8:31497268-32622558:+	0.29	3.99	8.0E-5	Thyroid hormone levels	
LIHC	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.63	-14	1.48E-35	Response to antipsychotic treatment	
LIHC	cis	1	rs9649891	chr8:36943655	PROSC	chr8:37620101-37637285:+	0.36	4.55	7.4E-6	Insulin resistance/response	
LIHC	cis	1	rs9649891	chr8:36943655	RAB11FIP1	chr8:37716470-37757003:-	0.38	5.3	2.1E-7	Insulin resistance/response	
LIHC	cis	1	rs9669295	chr12:123842670	ABCB9	chr12:123413540-123459752:-	-0.32	-4.12	4.75E-5	HDL cholesterol	
LIHC	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.49	7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.43	7.85	5.44E-14	Erythrocyte sedimentation rate	
LIHC	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.49	7.87	4.82E-14	Eye color traits	
LIHC	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.49	7.74	1.1E-13	Eye color traits	
LIHC	cis	1	rs9769882	chr7:65642925	CCT6P1	chr7:65216092-65228661:+	-0.28	-3.84	0.000145	Diabetic kidney disease	
LIHC	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.46	5.96	6.37E-9	Forced vital capacity	
LIHC	cis	1	rs9788721	chr15:78802869	CHRNA5	chr15:78857906-78886458:+	0.27	4.15	4.22E-5	Post bronchodilator FEV1;Emphysema imaging phenotypes;Local histogram emphysema pattern;Emphysema distribution in smoking;Post bronchodilator FEV1/FVC ratio in COPD;Post bronchodilator FEV1/FVC ratio	
LIHC	cis	1	rs9789748	chr2:17801397	GEN1	chr2:17935162-17966632:+	0.43	4.69	3.91E-6	Psychosis and Alzheimer's disease	
LIHC	cis	1	rs9795476	chr11:235894	PSMD13	chr11:236808-252984:+	-0.23	-4.1	5.06E-5	Menarche (age at onset)	
LIHC	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.65	9.44	6.03E-19	Height	
LIHC	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.66	9.51	3.47E-19	Height	
LIHC	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.64	-9.1	7.62E-18	Height	
LIHC	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.58	7.49	6.04E-13	Diastolic blood pressure	
LIHC	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.11E-14	Diastolic blood pressure	
LIHC	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.65	9.44	6.03E-19	Height	
LIHC	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs9822268	chr3:49719729	CYB561D2	chr3:50388289-50391494:+	0.3	4.06	6.12E-5	Crohn's disease;Ulcerative colitis	
LIHC	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.58	7.47	6.47E-13	Diastolic blood pressure	
LIHC	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.58	7.47	6.47E-13	Diastolic blood pressure	
LIHC	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.59	-7.87	4.78E-14	Diastolic blood pressure	
LIHC	cis	1	rs9826058	chr3:41762062	ULK4	chr3:41288091-42003660:-	0.6	8.05	1.33E-14	Diastolic blood pressure	
LIHC	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.65	9.44	5.81E-19	Height	
LIHC	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.67	9.55	2.49E-19	Height	
LIHC	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.66	9.3	1.64E-18	Height	
LIHC	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.59	7.9	3.71E-14	Diastolic blood pressure	
LIHC	cis	1	rs9830469	chr3:41762535	ULK4	chr3:41288091-42003660:-	0.59	7.95	2.76E-14	Diastolic blood pressure	
LIHC	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.67	9.57	2.11E-19	Height	
LIHC	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	0.58	7.97	2.36E-14	Diastolic blood pressure	
LIHC	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.66	9.46	5.03E-19	Height	
LIHC	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs9836291	chr3:49697459	CYB561D2	chr3:50388289-50391494:+	0.29	3.94	9.93E-5	Crohn's disease;Ulcerative colitis	
LIHC	cis	1	rs9837038	chr3:156568469	LEKR1	chr3:156544076-156763918:+	-0.26	-3.81	0.000163	Multiple sclerosis (severity)	
LIHC	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-0.61	-8.18	5.64E-15	Diastolic blood pressure	
LIHC	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-0.61	-8.18	5.64E-15	Diastolic blood pressure	
LIHC	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	0.57	7.84	5.86E-14	Diastolic blood pressure	
LIHC	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.58	7.84	5.72E-14	Diastolic blood pressure	
LIHC	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.52	7.9	3.86E-14	Height	
LIHC	cis	1	rs9841212	chr3:134191938	CEP63	chr3:134204575-134293852:+	0.28	4.47	1.08E-5	Height	
LIHC	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.36	-6	4.94E-9	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
LIHC	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.56	-7.6	2.82E-13	Diastolic blood pressure	
LIHC	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-0.59	-8.01	1.79E-14	Diastolic blood pressure	
LIHC	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.58	7.47	6.47E-13	Diastolic blood pressure	
LIHC	cis	1	rs9847006	chr3:41755359	ULK4	chr3:41288091-42003660:-	0.63	8.32	2.14E-15	Diastolic blood pressure	
LIHC	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.58	7.58	3.29E-13	Diastolic blood pressure	
LIHC	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.61	7.89	4.12E-14	Diastolic blood pressure	
LIHC	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.67	9.55	2.49E-19	Height	
LIHC	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.64	8.97	1.99E-17	Height	
LIHC	cis	1	rs9852303	chr3:41759525	ULK4	chr3:41288091-42003660:-	0.6	8.05	1.33E-14	Diastolic blood pressure	
LIHC	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.65	9.4	7.97E-19	Height	
LIHC	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.59	7.6	2.85E-13	Diastolic blood pressure	
LIHC	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	0.59	7.94	2.89E-14	Diastolic blood pressure	
LIHC	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.11E-14	Diastolic blood pressure	
LIHC	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.59	7.99	2.11E-14	Diastolic blood pressure	
LIHC	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.6	8.27	2.91E-15	Diastolic blood pressure	
LIHC	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.64	8.97	1.91E-17	Height	
LIHC	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.57	7.88	4.29E-14	Diastolic blood pressure	
LIHC	cis	1	rs9858213	chr3:49731861	CYB561D2	chr3:50388289-50391494:+	0.3	4.05	6.45E-5	Educational attainment	
LIHC	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs9863915	chr3:41762002	ULK4	chr3:41288091-42003660:-	0.6	8.05	1.33E-14	Diastolic blood pressure	
LIHC	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.6	7.75	1.06E-13	Diastolic blood pressure	
LIHC	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.65	9.25	2.44E-18	Height	
LIHC	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.63	8.95	2.29E-17	Height	
LIHC	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	0.58	7.84	5.62E-14	Diastolic blood pressure	
LIHC	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	0.58	7.82	6.74E-14	Diastolic blood pressure	
LIHC	cis	1	rs9866759	chr3:41758418	ULK4	chr3:41288091-42003660:-	0.63	8.32	2.14E-15	Diastolic blood pressure	
LIHC	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.56	-7.34	1.56E-12	Diastolic blood pressure	
LIHC	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.58	7.83	6.25E-14	Diastolic blood pressure	
LIHC	cis	1	rs9869282	chr3:41756064	ULK4	chr3:41288091-42003660:-	0.63	8.32	2.14E-15	Diastolic blood pressure	
LIHC	cis	1	rs9869440	chr3:41763155	ULK4	chr3:41288091-42003660:-	0.59	7.95	2.76E-14	Diastolic blood pressure	
LIHC	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.66	9.31	1.53E-18	Height	
LIHC	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.57	7.5	5.57E-13	Diastolic blood pressure	
LIHC	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.58	7.49	6.04E-13	Diastolic blood pressure	
LIHC	cis	1	rs9874517	chr3:53128371	RFT1	chr3:53122503-53164470:-	0.49	4.67	4.36E-6	Immune reponse to smallpox (secreted IL-2)	
LIHC	cis	1	rs9874975	chr3:41764300	ULK4	chr3:41288091-42003660:-	0.59	7.89	4.0E-14	Diastolic blood pressure	
LIHC	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.58	7.51	5.29E-13	Diastolic blood pressure	
LIHC	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.57	7.83	6.25E-14	Diastolic blood pressure	
LIHC	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.52	-7.8	7.47E-14	Height	
LIHC	cis	1	rs9876658	chr3:134179453	CEP63	chr3:134204575-134293852:+	-0.26	-4.06	6.09E-5	Height	
LIHC	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-0.58	-7.96	2.57E-14	Diastolic blood pressure	
LIHC	cis	1	rs9882329	chr3:41767154	ULK4	chr3:41288091-42003660:-	0.59	7.89	4.0E-14	Diastolic blood pressure	
LIHC	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.63	9.17	4.45E-18	Height	
LIHC	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.65	9.5	3.83E-19	Height	
LIHC	cis	1	rs9889618	chr17:40293467	HSPB9	chr17:40274756-40275371:+	0.28	4.28	2.43E-5	Fibrinogen levels	
LIHC	cis	1	rs9889640	chr17:40293497	HSPB9	chr17:40274756-40275371:+	0.28	4.28	2.43E-5	Fibrinogen levels	
LIHC	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.49	7.86	4.99E-14	Eye color traits	
LIHC	cis	1	rs9896285	chr17:17535847	ATPAF2	chr17:17918373-17942480:-	0.41	4.19	3.48E-5	Obsessive-compulsive symptoms	
LIHC	cis	1	rs9903204	chr17:40288062	HSPB9	chr17:40274756-40275371:+	0.28	4.17	3.84E-5	Fibrinogen levels	
LIHC	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.33	-5.36	1.54E-7	Glycated hemoglobin levels	
LIHC	cis	1	rs9909	chr11:47799775	C1QTNF4	chr11:47611216-47615961:-	-0.56	-8.88	3.69E-17	Subjective well-being	
LIHC	cis	1	rs9912088	chr17:40288278	HSPB9	chr17:40274756-40275371:+	0.28	4.17	3.84E-5	Fibrinogen levels	
LIHC	cis	1	rs9915255	chr17:40284191	HSPB9	chr17:40274756-40275371:+	0.28	4.19	3.5E-5	Fibrinogen levels	
LIHC	cis	1	rs9920753	chr15:51011078	USP8	chr15:50716579-50793276:+	-0.21	-4.15	4.14E-5	Alzheimer's disease (late onset)	
LIHC	cis	1	rs9928374	chr16:67811930	ATP6V0D1	chr16:67471917-67515089:-	0.48	4.33	1.92E-5	Crohn's disease	
LIHC	cis	1	rs9928374	chr16:67811930	DDX28	chr16:68055174-68057959:-	0.46	3.89	0.000119	Crohn's disease	
LIHC	cis	1	rs9928374	chr16:67811930	DUS2L	chr16:68057204-68113183:+	0.43	3.89	0.000121	Crohn's disease	
LIHC	cis	1	rs9928374	chr16:67811930	EDC4	chr16:67906999-67920270:+	0.63	5.06	6.88E-7	Crohn's disease	
LIHC	cis	1	rs9928374	chr16:67811930	RANBP10	chr16:67757006-67840555:-	0.44	4.25	2.81E-5	Crohn's disease	
LIHC	cis	1	rs9928374	chr16:67811930	SLC7A6	chr16:68298423-68335722:+	0.44	3.9	0.000115	Crohn's disease	
LIHC	cis	1	rs9928374	chr16:67811930	TMEM208	chr16:67261016-67263182:+	0.38	3.9	0.000115	Crohn's disease	
LIHC	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.66	-9.38	8.95E-19	Height	
LIHC	cis	1	rs997153	chr2:66771047	MEIS1	chr2:66662532-66799890:+	0.29	4.09	5.31E-5	PR interval	
LIHC	cis	1	rs997872	chr22:25878614	CRYBB2	chr22:25615612-25627836:+	0.86	9.69	8.61E-20	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs997873	chr22:25878282	CRYBB2	chr22:25615612-25627836:+	0.86	9.69	8.61E-20	Bipolar disorder with mood-incongruent psychosis	
LIHC	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.6	-8.8	6.83E-17	Height	
LIHC	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.63	9.17	4.45E-18	Height	
LIHC	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.61	-8.76	8.94E-17	Height	
LIHC	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.74	-15.67	3.82E-42	Migraine without aura	
LIHC	trans	1	rs10162376	chr14:81030493	ALKBH1	chr14:78138749-78174356:-	0.72	6	4.91E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	C14orf156	chr14:78174425-78183939:+	0.44	6.06	3.64E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	CINP	chr14:102808956-102829253:-	0.56	5.92	7.74E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	COX16	chr14:70791799-70826444:-	0.67	7.25	2.7E-12	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	DCAF5	chr14:69517638-69619914:-	0.65	6.11	2.76E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	ERH	chr14:69846840-69865021:-	0.66	6.15	2.11E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	FCF1	chr14:75179850-75203497:+	0.69	6.61	1.45E-10	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	KIAA0317	chr14:75127957-75179807:-	0.65	6.58	1.77E-10	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	MED6	chr14:71050958-71067384:-	0.71	6.08	3.27E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	MLH3	chr14:75480467-75518235:-	0.69	6.15	2.15E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	NUMB	chr14:73741918-73925286:-	0.63	6.18	1.85E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	PCNX	chr14:71374122-71582099:+	0.54	6.1	2.83E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	SLC39A9	chr14:69865407-69929105:+	0.73	6.52	2.48E-10	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	SNW1	chr14:78183946-78227497:-	0.79	6.9	2.51E-11	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	SYNJ2BP	chr14:70833215-70883807:-	0.58	5.86	1.1E-8	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	TDP1	chr14:90421283-90511106:+	0.59	5.9	8.55E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	TRIP11	chr14:92435462-92506817:-	0.56	6.23	1.36E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	WDR25	chr14:100842755-100996638:+	0.63	6.08	3.21E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	ZFYVE1	chr14:73436160-73493839:-	0.63	5.94	6.99E-9	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10162376	chr14:81030493	ZNF410	chr14:74318674-74398803:+	0.74	6.46	3.5E-10	Mild influenza (H1N1) infection	
LIHC	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.43	7.52	4.83E-13	Educational attainment	
LIHC	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.44	7.63	2.26E-13	Educational attainment	
LIHC	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.39	6.68	9.42E-11	Educational attainment	
LIHC	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.45	7.75	1.04E-13	Educational attainment	
LIHC	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.41	6.95	1.85E-11	Educational attainment	
LIHC	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.41	6.97	1.62E-11	Educational attainment	
LIHC	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.41	6.97	1.62E-11	Educational attainment	
LIHC	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.4	7.01	1.3E-11	Educational attainment	
LIHC	trans	1	rs12787909	chr11:117546482	C11orf57	chr11:111944968-111955872:+	0.7	5.97	5.79E-9	Lipoprotein (a) - cholesterol levels	
LIHC	trans	1	rs12787909	chr11:117546482	CWC15	chr11:94695789-94706776:-	0.67	6.08	3.19E-9	Lipoprotein (a) - cholesterol levels	
LIHC	trans	1	rs12787909	chr11:117546482	TIMM8B	chr11:111955872-111957459:-	0.57	6.52	2.53E-10	Lipoprotein (a) - cholesterol levels	
LIHC	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.38	-6.62	1.41E-10	Educational attainment	
LIHC	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.41	6.99	1.41E-11	Educational attainment	
LIHC	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.41	6.98	1.56E-11	Educational attainment	
LIHC	trans	1	rs13267838	chr8:25196710	BMP1	chr8:22022675-22069837:+	-0.6	-5.9	8.69E-9	Glucose homeostasis traits	
LIHC	trans	1	rs13267838	chr8:25196710	CHMP7	chr8:23101150-23119512:+	-0.77	-6.28	1.05E-9	Glucose homeostasis traits	
LIHC	trans	1	rs13267838	chr8:25196710	FAM160B2	chr8:21946714-21961890:+	-0.74	-6.24	1.27E-9	Glucose homeostasis traits	
LIHC	trans	1	rs13267838	chr8:25196710	XPO7	chr8:21777180-21864095:+	-0.62	-6.38	5.73E-10	Glucose homeostasis traits	
LIHC	trans	1	rs13333884	chr16:83142205	CT45A6	chrX:134963216-134971244:-	-0.35	-6.07	3.34E-9	Maximal oxygen uptake response	
LIHC	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.45	7.75	1.06E-13	Educational attainment	
LIHC	trans	1	rs17036023	chr1:117129711	BCAS2	chr1:115110183-115124265:-	0.61	6.09	3.05E-9	Asthma (childhood onset)	
LIHC	trans	1	rs17036023	chr1:117129711	CSDE1	chr1:115259538-115300671:-	0.61	6.51	2.68E-10	Asthma (childhood onset)	
LIHC	trans	1	rs17665162	chr6:50275258	NRP2	chr2:206547224-206662856:+	-0.4	-5.88	9.87E-9	Body mass index	
LIHC	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.4	6.9	2.53E-11	Educational attainment	
LIHC	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.45	7.75	1.06E-13	Educational attainment	
LIHC	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.45	7.75	1.06E-13	Educational attainment	
LIHC	trans	1	rs2043599	chr19:56451049	AQP9	chr15:58430395-58478110:+	0.43	5.93	7.24E-9	Immune reponse to smallpox (secreted IFN-alpha);Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);Exploratory eye movement dysfunction in schizophrenia (responsive search score)	
LIHC	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.39	6.68	9.42E-11	Educational attainment	
LIHC	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.43	7.58	3.21E-13	Educational attainment	
LIHC	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.39	6.54	2.28E-10	Educational attainment	
LIHC	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.41	6.97	1.62E-11	Educational attainment	
LIHC	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.41	6.97	1.62E-11	Educational attainment	
LIHC	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.39	6.62	1.41E-10	Educational attainment	
LIHC	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.39	6.68	9.42E-11	Educational attainment	
LIHC	trans	1	rs41343448	chr8:20271413	BIN3	chr8:22477949-22526661:-	0.51	6.35	6.7E-10	Preeclampsia	
LIHC	trans	1	rs41343448	chr8:20271413	CHMP7	chr8:23101150-23119512:+	0.58	6.67	1.05E-10	Preeclampsia	
LIHC	trans	1	rs41343448	chr8:20271413	FAM160B2	chr8:21946714-21961890:+	0.51	5.94	6.84E-9	Preeclampsia	
LIHC	trans	1	rs41343448	chr8:20271413	KCTD9	chr8:25285366-25315920:-	0.39	6.21	1.51E-9	Preeclampsia	
LIHC	trans	1	rs41343448	chr8:20271413	REEP4	chr8:21995533-21999448:-	0.42	6.08	3.23E-9	Preeclampsia	
LIHC	trans	1	rs41343448	chr8:20271413	XPO7	chr8:21777180-21864095:+	0.43	6.1	2.87E-9	Preeclampsia	
LIHC	trans	1	rs4270468	chr3:28904376	RGS1	chr1:192544857-192549159:+	-0.25	-5.86	1.11E-8	Alzheimer's disease	
LIHC	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.4	6.87	2.97E-11	Educational attainment	
LIHC	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.41	6.92	2.21E-11	Educational attainment	
LIHC	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.4	6.91	2.43E-11	Educational attainment	
LIHC	trans	1	rs641862	chr13:110790232	ABHD13	chr13:108870763-108886602:+	0.73	6.35	6.9E-10	Obesity-related traits	
LIHC	trans	1	rs641862	chr13:110790232	ARGLU1	chr13:107195664-107220514:-	0.65	6.41	4.78E-10	Obesity-related traits	
LIHC	trans	1	rs641862	chr13:110790232	CDC16	chr13:115000362-115038150:+	0.83	6.07	3.42E-9	Obesity-related traits	
LIHC	trans	1	rs641862	chr13:110790232	CUL4A	chr13:113863086-113919391:+	0.72	6.07	3.46E-9	Obesity-related traits	
LIHC	trans	1	rs641862	chr13:110790232	PCID2	chr13:113831925-113863029:-	0.84	7.06	9.3E-12	Obesity-related traits	
LIHC	trans	1	rs641862	chr13:110790232	TM9SF2	chr13:100153728-100215276:+	0.59	6.14	2.22E-9	Obesity-related traits	
LIHC	trans	1	rs641862	chr13:110790232	UPF3A	chr13:115047078-115071281:+	0.8	6.37	6.18E-10	Obesity-related traits	
LIHC	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.44	7.64	2.17E-13	Educational attainment	
LIHC	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.45	7.75	1.06E-13	Educational attainment	
LIHC	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.74	16.06	1.05E-43	Migraine without aura	
LIHC	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.39	6.54	2.28E-10	Educational attainment	
LIHC	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.4	6.77	5.64E-11	Educational attainment	
LIHC	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.45	-7.95	2.69E-14	Educational attainment	
LIHC	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.45	7.68	1.66E-13	Educational attainment	
LIHC	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.4	6.87	2.97E-11	Educational attainment	
LIHC	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.45	7.68	1.66E-13	Educational attainment	
LIHC	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.39	6.54	2.28E-10	Educational attainment	
LIHC	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.43	7.59	3.0E-13	Educational attainment	
LIHC	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.45	7.68	1.66E-13	Educational attainment	
LIHC	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.41	6.98	1.56E-11	Educational attainment	
LIHC	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.44	7.61	2.63E-13	Educational attainment	
LIHC	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.44	7.61	2.63E-13	Educational attainment	
LIHC	trans	1	rs7500067	chr16:80648296	KIAA1539	chr9:35104120-35115893:-	-0.33	-5.87	1.05E-8	Breast cancer	
LIHC	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.43	7.52	4.8E-13	Educational attainment	
LIHC	trans	1	rs7957635	chr12:1985156	MRPL51	chr12:6601316-6602957:-	0.37	6.18	1.8E-9	QRS duration in Tripanosoma cruzi seropositivity	
LIHC	trans	1	rs919586	chr8:13174671	CHMP7	chr8:23101150-23119512:+	0.55	5.98	5.46E-9	Obesity-related traits	
LIHC	trans	1	rs919586	chr8:13174671	MCPH1	chr8:6264121-6506025:+	0.49	5.95	6.69E-9	Obesity-related traits	
LIHC	trans	1	rs919586	chr8:13174671	XPO7	chr8:21777180-21864095:+	0.46	6.17	1.89E-9	Obesity-related traits	
LIHC	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.41	-7.09	7.58E-12	Educational attainment	
LIHC	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.37	6.39	5.45E-10	Educational attainment	
LIHC	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.39	6.68	9.42E-11	Educational attainment	
LIHC	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.41	6.97	1.62E-11	Educational attainment	
LIHC	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.41	6.97	1.62E-11	Educational attainment	
LIHC	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.41	6.97	1.62E-11	Educational attainment	
LIHC	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.39	6.68	9.42E-11	Educational attainment	
LIHC	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.43	7.59	3.0E-13	Educational attainment	
LIHC	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.39	6.54	2.28E-10	Educational attainment	
LIHC	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.39	6.68	9.42E-11	Educational attainment	
LIHC	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.41	6.97	1.62E-11	Educational attainment	
LIHC	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.43	-7.43	8.58E-13	Educational attainment	
LIHC	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.4	6.91	2.43E-11	Educational attainment	
LIHC	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.41	7	1.34E-11	Educational attainment	
LIHC	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.43	7.59	3.0E-13	Educational attainment	
LIHC	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.47	-8.38	1.33E-15	Educational attainment	
LIHC	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.45	7.75	1.06E-13	Educational attainment	
LIHC	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.45	7.75	1.06E-13	Educational attainment	
LIHC	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.42	7.36	1.37E-12	Educational attainment	
